UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 20-F

 

REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of event requiring this shell company report ____________

 

For the transition period from ____________ to ____________

 

Commission File No.:  001-41523

 

Beamr Imaging Ltd.

(Exact name of registrant as specified in its charter)

 

Translation of registrant’s name into English: Not applicable

 

State of Israel  

10 HaManofim Street

Herzeliya, 4672561, Israel

Tel: +1-888-520-8735

(Jurisdiction of incorporation or organization)   (Address of principal executive offices)

 

Sharon Carmel

Chief Executive Officer

sharon@beamr.com

10 HaManofim Street

Herzeliya, 4672561, Israel

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be registered   Trading Symbol(s)   Name of each exchange on which each
class is to be registered
Ordinary shares, par value NIS 0.05 per share   BMR   Nasdaq Capital Market

 

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

 

 

 

 

Number of outstanding shares of each of the issuer’s classes of capital or common stock as of December 31, 2024: 15,518,794 ordinary shares.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes ☐  No

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act of 1934.

 

Yes ☐  No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months.

 

Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company.

 

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer
    Emerging Growth Company

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing.

 

U.S. GAAP

 

International Financial Reporting Standards as issued by the International Accounting Standards Board ☐

 

Other ☐

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

 

☐ Item 17  ☐ Item 18

 

If this is an annual report, indicate by check mark whether the registrant is a shell company.

 

Yes ☐  No

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page
INTRODUCTION iii
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS iv
INDUSTRY AND MARKET DATA vi
PRESENTATION OF FINANCIAL INFORMATION vi
EMERGING GROWTH COMPANY STATUS vi
TRADEMARKS AND TRADE NAMES vii
GLOSSARY OF INDUSTRY TERMS AND CONCEPTS vii
   
PART I   1
   
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 1
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 1
ITEM 3. KEY INFORMATION 1
A. Reserved 1
B. Capitalization and Indebtedness 1
C. Reasons for the Offer and Use of Proceeds 1
D. Risk Factors 1
ITEM 4. INFORMATION ON THE COMPANY 43
A. History and Development of the Company 43
B. Business Overview 45
C. Organizational Structure  64
D. Property, Plants and Equipment 64
ITEM 4A. UNRESOLVED STAFF COMMENTS 64
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 64
A. Operating Results 69
B. Liquidity and Capital Resources 71
C. Research and Development, Patents and Licenses 74
D. Trend Information 74
E. Critical Accounting Estimates 74
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 75
A. Directors and Senior Management 75
B. Compensation 77
C. Board Practices 79
D. Employees 93
E. Share Ownership 94
F. Disclosure of a registrant’s action to recover erroneously awarded compensation 97
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 97
A. Major Shareholders 97
B. Related Party Transactions 99
C. Interests of Experts and Counsel 100
ITEM 8. FINANCIAL INFORMATION 100
A. Consolidated Statements and Other Financial Information 100
B. Significant Changes 101

 

i

 

ITEM 9. THE OFFER AND LISTING 101
A. Offer and Listing Details 101
B. Plan of Distribution 101
C. Markets 101
D. Selling Shareholders 101
E. Dilution 101
F. Expenses of the Issue 101
ITEM 10. ADDITIONAL INFORMATION 101
A. Share Capital 101
B. Articles of Association 102
C. Material Contracts 102
D. Exchange Controls 102
E. Taxation 102
F. Dividends and Paying Agents 111
G. Statement by Experts 111
H. Documents on Display 111
I. Subsidiary Information 112
J. Annual Report to Security Holders 112
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 112
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 112
A. Debt Securities 112
B. Warrants and rights 112
C. Other Securities 112
D. American Depositary Shares 112
   
PART II   113
     
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 113
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 113
ITEM 15. CONTROLS AND PROCEDURES 113
ITEM 16. [RESERVED] 114
ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 114
ITEM 16B. CODE OF ETHICS 114
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 115
ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 115
ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 115
ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT 115
ITEM 16G. CORPORATE GOVERNANCE 115
ITEM 16H. MINE SAFETY DISCLOSURE 117
ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 117
ITEM 16J INSIDER TRADING POLICIES 118
ITEM 16K CYBERSECURITY 119
   
PART III   119
   
ITEM 17.   119
ITEM 18.   119
ITEM 19.   119
SIGNATURES 121

 

ii

 

INTRODUCTION

 

We are a leading innovator of video encoding, transcoding and optimization solutions that enable high-quality, high-performance, and unmatched bitrate efficiency for video and images. With our Emmy®-winning patented technology and award-winning services, we help our customers realize the potential of video encoding and media optimization to address business-critical challenges. Our customers include tier one over-the-top, or OTT, content distributors, video streaming platforms, and Hollywood studios who rely on our suite of products and expertise to reduce the cost and complexity associated with storing, distributing and monetizing video and images across devices.

 

At the heart of our patented optimization technology is the proprietary Beamr Quality Measure, or BQM, that is highly correlated with the human visual system. BQM is integrated into our Content Adaptive Bitrate, or CABR, system, which together maximizes quality and removes visual redundancies resulting in a smaller file size. The BQM has excellent correlation with subjective results, confirmed in testing under ITU BT.500, an international standard for rigorous testing of image quality. The perceptual quality preservation of CABR has been repeatedly verified using large scale crowd-sourcing based testing sessions, as well as by industry leaders and studio “golden eyes”.

 

We currently license two core video and image compression products that help our customers use video and images to further their businesses in meaningful ways: (1) a suite of video compression software encoder solutions including the Beamr 4 H.264 encoder, Beamr 4X H.264 content adaptive encoder, Beamr 5 HEVC encoder and the Beamr 5X HEVC content adaptive encoder and (2) Beamr JPEGmini photo optimization software solutions for reducing JPEG file sizes,

 

In February 2024, we launched Beamr Cloud, our video Software-as-a-Service, or SaaS, solution. It is a cloud based CABR solution, accelerated by NVIDIA graphics processing units, or GPUs. We launched Beamr Cloud, and are constantly exploring ways to improve it, to allow end-users from emerging markets to enjoy significant storage and networking cost savings, by 30%-50%. Our service also enables easy-to-use, efficient and scalable upgrade of video libraries to advanced video formats (codec modernization).

 

Our Cloud Video SaaS was initially operating over and integrated with Amazon Web Services, or AWS. In February 2025, Beamr Cloud also joined the AWS ISV Accelerate program, a global co-sell initiative for AWS partners, while demonstrating strong alignment with AWS’s go-to-market strategies and initiatives. Before that, in June 2024, Beamr Cloud achieved Powered by Expertise and became available in the Oracle Cloud Marketplace for Oracle Cloud Infrastructure, or OCI, customers, with plans to extend our services to other cloud platforms.

 

In July 2024, Beamr Cloud was integrated with its first AI capability to allow for automatic caption and transcription generation for videos in multiple languages. Since then, we have invested significant efforts in augmenting our service with more capabilities, to address the specific needs of customers in markets such as media and entertainment, user-generated content, autonomous vehicles, machine learning and more, all of which rely on video as a core component of their business operations and can benefit from our offering of GPU-accelerated, high-quality and AI-driven video pipelines, whether deployed via cloud platforms such as AWS and OCI, private cloud environments for enterprises, or on-premises infrastructure. During the second half of 2024, we incorporated additional customer feedback by enhancing Beamr Cloud’s core functionality, making it ready for adoption at scale, which includes giving users more control over the compression process using custom presets and adding packaging for streaming.

 

Upon listing of our ordinary shares in our initial public offering on February 28, 2023, we effected a reverse share spit at a ratio of 1-for-5. All share numbers in this Annual Report on Form 20-F have been retroactively adjusted and are reflected on a post-reverse share split basis. 

 

Unless the context requires otherwise, the terms “Beamr,” “we,” “us,” “our,” “the Company,” and similar designations refer to Beamr Imaging Ltd. and its wholly-owned subsidiary, Beamr, Inc. References to “ordinary shares”, “warrants” and “share capital” refer to our ordinary shares, warrants and share capital, respectively, of Beamr.

 

References to “U.S. dollars” and “$” are to currency of the United States of America, and references to “NIS” are to New Israeli Shekels. References to “ordinary shares” are to our ordinary shares, par value NIS 0.05 per share. We report financial information under generally accepted accounting principles in the United States of America or U.S. GAAP. 

 

iii

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain information included or incorporated by reference in this Annual Report on Form 20-F may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified.

 

These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition, expected capital needs and expenses, statements relating to the research, development, completion and use of our products, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.

 

Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.

 

Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among other things:

 

our business, development and operating goals and strategies and plans for the development of existing and new businesses, ability to implement such strategies and plans and expected time;

 

our future business development, financial condition and results of operations;

 

the commercialization and market acceptance of our current and future products;

 

expected changes in our revenues, costs or expenditures;

 

our expectations regarding demand for and market acceptance of our products and services;

 

our expectations regarding our relationships with customers, business partners and strategic partners;

 

our dependence on and the success of our strategic relationships with third parties and service providers;

 

the trends in, expected growth in and market size of the global image and video storage, video streaming, and public cloud video storage industries;

 

our estimates of, and future expectations regarding, our market opportunity;

 

our ability to maintain and enhance our market position;

  

our ability to attract customers, grow our retention rates, expand usage and sell subscription plans;

 

iv

 

our ability to continue to develop new technologies and/or upgrade our existing technologies;

 

our ability to ensure that our SaaS solution interoperates with a variety of software and hardware applications that are developed by third parties;

 

competitive environment and landscape and potential competitor behavior in our industry and the overall outlook in our industry;

 

our ability to maintain the security and availability of our products and solutions and to maintain privacy, data protection and cybersecurity;

 

our plans and ability to obtain or protect intellectual property rights, or to obtain, maintain, protect and enforce sufficiently broad intellectual property rights therein, including extensions of patent terms where available and our ability to avoid infringing the intellectual property rights of others;

 

the need to hire additional personnel and our ability to attract, train and retain such personnel;

 

our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;

 

the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our future development and operating expenses and capital expenditure requirements;

 

risks related to our international operations and our ability to expand our international business operations;

 

changes in applicable tax law, the stability of effective tax rates and adverse outcomes resulting from examination of our income or other tax returns;

 

the effects of currency exchange rate fluctuations on our results of operations;

 

risks related to unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk;

 

our ability to generate revenue and profit margin under our collaboration with third parties and anticipated contracts which is subject to certain risks; and

 

security, political and economic instability in the Middle East that could harm our business, including due to the current security situation in Israel.

 

those factors referred to in “Item 3.D. Risk Factors,” “Item 4. Information on the Company,” and “Item 5. Operating and Financial Review and Prospects”, as well as in this annual report on Form 20-F generally.

 

Readers are urged to carefully review and consider the various disclosures made throughout this Annual Report on Form 20-F which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

 

You should not put undue reliance on any forward-looking statements. Any forward-looking statements in this annual report on Form 20-F are made as of the date hereof and are expressly qualified in their entirety by the cautionary statements included in this Annual Report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

In addition, the section of this Annual Report on Form 20-F entitled “Item 4. Information on the Company” contains information obtained from independent industry sources and other sources that we have not independently verified.

 

v

 

INDUSTRY AND MARKET DATA

 

Market data and certain industry data and forecasts used throughout this Annual Report on Form 20-F were obtained from internal company surveys, market research, consultant surveys commissioned by the Company, publicly available information, reports of governmental agencies and industry publications and surveys. Industry surveys, publications, consultant surveys commissioned by the Company and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable. However, this information may prove to be inaccurate because of the method by which some of the data for the estimates is obtained or because this information cannot always be verified with complete certainty due to the limits on the availability and reliability of raw data, the voluntary nature of the data gathering process and other limitations and uncertainties. As a result, the market and industry data and forecasts included or incorporated by reference in this annual report, and estimates and beliefs based on that data, may not be reliable. We have relied on certain data from third-party sources, including internal surveys, industry forecasts and market research, which we believe to be reliable based on our management’s knowledge of the industry. However, we have not ascertained the underlying economic assumptions relied upon therein. Forecasts are particularly likely to be inaccurate, especially over long periods of time. In addition, we do not necessarily know what assumptions regarding general economic growth were used in preparing the forecasts we cite. Statements as to our market position are based to the best of our knowledge on the most currently available data. While we are not aware of any misstatements regarding the industry data presented in this annual report, our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the heading “Risk Factors” in this Annual Report.

 

Statements made in this Annual Report on Form 20-F concerning the contents of any agreement, contract or other document are summaries of such agreements, contracts or documents and are not a complete description of all of their terms. If we filed any of these agreements, contracts or documents as exhibits to this Report or to any previous filing with the Securities and Exchange Commission, or SEC, you may read the document itself for a complete understanding of its terms.

 

PRESENTATION OF FINANCIAL INFORMATION

 

Our financial statements were prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. We present our consolidated financial statements in U.S. dollars.

 

Our fiscal year ends on December 31 of each year. Our most recent fiscal year ended on December 31, 2024.

 

Certain figures included in this Annual Report have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables may not be an arithmetic aggregation of the figures that precede them.

 

EMERGING GROWTH COMPANY STATUS

 

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

 

vi

 

In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section 13(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, for complying with new or revised accounting standards. We have elected to opt out of this extended transition period and, as a result, we are required to comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. Under federal securities laws, our decision to opt out of the extended transition period is irrevocable.

 

We will remain an emerging growth company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues exceed $1.235 billion; (ii) the last day of the fiscal year following the fifth anniversary of the date of our initial public offering (i.e., December 31, 2028); (iii) the date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the aggregate worldwide market value of our ordinary shares, including ordinary shares represented by ADSs, held by non-affiliates is at least $700 million as of the last business day of our most recently completed second fiscal quarter; or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during any three-year period.

 

TRADEMARKS AND TRADE NAMES

 

We own or have rights to trademarks, service marks and trade names that we use in connection with the operation of our business, including our corporate name, logos and website names. Other trademarks, service marks and trade names appearing in this Annual Report are the property of their respective owners. Solely for convenience, some of the trademarks, service marks and trade names referred to in this Annual Report are listed without the ® and ™ symbols, but we will assert, to the fullest extent under applicable law, our rights to our trademarks, service marks and trade names.

 

GLOSSARY OF INDUSTRY TERMS AND CONCEPTS

 

The following is a list of certain industry terms and concepts that are used in this Annual Report:

 

AI” is the intelligence of machines or software, as opposed to the intelligence of other living beings, primarily of humans.

 

API” means application programming interface, which is a software intermediary that allows two applications to talk to each other.

  

AVC” means advanced video coding, also referred to as H.264 or MPEG-4 Part 10, which is a video compression standard based on block-oriented, motion-compensated integer-discrete cosine transform coding.

 

Beamr Cloud” means our cloud-based Beamr HW-Accelerated Content Adaptive Encoding SaaS solution that launched in February 2024.

 

BQM” means the proprietary Beamr quality measure which is an artificial intelligence trained computer vision processing architecture.

 

CABR” means content adaptive bitrate which refers to our technology combined with our BQM that uses a flexible computer vision engine programmed with a high level algorithm description to achieve maximal compression of the video input while maintaining the input video resolution, format, and visual quality.

 

Codec” means a device or computer program which encodes or decodes a data stream, bitstream or signal.

 

CPU” means central processing unit which is the electronic circuitry in a computer that executes instructions. 

 

vii

 

FPGA” means field-programmable gate array which is a hardware circuit that a user can program to carry out one or more logical operations.

 

Generative AI” means generative artificial intelligence, which is artificial intelligence capable of generating text, images, or other media, using generative models.

 

GPU” means graphics processing unit which is a specialized electronic circuit designed to rapidly manipulate and alter memory using parallel computations to accelerate the creation of images in a frame buffer intended for output to a display device.

 

HDR” means high dynamic range imaging which is the set of techniques used to reproduce a greater range of luminosity than that which is possible with standard photographic or video graphic techniques.

 

HEVC” means high efficiency video coding, also known as H.265 and MPEG-H Part 2, which is a video compression standard designed as part of the MPEG-H project as a successor to the widely used AVC standard.

 

HLG” means hybrid log-gamma, an HDR format that uses the HLG transfer function, BT.2020 color primaries and a bit depth of 10-bits.

 

JPEG” means joint photographic experts group which is a commonly used format for lossy compression for digital images, particularly for images produced by digital photography.

 

IoT” means Internet of Things, which describes devices with sensors, processing ability, software and other technologies that connect and exchange data with other devices and systems over the Internet or other communications networks.

 

ITU BT. 500” is an international standard for testing image quality.

 

ML” Machine learning is a field of study in artificial intelligence concerned with the development and study of statistical algorithms that can learn from data and generalize to unseen data, and thus perform tasks without explicit instructions.

 

OTT” means over-the-top which is a means of providing television and film content over the internet at the request and to suit the requirements of the individual consumer. Services like Netflix and Paramount are video OTT services.

 

PSNR” means peak signal to noise ratio which is a quality measure which represents the ratio between the highest power of an original signal and the power level of the distortion, on logarithmic scale.

 

SaaS” means software-as-a-service.

 

SSIM” means structural similarity index measure which is a technique to predict the perceived quality of digital images and videos.

 

UGC” means user-generated content which refers to any form of content, such as images, videos, text, and audio, that has been created or posted by users on online platforms.

 

VBR” means variable bit rate which relates to the bitrate used in sound or video encoding.

 

viii

 

PART I

 

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

 

Not applicable.

 

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

 

Not applicable.

 

ITEM 3. KEY INFORMATION

 

A. Reserved.

 

B. Capitalization and Indebtedness

 

Not applicable.

 

C. Reasons for the Offer and Use of Proceeds

 

Not applicable.

 

D. Risk Factors

 

You should carefully consider the risks described below, together with all of the other information in this Annual Report on Form 20-F. The risks and uncertainties described below are those significant risk factors, currently known and specific to us, that we believe are relevant to an investment in our securities. Additional risks and uncertainties not currently known to us or that we now deem immaterial may also harm us. If any of these risks materialize, our business, results of operations or financial condition could suffer, and the price of our ordinary shares could decline substantially.

 

Summary Risk Factors

 

Investing in our ordinary shares involves a high degree of risk, as fully described below. The principal factors and uncertainties that make investing in our ordinary shares risky, include, among others:

 

Risks Related to Our Business and Industry

 

We have a history of losses and may not be able to achieve or maintain profitability.

 

We will need to raise additional capital to meet our business requirements in the future, and such capital raising may be costly or difficult to obtain and could dilute our shareholders’ ownership interests.

 

To support our business growth we expanded our product offering to include the Beamr Cloud, a new SaaS solution, the development and commercialization of which may not be successful. This change in our products and services also makes it difficult to evaluate our current business and future prospects and may increase the risk that we will not be successful.

 

We may not be successful in establishing and maintaining strategic partnerships, which could adversely affect our ability to commercialize and further develop our SaaS solution and other future products.

 

Our future growth depends in part upon the successful deployment of the Beamr Cloud SaaS solution in the cloud.

 

The failure to effectively develop and expand our sales and marketing and research and development capabilities could harm our ability to increase our customer base and achieve broader market acceptance of our offerings.

 

Our business and operations have experienced growth, and if we do not appropriately manage this growth and any future growth, or if we are unable to improve our systems, processes and controls, our business, financial condition, results of operations and prospects will be adversely affected.

 

 1

 

 

The markets for our offerings are new and evolving and may develop more slowly or differently than we expect. Our future success depends on the growth and expansion of these markets and our ability to adapt and respond effectively to evolving market conditions.

 

Our results of operations are likely to fluctuate from quarter to quarter and year to year, which could adversely affect the trading price of our ordinary shares.

 

The loss of one or more of our significant customers, or any other reduction in the amount of revenue we derive from any such customer, would adversely affect our business, financial condition, results of operations and growth prospects.

 

If we are not able to keep pace with technological and competitive developments and develop or otherwise introduce new products and solutions and enhancements to our existing offerings, our offerings may become less marketable, less competitive or obsolete, and our business, financial condition and results of operations may be adversely affected.

 

If we are not able to maintain and expand our relationships with third-party technology partners to integrate our offerings with their products and solutions, our business, financial condition and results of operations may be adversely affected.

 

We may not be able to compete successfully against current and future competitors, some of whom have greater financial, technical, and other resources than we do. If we do not compete successfully, our business, financial condition and results of operations could be harmed.

 

We depend on our management team and other key employees, and the loss of one or more of these employees or an inability to attract and retain highly skilled employees could adversely affect our business.

 

Our international operations and expansion expose us to risk.

 

Currency exchange rate fluctuations affect our results of operations, as reported in our financial statements.

 

Our business, operating results and growth rates may be adversely affected by current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk.

  

Risks Related to Information Technology, Intellectual Property and Data Security and Privacy

 

A real or perceived bug, defect, security vulnerability, error, or other performance failure involving our products and services could cause us to lose revenue, damage our reputation, and expose us to liability.

 

If we or our third-party service providers experience a security breach, data loss or other compromise, including if unauthorized parties obtain access to our customers’ data, our reputation may be harmed, demand for our products and services may be reduced, and we may incur significant liabilities.

  

Insufficient investment in, or interruptions or performance problems associated with, our technology and infrastructure, including in connection with our Beamr Cloud, which is deployed on a public cloud infrastructure, and our reliance on technologies from third parties, may adversely affect our business operations and financial results.

 

Failure to protect our proprietary technology, or to obtain, maintain, protect and enforce sufficiently broad intellectual property rights therein, could substantially harm our business, financial condition and results of operations.

 

 2

 

 

We could incur substantial costs and otherwise suffer harm as a result of any claim of infringement, misappropriation or other violation of another party’s intellectual property or proprietary rights.

 

We could incur substantial costs and otherwise suffer harm as a result of patent royalty claims, in particular patents related to the implementation of image and video standards.

 

We rely on software and services licensed from other parties. The loss of software or services from third parties could increase our costs and limit the features available in our products and services.

 

Risks Related to Other Legal, Regulatory and Tax Matters

 

Changes in laws and regulations related to the internet or video standards, changes in the internet infrastructure itself, or increases in the cost of internet connectivity and network access may diminish the demand for our offerings and could harm our business.

 

Changes in U.S. and foreign tax laws could have a material adverse effect on our business, cash flow, results of operations or financial conditions.

 

Our corporate structure and intercompany arrangements are subject to the tax laws of various jurisdictions, and we could be obligated to pay additional taxes, which would adversely affect our results of operations.

 

Risks Related to Our Operations in Israel and Russia

 

Political, economic and military conditions in Israel could materially and adversely affect our business.

 

Russia’s invasion of Ukraine and sanctions brought against Russia could disrupt our software development operations in Russia.

 

Political, military conditions or other risks in Russia could adversely affect our business.

 

Risks Related to Ownership of our Ordinary Shares

 

The market price for our ordinary shares may be volatile or may decline regardless of our operating performance.

  

Our principal shareholders will continue to have significant influence over us.

 

Your ownership and voting power may be diluted by the issuance of additional shares of our ordinary shares in connection with financings, acquisitions, investments, our equity incentive plans or otherwise.

 

Our management team has limited experience managing a public company, and the requirements of being a public company may strain our resources, divert management’s attention, and affect our ability to attract and retain qualified board members.

 

We incur significant increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives.

 

If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, our shareholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our ordinary shares.

 

 3

 

 

Risks Related to Our Business and Industry

 

We have a history of losses and may not be able to achieve or maintain profitability.

 

We have incurred losses in each year since our incorporation in 2009, including net losses of $3.3 million, $0.7 million and $1.2 million in the years ended December 31, 2024, 2023 and 2022. As a result, we had an accumulated deficit of $35 million and $31.7 million as of December 31, 2024 and 2023, respectively. We intend to continue to expend substantial financial and other resources on, among other things:

 

extending our product leadership by investing in our video storage optimization products and services, and other recently introduced offerings, as well as by developing new products, expanding our platform into additional industries and enhancing our offerings with additional core capabilities and technologies;

 

sales and marketing expenses by hiring customer success personnel and investment in online marketing to attract new customers;

 

augmenting our current offerings by increasing the breadth of our technology partnerships and exploring potential transactions that may enhance our capabilities or increase the scope of our technology footprint; and

 

general administration, including legal, accounting, and other expenses related to our transition to being a new public company.

 

These efforts may prove more expensive than we currently anticipate, and we may not succeed in increasing our revenue sufficiently, or at all, to offset these higher expenses. In addition, to the extent we are successful in increasing our customer base, we may also incur increased losses because of unforeseen costs. If our revenue does not increase to offset our operating expenses, we will not achieve profitability in future periods and our net losses may increase. Revenue growth may slow or revenue may decline for a number of possible reasons, many of which are beyond our control, including inability to penetrate new markets, slowing demand for our products and services, increasing competition, or any of the other factors discussed in this Risk Factors section. Any failure to increase our revenue as we grow our business could prevent us from achieving profitability at all or on a consistent basis, which would cause our business, financial condition and results of operations to suffer and the market price of our ordinary shares to decline.

 

We will need to raise additional capital to meet our business requirements in the future, and such capital raising may be costly or difficult to obtain and could dilute our shareholders’ ownership interests.

 

In order for us to pursue our business objectives, we will need to raise additional capital, which additional capital may not be available on reasonable terms or at all. Any additional capital raised through the sale of equity or equity-backed securities may dilute our shareholders’ ownership percentages and could also result in a decrease in the market value of our equity securities. The terms of any securities issued by us in future capital transactions may be more favorable to new investors, and may include preferences, superior voting rights and the issuance of warrants or other derivative securities, which may have a further dilutive effect on the holders of any of our securities then outstanding. In addition, we may incur substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accounting fees, securities law compliance fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we issue, such as convertible notes and warrants, which may adversely impact our financial condition.

  

Our indebtedness could adversely affect our ability to raise additional capital to fund operations, limit our ability to react to changes in the economy or our industry and prevent us from meeting our financial obligations.

 

On July 7, 2022, we entered into a funding agreement with IBI Spikes, Ltd., or IBI, providing for a loan in the amount of NIS 3.1 million (approximately $0.9 million) and the issuance of 65,562 warrants to purchase ordinary shares. During 2024, we issued 31,189 ordinary shares to IBI upon cashless exercises of their warrants. As of December 31, 2024, the remaining loan to IBI was NIS 0.91 million (approximately $0.25 million). See “Item 5.B—Operating and Financial Review and Prospects—Liquidity and Resources—IBI Spikes Loan”.

 

 4

 

 

If we cannot generate sufficient cash flow from operations to service our debt, we may need to further refinance our debt, dispose of assets or issue additional equity to obtain necessary funds. We do not know whether we will be able to do any of this on a timely basis, on terms satisfactory to us, or at all. Our indebtedness could have important consequences, including: 

 

our ability to obtain additional debt or equity financing for working capital, capital expenditures, debt service requirements, acquisitions and general corporate or other purposes may be limited;

 

a portion of our cash flows from operations will be dedicated to the payment of principal and interest on the indebtedness and will not be available for other purposes, including operations, capital expenditures and future business opportunities;

 

our ability to adjust to changing market conditions may be limited and may place us at a competitive disadvantage compared to less-leveraged competitors; and

 

we may be vulnerable during a downturn in general economic conditions or in our business, or may be unable to carry on capital spending that is important to our growth.

 

To support our business growth we expanded our product offering to include the Beamr Cloud, a new SaaS solution, the further development and commercialization of which may not be successful. This change in our products and services also makes it difficult to evaluate our current business and future prospects and may increase the risk that we will not be successful.

 

Our current product line has up until recently been mainly geared to the high end, high quality media customers and we count among our customers Netflix, Paramount, Snapfish, Deluxe and other leading media companies using video and photo solutions.  This product line involves high cost and complexity of deploying our existing software solutions and the long sales lead times.

 

In order to grow our business, in 2019, we resolved to build a lower cost offering which requires hardware acceleration and started to integrate with hardware encoders. In the first quarter of 2020, we introduced our first proof of concept results with Intel’s GPU. Then, we made a strategic decision to focus our resources on the development and commercialization of our next-generation product, the Beamr Cloud, a SaaS solution that is designed, based on our own internal testing, to provide up to 10x cost-effective video optimization than existing solutions to an industry agnostic target market. In February 2024, we launched our SaaS solution, which was initially operating over and integrated with AWS. In February 2025, Beamr Cloud also joined the AWS ISV Accelerate program, a global co-sell initiative for AWS partners, while demonstrating strong alignment with AWS’s go-to-market strategies and initiatives. In June 2024, Beamr Cloud achieved Powered by Expertise and became available in the Oracle Cloud Marketplace for OCI customers, and in July 2024, Beamr Cloud was integrated with its first AI capability to allow for automatic caption and transcription generation for videos in multiple languages, with plans to offer additional features and capabilities and to extend to other cloud platforms. This change in strategy and these efforts may prove more expensive than we currently anticipate, or may require longer development and deployment times, and we may not succeed in further developing and commercializing our SaaS solution sufficiently, or at all.

  

We may not be successful in establishing and maintaining strategic partnerships, which could adversely affect our ability to commercialize and further develop our SaaS solution and other future products.

 

To successfully commercialize and further develop our SaaS solution and other product offerings, we will need substantial financial resources as well as expertise and physical resources and systems. We may elect to develop some or all of these physical resources and systems and expertise ourselves, or we may seek to collaborate with another company or companies that can provide some or all of such physical resources and systems as well as financial resources and expertise. For example, we are collaborating with NVIDIA, a leading developer of GPUs, in the development of our next generation product, the Beamr Cloud.

 

 5

 

 

We face significant competition in seeking appropriate partners for our products, and the negotiation process is time-consuming and complex. In order for us to successfully develop and commercialize our products with a strategic partner, potential partners must view our products as economically valuable in markets they determine to be attractive in light of the terms that we are seeking and other available products for licensing by other companies. Even if we are successful in our efforts to establish strategic partnerships, the terms that we agree upon may not be favorable to us, and we may not be able to maintain such strategic partnerships if, for example, development of a product is delayed or sales of a product are disappointing. Any delay in entering into strategic partnership agreements related to our products could delay the development and commercialization of our products and reduce their competitiveness even if they reach the market. If we fail to establish and maintain strategic partnerships related to our products, we will bear all of the risk and costs related to the development and commercialization of our products, and we will need to seek additional financing, hire additional employees and otherwise develop expertise which we do not have and for which we have not budgeted.

 

The risks in a strategic partnership include the following:

 

the strategic partner may not apply the expected financial resources, efforts, or required expertise in developing the physical resources and systems necessary to successfully develop and commercialize a product;

 

the strategic partner may not invest in the development of a sales and marketing force and the related infrastructure at levels that ensure that sales of the products reach their full potential;

 

we may be required to undertake the expenditure of substantial operational, financial, and management resources;

 

we may be required to issue equity securities that would dilute our existing shareholders’ percentage ownership;

 

we may be required to assume substantial actual or contingent liabilities;

 

strategic partners could decide to withdraw a development program or a collaboration, or move forward with a competing product developed either independently or in collaboration with others, including our competitors;

 

disputes may arise between us and a strategic partner that delay the development or commercialization or adversely affect the sales or profitability of the product; or

 

the strategic partner may independently develop, or develop with third parties, products that could compete with our products.

 

In addition, a strategic partner for one or more of our products may have the right to terminate the collaboration at its discretion. For example, our collaboration with NVIDIA is based on a mutual development program of our Beamr Cloud SaaS solution that launched in February 2024 and that has been approved at senior levels at NVIDIA. However, our collaboration has not been reduced to a written agreement and we have not signed any agreement with NVIDIA, which exposes us to the risk of termination of our collaboration at any time for any or no reason. Any early termination of our collaboration in a manner adverse to us could have a material adverse effect on our liquidity, financial condition and results of operations. Any termination may require us to seek a new strategic partner or partners, which we may not be able to do on a timely basis, if at all, or require us to delay or scale back our development and commercialization efforts. The occurrence of any of these events could adversely affect the development and commercialization of our products or product candidates and materially harm our business and share price by delaying the development of our products, and the sale of any products, by slowing the growth of such sales, by reducing the profitability of the product and/or by adversely affecting the reputation of the product.

 

 6

 

 

Further, a strategic partner may breach an agreement with us, and we may not be able to adequately protect our rights under these agreements. Furthermore, a strategic partner will likely negotiate for certain rights to control decisions regarding the development and commercialization of our products and may not conduct those activities in the same manner as we would do so.

 

Our future growth depends in part upon the successful deployment of the Beamr Cloud SaaS solution in the cloud.

 

Until recently, our current business was based on software licensing and is not capital intensive, usually paid for by our customers upfront on an annual basis. Our new product offering, the Cloud, a SaaS solution, which has been deployed on AWS and Oracle, and we plan to continue to be deploy on additional cloud platforms (e.g., Azure, and Google Cloud Platform or GCP) and is a volume-based solutions. Future payments that we will make to cloud platforms and payments we will receive from customers are hard to predict and will be based on different terms and conditions. We may also be at risk if there will be gaps between account receivables and account payables. In addition, attracting new customers to our SaaS offering may involve evaluation processes that prospects may not be willing to cover before experiencing satisfying results with our products and services, while we will continue to accrue cloud platform service costs.

 

Our SaaS operation is initially based on spreads in which we first pay for computing platforms (e.g. GPU instances), and then we sell storage/bandwidth savings (e.g., AWS S3, CloudFront). Any future margins may be at risk if computing platform costs increase and storage/bandwidth costs decrease. In addition, our ability to grow and maintain customer base and revenue also depends on achieving significant storage/bitrate savings, translating into superior total cost of ownership and return on investment for our customers. While we believe that the Beamr Cloud will result in significant savings for our customers, there is a risk that our savings for the customers might not be significant.

 

There is a risk that we may not win customers that moved their long-tail assets to cold, or off-line storage services (e.g., Amazon S3 Glacier) for reduced storage costs. In addition, improvements in general encoding solutions that are based on “content-adaptive” or “content-aware” technologies may reduce the savings which our products and services can provide. Moreover, if the public cloud data services that utilize NVIDIA GPUs (e.g., Amazon, GCP, Azure, OCI) do not adopt, or take significant time to adopt, the Nvidia driver and firmware with our new capabilities, that could adversely affect our market penetration and future revenue growth.

 

We believe any future revenue growth will depend on a number of factors, including, among other things, our ability to:

 

continually enhance and improve our products and services, including the features, integrations and capabilities we offer, and develop or otherwise introduce new products and solutions;

 

attract new customers and maintain our relationships with, and increase revenue from, our existing customers;

 

provide excellent customer and end user experiences;

 

maintain the security and reliability of our products and services;

 

introduce and grow adoption of our offerings in new markets outside the United States;

 

hire, integrate, train and retain skilled personnel;

 

adequately expand our sales and marketing force and distribution channels;

 

obtain, maintain, protect and enforce intellectual property protection for our platform and technologies;

 

 7

 

 

expand into new technologies, industries and use cases;

 

expand and maintain our partner ecosystem;

 

comply with existing and new applicable laws and regulations, including those related to data privacy and security;

 

price our offerings effectively and determine appropriate contract terms;

 

determine the most appropriate investments for our limited resources;

 

successfully compete against established companies and new market entrants; and

 

increase awareness of our brand on a global basis.

 

If we are unable to accomplish any of these objectives, any revenue growth will be impaired. Many factors may contribute to declines in growth rate, including increased competition, slowing demand for our offerings, a failure by us to continue capitalizing on growth opportunities, the maturation of our business, and global economic downturns, among others. If our growth rate declines as a result of this or any of the other factors described above, investors’ perceptions of our business and the market price of our ordinary shares could be adversely affected.

 

Our ability to forecast our future results of operations is subject to a number of uncertainties, including our ability to effectively plan for and model future growth. We have encountered in the past, and may encounter in the future, risks and uncertainties frequently experienced by growing companies in rapidly changing industries that may prevent us from achieving the objectives outlined herein. If we fail to achieve the necessary level of efficiency in our organization as it grows, or if we are not able to accurately forecast future growth, our business would be adversely affected. Moreover, if the assumptions that we use to plan our business are incorrect or change in reaction to changes in our market, or if we are unable to maintain consistent revenue or revenue growth, the market price of our ordinary shares could be volatile, and it may be difficult to achieve and maintain profitability.

  

The failure to effectively develop and expand our sales and marketing and research and development capabilities could harm our ability to increase our customer base and achieve broader market acceptance of our offerings.

 

Our ability to increase our customer base and achieve broader market acceptance of our products and services and in particular the Beamr Cloud will depend to a significant extent on our ability to expand our sales and marketing operations, including costs inherent to acquiring new customers, and invest in further research and development efforts to add new features and capabilities. As part of our growth strategy, we plan to dedicate significant resources to our marketing programs. All of these efforts will require us to invest significant financial and other resources. Our business will be harmed if our efforts do not generate a correspondingly significant increase in revenue. 

 

Our business and operations have experienced growth, and if we do not appropriately manage this growth and any future growth, or if we are unable to improve our systems, processes and controls, our business, financial condition, results of operations and prospects will be adversely affected.

 

We plan to make continued investments in the growth and expansion of our business and customer base including in particular substantial investment of resources in the commercialization and future development of our next-generation product, the Beamr Cloud SaaS solution, which we launched in February 2024. The growth and expansion of our business places a continuous and significant strain on our management, operational, financial and other resources. In addition, as customers adopt our offerings for an increasing number of use cases, we have had to support more complex commercial relationships. In order to manage our growth effectively, we must continue to improve and expand our information technology and financial infrastructure, our security and compliance requirements, our operating and administrative systems, our customer service and support capabilities, our relationships with various partners and other third parties, and our ability to manage headcount and processes in an efficient manner.

 

 8

 

 

We may not be able to sustain the pace of improvements to our products and services, or the development and introduction of new offerings, successfully, or implement systems, processes, and controls in an efficient or timely manner or in a manner that does not negatively affect our results of operations. Our failure to improve our systems, processes, and controls, or their failure to operate in the intended manner, may result in our inability to manage the growth of our business and to forecast our revenue, expenses, and earnings accurately, or to prevent losses.

 

As we continue to expand our business and operate as a public company, we may find it difficult to maintain our corporate culture while managing our employee growth. Any failure to manage our anticipated growth and related organizational changes in a manner that preserves our culture could negatively impact future growth and achievement of our business objectives. Additionally, our productivity and the quality of our offerings may be adversely affected if we do not integrate and train our new employees quickly and effectively. Failure to manage our growth to date and any future growth effectively could result in increased costs, negatively affect customer satisfaction and adversely affect our business, financial condition, results of operations and growth prospects.

 

The markets for our offerings are new and evolving and may develop more slowly or differently than we expect. Our future success depends on the growth and expansion of these markets and our ability to adapt and respond effectively to evolving market conditions.

 

The markets in which we operate, in particular the video storage market, are relatively new and rapidly evolving. Accordingly, it is difficult to predict customer adoption, renewals and demand, the entry of new competitive products, the success of existing competitive products, and the future growth rate, expansion, longevity, and size of the markets for our products and services. The expansion of these new and evolving markets depends on a number of factors, including the cost, performance, and perceived value associated with the technologies that we and others in our industry develop. If we or other companies in our industry experience security incidents, loss of customer data, or disruptions in delivery or service, the market for these applications as a whole, including the demand for our offerings, may be negatively affected. If video products and solutions such as ours do not continue to achieve market acceptance, or there is a reduction in demand caused by decreased customer acceptance, technological challenges, weakening economic conditions, privacy, data protection and data security concerns, governmental regulation, competing technologies and products, or decreases in information technology spending or otherwise, the market for our offerings might not continue to develop or might develop more slowly than we expect, which could adversely affect our business, financial condition, results of operations and growth prospects.

  

Our results of operations are likely to fluctuate from quarter to quarter and year to year, which could adversely affect the trading price of our ordinary shares.

 

Our results of operations, including our revenue, cost of revenue, gross margin, operating expenses, cash flow, and deferred revenue, have fluctuated from quarter to quarter and year to year in the past and may continue to vary significantly in the future so that period-to-period comparisons of our results of operations may not be meaningful. In addition, our future cloud-based SaaS revenues will have lower gross margins than our legacy software licensing revenues due to the associated cloud costs for processing. Accordingly, our financial results in any one quarter should not be relied upon as indicative of future performance. Our quarterly financial results may fluctuate as a result of a variety of factors, many of which are outside of our control, may be difficult to predict, and may not fully reflect the underlying performance of our business. Factors that may cause fluctuations in our quarterly financial results include:

 

our ability to attract new customers and increase revenue from our existing customers;

 

the loss of existing customers;

 

customer satisfaction with our products, solutions, platform capabilities and customer support;

 

the commercialization and market acceptance of our current and future products;

  

mergers and acquisitions or other factors resulting in the consolidation of our customer base;

 

 9

 

 

mix of our revenue;

 

our ability to gain new partners and retain existing partners;

 

fluctuations in share-based compensation expense;

 

decisions by potential customers to purchase competing offerings or develop in-house technologies and solutions as alternatives to our offerings;

 

changes in the spending patterns of our customers;

 

the amount and timing of operating expenses related to the maintenance and expansion of our business and operations, including investments in research and development, sales and marketing, and general and administrative resources;

 

network outages;

 

developments or disputes concerning our intellectual property or proprietary rights, our products and services, or third-party intellectual property or proprietary rights;

 

negative publicity about our company, our offerings or our partners, including as a result of actual or perceived breaches of, or failures relating to, privacy, data protection or data security;

 

the timing of expenses related to the development or acquisition of technologies or businesses and potential future charges for impairment of goodwill from acquired companies;

 

general economic, industry, and market conditions;

 

the impact any pandemic, epidemic, outbreak of infectious disease or other global health crises on our business, the businesses of our customers and partners and general economic conditions;

 

the impact of political uncertainty or unrest;

 

changes in our pricing policies or those of our competitors;

  

fluctuations in the growth rate of the markets that our offerings address;

 

seasonality in the underlying businesses of our customers, including budgeting cycles, purchasing practices and usage patterns;

 

the business strengths or weakness of our customers;

 

our ability to collect timely on invoices or receivables;

 

the cost and potential outcomes of future litigation or other disputes;

 

future accounting pronouncements or changes in our accounting policies;

 

our overall effective tax rate, including impacts caused by any reorganization in our corporate tax structure and any new legislation or regulatory developments;

 

our ability to successfully expand our business in the United States and internationally;

  

fluctuations in foreign currency exchange rates; and

 

the timing and success of new products and solutions introduced by us or our competitors, or any other change in the competitive dynamics of our industry, including consolidation among competitors, customers or partners.

 

 10

 

 

In particular, our cost of revenue is generally higher in periods during which we acquire new customers.

 

The impact of one or more of the foregoing or other factors may cause our results of operations to vary significantly. Such fluctuations make forecasting more difficult and could cause us to fail to meet the expectations of investors and securities analysts, which could cause the trading price of our ordinary shares to fall substantially, resulting in the loss of all or part of your investment, and subject us to costly lawsuits, including securities class action suits.

 

The loss of one or more of our significant customers, or any other reduction in the amount of revenue we derive from any such customer, would adversely affect our business, financial condition, results of operations and growth prospects.

 

Our future success is dependent on our ability to establish and maintain successful relationships with a diverse set of customers. We currently derive a significant portion of our revenue from a limited number of our customers. For the years ended December 31, 2024 2023 and 2022, our top ten customers in the aggregate accounted for approximately 68%, 67% and 61% of our revenues, respectively.

 

Until we can derive significant revenue from the Beamr Cloud, we expect to continue to derive a significant portion of our revenue from a limited number of customers in the future and, in some cases, the portion of our revenue attributable to individual customers may increase. The loss of one or more significant customers or a reduction in the amount of revenue we derive from any such customer could significantly and adversely affect our business, financial condition and results of operations. Customers may choose not to renew their contracts or may otherwise reduce the breadth of the offerings which they purchase for any number of reasons. We are also subject to the risk that any such customer will experience financial difficulties that prevent them from making payments to us on a timely basis or at all.

 

If we are not able to keep pace with technological and competitive developments and develop or otherwise introduce new products and solutions and enhancements to our existing offerings, our offerings may become less marketable, less competitive or obsolete, and our business, financial condition and results of operations may be adversely affected.

 

The markets in which we compete are characterized by rapid technological change, frequent introductions of new products, services, features and capabilities, and evolving industry standards and regulatory requirements. Our ability to grow our customer base and increase our revenue will depend in significant part on our ability to develop or otherwise introduce new products and solutions; develop or otherwise introduce new features, integrations, capabilities and other enhancements to our existing offerings on a timely basis; and interoperate across an increasing range of devices, operating systems and third-party applications. The success of any new products or solutions, or enhancements to our existing offerings, will depend on a number of factors including, but not limited to, the timeliness and effectiveness of our research and product development activities and go-to-market strategy, our ability to anticipate customer needs and achieve market acceptance, our ability to manage the risks associated with new product releases, the effective management of development and other spending in connection with the product development process, and the availability of other newly developed products and technologies by our competitors.

  

In addition, in connection with our product development efforts, we may introduce significant changes to our existing products or solutions, or develop or otherwise introduce new and unproven products or solutions, including technologies with which we have little or no prior development or operating experience. These new products, solutions and updates may not perform as expected, may fail to engage our customer base or other end users of our products, or may otherwise create a lag in adoption of such new products. New products may initially suffer from performance and quality issues that may negatively impact our ability to market and sell such products to new and existing customers. We have in the past experienced bugs, errors, or other defects or deficiencies in new products and product updates and delays in releasing new products, deployment options, and product enhancements and may have similar experiences in the future. As a result, some of our customers may either defer purchasing our offerings until the next upgrade is released or switch to a competitor if we are not able to keep up with technological developments. To keep pace with technological and competitive developments we have in the past invested, and may in the future invest, in the acquisition of complementary businesses, technologies, services, products, and other assets that expand our offerings. We may make these investments without being certain that they will result in products or enhancements that will be accepted by existing or prospective customers or that will achieve market acceptance. The short- and long-term impact of any major change to our offerings, or the introduction of new products or solutions, is particularly difficult to predict. If new or enhanced offerings fail to engage our customer base or other end users of our products, or do not perform as expected, we may fail to generate sufficient revenue, operating margin, or other value to justify our investments in such products, any of which may adversely affect our reputation and negatively affect our business in the short-term, long-term, or both. If we are unable to successfully enhance our existing offerings to meet evolving customer requirements, increase adoption and use cases of our offerings, develop or otherwise introduce new products and solutions and quickly resolve security vulnerabilities or other errors or defects, or if our efforts in any of these areas are more expensive than we expect, our business, financial condition and results of operations would be adversely affected.

 

 11

 

 

If we are not able to maintain and expand our relationships with third-party technology partners to integrate our offerings with their products and solutions, our business, financial condition and results of operations may be adversely affected.

 

Our success depends in part on our ability to integrate our products and services with a variety of network, hardware and software platforms, and we need to continuously modify and enhance our offerings to adapt to changes in hardware, software, networking, browser and database technologies. Third-party products and services are constantly evolving, and we may not be able to modify our offerings to ensure their compatibility with those of other third parties following development changes. Any losses or shifts in the market position of the providers of these third-party products and services could require us to identify and develop integrations with new third-party technologies. Such changes could consume substantial resources and may not be effective. Any expansion into new geographies may also require us to integrate our offerings with new third-party technologies, products and services and invest in developing new relationships with these providers. If we are unable to respond to changes in a cost-effective manner, our offerings may become less marketable, less competitive, or obsolete, and our business, financial condition and results of operations may be negatively impacted.

 

In addition, a significant percentage of our customers may choose to integrate our products and services with certain capabilities of third-party hardware and software providers using APIs. The functionality and popularity of our products and services may depend, in part, on their ability to integrate with a wide variety of third-party applications and software. Third-party providers of applications may change the features of their applications and software, restrict our access to their applications and software or alter the terms governing use of their applications and access to those applications and software in an adverse manner. Such changes could functionally limit or eliminate our ability to use these third-party applications and software in conjunction with our offerings, which could negatively impact customer demand, our competitive position and adversely affect our business.

 

We may not be able to compete successfully against current and future competitors, some of whom have greater financial, technical, and other resources than we do. If we do not compete successfully, our business, financial condition and results of operations could be harmed.

 

While there are several companies offering video compression solutions such as MainConcept, Ateme, Visionular and open source (x264/x265), we believe there is currently no direct competitor with our content-adaptive video compression solutions. There are companies that offer software solutions for video optimization such as Harmonic and Elemental, and other companies offering storage optimization (but not involving video technologies) such as EMC and Seagate. In addition, for our quality measure, some of our current competitors include SSIMWave (SSIMPlus), Apple (AVQT), Google (YouVQ) and open source (VMAF). We operate in a highly specialized area that is evolving very quickly with rapid developments. In the future, competitors could develop products or solutions that compete with our video compression solutions. For example, the public cloud platforms such as AWS, Azure, OCI, and GCP could in the future develop their own video optimization hardware accelerated solutions.

 

 12

 

 

We believe the following competitive attributes are necessary for our solutions to successfully compete in the video compression market:

 

the performance and reliability of our solutions;

 

cost of deployment and return on investment in terms of cost savings;

 

sophistication, novel and innovative intellectual property and technology, and functionality of our offerings;

 

cross-platform operability;

 

security;

 

ease of implementation and use of service;

 

high quality customer support; and

 

price.

 

We believe that we compare favorably on the basis of the factors listed above. However, many of our competitors have substantially greater financial, technical, and marketing resources; relationships with large vendor partners; larger global presence; larger customer bases; longer operating histories; greater brand recognition; and more established relationships in the industry than we do. Furthermore, new entrants not currently considered to be competitors may enter the market through acquisitions, partnerships, or strategic relationships. 

 

Additionally, we compete with home-grown, start-up, and open source technologies across the categories described above. With the introduction of new technologies and the entrance of new market participants, competition has intensified, and we expect it to continue to intensify in the future. Established companies are also developing their own video encoding and optimization platforms, products and solutions within their own core product lines, and may continue to do so in the future. Established companies may also acquire or establish product integration, distribution or other cooperative relationships with our current competitors. New competitors or alliances among competitors may emerge from time to time and rapidly acquire significant market share due to various factors such as their greater brand name recognition, larger existing user or customer base, consumer preferences for their offerings, a larger or more effective sales organization and greater financial, technical, marketing and other resources and experience. Furthermore, with the recent increase in large merger and acquisition transactions in the technology industry, particularly transactions involving cloud-based technologies, there is a greater likelihood that we will compete with other larger technology companies in the future. Companies resulting from these potential consolidations may create more compelling product offerings and be able to offer more attractive pricing options, making it more difficult for us to compete effectively. 

 

Many of our competitors have, and some of our potential competitors may have, greater financial, technical, and other resources, longer operating histories, greater brand recognition, larger sales forces and marketing budgets, broader distribution networks, more diverse product and services offerings, larger and more mature intellectual property portfolios, more established relationships in the industry and with customers, lower cost structures and greater customer experience resources. These competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards and customer requirements. They may be able to leverage these resources to gain business in a manner that discourages customers from purchasing our offerings, including through selling at zero or negative margins, product bundling, forced product migrations, auto-installation of applications, or closed technology platforms. Potential customers may also prefer to purchase from companies with which they have an existing relationship rather than a new supplier, regardless of product performance or features. Furthermore, we expect that our industry will continue to attract new companies, including smaller emerging companies, which could introduce new offerings. We may also expand into new markets and encounter additional competitors in such markets. These competitive pressures in the markets in which we operate, or our failure to compete effectively, may result in price reductions, fewer customers, reduced revenue, gross profit and gross margins, increased net losses and loss of market share. Any failure to effectively address these factors could significantly and adversely affect our business, financial condition and results of operations.

 

 13

 

 

If we are unable to increase sales of our products and services to new customers, expand the offerings to which our existing customers subscribe, or expand the value of our existing sales, our future revenue and results of operations will be adversely affected.

 

Our success depends on our ability to sell our products and services to new customers and to expand within our existing customer base by selling products and services for additional offerings to our existing customers and expanding the value of existing customers’ subscriptions, and to do so in a cost-effective manner. Our ability to sell new products and services and expand the value of existing sales depends on a number of factors, including the prices of our offerings and their functionality, the prices of products offered by our competitors, and the budgets of our customers. We also plan to offer an initial trial period for certain of our offerings. To the extent prospective customers utilize this trial period without becoming, or lead others not to become, paying customers, our expenses may increase as a result of associated hosting costs, and our ability to grow our business may be adversely affected. There is no guarantee that such events will translate into new customers.

 

In addition, a significant aspect of our sales and marketing focus is to expand deployments within existing customers. The rate at which our customers purchase additional offerings and expand the value of their existing offerings depends on a number of factors, including, among other things, customers’ level of satisfaction with our offerings and customer support, the nature and size of the deployments, the desire to address additional use cases, and the availability of, and customers’ awareness of and perceived need for, additional features, integrations, capabilities or other enhancements, as well as general economic conditions. If our customers do not recognize the potential of our offerings, our business would be materially and adversely affected.

 

If our existing customers do not renew their order of products or subscription to services, or if they renew on terms that are less economically beneficial to us, it could have an adverse effect on our business, financial condition and results of operations.

 

We expect to derive a significant portion of our revenue from renewals of subscriptions. Customers have no contractual obligation to renew their subscriptions after the completion of their subscription term. Subscriptions for most of our offerings are offered on either an annual or multi-year basis. Our subscriptions may also generally include committed usage amounts. As a result, we cannot provide assurance that customers will renew their subscriptions for a similar contract period or with the same or greater product depth, number of users, functionality or other terms that are equally or more economically beneficial to us, if they renew at all.

 

Our customers’ renewals may decline or fluctuate as a result of a number of factors, including their satisfaction with our products and our customer support, the frequency and severity of product outages, our product uptime or latency, the pricing of our offering in relation to competing offerings, additional new features, integrations, capabilities or other enhancements that we offer, updates to our products as a result of updates by technology partners, and customers or users no longer having a need for our offerings. Renewal rates may also be impacted by general economic conditions or other factors that reduce customers’ spending levels. If our customers do not renew their subscriptions or renew on terms less economically favorable to us, our revenue may decline or grow less quickly than anticipated, which would adversely affect our business, financial condition and results of operations.

 

If we fail to meet contractual commitments under our customer agreements, we could be subject to contractual penalties, litigation and other liabilities, and could experience an increase in contract terminations or decrease in contract renewals in future periods, which would lower our revenue, increase our costs and otherwise adversely affect our business, financial condition and results of operations.

 

Our customer agreements may contain service-level commitments. If we are unable to meet the stated service-level commitments, including failure to meet the uptime and response time requirements under our customer agreements, we may be contractually obligated to provide these customers with service credits, or customers could elect to terminate and receive refunds for prepaid amounts related to unused subscriptions, either of which could significantly affect our revenue in the periods in which the failure occurs and the credits are applied or refunds paid out. In addition, customer terminations or any reduction in renewals resulting from service-level failures could significantly affect both our current and future revenue. We cannot guarantee that we will not experience a material decrease in customer renewals in future periods as additional customers cycle through their subscription terms.

 

 14

 

 

Furthermore, any service-level failures or failure to meet committed delivery schedules and milestones could also create negative publicity and damage our reputation, which may discourage prospective customers from adopting our offerings. In addition, if we modify the terms of our contractual commitments in future customer agreements in a manner customers perceive to be unfavorable, demand for our offerings could be reduced. The occurrence of these or any of the events discussed above could have a significant adverse effect on our business, financial condition, results of operations and cash flow, as well as our ability to grow our business.

 

We rely on third parties, including third parties outside the United States, for some of our software development, quality assurance, operations, and customer support.

 

We currently depend on various third parties for some of our software development efforts, quality assurance, operations, and customer support services. Our dependence on third-parties creates a number of risks, in particular, (i) the risk that we may not maintain development quality, control, or effective management with respect to these business operations; (ii) such third parties may not perform to our standards or legal requirements; (iii) such third parties may not produce reliable results; (iv) such third parties may not perform in a timely manner; (v) such third parties may not maintain confidentiality of our proprietary information; (vi) disputes may arise with respect to ownership of rights to technology developed with our partners; and (vii) disagreements could cause delays in, or termination of, the research, development or commercialization of our products or result in litigation or arbitration.

 

Moreover, some third parties are located in markets subject to political and social risk, corruption, violence, infrastructure problems and natural disasters, in addition to country-specific privacy and data security risk given current legal and regulatory environments. Failure of third parties to meet their contractual, regulatory, and other obligations may materially affect our business.

 

We anticipate that we will continue to depend on these and other third-party relationships in order to grow our business for the foreseeable future. If we are unsuccessful in maintaining existing and, if needed, establishing new relationships with third parties, our ability to efficiently operate existing services or develop new services and provide adequate customer support could be impaired, and, as a result, our competitive position or our results of operations could suffer.

 

 We depend on our management team and other key employees, and the loss of one or more of these employees or an inability to attract and retain highly skilled employees could adversely affect our business.

 

Our future success depends, in part, on our ability to continue to attract and retain highly skilled personnel. The loss of the services of any of our key personnel, the inability to attract or retain qualified personnel, or delays in hiring required personnel, particularly in engineering and sales, may seriously and adversely affect our business, financial condition and results of operations. Although we have entered into employment or consulting agreements with our personnel, their employment is generally for no specific duration. We are also substantially dependent on the continued service of our existing IT personnel because of the complexity of our products.

 

Our future performance also depends on the continued services and continuing contributions of our senior management team, which includes Sharon Carmel, our founder and Chief Executive Officer, to execute on our business plan and to identify and pursue new opportunities and product innovations. The loss of services of our senior management team, particularly our Chief Executive Officer, could significantly delay or prevent the achievement of our development and strategic objectives, which could adversely affect our business, financial condition and results of operations.

 

 15

 

 

Additionally, the industry in which we operate is generally characterized by significant competition for skilled personnel, as well as high employee attrition. There is currently a high demand for experienced software industry personnel, particularly for engineering, research and development, sales and support positions, and we may not be successful in attracting, integrating and retaining qualified personnel to fulfill our current and future needs. This intense competition has resulted in increasing wages, especially in Israel, where our headquarters is located and most of our research and development positions are located, and in California, where our sales offices are located, which may make it more difficult for us to attract and retain qualified personnel, as many of the companies against which we compete for personnel have greater financial resources than we do. These competitors may also actively seek to hire our existing personnel away from us, even if such employee has entered into a non-compete agreement. We may be unable to enforce these agreements under the laws of the jurisdictions in which our employees work. For example, Israeli labor courts have required employers seeking to enforce non-compete undertakings of a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material interests of the employer that have been recognized by the courts, such as the protection of a company’s confidential information or other intellectual property, taking into account, among other things, the employee’s tenure, position, and the degree to which the non-compete undertaking limits the employee’s freedom of occupation. We may not be able to make such a demonstration. Also, to the extent we hire personnel from competitors, we may be subject to allegations that they have been improperly solicited or that they have divulged their former employers’ proprietary or other confidential information or incorporated such information into our products, which could include claims that such former employers therefore own or otherwise have rights to their inventions or other work product developed while employed by us.

  

In addition, in making employment decisions, particularly in the internet and high-technology industries, job candidates often consider the value of the equity they are to receive in connection with their employment. Employees may be more likely to leave us if the shares they own or the shares underlying their equity incentive awards have significantly appreciated or significantly reduced in value. Many of our employees may receive significant proceeds from sales of our equity in the public markets, which may reduce their motivation to continue to work for us and could lead to employee attrition. If we fail to attract new personnel, or fail to retain and motivate our current personnel, our business, financial condition, results of operations and growth prospects could be adversely affected.

 

If we are not able to maintain and enhance awareness of our brand, especially among companies who store large amounts of video files, our business, financial condition and results of operations may be adversely affected.

 

We believe that developing and maintaining widespread awareness of our brand, especially with companies who store large amounts of video files, is critical to achieving widespread acceptance of our products and services and attracting new users and customers. Brand promotion activities may not generate user or customer awareness or increase revenue, and even if they do, any increase in revenue may not offset the expenses we incur in building our brand. If we fail to successfully promote and maintain our brand, we may fail to attract and retain users and customers necessary to realize a sufficient return on our brand-building efforts, and may fail to achieve the widespread brand awareness that is critical for broad customer adoption of our offerings.

  

Our corporate culture has contributed to our success, and if we cannot maintain this culture as we grow, we could lose the innovation, creativity, and entrepreneurial spirit we have worked to foster, which could adversely affect our business.

 

We believe that our corporate culture, which is based on openness, flexibility, and collaboration, has been and will continue to be a key contributor to our success. We expect to hire aggressively as we expand. If we do not continue to maintain our corporate culture as we grow, we may be unable to foster the innovation, creativity, and entrepreneurial spirit we believe we need to support our growth. The growth and expansion of our business and our transition from a private company to a public company may result in changes to our corporate culture, which could adversely affect our business, including our ability to recruit and retain qualified personnel.

 

Our failure to offer high quality customer support would have an adverse effect on our business, reputation and results of operations.

 

Our customers depend on our customer success managers to resolve issues and realize the full benefits relating to our products and services. If we do not succeed in helping our customers quickly resolve post-deployment issues or provide effective ongoing support and education, our ability to renew contracts with, or establish contracts for additional offerings to, existing customers, or expand the value of existing customers’ contracts, would be adversely affected and our reputation with potential customers could be damaged. In addition, most of our existing customers are large enterprises with complex information technology environments and, as a result, require significant levels of support. If we fail to meet the requirements of these customers, it may be more difficult to grow sales or maintain our relationships with them.

 

 16

 

 

Additionally, while growing our need for customer success managers is a key component of our growth strategy, it can take several months to recruit, hire and train qualified engineering-level customer support employees, and we may not be able to hire such resources fast enough to keep up with demand during the relevant time in the future. To the extent that we are unsuccessful in hiring, training and retaining adequate support resources, our ability to provide adequate and timely support to our customers, and our customers’ satisfaction with our products and services, will be adversely affected. Any failure by us to provide and maintain high-quality customer support services would have an adverse effect on our business, reputation and results of operations.

  

The sales prices of our offerings may change, which may reduce our revenue and gross profit and adversely affect our financial results.

 

The sales prices for our offerings may be subject to change for a variety of reasons, including competitive pricing pressures, discounts, anticipation of the introduction of new products, promotional programs, general economic conditions, or our marketing, user acquisition and technology costs and, as a result, we anticipate that we will need to change our pricing model from time to time. In the past, we have sometimes adjusted our prices for individual customers in certain situations, and expect to continue to do so in the future. Moreover, demand for our offerings is price-sensitive. Competition continues to increase in the market segments in which we operate, and we expect competition to further increase in the future, thereby leading to increased pricing pressures. Larger competitors with more diverse offerings may reduce the price of offerings that compete with ours or may bundle them with other offerings and provide for free. Similarly, certain competitors may use marketing strategies that enable them to acquire customers more rapidly or at a lower cost than us, or both, and we may be unable to attract new customers or grow and retain our customer base based on our historical pricing. Additionally, currency fluctuations in certain countries and regions may negatively impact actual prices that customers and resellers are willing to pay in those countries and regions. As we develop and introduce new offerings, as well as features, integrations, capabilities and other enhancements, we may need to, or choose to, revise our pricing. There can be no assurance that we will not be forced to engage in price-cutting initiatives or to increase our marketing and other expenses to attract customers in response to competitive or other pressures. Any decrease in the sales prices for our products, without a corresponding decrease in costs, increase in volume or increase in revenue from our other offerings, would adversely affect our revenue and gross profit. We cannot assure you that we will be able to maintain our prices and gross profits at levels that will allow us to achieve and maintain profitability.

 

Our international operations and expansion expose us to risk.

 

Our products and services address the needs of customers and end users around the world, and we see continued international expansion as a significant opportunity. For the years ended December 31, 2024, 2023 and 2022, we generated approximately 30%, 28% and 25% of our revenue, respectively, from customers outside the United States. Our customers, end users, employees and partners are located in a number of different jurisdictions worldwide, and we expect our operations will become increasingly global as our business continues to grow. Our current international operations involve, and future initiatives will also involve, a variety of risks, including:

 

unexpected changes in practices, tariffs, export quotas, custom duties, trade disputes, tax laws and treaties, particularly due to economic tensions and trade negotiations or other trade restrictions;

 

different labor regulations, especially in the EU, where labor laws are generally more advantageous to employees as compared to the United States, including deemed hourly wage and overtime regulations in these locations;

 

exposure to many evolving stringent and potentially inconsistent laws and regulations relating to privacy, data protection, and information security, particularly in the EU;

 

changes in a specific country’s or region’s political or economic conditions;

 

risks resulting from any pandemic, epidemic or outbreak of infectious disease, including uncertainty regarding what measures the U.S. or foreign governments will take in response;

 

 17

 

 

risks resulting from changes in currency exchange rates;

 

challenges inherent to efficiently managing an increased number of employees over large geographic distances, including the need to implement appropriate systems, policies, benefits and compliance programs;

  

difficulties in maintaining our corporate culture with a dispersed workforce;

 

risks relating to the implementation of exchange controls, including restrictions promulgated by the United States Department of the Treasury’s Office of Foreign Assets Control, or OFAC, and other similar trade protection regulations and measures in the United States or in other jurisdictions;

 

reduced ability to timely collect amounts owed to us by our customers in countries where our recourse may be more limited;

 

slower than anticipated availability and adoption of cloud infrastructures by international businesses, which would increase our on-premise deployments;

 

limitations on our ability to reinvest earnings from operations derived from one country to fund the capital needs of our operations in other countries;

 

limited or unfavorable—including greater difficulty in enforcing—intellectual property protection; and

 

exposure to liabilities under anti-corruption and anti-money laundering laws, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, and similar applicable laws and regulations in other jurisdictions.

 

If we are unable to address these difficulties and challenges or other problems encountered in connection with our international operations and expansion, we might incur unanticipated liabilities or we might otherwise suffer harm to our business generally.

  

Currency exchange rate fluctuations and inflation affect our results of operations, as reported in our financial statements.

 

We report our financial results in U.S. dollars. We collect our revenue primarily in U.S. dollars and NIS. A portion of the cost of revenue, research and development, selling and marketing and general and administrative expenses of our Israeli and Russian operations are incurred in NIS or in Russian Ruble, or RUB. As a result, we are exposed to exchange rate risks that may materially and adversely affect our financial results. If the NIS or RUB appreciates against the U.S. dollar, or if the value of the NIS or RUB decline against the U.S. dollar, at a time when the rate of inflation in the cost of Israeli and Russian goods and services exceed the rate of decline in the relative value of the NIS and RUB, then the U.S. dollar-denominated cost of our operations in Israel and Russia would increase and our results of operations could be materially and adversely affected.

 

Inflation in Israel compounds the adverse impact of a devaluation of the NIS against the U.S. dollar by further increasing the amount of our Israeli expenses. Israeli inflation may also (in the future) outweigh the positive effect of any appreciation of the U.S. dollar relative to the NIS, if, and to the extent that, it outpaces such appreciation or precedes such appreciation. The Israeli rate of inflation did not have a material adverse effect on our financial condition during the years ended December 31, 2022, 2023 and 2024. Given our general lack of currency hedging arrangements to protect us from fluctuations in the exchange rates of the NIS or the RUB in relation to the U.S. dollar (and/or from inflation of such non-U.S. currencies), we may be exposed to material adverse effects from such movements. We cannot predict any future trends in the rate of inflation in Israel or in Russia or the rate of devaluation (if any) of the U.S. dollar against the NIS or the RUB.

 

 18

 

 

In particular, due to the Russian invasion of Ukraine, there has been significant currency rate fluctuations between the U.S. dollar and RUB. We cannot predict any future exchange-rate fluctuations and future trends in the rate of inflation in Israel and Russia and our ability to hedge our exposure to currency exchange rate fluctuations may be limited.

 

In addition, we use products and services and offer our products and services through cloud services, which may publish different prices in different locations. These differences in prices and locations may impact our costs and margins, and value we bring to our customers. 

 

Our business, operating results and growth rates may be adversely affected by current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk.

 

Our business depends on the economic health of the global economies. If the conditions in the global economies remain uncertain or continue to be volatile, or if they deteriorate, including as a result of the impact of military conflicts, such as the war between Russia and Ukraine and the security situation in Israel, terrorism or other geopolitical events, our business, operating results and financial condition may be materially adversely affected. Economic weakness, inflation and increases in interest rates, limited availability of credit, liquidity shortages and constrained capital spending have at times in the past resulted, and may in the future result, in challenging and delayed sales cycles, slower adoption of new technologies and increased price competition, and could negatively affect our ability to forecast future periods, which could result in an inability to satisfy demand for our products and a loss of market share.

 

In addition, increases in inflation raise our costs for commodities, labor, materials and services and other costs required to grow and operate our business, and failure to secure these on reasonable terms may adversely impact our financial condition. Additionally, increases in inflation, along with the uncertainties surrounding geopolitical developments and global supply chain disruptions, have caused, and may in the future cause, global economic uncertainty and uncertainty about the interest rate environment, which may make it more difficult, costly or dilutive for us to secure additional financing. A failure to adequately respond to these risks could have a material adverse impact on our financial condition, results of operations or cash flows.

  

There can be no assurance that future credit and financial market instability and a deterioration in confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, liquidity shortages, volatile business environment or continued unpredictable and unstable market conditions. If the current equity and credit markets deteriorate, or if adverse developments are experienced by financial institutions, it may cause short-term liquidity risk and also make any necessary debt or equity financing more difficult, more costly, more onerous with respect to financial and operating covenants and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to alter our operating plans. In addition, there is a risk that one or more of our service providers, financial institutions, manufacturers, suppliers and other partners may be adversely affected by the foregoing risks, which could directly affect our ability to attain our operating goals on schedule and on budget.

 

Scrutiny of sustainability and environmental, social, and governance, or ESG, initiatives could increase our costs or otherwise adversely impact our business.

 

Public companies have recently faced scrutiny related to ESG practices and disclosures from certain investors, capital providers, shareholder advocacy groups, other market participants and other stakeholder groups. Such scrutiny may result in increased costs, enhanced compliance or disclosure obligations, or other adverse impacts on our business, financial condition or results of operations. If our ESG practices and reporting do not meet investor or other stakeholder expectations, we may be subject to investor or regulator engagement regarding such matters. Our failure to comply with any applicable ESG rules or regulations could lead to penalties and adversely impact our reputation, access to capital and employee retention. Such ESG matters may also impact our third-party contract manufacturers and other third parties on which we rely, which may augment or cause additional impacts on our business, financial condition, or results of operations.

 

 19

 

 

Risks Related to Information Technology, Intellectual Property and Data Security and Privacy

 

A real or perceived bug, defect, security vulnerability, error, or other performance failure involving our products and services could cause us to lose revenue, damage our reputation, and expose us to liability.

 

Our products and services are inherently complex and, despite extensive testing and quality control, have in the past and may in the future contain bugs, defects, security vulnerabilities, errors, or other performance failures, especially when first introduced, or otherwise not perform as intended. Any such bug, defect, security vulnerability, error, or other performance failure could cause damage to our reputation, loss of customers or revenue, order cancellations, service terminations, and lack of market acceptance of our offerings. As the use of our offerings among new and existing customers expands, particularly to more sensitive, secure, or mission critical uses, we may be subject to increased scrutiny, potential reputational risk, or potential liability should our offerings fail to perform as contemplated in such deployments. We have in the past and may in the future need to issue corrective releases of our software to fix these defects, errors or performance failures, which could require us to allocate significant research and development and customer support resources to address these problems. Despite our efforts, such corrections may take longer to develop and release than we or our customers anticipate and expect.

 

Any limitation of liability provision contained in an agreement with a customer, user, third-party vendor, service provider, or partner may not be enforceable, adequate or effective as a result of existing or future applicable law or judicial decisions, and may not function to limit our liability arising from regulatory enforcement or other specific circumstances. The sale and support of our offerings entail the risk of liability claims, which could be substantial in light of the use of our offerings in enterprise-wide environments. In addition, our insurance against any such liability may not be adequate to cover a potential claim, and may be subject to exclusions, or subject us to the risk that the insurer will deny coverage as to any future claim or exclude from our coverage such claims in policy renewals, increase our fees or deductibles or impose co-insurance requirements. Any such bugs, defects, security vulnerabilities, errors, or other performance failures in our products and services, including as a result of denial of claims by our insurer or the successful assertion of claims by others against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including increases or the imposition of large deductible or co-insurance requirements, could have a material adverse effect on our business, including our financial condition, results of operations and reputation.

 

If we or our third-party service providers experience a security breach, data loss or other compromise, including if unauthorized parties obtain access to our customers’ data, our reputation may be harmed, demand for our products and services may be reduced, and we may incur significant liabilities.

 

Our business products and services involve the collection, storage, processing, transmission and other use of data, including certain confidential, sensitive, and personal information. Any security breach, data loss, or other compromise, including those resulting from a cybersecurity attack, phishing attack, or any unauthorized access, unauthorized usage, virus or similar breach or disruption could result in the loss or destruction of or unauthorized access to, or use, alteration, disclosure, or acquisition of, data, damage to our reputation, litigation, regulatory investigations, or other liabilities. These attacks may come from individual hackers, criminal groups, and state-sponsored organizations. If our security measures are breached as a result of third-party action, employee error or negligence, a defect or bug in our offerings or those of our third-party service providers, malfeasance or otherwise and, as a result, someone obtains unauthorized access to any data, including our confidential, sensitive, or personal information or the confidential, sensitive, or personal information of our customers, or other persons, or any of these types of information is lost, destroyed, or used, altered, disclosed, or acquired without authorization, our reputation may be damaged, our business may suffer, and we could incur significant liability, including under applicable data privacy and security laws and regulations. Even the perception of inadequate security may damage our reputation and negatively impact our ability to win new customers and retain and receive timely payments from existing customers. Further, we could be required to expend significant capital and other resources to protect against and address any data security incident or breach, which may not be covered or fully covered by our insurance and which may involve payments for investigations, forensic analyses, regulatory compliance, breach notification, legal advice, public relations advice, system repair or replacement, or other services. In addition, we do not maintain cybersecurity insurance and therefore have no insurance coverage in the event of any breach or disruption of our or our customers’ or service providers’ systems, including any unauthorized access or loss of any personal data that we may collect, store or otherwise process. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or systems, or inappropriate disclosure of confidential or proprietary information, we could incur liability, our competitive position could be harmed and our business, operations, and financial results could be adversely affected.

 

 20

 

 

In addition, part of the process of our solution is replacing our customer’s native image and video files with optimized, compressed files. This process and replacement of files can result in data loss. Additionally, we do not directly control content that our customers store or use in our products. If our customers use our products for the transmission or storage of personal, confidential, sensitive, or other information about individuals and our security measures are or are believed to have been breached as a result of third-party action, employee error, malfeasance or otherwise, our reputation could be damaged, our business may suffer, and we could incur significant liability.

 

We engage third-party vendors and service providers, such as AWS and Stripe, Inc. that have comprehensive internal policies, to store and otherwise process some of our and our customers’ data, including personal, confidential, sensitive, and other information about individuals. Our vendors and service providers may also be the targets of cyberattacks, malicious software, phishing schemes, and fraud. Our ability to monitor our vendors and service providers’ data security is limited, and, in any event, third parties may be able to circumvent those security measures, resulting in the unauthorized access to, misuse, acquisition, disclosure, loss, alteration, or destruction of our and our customers’ data, including confidential, sensitive, and other information about individuals.

 

Techniques used to sabotage or obtain unauthorized access to systems or networks are constantly evolving and, in some instances, are not identified until after they have been launched against a target. We and our service providers may be unable to anticipate these techniques, react in a timely manner, or implement adequate preventative and mitigating measures. If we are unable to efficiently and effectively maintain and upgrade our system safeguards, we may incur unexpected costs and certain of our systems may become more vulnerable to unauthorized access or disruption. Any of the foregoing could have a material adverse effect on our business, including our financial condition, results of operations and reputation.

 

We have developed and maintain a cybersecurity risk management program, consisting of cybersecurity policies, procedures, compliance and awareness programs to mitigate risk and to ensure compliance with security, availability and confidentiality trust principles. The cybersecurity process has been integrated into our overall risk management system and process, and is solely internally managed. See “Item 16.K—Cybersecurity” for additional information.

 

Insufficient investment in, or interruptions or performance problems associated with, our technology and infrastructure, including in connection with our Beamr Cloud SaaS solution, which is deployed on a public cloud infrastructure, and our reliance on technologies from third parties, may adversely affect our business operations and financial results.

 

Customers of our offerings will need to be able to access our platform at any time, without interruption or degradation of performance. Our Beamr Cloud SaaS solution is deployed on a public cloud infrastructure with the goal of providing improved stability, reliability, scalability and elasticity for our offerings. Following the launch of our Beamr Cloud in February 2024, we may discover deficiencies in our design, implementation or maintenance that could adversely affect our business, financial condition and results of operations. Furthermore, we cannot yet know the ultimate impact of this or any similar future event on our customer relationships.

  

In addition, third-party cloud providers run their own platforms that we access, and we are, therefore, vulnerable to their service interruptions and any changes in their product offerings. Any limitation on the capacity of our third-party hosting services could impede our ability to onboard new customers or expand the usage of our existing customers, which could adversely affect our business, financial condition and results of operations. In addition, any incident affecting our third-party hosting services’ infrastructure that may be caused by cyber-attacks, computer viruses, malware, systems failures or other technical malfunctions, natural disasters, fire, flood, severe storm, earthquake, power loss, telecommunications failures, terrorist or other attacks, protests or riots, and other similar events beyond our control could negatively affect our cloud-based offerings. It is also possible that our customers and regulators would seek to hold us accountable for any breach of security affecting a third-party cloud provider’s infrastructure and we may incur significant liability in investigating such an incident and responding to any claims, investigations, or proceedings made or initiated by those customers, regulators, and other third parties. We may not be able to recover a material portion of such liabilities from any of our third-party cloud providers. It may also become increasingly difficult to maintain and improve our performance and cost, especially during peak usage times, as our processing cost might be higher during peak hours. Moreover, our insurance may not be adequate to cover such liability and may be subject to exclusions. Any of the above circumstances or events may adversely affect our business, financial condition and results of operations.

 

 21

 

 

In the event that our service agreements with our third-party hosting services are terminated, or there is a lapse of service, elimination of services or features that we utilize, interruption of internet service provider connectivity or damage to our providers’ facilities, we could experience interruptions in access to our platform as well as significant delays and additional expense in arranging or creating new facilities and services and/or re-architecting our cloud-based offerings for deployment on a different cloud infrastructure service provider, which could adversely affect our business, financial condition and results of operations. Upon the termination or expiration of such service agreements, we cannot guarantee that adequate third-party hosting services will be available to us on commercially acceptable terms or within adequate timelines from the same or different hosting services providers or at all.

 

We may also rely on cloud technologies from third parties in order to operate critical functions of our business, including financial management services, relationship management services, and lead generation management services. If these services become unavailable due to extended outages or interruptions or because they are no longer available on commercially reasonable terms or prices, our expenses could increase, our ability to manage our finances could be interrupted, our processes for managing sales of our products and supporting our customers could be impaired, and our ability to generate and manage sales leads could be weakened until equivalent services are identified, obtained, and implemented. Even if such services are available, we may not be able to identify, obtain and implement such services in time to avoid disruption to our business, and such services may only be available on a more costly basis or otherwise less favorable terms. Any of the foregoing could have a material adverse effect on our business, including our financial condition, results of operations and reputation.

 

Failure to protect our proprietary technology, or to obtain, maintain, protect and enforce sufficiently broad intellectual property rights therein, could substantially harm our business, financial condition and results of operations.

 

Our success depends to a significant degree on our ability to protect our proprietary technology, methodologies, know-how, and brand. We rely on a combination of trademarks, copyrights, patents, trade secret laws, contractual restrictions, and other intellectual property laws and confidentiality procedures to establish and protect our proprietary rights. However, our competitors or other third parties could reverse engineering our code and use it to create software and service offerings that compete with ours. While software can, in some cases, be protected under copyright law, in order to bring a copyright infringement lawsuit in the United States, the copyright must first be registered. We have chosen not to register any copyrights and rely on trade secret protection in addition to unregistered copyrights to protect our proprietary software. Accordingly, the remedies and damages available to us for unauthorized use of our software may be limited. 

 

Further, the steps we take to protect our intellectual property and proprietary rights may be inadequate. We may not be able to register our intellectual property rights in all jurisdictions where we conduct or anticipate conducting business, and may experience conflicts with third parties who contest our applications to register our intellectual property. Even if registered or issued, we cannot guarantee that our trademarks, patents, copyrights or other intellectual property or proprietary rights will be of sufficient scope or strength to provide us with any meaningful protection or commercial advantage. We will not be able to protect our intellectual property and proprietary rights if we are unable to enforce our rights or if we do not detect infringement, misappropriation, dilution or other unauthorized use or violation thereof. If we fail to defend and protect our intellectual property rights adequately, our competitors and other third parties may gain access to our proprietary technology, information and know-how, reverse-engineer our software, and infringe upon or dilute the value of our brand, and our business may be harmed. In addition, obtaining, maintaining, defending, and enforcing our intellectual property rights might entail significant expense. Any patents, trademarks, copyrights, or other intellectual property rights that we have or may obtain may be challenged by others or invalidated through administrative process or litigation. Even if we continue to seek patent protection in the future, we may be unable to obtain further patent protection for our technology. In addition, any patents issued in the future may not provide us with competitive advantages, may be designed around by our competitors, or may be successfully challenged by third parties. Furthermore, legal standards relating to the validity, enforceability, and scope of protection of intellectual property rights are uncertain.

 

 22

 

 

We may be unable to prevent third parties from acquiring domain names or trademarks that are similar to, infringe upon, dilute or diminish the value of our trademarks and other proprietary rights. Additionally, our trademarks may be opposed, otherwise challenged or declared invalid, unenforceable or generic, or determined to be infringing on or dilutive of other marks. We may not be able to protect our rights in these trademarks, which we need in order to build name recognition with customers. If third parties succeed in registering or developing common law rights in such trademarks and we are not successful in challenging such third-party rights, or if our trademark rights are successfully challenged, we may not be able to use our trademarks to commercialize our products in certain relevant jurisdictions.

 

Despite our precautions, it may be possible for unauthorized third parties to copy our products and use information that we regard as proprietary to create offerings that compete with ours. Effective patent, trademark, copyright, and trade secret protection may not be available to us in every country in which our products are available. The laws of some countries may not be as protective of intellectual property rights as those in the United States, and mechanisms for enforcement of intellectual property rights may be inadequate. As we continue to expand our international activities, our exposure to unauthorized copying and use of our products and proprietary information will likely increase. Accordingly, despite our efforts, we may be unable to prevent third parties from infringing upon, diluting, misappropriating or otherwise violating our intellectual property rights.

 

We have devoted substantial resources to the development of our technology, business operations and business plans. We attempt to protect our intellectual property and proprietary information, including trade secrets, by implementing administrative, technical and physical practices, including source code access controls, to secure our proprietary information. We also seek to enter into confidentiality, non-compete, proprietary, and inventions assignment agreements with our employees, consultants and contractors, and enter into confidentiality agreements with other parties, such as licensees and customers. However, such agreements may not be self-executing, and there can be no guarantee that all applicable parties have executed such agreements. No assurance can be given that these practices or agreements will be effective in controlling access to and distribution of our proprietary information, or in providing adequate remedies in the event of unauthorized access or distribution, especially in certain states and countries, including Israel and Russia, that are less willing to enforce such agreements or otherwise provide protection for trade secrets. Further, these agreements may not prevent our competitors from independently developing technologies that are substantially equivalent or superior to our products, and in such cases we would not be able to assert trade secret rights against such parties. We also employ individuals who were previously employed at other companies in our field, and our efforts to ensure that such individuals do not use the proprietary information or know-how of others in their work for us may not prevent others from claiming that we or our employees or independent contractors have used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third parties. Litigation may be necessary to defend against any such claims. If we are unsuccessful in defending against any such claims, we may be liable for damages or prevented from using certain intellectual property, which in turn could materially adversely affect our business, financial condition or results of operations; even if we are successful in defending against such claims, litigation could result in substantial costs and distract management and other employees.

 

In order to protect our intellectual property and proprietary rights and to monitor for and take action against any infringement, misappropriation or other violations thereof, we may be required to spend significant resources. Litigation may be necessary to enforce and protect our trade secrets and other intellectual property and proprietary rights, which could be costly, time-consuming, and distracting to management, and could result in the impairment or loss of portions of our intellectual property. Further, our efforts to enforce our intellectual property and proprietary rights may be met with defenses, counterclaims, and countersuits attacking the ownership, scope, validity and enforceability of such rights. Our inability to protect our proprietary technology or our brand against unauthorized copying or use, as well as any costly litigation or diversion of our management’s attention and resources, could delay further sales or the implementation of our offerings or impair their functionality, delay introductions of new offerings, result in our substituting inferior or more costly technologies into our offerings, or injure our reputation. Any of the foregoing could materially and adversely affect our business, financial condition, results of operations and growth prospects.

 

 23

 

 

We could incur substantial costs and otherwise suffer harm as a result of any claim of infringement, misappropriation or other violation of another party’s intellectual property or proprietary rights.

 

In recent years, there has been significant litigation involving patents and other intellectual property and proprietary rights in the software industry. Our competitors and others may now and in the future have significantly larger and more mature patent portfolios than we have. Even a large patent portfolio may not serve as a deterrent to litigation by certain third parties, some of whose sole or primary business is to assert patent claims and some of whom have sent letters to and/or filed suit alleging infringement against us or some of our customers. We could incur substantial costs in prosecuting or defending any intellectual property litigation. If we sue to enforce our rights or are sued by a third party claiming that our offerings infringe, misappropriate or violate their rights, the litigation could be expensive and could divert management attention and resources away from our core business operations. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our ordinary shares.

 

Any intellectual property litigation to which we might become a party, or for which we are required to provide indemnification, may require us to do one or more of the following:

 

cease selling or using offerings that incorporate or are otherwise covered by the intellectual property rights that we allegedly infringe, misappropriate or otherwise violate;

 

make substantial payments for legal fees, settlement payments or other costs or damages, including potentially treble damages if we are found liable for willful infringement;

 

obtain a license to sell or use the relevant technology, which may not be available on reasonable terms or at all, may be non-exclusive and thereby allow our competitors and other parties access to the same technology, and may require the payment of substantial licensing, royalty or other fees; or

 

redesign the allegedly infringing offerings to avoid infringement, misappropriation or other violation, which could be costly, time-consuming or impossible.

  

If we are required to make substantial payments or undertake or suffer any of the other actions and consequences noted above as a result of any intellectual property infringement, misappropriation or violation claims against us or any obligation to indemnify our customers for such claims, such payments, actions and consequences could materially and adversely affect our business, financial condition, results of operations and growth prospects. 

 

We could incur substantial costs and otherwise suffer harm as a result of patent royalty claims, in particular patents related to the implementation of image and video standards

 

Our products and services decode and encode media files which are compressed using compression methods that are standardized by international standard bodies such as ISO and ITU. These standard compression methods include, for example, JPEG and HEIC for images, and H.264, HEVC, EVC and VVC for video. Some of the algorithms included in these image and video compression standards are covered by patents which are licensed by patent pools, such as MPEG-LA, Access Advance and Velos Media, and by independent patent holders. Depending on the use case and application of these image and video standards in our products and services, we may be required to pay patent royalties to such patent pools and independent patent holders, which might affect our margins and our profitability. Historically, almost all of our products and services have not required such patent royalty payment however as we expand our SaaS offering, we expect to pay such patent royalties in the future. In addition, in order to avoid paying patent royalties, some of our customers may opt to use open source compression standards such as VP9 or AV1, which in turn would require us to support such standards in our products and services, causing additional product development costs due to this fragmentation.

 

 24

 

 

Indemnity provisions in various agreements potentially expose us to substantial liability for intellectual property infringement, misappropriation, violation, and other losses.

 

Our agreements with customers and other third parties may include indemnification provisions under which we agree to indemnify them for losses suffered or incurred as a result of claims of intellectual property infringement, misappropriation or violation, damages caused by us to property or persons, or other liabilities relating to or arising from our software, services or other contractual obligations. Large indemnity payments could adversely affect our business, financial condition and results of operations. Although we normally seek to contractually limit our liability with respect to such indemnity obligations, we do not and may not in the future have a cap on our liability in certain agreements, which could result in substantial liability. Substantial indemnity payments under such agreements could harm our business, financial condition and results of operations. Any dispute with a customer or other third party with respect to such obligations could have adverse effects on our relationship with that customer, other existing customers and new customers, and other parties, and could harm our reputation, business, financial condition and results of operations.

 

We rely on software and services licensed from other parties. The loss of software or services from third parties could increase our costs and limit the features available in our products and services.

 

Components of our offerings include various types of software and services licensed from unaffiliated parties. If any of the software or services we license from others or functional equivalents thereof were either no longer available to us or no longer offered on commercially reasonable terms, we would be required to either redesign the offerings that include such software or services to function with software or services available from other parties or develop these components ourselves, which we may not be able to do without incurring increased costs, experiencing delays in our product launches and the release of new offerings, or at all. Furthermore, we might be forced to temporarily limit the features available in our current or future products and solutions. If we fail to maintain or renegotiate any of these software or service licenses, we could face significant delays and diversion of resources in attempting to license and integrate functional equivalents. We and our customers may also be subject to suits by parties claiming infringement, misappropriation or other violation of third-party intellectual property or proprietary rights due to the reliance by our solutions on such third-party software and services, such third-party software and services may contain bugs or other errors that cause our own offerings to malfunction, and our agreements with such third parties may not contain any, or adequate, warranties, indemnities or other protective provisions on our behalf. Any of the foregoing could materially and adversely affect our business, financial condition and results of operations.

  

We incorporate artificial intelligence into our product. This technology is new and developing and may present both compliance and reputational risks.

 

We rely on AI algorithms and models in the operation of Beamr Cloud. The AI models that we use are trained using various data sets. If our AI models are incorrectly designed or implemented or do not receive pictures or visual data, they may produce inaccurate or unreliable results, negatively impacting the performance and reliability of Beamr Cloud. The effectiveness of our AI models depends on the quality and completeness of the data used for training. If the data is incomplete, inadequate, or biased, it could lead to suboptimal model performance, impairing the functionality of Beamr Cloud. Any malfunction or unexpected behavior in our AI-driven systems could disrupt our operations, leading to increased downtime and higher maintenance costs for our customers, and potential loss of revenue. Additionally, failures in the performance of our AI models could damage our reputation, erode customer trust, and result in loss of business and negative publicity.

 

 25

 

 

In addition, Beamr Cloud uses AI and automated decision making technologies, including artificial intelligence and machine learning algorithms, and we are making significant investments to continuously improve the use of such technologies. There are significant risks involved in developing, maintaining and deploying AI and automated decision making technologies and there can be no assurance that the usage of such technologies will always enhance our products or services or be cost effective and more generally beneficial to our business, including our efficiency or profitability. In particular, if these AI models or automated decision making technologies are incorrectly designed or implemented, trained or reliant on incomplete, inadequate, inaccurate, biased or otherwise poor quality data or on data to which we do not have sufficient rights, and/or are adversely impacted by unforeseen defects, technical challenges, cybersecurity threats or material performance issues, the performance of our products, services, and business, as well as our reputation and the reputations of our customers, could suffer or we could incur liability through the violation of laws or contracts to which we are a party or through other civil claims. Further, our ability to continue to develop or use such models or technologies may be dependent on access to specific third-party software and infrastructure, such as processing hardware or third-party artificial intelligence models, and we cannot control the availability or pricing of such third-party software and infrastructure. In addition, market acceptance and consumer perceptions of AI technologies is uncertain at this point.

 

Risks Related to Other Legal, Regulatory and Tax Matters

 

Changes in laws and regulations related to the internet, changes in the internet infrastructure itself, or increases in the cost of internet connectivity and network access may diminish the demand for our offerings and could harm our business.

 

The future success of our business depends upon the continued use of the internet as a primary medium for commerce, communication, and business applications. Federal, state, or foreign governmental bodies or agencies have in the past adopted, and may in the future adopt, laws or regulations affecting the use of the internet as a commercial medium. The adoption of any laws or regulations that could reduce the growth, popularity, or use of the internet, including laws or practices limiting internet neutrality, could decrease the demand for our offerings, increase our cost of doing business, and adversely affect our results of operations. Changes in these laws or regulations could require us to modify our offerings, or certain aspects of our offerings, in order to comply with these changes. In addition, government agencies or private organizations have imposed and may impose additional taxes, fees, or other charges for accessing the internet or commerce conducted via the internet. These laws or charges could limit the growth of internet-related commerce or communications generally or result in reductions in the demand for internet-based products such as ours. In addition, the use of the internet as a business tool could be harmed due to delays in the development or adoption of new standards and protocols to handle increased demands of internet activity, security, reliability, cost, ease-of-use, accessibility, and quality of service. Further, our platform depends on the quality of our customers’ and end users’ access to the internet.

 

On June 11, 2018, the repeal of the “net neutrality” rules of the Federal Communications Commission, or the FCC, took effect and returned to a “light-touch” regulatory framework. The prior rules were designed to ensure that all online content is treated the same by internet service providers and other companies that provide broadband services. Additionally, on September 30, 2018, California enacted the California Internet Consumer Protection and Net Neutrality Act of 2018, making California the fourth state to enact a state-level net neutrality law since the FCC repealed its nationwide regulations, mandating that all broadband services in California must be provided in accordance with state net neutrality requirements. The U.S. Department of Justice has sued to block the law going into effect, and California has agreed to delay enforcement until the resolution of the FCC’s repeal of the federal rules. A number of other states are considering legislation or executive actions that would regulate the conduct of broadband providers. We cannot predict whether the FCC order or state initiatives will be modified, overturned, or vacated by legal action of the court, federal legislation or the FCC. With the repeal of net neutrality rules in effect, we could incur greater operating expenses, which could harm our results of operations.

 

As the internet continues to experience growth in the number of users, frequency of use, and amount of data transmitted, the internet infrastructure that we and our customers and end users rely on may be unable to support the demands placed upon it. The failure of the internet infrastructure that we or our customers and end users rely on, even for a short period of time, could adversely affect our business, financial condition and results of operations. In addition, the performance of the internet and its acceptance as a business tool has been harmed by “viruses,” “worms” and similar malicious programs and the internet has experienced a variety of outages and other delays as a result of damage to portions of its infrastructure. If the use of the internet is adversely affected by these issues, demand for our offerings could decline.

 

 26

 

 

Internet access is frequently provided by companies that have significant market power and the ability to take actions that degrade, disrupt, or increase the cost of user access to our offerings. As demand for online media increases, there can be no assurance that internet and network service providers will continue to price their network access services on reasonable terms. The distribution of online media requires delivery of digital content files and providers of network access and distribution may change their business models and increase their prices significantly, which could slow the widespread adoption of such services. We could incur greater operating expenses and our customer acquisition and retention could be negatively impacted if network operators:

 

implement usage-based pricing;

 

discount pricing for competitive products;

 

otherwise materially change their pricing rates or schemes;

 

charge us to deliver our traffic at certain levels or at all;

 

throttle traffic based on its source or type;

 

implement bandwidth caps or other usage restrictions; or

 

  otherwise try to monetize or control access to their networks.

 

In order for our services to be successful, there must be a reasonable price model in place to allow for the continuous distribution of digital media files. We have limited or no control over the extent to which any of these circumstances may occur, and if network access or distribution prices rise, our business, financial condition and results of operations would likely be adversely affected.

 

Failure to comply with anti-bribery, anti-corruption, anti-money laundering laws, and similar laws, could subject us to penalties and other adverse consequences.

 

We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. § 201, the U.S. Travel Act, the USA PATRIOT Act, Chapter 9 (sub-chapter 5) of the Israeli Criminal Law, 5737-1977, the Israeli Prohibition on Money Laundering Law, 5760-2000 and other anti-bribery and anti-money laundering laws in countries outside of the United States in which we conduct our activities, such as Russia. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to generally prohibit companies, their employees, and their third-party intermediaries from authorizing, offering, or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector.

 

We sometimes leverage third parties to sell our offerings and conduct our business abroad. We and our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities and may be held liable for the corrupt or other illegal activities of these third-party business partners and intermediaries, our employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize such activities. We cannot assure you that our employees and agents will not take actions in violation of applicable law, for which we may be ultimately held responsible. As we increase our international sales and business operations, our risks under these laws are likely to increase.

 

Any actual or alleged violation of the FCPA or other applicable anti-bribery, anti-corruption or anti-money laundering laws could result in whistleblower complaints, sanctions, settlements, prosecution, enforcement actions, fines, damages, adverse media coverage, investigations, loss of export privileges, severe criminal or civil sanctions, or suspension or debarment from U.S. government contracts, any of which would adversely affect our reputation, as well as our business, financial condition, results of operations and growth prospects. Responding to any investigation or action would likely result in a materially significant diversion of management’s attention and resources and significant defense costs and other professional fees. In addition, the U.S. government may seek to hold us liable for successor liability for FCPA violations committed by companies in which we invest or that we acquire.

 

 27

 

 

Changes in financial accounting standards or practices may cause adverse, unexpected financial reporting fluctuations and affect our results of operations.

 

The accounting rules and regulations that we must comply with are complex and subject to interpretation by the Financial Accounting Standards Board, or the FASB, the SEC and various bodies formed to promulgate and interpret appropriate accounting principles. Recent actions and public comments from the FASB and the SEC have focused on the integrity of financial reporting and internal controls. In addition, many companies’ accounting policies are being subject to heightened scrutiny by regulators and the public. Further, the accounting rules and regulations are continually changing in ways that could materially impact our financial statements.

  

We cannot predict the impact of future changes to accounting principles or our accounting policies on our financial statements going forward, which could have a significant effect on our reported financial results and could affect the reporting of transactions completed before the announcement of the change. In addition, if we were to change our critical accounting estimates, including those related to the recognition of subscription revenue and other revenue sources, our operating results could be significantly affected.

 

Changes in U.S. and foreign tax laws could have a material adverse effect on our business, cash flow, results of operations or financial conditions.

 

We are subject to taxation in several countries, including the United States and Israel; changes in tax laws or challenges to our tax positions could adversely affect our business, results of operations, and financial condition. As such, we are subject to tax laws, regulations, and policies of the U.S. federal, state, and local governments and of comparable taxing authorities in foreign jurisdictions. Changes in tax laws, including the U.S. federal tax legislation enacted in 2017, commonly referred to as the Tax Cuts and Jobs Act of 2017, as well as other factors, could cause us to experience fluctuations in our tax obligations and effective tax rates in the future and otherwise adversely affect our tax positions and/or our tax liabilities. There can be no assurance that our effective tax rates, tax payments, tax credits, or incentives will not be adversely affected by changes in tax laws in various jurisdictions.

 

Unanticipated changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could expose us to greater than anticipated tax liabilities.

 

The tax laws applicable to our business, including the laws of the United States, Israel, Russia, and other jurisdictions, are subject to interpretation, and certain jurisdictions may aggressively interpret their laws in an effort to raise additional tax revenue. The taxing authorities of the jurisdictions in which we operate may challenge our methodologies for valuing developed technology or intercompany arrangements or our revenue recognition policies, which could increase our worldwide effective tax rate and adversely affect our financial position and results of operations. It is possible that tax authorities may disagree with certain positions we have taken, and any adverse outcome of such a review or audit could have a negative effect on our business, financial condition and results of operations. Further, the determination of our worldwide provision for income taxes and other tax liabilities requires significant judgment by management, and there are transactions where the ultimate tax determination is uncertain. Although we believe that our estimates are reasonable, the ultimate tax outcome may differ from the amounts recorded in our consolidated financial statements and may materially affect our financial results in the period or periods for which such determination is made.

 

Our corporate structure and intercompany arrangements are subject to the tax laws of various jurisdictions, and we could be obligated to pay additional taxes, which would adversely affect our results of operations.

 

Based on our current corporate structure, we are subject to taxation in several jurisdictions around the world with increasingly complex tax laws, the application of which can be uncertain. The amount of taxes we pay in these jurisdictions could increase substantially as a result of changes in the applicable tax principles, including increased tax rates, new tax laws or revised interpretations of existing tax laws and precedents. The authorities in these jurisdictions could review our tax returns or require us to file tax returns in jurisdictions in which we are not currently filing, and could impose additional tax, interest, and penalties. These authorities could also claim that various withholding requirements apply to us or our subsidiaries, assert that benefits of tax treaties are not available to us or our subsidiaries, or challenge our methodologies for valuing developed technology or intercompany arrangements, including our transfer pricing. The relevant taxing authorities may determine that the manner in which we operate our business does not achieve the intended tax consequences. If such a disagreement were to occur, and our position was not sustained, we could be required to pay additional taxes, interest, and penalties. Such authorities could claim that various withholding requirements apply to us or our subsidiaries or assert that benefits of tax treaties are not available to us or our subsidiaries. Any increase in the amount of taxes we pay or that are imposed on us could increase our worldwide effective tax rate and adversely affect our business, financial condition and results of operations.

 

 28

 

 

We could be required to collect additional sales, use, value added, digital services or other similar taxes or be subject to other liabilities that may increase the costs our customers would have to pay for our offerings and adversely affect our results of operations.

 

We could be required to collect sales, value added and other similar taxes in a number of jurisdictions. One or more U.S. states or countries may seek to impose incremental or new sales, use, value added, digital services, or other tax collection obligations on us. Further, an increasing number of U.S. states have considered or adopted laws that attempt to impose tax collection obligations on out-of-state companies. Additionally, the Supreme Court of the United States has ruled that online sellers can be required to collect sales and use tax despite not having a physical presence in the state of the customer. As a result, U.S. states and local governments may adopt, or begin to enforce, laws requiring us to calculate, collect, and remit taxes on sales in their jurisdictions, even if we have no physical presence in that jurisdiction. A successful assertion by one or more U.S. states requiring us to collect taxes where we presently do not do so, or to collect more taxes in a jurisdiction in which we currently do collect some taxes, could result in substantial liabilities, including taxes on past sales, as well as interest and penalties. Furthermore, certain jurisdictions, such as the United Kingdom and France, have recently introduced a digital services tax, which is generally a tax on gross revenue generated from users or customers located in those jurisdictions, and other jurisdictions have enacted or are considering enacting similar laws. A successful assertion that we should have been or should currently be collecting additional sales, use, value added, digital services or other similar taxes in a particular jurisdiction could, among other things, result in substantial tax payments, create significant administrative burdens for us, discourage potential customers from subscribing to our platform due to the incremental cost of any such sales or other related taxes, or otherwise adversely affect our business.

 

Risks Related to Our Operations in Israel

 

Political, economic and military conditions in Israel could materially and adversely affect our business.

 

We have offices in Herzeliya, near Tel Aviv, Israel where our primary operations, research and development, and certain other finance activities are based. In addition, all of our officers and several of our directors, are residents of Israel. As of March 3, 2025, we had 21 full-time and part-time employees and four subcontractors in Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly affect our business and operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its neighboring countries, as well as terrorist acts committed within Israel by hostile elements.

 

In particular, in October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in thousands of deaths and injuries, and Hamas additionally kidnapped many Israeli civilians and soldiers. Following the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and these terrorist organizations in parallel continued rocket and terror attacks. On January 19, 2025, a temporary ceasefire went into effect, the result of which is uncertain. As a result of the events of October 7, 2023, the Israeli government declared that the country was at war and the Israeli military began to call-up reservists for active duty, including three of our full-time or part-time employees in Israel who were called up for reserve service and one of our part-time employees in Israel volunteered for military service, but have since returned to work full time and their pre-war military reserve duties. Military service call ups that result in absences of personnel from us for an extended period of time may materially and adversely affect our business, prospects, financial condition and results of operations.

 

 29

 

 

Since the commencement of these events, there have been continued hostilities along Israel’s northern border with Lebanon (with the Hezbollah terror organization) and on other fronts from various extremist groups in the region, such as the Houthis in Yemen and various rebel militia groups in Syria and Iraq. Israel has carried out a number of targeted strikes on sites belonging to these terror organizations. In October 2024, Israel began limited ground operations against Hezbollah in Lebanon, and in November 2024, a ceasefire was brokered between Israel and Hezbollah. In addition, Iran recently launched direct attacks on Israel involving hundreds of drones and missiles, has threatened to continue to attack Israel, and is widely believed to be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza, Hezbollah in Lebanon, the Houthis in Yemen and various rebel militia groups in Syria and Iraq. These situations may potentially escalate in the future to more violent events which may affect Israel and us. Any hostilities, armed conflicts, terrorist activities involving Israel or the interruption or curtailment of trade between Israel and its trading partners, or any political instability in the region could adversely affect business conditions and our results of operations and could make it more difficult for us to raise capital and could adversely affect the market price of our ordinary share. An escalation of tensions or violence might result in a significant downturn in the economic or financial condition of Israel, which could have a material adverse effect on our operations in Israel and our business. Parties with whom we do business have sometimes declined to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements, when necessary, in order to meet our business partners face to face. In addition, the political and security situation in Israel may result in parties with whom we have agreements involving performance in Israel claiming that they are not obligated to perform their commitments under those agreements pursuant to force majeure provisions in such agreements. 

  

Since the war broke out on October 7, 2023, our operations have not been adversely affected by this situation, and we have not experienced disruptions to our business operations. As such, our product and business development activities remain on track. However, the intensity and duration of Israel’s current war against Hamas is difficult to predict at this stage, as are such war’s economic implications on our business and operations and on Israel’s economy in general. If the ceasefires declared collapse or a new war commences or hostilities expand to other fronts, our operations may be adversely affected.

 

Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have a material adverse effect on our business. Any armed conflicts or political instability in the region would likely negatively affect business conditions and could adversely affect our results of operations.

  

Finally, political conditions within Israel may affect our operations. Israel has held five general elections between 2019 and 2022, and prior to October 2023, the Israeli government pursued extensive changes to Israel’s judicial system, which sparked extensive political debate and unrest. Actual or perceived political instability in Israel or any negative changes in the political environment, may individually or in the aggregate adversely affect the Israeli economy and, in turn, our business, financial condition, results of operations and growth prospects.

 

Our operations could be disrupted as a result of the obligation of certain of our personnel residing in Israel to perform military service.

 

Many of our officers and employees reside in Israel and may be required to perform annual military reserve duty. Currently, all male adult citizens and permanent residents of Israel under the age of 40 (or older, depending on their position with the Israeli Defense Forces reserves), unless exempt, are obligated to perform military reserve duty annually and are subject to being called to active duty at any time under emergency circumstances. Military service call ups that result in absences of personnel from us for an extended period of time may materially and adversely affect our business, prospects, financial condition and results of operations. Our operations could be disrupted by the absence for a significant period of one or more of our key officers and employees due to military service. Any such disruption could have a material adverse effect on our business, results of operations and financial condition.

 

 30

 

 

We may not be able to enforce covenants not-to-compete under current Israeli law.

 

We have non-competition agreements with most of our employees, many of which are governed by Israeli law. These agreements generally prohibit our employees from competing with us or working for our competitors for a specified period following termination of their employment. However, Israeli courts are reluctant to enforce non-compete undertakings of former employees and tend, if at all, to enforce those provisions for relatively brief periods of time in restricted geographical areas and only when the employee has unique value specific to that employer’s business and not just regarding the professional development of the employee. Any such inability to enforce non-compete covenants may cause us to lose any competitive advantage resulting from advantages provided to us by such confidential information.

  

We may become subject to claims for remuneration or royalties for assigned service invention rights by our employees and consultants, which could result in litigation and would adversely affect our business.

 

A significant portion of our intellectual property has been developed by our employees and consultants in the course of their engagement with us. Under the Israeli Patent Law, 5727-1967, or the Patent Law, inventions conceived by an employee during the scope of his or her employment relationship with a company are regarded as “service inventions,” which belong to the employer, absent a specific agreement stating otherwise. The Patent Law also provides that absent an agreement providing otherwise, the Israeli Compensation and Royalties Committee, or the Committee, a body constituted under the Patent Law, shall determine whether the employee is entitled to remuneration for his or her inventions. Case law clarifies that the right to receive consideration for “service inventions” can be waived by the employee and that such waiver does not necessarily have to be explicit. The Committee will examine, on a case-by-case basis, the general contractual framework between the parties, using interpretation rules of the general Israeli contract laws. Further, the Committee has not yet determined one specific formula for calculating this remuneration, but rather uses the criteria specified in the Patent Law. Although we generally seek to enter into assignment-of-invention agreements with our employees and consultants pursuant to which such individuals assign to us all rights to any inventions created in the scope of their employment or engagement with us, we cannot guarantee that all such agreements are self-executing or have been entered into by all applicable individuals. Even when such agreements include provisions regarding the assignment and waiver of rights to additional compensation in respect of inventions created within the course of their employment or consulting relationship with us, including in respect of service inventions, we cannot guarantee that such provisions will be upheld by Israeli courts, as a result of uncertainty under Israeli law with respect to the efficacy of such provisions. We may face claims demanding remuneration in consideration for assigned inventions, which could require us to pay additional remuneration or royalties to our current and former employees and consultants, or be forced to litigate such claims, which could negatively affect our business. 

 

It may be difficult for investors in the United States to enforce any judgments obtained against us or some of our directors or officers.

 

The majority of our assets are located outside the U.S. In addition, our officers are nationals and/or residents of countries other than the U.S., and all or a substantial portion of such persons’ assets are located outside the U.S. As a result, it may be difficult for investors to enforce within the United States any judgments obtained against us or any of our non-U.S. officers, including judgments predicated upon the civil liability provisions of the securities laws of the U.S. or any state thereof. Additionally, it may be difficult to assert U.S. securities law claims in actions originally instituted outside of the U.S. Israeli courts may refuse to hear a U.S. securities law claim because Israeli courts may not be the most appropriate forums in which to bring such a claim. Even if an Israeli court agrees to hear a claim, it may determine that the Israeli law, and not U.S. law, is applicable to the claim. Further, if U.S. law is found to be applicable, certain content of applicable U.S. law must be proved as a fact, which can be a time-consuming and costly process, and certain matters of procedure would still be governed by the Israeli law. Consequently, you may be effectively prevented from pursuing remedies under U.S. federal and state securities laws against us or any of our non-U.S. directors or officers.

 

Our amended and restated articles of association provide that, unless we consent to an alternative forum, the federal district courts of the United States shall be the exclusive forum for resolution of any complaint asserting a cause of action arising under the Securities Act, and under the Courts Law 5744-1984 [consolidated version] (“Courts Law”) the competent courts of Tel Aviv, Israel, shall be the exclusive forum for resolution of substantially all disputes between the Company and its shareholders under the Companies Law and the Israeli Securities Law, which could limit our shareholders’ ability to choose the judicial forum for disputes with us, our directors, shareholders, or other employees.

 

Section 22 of the Securities Act creates concurrent jurisdiction for U.S. federal and state courts over all such Securities Act actions. Accordingly, both U.S. state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated articles of association provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange Act, and our shareholders cannot and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder as a result of our exclusive forum provision.

 

 31

 

 

Under the Courts Law, the competent courts of Tel Aviv, Israel, is the exclusive forum for the resolution of (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company’s shareholders, or (iii) any action asserting a claim arising pursuant to any provision of the Companies Law or the Israeli Securities Law, 1968, or the Israeli Securities Law. Such exclusive forum provision is intended to apply to claims arising under Israeli law and does not apply to claims for which the federal courts would have exclusive jurisdiction, whether by law or pursuant to our amended and restated articles of association, as described above.

 

Any person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to the foregoing provisions of our amended and restated articles of association. However, the enforceability of similar forum provisions (including exclusive federal forum provisions for actions, suits, or proceedings asserting a cause of action arising under the Securities Act) in other companies’ organizational documents has been challenged in legal proceedings, and there is uncertainty as to whether courts would enforce the exclusive forum provisions in our amended and restated articles of association. If a court were to find the exclusive forum provisions contained in our amended and restated articles of association to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and results of operations.

  

Although we believe these exclusive forum provisions benefit us by providing increased consistency in the application of U.S. federal securities laws or the Companies Law, as applicable, in the types of lawsuits to which they apply, such exclusive forum provisions may limit a shareholder’s ability to bring a claim in the judicial forum of their choosing for disputes with us or any of our directors, shareholders, officers, or other employees, which may discourage lawsuits with respect to such claims against us and our current and former directors, shareholders, officers, or other employees.

 

Risks Related to Our Operations in Russia

 

Russia’s invasion of Ukraine and sanctions brought against Russia could disrupt our software development operations in Russia.

 

In addition to our U.S. and Israel operations, we have operations in Russia through our wholly owned subsidiary, Beamr Imaging RU. Specifically, we undertake some of our software development, quality assurance, and support in Russia using personnel located there. While some of our developers are located in Russia, our research and development leadership is located in Israel.

 

On February 24, 2022, Russia invaded Ukraine. The outbreak of hostilities between the two countries could result in more widespread conflict and could have a severe adverse effect on the region. Following Russia’s actions, various countries, including the U.S., Canada, the United Kingdom, Germany and France, as well as the European Union, issued broad-ranging economic sanctions against Russia. Such sanctions included, among other things, a prohibition on doing business with certain Russian companies, officials and citizens; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications (SWIFT) electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. In response to sanctions, the Russian Central Bank raised its interest rates and banned sales of local securities by foreigners. Russia may take additional counter measures or retaliatory actions in the future. The continuation of these hostilities may result in additional economic and other sanctions against Russia. The potential impact of the conflict and any resulting bans, sanctions and boycotts on companies doing business in Russia is currently uncertain due to the fluid nature of the conflict as it is unfolding and has the potential to result in broadened military actions. The duration of ongoing hostilities and such sanctions and related events cannot be predicted. Uncertainty as to future relations between Russia and the U.S. and other countries in the west, or between Russia and other eastern European countries, may have a negative impact on our operations.

 

 32

 

 

We do not operate in any sectors of the Russian economy that have been targeted by U.S. or EU sanctions and have no reason to believe that we would be targeted by any sanctions in the future. Nonetheless such sanctions and potential responses to such sanctions, including those that may limit or restrict transfer funds into Russia, may in the future significantly affect our ability to pay our personnel based in Russia. In response, we have begun to partially implement a business continuity plan in order to address risks related to the conflict on our personnel, operations and product development that includes alternative payment solutions for personnel in Russia and relocation of personnel to territories outside Russia. In addition, we have focused our hiring efforts on other locations. As of March 3, 2025, some of the Russian employees and contractors of our wholly owned subsidiary in St. Petersburg, Russia have relocated to other countries, including Serbia and Poland, and we are continuing to monitor the situation with respect to our business continuity plan.

 

Our operations and presence in Russia is limited. We have no manufacturing operations in Russia and we do not sell any products in Russia and as a consequence we have not derived any revenues from there. To date, none of our investors expressed concern with respect to our operations in Russia and none of our customers terminated or downsized their engagement with us as a result of such operations. Our employees in Russia have not to date experienced any change in their daily ability to perform their tasks. We do not expect Russia or another government to nationalize our assets or operations in Russia. In particular, our primary asset is software that are stored outside of Russia and our products and services are all delivered outside of Russia. In addition, we believe that if we needed to, we would be able to recruit personnel outside Russia without any material interruption to our operations. As a result, we believe that if nationalization were to occur, any impact on our financial statements would be immaterial. Nevertheless, we cannot predict the progress or outcome of the situation in Ukraine, as the conflict and governmental reactions are rapidly developing and beyond our control.

 

Political, military conditions or other risks in Russia could adversely affect our business.

 

Russia is a federative state consisting of 85 constituent entities, or “subjects.” The Russian Constitution reserves some governmental powers for the Russian Government, some for the subjects and some for areas of joint competence. In addition, eight “federal districts” (“federal’nye okruga”), which are overseen by a plenipotentiary representative of the President, supplement the country’s federal system. The delineation of authority among and within the subjects is, in many instances, unclear and contested, particularly with respect to the division of tax revenues and authority over regulatory matters. For these reasons, the Russian political system is vulnerable to tension and conflict between federal, subject and local authorities. This tension creates uncertainties in the operating environment in Russia, which may prevent us from carrying out our strategy effectively. The risks associated with these events or potential events could materially and adversely affect the investment environment and overall consumer and entrepreneurial confidence in Russia, and our business, prospects, financial condition, hiring ability, and results of operations could be materially and adversely affected.

 

Furthermore, high levels of corruption reportedly exist in Russia, including the bribing of officials for the purpose of initiating investigations by government agencies. Corruption and other illegal activities could disrupt our ability to conduct our business effectively, and claims that the we are involved in such corruption or illegal activities could generate negative publicity, of which could harm our development, financial condition, results of operations or prospects.

 

Economic and other risks in Russia could adversely affect our business.

 

Operating a business in an emerging market such as Russia can involve a greater degree of risk than operating a business in more developed markets.

 

 33

 

 

Over the last two decades, the Russian economy has experienced or continues to experience at various times:

 

  significant volatility in its GDP;
     
  the impact of international sanctions;
     
  high levels of inflation;
     
  increases in, or high, interest rates;
     
  price volatility in oil and other natural resources;
     
  instability in the local currency market;
     
  budget deficits;
     
  the continued operation of loss-making enterprises due to the lack of effective bankruptcy proceedings;
     
  capital flight; and
     
  significant increases in poverty rates, unemployment and underemployment.

 

The Russian economy has been subject to abrupt downturns in the past, including as a result of the invasion of Ukraine, global financial crisis, and, as an emerging market, remains particularly vulnerable to further external shocks and any future fluctuations in the global markets. Any further deterioration in the general economic conditions in Russia (whether or not as a result of the events mentioned above) could have a material adverse effect on the Russian economy and may result in hiring and operational difficulties, as well as potential flight of human capital, which could have a material adverse effect on our business, product development and results of operations.

 

Legal risks in Russia could materially adversely affect our operations and Russian tax legislation is subject to frequent change.

 

Among the risks of the Russian legal system are: inconsistencies among laws, presidential decrees, and government and ministerial orders and resolutions; conflicting local, regional and federal laws and regulations; the untested nature of the independence of the judiciary and its sensitivity to economic or political influences; substantial gaps in the regulatory structure due to the delay or absence of implementing legislation; a high degree of discretion on the part of governmental authorities; reported corruption within governmental entities and other governmental authorities; the relative inexperience of judges and courts in interpreting laws applicable to complex transactions; and the unpredictability of enforcement of foreign judgments and foreign arbitral awards. Many Russian laws and regulations are construed in a way that provides for significant administrative discretion in application and enforcement. Unlawful, selective or arbitrary actions of the Russian Government have reportedly included the denial or withdrawal of licenses, sudden and unexpected tax audits, criminal prosecutions, and civil claims. Any of the above events may have a material adverse effect on our product development and results of operations.

 

Despite certain improvements in the taxation system made by the Russian Government over the past decade, Russian tax legislation is still subject to frequent change, varying interpretations, and inconsistent and selective enforcement. There are currently no clear rules for distinguishing between lawful tax optimization and tax evasion. In addition, Russian tax laws do not contain detailed rules on the taxation in Russia of foreign companies. As such, taxpayers often have to resort to court proceedings to defend their position against the Russian tax authorities. However, in the absence of consistent court practice or binding precedents, there is inconsistency amongst court decisions. Further, the possibility exists that the Russian Federation would impose arbitrary or onerous taxes and penalties in the future, which could have a material adverse effect on our product development and results of operations.

 

 34

 

 

Risks Related to Ownership of our Ordinary Shares

 

The market price for our ordinary shares may be volatile or may decline regardless of our operating performance.

 

The market price of our ordinary shares may be highly volatile and may fluctuate or decline substantially as a result of a variety of factors, many of which are beyond our control, including:

 

actual or anticipated changes or fluctuations in our results of operations;

 

  the guidance we may provide to analysts and investors from time to time, and any changes in, or our failure to perform in line with, such guidance;

 

  announcements by us or our competitors of new offerings or new or terminated contracts, commercial relationships or capital commitments;

 

  industry or financial analyst or investor reaction to our press releases, other public announcements, and filings with the SEC;

 

  rumors and market speculation involving us or other companies in our industry;

 

  future sales or expected future sales of our ordinary shares;

 

  investor perceptions of us and the industries in which we operate;

 

  price and volume fluctuations in the overall stock market from time to time;

 

  changes in operating performance and stock market valuations of other technology companies generally, or those in our industry in particular;

 

  failure of industry or financial analysts to maintain coverage of us, the issuance of new or updated reports or recommendations by any analysts who follow our company, or our failure to meet the expectations of investors;

 

  actual or anticipated developments in our business or our competitors’ businesses or the competitive landscape generally;

 

  litigation involving us, other companies in our industry or both, or investigations by regulators into our operations or those of our competitors;

 

  developments or disputes concerning our intellectual property or proprietary rights or our solutions, or third-party intellectual or proprietary rights;

  

  announced or completed acquisitions of businesses or technologies, or other strategic transactions by us or our competitors;

 

  actual or perceived breaches of, or failures relating to, privacy, data protection or data security;

 

  new laws or regulations or new interpretations of existing laws or regulations applicable to our business;

 

  actual or anticipated changes in our management or our board of directors;

 

  general economic conditions and slow or negative growth of our target markets; and

 

  other events or factors, including those resulting from war, incidents of terrorism or responses to these events.

 

 35

 

 

Furthermore, the stock market has experienced extreme volatility that in some cases has been unrelated or disproportionate to the operating performance of particular companies. These and other factors may cause the market price and demand for our ordinary shares to fluctuate substantially, which may limit or prevent investors from readily selling their shares and may otherwise negatively affect the liquidity of our ordinary shares. In addition, in the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted securities class action litigation against the company that issued the stock. If any of our shareholders were to bring a lawsuit against us, we could incur substantial costs defending the lawsuit. Such a lawsuit could also divert the time and attention of our management from our business. 

 

Our principal shareholders have significant influence over us.

 

As of March 3, 2025, our principal shareholders each holding more than 5% of our outstanding ordinary shares collectively beneficially own approximately 29.3% of our outstanding ordinary shares. See “Item 7.A. Major Shareholders”. These shareholders or their affiliates will be able to exert significant influence over us and, if acting together, will be able to control matters requiring shareholder approval, including the election of directors and approval of significant corporate transactions, including a merger, consolidation or sale of all or substantially all of our assets and the issuance or redemption of equity interests in certain circumstances. The interests of these shareholders may not always coincide with, and in some cases may conflict with, our interests and the interests of our other shareholders. For instance, these shareholders could attempt to delay or prevent a change in control of our company, even if such change in control would benefit our other shareholders, which could deprive our shareholders of an opportunity to receive a premium for their ordinary shares. This concentration of ownership may also affect the prevailing market price of our ordinary shares due to investors’ perceptions that conflicts of interest may exist or arise. As a result, this concentration of ownership may not be in your best interests.

  

Future sales of substantial amounts of our ordinary shares in the public markets, or the perception that such sales might occur, could reduce the price that our ordinary shares might otherwise attain.

 

Future sales of a substantial number of shares of our ordinary shares in the public market, particularly sales by our directors, executive officers and significant shareholders, or the perception that these sales could occur, could adversely affect the market price of our ordinary shares and may make it more difficult for you to sell your ordinary shares at a time and price that you deem appropriate.

 

In addition, we intend to register the offer and sale of all ordinary shares that we may issue from time to time under our equity compensation plans. Once we register these shares, they will be freely tradable in the public market, subject to the volume limitations under Rule 144 of the Securities Act in the case of our affiliates and the lock-up agreements or market stand-off provisions agreed with the representative of the underwriters in connection with our initial public offering on February 28, 2023.

 

Your ownership and voting power may be diluted by the issuance of additional shares of our ordinary shares in connection with financings, acquisitions, investments, our equity incentive plans or otherwise.

 

We have 222,000,000 ordinary shares authorized. Subject to compliance with applicable rules and regulations, we may issue ordinary shares or securities convertible into ordinary shares from time to time for the consideration and on the terms and conditions established by our board of directors in its sole discretion, whether in connection with a financing, acquisition, investment, our equity incentive plans or otherwise. As of December 31,2024, 15,518,794 ordinary shares were outstanding and we had 1,345,036 ordinary shares issuable upon the exercise of outstanding options at a weighted average exercise price of $2.95 per share, of which 641,851 were vested as of such date, warrants to purchase 153,367 ordinary shares and an additional 1,012,006 ordinary shares reserved for future issuance under our 2015 Plan. See “Item 6.C—Director, Senior Management and Employees—Compensation.” Any additional ordinary shares that we issue, including under our 2015 Plan or other equity incentive plans that we may adopt in the future, or in connection with the exercise of our warrants, would dilute the percentage ownership and voting power held by investors. In the future, we may also issue additional securities if we need to raise capital, including, but not limited to, in connection with acquisitions, which could constitute a material portion of our then-outstanding ordinary shares. Any such issuance could substantially dilute the ownership and voting power of our existing shareholders and cause the market price of our ordinary shares to decline. 

 

 36

 

 

Our management team has limited experience managing a public company, and the requirements of being a public company may strain our resources, divert management’s attention, and affect our ability to attract and retain qualified board members.

 

As a public company listed in the United States, we incur significant additional legal, accounting, and other expenses. In addition, changing laws, regulations, and standards relating to corporate governance and public disclosure, including regulations implemented by the SEC and The Nasdaq Stock Market LLC, or Nasdaq, may increase legal and financial compliance costs, and make some activities more time consuming. These laws, regulations and standards are subject to varying interpretations, and as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies.

 

Most members of our management team have no prior experience managing a publicly traded company, interacting with public company investors, and complying with the increasingly complex laws pertaining to public companies. Our management team may not successfully or efficiently manage our transition of becoming a public company that is subject to significant regulatory oversight and reporting obligations under the federal securities laws and the continuous scrutiny of securities analysts and investors. Furthermore, we are committed to maintaining high standards of corporate governance and public disclosure, and our efforts to establish the corporate infrastructure required of a public company and to comply with evolving laws, regulations and standards are likely to divert management’s time and attention away from revenue-generating activities to compliance activities, which may prevent us from implementing our business strategy and growing our business. Moreover, we may not be successful in implementing these requirements. If we do not effectively and efficiently manage our transition into a public company and continue to develop and implement the right processes and tools to manage our changing enterprise and maintain our culture, our ability to compete successfully and achieve our business objectives could be impaired, which could negatively impact our business, financial condition and results of operations.

 

Additionally, as a public company, we may from time to time be subject to proposals by shareholders urging us to take certain corporate actions. If activist shareholder activity ensues, we may be required to incur additional costs to retain the services of professional advisors, management time and attention will be diverted from our core business operations, and perceived uncertainties as to our future direction, strategy or leadership may cause us to lose potential business opportunities and impair our brand and reputation, any of which could materially and adversely affect our business, financial condition and results of operations.

 

In addition to increasing our legal and financial compliance costs, the additional rules and regulations described above might also make it more difficult for us to obtain certain types of insurance, including director and officer liability insurance, and we might be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified persons to serve on our board of directors, on committees of our board of directors or as members of our senior management team.

 

We are an “emerging growth company” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our ordinary shares less attractive to investors.

 

We are an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, our shareholders may not have access to certain information they may deem important. We cannot predict whether investors will find our securities less attractive because we intend to rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.

 

 37

 

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable.

 

We have elected to opt out of this extended transition period and, as a result, we are required to comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. Under federal securities laws, our decision to opt out of the extended transition period is irrevocable.

 

We may take advantage of these provisions until December 31, 2028 or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company upon the earlier to occur of: (1) the last day of the fiscal year in which we have total annual gross revenue of $1.235 billion or more; (2) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years; or (3) the date on which we are deemed to be a large accelerated filer under the rules of the SEC. We may choose to take advantage of some but not all of these reduced burdens, and therefore the information that we provide holders of our ordinary shares may be different than the information you might receive from other public companies in which you hold equity.

 

When we are no longer deemed to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS Act discussed above. We cannot predict if investors will find our ordinary shares less attractive as a result of our reliance on exemptions under the JOBS Act. If some investors find our ordinary shares less attractive as a result, there may be a less active trading market for our ordinary shares and our share price may be more volatile.  

  

We do not anticipate paying dividends on our ordinary shares in the foreseeable future. As a result, your ability to achieve a return on your investment will depend on appreciation in the price of our ordinary shares.

 

We have never declared or paid any cash dividends on our ordinary shares and do not anticipate paying any cash dividends on our ordinary shares in the foreseeable future. We anticipate that we will retain all of our available funds and any future earnings for use in the operation and expansion of our business and the repayment of outstanding debt. Any future determination as to the payment of cash dividends will be at the discretion of our board of directors and will depend on, among other things, our business prospects, financial condition, results of operations, current and anticipated cash needs and availability, industry trends and other factors that our board of directors may consider to be relevant. Our ability to pay cash dividends on our ordinary shares in the future may also be limited by the terms of any preferred securities we may issue or financial and other covenants in any instruments or agreements governing any additional indebtedness we may incur in the future. Consequently, investors who purchase ordinary shares may be unable to realize a return on their investment except by selling sell such shares after price appreciation, which may never occur. Our inability or decision not to pay dividends, particularly when others in our industry have elected to do so, could also adversely affect the market price of our ordinary shares.

 

 38

 

 

There can be no assurance that we will not be classified as a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S. Holders of our ordinary shares.

 

We would be classified as a passive foreign investment company, or PFIC, for any taxable year if, after the application of certain look-through rules, either: (i) 75% or more of our gross income for such year is “passive income” (as defined in the relevant provisions of the Internal Revenue Code of 1986, as amended, or the Code), or (ii) 50% or more of the value of our assets (generally determined on the basis of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive income. For these purposes, cash and other assets readily convertible into cash or that do or could generate passive income are categorized as passive assets, and the value of goodwill and other unbooked intangible assets is generally taken into account. Passive income generally includes, among other things, rents, dividends, interest, royalties, gains from the disposition of passive assets and gains from commodities and securities transactions. For purposes of this test, we will be treated as owning a proportionate share of the assets and earning a proportionate share of the income of any other corporation of which we own, directly or indirectly, at least 25% (by value) of the stock. Based on our market capitalization and the composition of our income, assets and operations, we believe that we were not a PFIC for the year ended December 31, 2024 and we do not expect to be a PFIC for United States federal income tax purposes for the current taxable year or in the foreseeable future. However, this is a factual determination that must be made annually after the close of each taxable year. Moreover, the value of our assets for purposes of the PFIC determination may be determined by reference to the public price of our ordinary shares, which could fluctuate significantly. In addition, it is possible that the Internal Revenue Service may take a contrary position with respect to our determination in any particular year, and therefore, there can be no assurance that we will not be classified as a PFIC in the current taxable year or in the future. Certain adverse consequences of PFIC status may be alleviated if a U.S. Holder (as defined below) makes a “mark to market” election or an election to treat us as a qualified electing fund, or QEF. These elections would result in an alternative treatment (such as mark-to-market treatment) of our ordinary shares. It is not expected that a U.S. Holder will be able to make a QEF election because we do not intend to provide U.S. Holders with the information necessary to make a QEF election. Certain adverse U.S. federal income tax consequences could apply to a U.S. Holder (as defined in “Certain Material U.S. Federal Income Tax Considerations”) if we are treated as a PFIC for any taxable year during which such U.S. Holder holds our ordinary shares. U.S. Holders should consult their tax advisors about the potential application of the PFIC rules to their investment in our ordinary shares. For further discussion, see “Item 10.E—Additional Information—Taxation—Certain Material U.S. Federal Income Tax Considerations—Passive Foreign Investment Companies.”

 

If a United States person is treated as owning at least 10% of our ordinary shares, such holder may be subject to adverse U.S. federal income tax consequences.

 

If a United States person is treated as owning (directly, indirectly, or constructively) at least 10% of the value or voting power of our ordinary shares, such person may be treated as a “United States shareholder” with respect to each controlled foreign corporation, or CFC, in our group (if any). Because our group includes a U.S. subsidiary, certain of our non-U.S. subsidiaries will be treated as CFCs (regardless of whether or not we are treated as a CFC). A United States shareholder of a CFC may be required to report annually and include in its U.S. taxable income its pro rata share of “Subpart F income,” “global intangible low-taxed income,” and investments in U.S. property by CFCs, regardless of whether we make any distributions. An individual that is a United States shareholder with respect to a CFC generally would not be allowed certain tax deductions or foreign tax credits that would be allowed to a United States shareholder that is a U.S. corporation. Failure to comply with these reporting obligations may subject a United States shareholder to significant monetary penalties and may prevent the statute of limitations with respect to such shareholder’s U.S. federal income tax return for the year for which reporting was due from starting. We cannot provide any assurances that we will assist investors in determining whether we are or any of our non-U.S. subsidiaries is treated as CFC or whether any investor is treated as a United States shareholder with respect to any such CFC or furnish to any United States shareholders information that may be necessary to comply with the aforementioned reporting and tax paying obligations. The United States Internal Revenue Service has provided limited guidance on situations in which investors may rely on publicly available information to comply with their reporting and tax paying obligations with respect to foreign-controlled CFCs. A United States investor should consult its advisors regarding the potential application of these rules to an investment in our ordinary shares. 

  

We incur significant increased costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives.

 

As a public company whose ordinary shares are listed in the United States, we incur significant legal, accounting and other expenses that we did not incur as a private company. We are subject to the reporting requirements of the Exchange Act, the other rules and regulations of the SEC, and the rules and regulations of Nasdaq and provisions of the Companies Law that apply to public companies such as us. The expenses that are required in order to be a public company are material and compliance with the various reporting and other requirements applicable to public companies require considerable time and attention of management. For example, the Sarbanes-Oxley Act and the rules of the SEC and national securities exchanges have imposed various requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls. Our management and other personnel devote a substantial amount of time to these compliance initiatives. These rules and regulations will continue to increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits on coverage or incur substantial costs to maintain the same or similar coverage. The impact of these events could also make it more difficult for us to attract and retain qualified personnel to serve on our board of directors, our board committees, or as executive officers.

 

 39

 

 

The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act,. In addition, we will be required to have our independent registered public accounting firm attest to the effectiveness of our internal control over financial reporting beginning with our annual report on Form 20-F following the date on which we are no longer an emerging growth company. Our compliance with Section 404 of the Sarbanes-Oxley Act will require that we incur substantial accounting expense and expend significant management efforts. We currently do not have an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. If we are not able to comply with the requirements of Section 404 in a timely manner, or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our shares could decline and we could be subject to sanctions or investigations by Nasdaq, the SEC or other regulatory authorities, which would require additional financial and management resources.

 

Our ability to successfully implement our business plan and comply with Section 404 requires us to be able to prepare timely and accurate financial statements. We expect that we will need to continue to improve existing, and implement new operational and financial systems, procedures and controls to manage our business effectively. Any delay in the implementation of, or disruption in the transition to, new or enhanced systems, procedures or controls, may cause our operations to suffer and we may be unable to conclude that our internal control over financial reporting is effective and to obtain an unqualified report on internal controls from our auditors as required under Section 404 of the Sarbanes-Oxley Act. This, in turn, could have an adverse impact on trading prices for our ordinary shares and could adversely affect our ability to access the capital markets.

 

If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, our shareholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our ordinary shares. 

 

Effective internal controls over financial reporting are necessary for us to provide reliable financial reports. Together with adequate disclosure controls and procedures, effective internal controls are designed to prevent fraud. Any failure to implement required new or improved controls or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses, may require prospective or retroactive changes to our financial statements, or may identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our ordinary shares.

  

We are required to disclose changes made in our internal controls and procedures on an annual basis and our management is required to assess the effectiveness of these controls annually. However, for as long as we are an “emerging growth company” under the Jumpstart Our Business Startups Act, or the JOBS Act, or a "non-accelerated filer" under SEC rules, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We could be an emerging growth company for up to the date that is the last date of the fiscal year that includes the fifth anniversary of our first sale of our common equity securities pursuant to an effective registration statement (i.e. December 31, 2023). An independent assessment of the effectiveness of our internal controls could detect problems that our management’s assessment might not. Undetected material weaknesses in our internal controls could lead to financial statement restatements and require us to incur the expense of remediation.

 

 40

 

 

We previously identified control deficiencies in our financial reporting process that constitute a material weakness for the years ended December 31, 2021 and 2022 which were primarily due to the fact that we were a private company prior to February 28, 2023. The material weakness were related to lack of sufficient internal accounting personnel, segregation of duties, lack of sufficient internal controls (including IT general controls, entity level controls and transaction level controls).

 

We took a number of measures to address the material weaknesses that have were identified, including the appointment of a Sarbanes Oxley consultant, or the SOX Consultant, for the provision of internal audit and Sarbanes Oxley advisory services during which time we have worked together with the SOX Consultant to build internal control processes and controls to ensure our internal control over financial reporting is effective. As of December 31, 2023, the material weaknesses in our internal control over financial reporting had been remediated and as of the years ended December 31, 2023 and 2024, we did not have material weaknesses. Except for additional personnel costs, the cost of systems and the costs of our third-party service providers, we do not expect to incur any material costs related to our remediation plan. See “Item 5.E — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Internal Control Over Financial Reporting.”

 

Although as of December 31, 2024, we did not have any material weaknesses in our internal control over financial reporting, there can be no assurance that we will not suffer from other material weaknesses in the future. If we fail to maintain effective internal controls over financial reporting in the future, such failure could result in a material misstatement of our annual or quarterly financial statements that would not be prevented or detected on a timely basis and which could cause investors and other users to lose confidence in our financial statements, limit our ability to raise capital and have a negative effect on the trading price of our ordinary shares. Additionally, failure to remediate the material weakness or otherwise maintain effective internal controls over financial reporting may also negatively impact our operating results and financial condition, impair our ability to timely file our periodic and other reports with the SEC, subject us to additional litigation and regulatory actions and cause us to incur substantial additional costs in future periods relating to the implementation of remedial measures.

 

Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.

 

We are subject to the periodic reporting requirements of the Exchange Act. We designed our disclosure controls and procedures to provide reasonable assurance that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

  

These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected.

 

If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our results of operations could fall below the expectations of securities analysts and investors, resulting in a decline in the trading price of our ordinary shares.

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. See “Item 5 –Operating and Financial Review and Prospects”, the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue, and expenses that are not readily apparent from other sources. Our results of operations may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our results of operations to fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our ordinary shares.

 

 41

 

 

Unfavorable conditions in our industry or the global economy or reductions in information technology spending could limit our ability to grow our business and negatively affect our results of operations.

 

Our results of operations may vary based on the impact of changes in our industry and the global economy on us and our customers. Current or future economic uncertainties or downturns could adversely affect our business, financial condition and results of operations. Negative conditions in the general economy both in the United States and abroad, including conditions resulting from changes in gross domestic product growth, financial, and credit market fluctuations, political turmoil, natural catastrophes, any pandemic, epidemic or outbreak of infectious disease, warfare, protests and riots, and terrorist attacks on the United States, Europe, the Asia Pacific region, or elsewhere, could cause a decrease in business investments by our customers and potential customers, including spending on information technology, and negatively affect the growth of our business. To the extent our offerings are perceived by customers and potential customers as discretionary, our revenue may be disproportionately affected by delays or reductions in general information technology spending. Also, customers may choose to develop in-house software as an alternative to using our offerings. Moreover, competitors may respond to market conditions by lowering prices. We cannot predict the timing, strength or duration of any economic slowdown, instability or recovery, generally or within any particular industry. If the economic conditions of the general economy or markets in which we operate do not improve, or worsen from present levels, our business, financial condition and results of operations could be adversely affected. 

 

The estimates of market opportunity and forecasts of market growth included in this Annual Report may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our business could fail to grow at similar rates, or at all.

 

The estimates of market opportunity and forecasts of market growth included in this Annual Report may prove to be inaccurate. Market opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate, including as a result of any of the risks described in this Annual Report.

 

In addition, the variables that go into the calculation of our market opportunity are subject to change over time, and there is no guarantee that any particular number or percentage of addressable users or companies covered by our market opportunity estimates will purchase our offerings or generate any particular level of revenue for us. In addition, our ability to expand in any of our target markets depends on a number of factors, including the cost, performance, and perceived value associated with our platform and those of our competitors. Even if the markets in which we compete meet the size estimates and growth forecasted in this Annual Report, our business could fail to grow at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many risks and uncertainties. Accordingly, the forecasts of market growth included in this Annual Report should not be taken as indicative of our future growth.

 

If industry or financial analysts do not publish research or reports about our business, or if they issue inaccurate or unfavorable research regarding our ordinary shares, the market price and trading volume of our ordinary shares could decline.

 

The trading market for our ordinary shares is influenced by the research and reports that industry or financial analysts publish about us and our business. We do not control these analysts or the content and opinions included in their reports. As a new public company, we may be slow to attract research coverage and the analysts who publish information about our ordinary shares will have had relatively little experience with our company, which could affect their ability to accurately forecast our results and make it more likely that we fail to meet their estimates. In the event we obtain industry or financial analyst coverage, if any of the analysts who cover us issues an inaccurate or unfavorable opinion regarding our company, the market price of our ordinary shares would likely decline. In addition, the share prices of many companies in the technology industry have declined significantly after those companies have failed to meet, or significantly exceed, the financial guidance they have publicly announced or the expectations of analysts and investors. If our financial results fail to meet, or significantly exceed, our announced guidance or the expectations of analysts or investors, analysts could downgrade our ordinary shares or publish unfavorable research about us. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, our visibility in the financial markets could decrease, which in turn could cause the market price or trading volume of our ordinary shares to decline.

 

 42

 

 

ITEM 4. INFORMATION ON THE COMPANY

 

A. History and Development of the Company

 

We are a leading innovator of video encoding, transcoding and optimization solutions that enable high-quality, high-performance, and unmatched bitrate efficiency for video and images. With our Emmy®-winning patented technology and award-winning services, we help our customers realize the potential of video encoding and media optimization to address business-critical challenges. Our customers include tier one OTT, content distributors, video streaming platforms, and Hollywood studios who rely on our suite of products and expertise to reduce the cost and complexity associated with storing, distributing and monetizing video and images across devices.

 

At the heart of our patented optimization technology is the proprietary BQM, that is highly correlated with the human visual system. BQM is integrated into our CABR, system which together maximizes quality and removes visual redundancies resulting in a smaller file size. The BQM has excellent correlation with subjective results, confirmed in testing under ITU BT.500, an international standard for rigorous testing of image quality. The perceptual quality preservation of CABR has been repeatedly verified using large scale crowd-sourcing based testing sessions, as well as by industry leaders and studio “golden eyes”.

 

We currently license three core video and image compression products that help our customers use video and images to further their businesses in meaningful ways: (1) a suite of video compression software encoder solutions including the Beamr 4 H.264 encoder, Beamr 4X H.264 content adaptive encoder, Beamr 5 HEVC encoder and the Beamr 5X HEVC content adaptive encoder, and (2) Beamr JPEGmini photo optimization software solutions for reducing JPEG file sizes.

 

In February 2024, we launched Beamr Cloud, our video SaaS solution. It is a cloud based CABR solution, accelerated by NVIDIA GPUs. We launched Beamr Cloud, and constantly improving it, to allow end-users from emerging markets to enjoy significant storage and networking cost savings by 30%-50%. Our service also enables easy-to-use, efficient and scalable upgrade of video libraries to advanced video formats (codec modernization).

 

Our Cloud Video SaaS was initially operating over and integrated with AWS. In February 2025, Beamr Cloud also joined the AWS ISV Accelerate program, a global co-sell initiative for AWS partners, while demonstrating strong alignment with AWS’s go-to-market strategies and initiatives. Before that, in June 2024, Beamr Cloud achieved Powered by Expertise and became available in the Oracle Cloud Marketplace for OCI customers, with plans to extend our services to other cloud platforms.

 

In July 2024, Beamr Cloud was integrated with its first AI capability to allow for automatic caption and transcription generation for videos in multiple languages. During the second half of 2024, we incorporated additional customer feedback by enhancing Beamr Cloud’s core functionality, making it ready for adoption at scale, which includes giving users more control over the compression process using custom presets and adding packaging for streaming.

 

We will continue to invest significant efforts in augmenting our service with more AI-driven capabilities, to address the specific needs of customers in markets such as media and entertainment, user-generated content, autonomous vehicles, machine learning and more, all of which rely on video as a core component of their business operations and can benefit from our offering of GPU-accelerated, high-quality and AI-driven video pipelines, whether deployed via cloud platforms such as AWS and OCI, private cloud environments for enterprises, or on-premises infrastructure.

  

Our legal and commercial name is Beamr Imaging Ltd. We were incorporated in Israel on October 1, 2009 under the name I.C.V.T Ltd. On January 11, 2015, we changed our name to Beamr Imaging Ltd.

 

We have two wholly owned subsidiaries: Beamr, Inc. and Beamr Imaging RU LLC. Beamr, Inc. is our wholly owned subsidiary incorporated in 2012 in the State of Delaware. Beamr, Inc. is engaged in reselling our software and products in the U.S. and Canada. Beamr Imaging RU LLC is our wholly owned subsidiary, a limited Russian partnership formed in 2016. Beamr Imaging RU LLC is engaged in research and development for us.

 

 43

 

 

On February 27, 2023, our ordinary shares were approved for trading on the Nasdaq Capital Market under our ticker symbol “BMR” and began trading at the open of market on February 28, 2023.

 

Our principal office is located at 10 HaManofim Street, Herzeliya, 4672561, Israel, and our telephone number is +1-888-520-8735. Our primary internet address is https://beamr.com/. None of the information on our website is incorporated by reference herein. Our wholly-owned subsidiary, Beamr, Inc., serves as our agent for service of process in the United States for certain limited matters, and its address is 16185 Los Gatos Blvd, Ste 205, Mailbox 12, Los Gatos, CA 95032.

 

We use our website (https://beamr.com/) as a channel of distribution of Company information. The information we post on our website may be deemed material. Accordingly, investors should monitor our website, in addition to following our press releases, SEC filings and public conference calls and webcasts. The contents of our website are not, however, a part of this Annual Report.

 

We are an emerging growth company, as defined in Section 2(a) of the Securities Act, as implemented under the JOBS Act. As such, we are eligible to, and intend to, take advantage of certain exemptions from reporting requirements that generally apply to public companies, including the auditor attestation requirements with respect to internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act, compliance with new standards adopted by the Public Company Accounting Oversight Board which may require mandatory audit firm rotation or auditor discussion and analysis, exemption from say on pay, say on frequency, and say on golden parachute voting requirements, and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We will be an emerging growth company until the earliest of: (i) the last day of the fiscal year during which we had total annual gross revenues of $ $1.235 billion or more, (ii) the last day of the fiscal year following the fifth anniversary of the date of the first sale of the ordinary shares pursuant to an effective registration statement (i.e., December 31, 2028), (iii) the date on which we have, during the previous three-year period, issued more than $1 billion in non-convertible debt, or (iv) the date on which we are deemed a “large accelerated filer” as defined in Regulation S-K under the Securities Act, which means the market value of our ordinary shares that is held by non-affiliates exceeds $700 million as of the prior June 30th. 

 

We report under the Exchange Act as a non-U.S. company with foreign private issuer status. Even after we no longer qualify as an emerging growth company, as long as we continue to qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including:

 

  the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations with respect to a security registered under the Exchange Act;

 

  the sections of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and

 

  the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial statements and other specified information, and current reports on Form 8-K upon the occurrence of specified significant events.

 

We are required to file an annual report on Form 20-F within four months of the end of each fiscal year. In addition, we intend to publish our results on a quarterly basis through press releases, distributed pursuant to the rules and regulations of the Nasdaq. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or information, which would be made available to you, were you investing in a U.S. domestic issuer.

 

We may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We would cease to be a foreign private issuer at such time as more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (i) the majority of our executive officers or directors are U.S. citizens or residents; (ii) more than 50% of our assets are located in the United States; or (iii) our business is administered principally in the United States.

 

 44

 

 

Both foreign private issuers and emerging growth companies are also exempt from certain more stringent executive compensation disclosure rules. Thus, even if we no longer qualify as an emerging growth company, but remain a foreign private issuer, we will continue to be exempt from the more stringent compensation disclosures required of companies that are neither an emerging growth company nor a foreign private issuer.

 

B. Business Overview

 

Overview

 

We are a leading innovator of video encoding, transcoding and optimization solutions that enable high-quality, high-performance, and unmatched bitrate efficiency for video and images. With our Emmy®-winning patented technology and award-winning services, we help our customers realize the potential of video encoding and media optimization to address business-critical challenges. Our customers include tier one OTT, content distributors, video streaming platforms, and Hollywood studios who rely on our suite of products and expertise to reduce the cost and complexity associated with storing, distributing and monetizing video and images across devices.

 

At the heart of our patented optimization technology is the proprietary BQM, that is highly correlated with the human visual system. BQM is integrated into our CABR, system which together maximizes quality and removes visual redundancies resulting in a smaller file size. The BQM has excellent correlation with subjective results, confirmed in testing under ITU BT.500, an international standard for rigorous testing of image quality. The perceptual quality preservation of CABR has been repeatedly verified using large scale crowd-sourcing based testing sessions, as well as by industry leaders and studio “golden eyes”.

 

We currently license three core video and image compression products that help our customers use video and images to further their businesses in meaningful ways: (1) a suite of video compression software encoder solutions including the Beamr 4 H.264 encoder, Beamr 4X H.264 content adaptive encoder, Beamr 5 HEVC encoder and the Beamr 5X HEVC content adaptive encoder, (2) Beamr JPEGmini photo optimization software solutions for reducing JPEG file sizes.

 

Until recently, our current product line was mainly geared to the high end, high quality media customers and we count among our enterprise customers Netflix, Snapfish, Paramount, TAG, VMware, Genesys, Deluxe, Encoding.com, Citrix, Walmart, Photobox, Antix, Dalet, and other leading media companies using video and photo solutions. Due to the high cost and complexity of deploying our existing software solutions and the long sales lead times, we have made a strategic decision to focus our resources on the development and commercialization of our next-generation product, the Beamr Cloud solution, a SaaS solution that is designed, based on our own internal testing, to be up to 10x more cost efficient than our existing software-based solutions, resulting in reduced media storage, processing and delivery costs.

 

We collaborated with NVIDIA, a multinational technology company and a leading developer of GPUs, with an annual revenue of $130.5 billion for the fiscal year 2025, to develop the Beamr Cloud SaaS solution, the world’s first GPU-accelerated encoding solution powered by our CABR, which allows fast and easy end-user deployment combined with superior video compression rates, as well as enriching the video with AI-powered in real time with the transcoding process, increasing the value and efficiency of our services. Our CABR software executes directly on NVIDIA GPU cores and interacts with the NVIDIA video accelerator encoder known as NVENC. NVIDIA NVENC is a high-quality, high-performance hardware video encoder that is built into most NVIDIA GPUs. NVENC offloads video encoding to hardware, and provides extreme performance for applications such as live video encoding, cloud gaming and cloud storage. NVIDIA GPUs with NVENC are available on all major cloud platforms. We plan to further collaborate with NVIDIA on enhancing the capabilities of our Beamr Cloud SaaS solution.

 

The first version of the integrated video optimization engine was ready at the end of the first quarter of 2023. Following this, we launched the first beta version of the cloud based SaaS platform and began testing it with beta customers in June 2023. After the initial release, we launched the second and third beta versions of the cloud based SaaS platform in September 2023 and October 2023, respectively, as we built up to the commercial launch of the platform. Following that, we commercially launched our Beamr Cloud SaaS solution in February 2024 and expect that end-users of the solution will enjoy significant end-user storage and networking cost savings, by 30%-50%. Using the Beamr Cloud SaaS solution will potentially reduce their return on investment for storage optimization to approximately four months, compared to approximately two years with our existing software encoder solutions. Our Beamr Cloud SaaS solution, accelerated by NVIDIA GPUs, was initially operating over and integrated with AWS. In February 2025, Beamr Cloud also joined the AWS ISV Accelerate program, a global co-sell initiative for AWS partners, while demonstrating strong alignment with AWS’s go-to-market strategies and initiatives. In June 2024, Beamr Cloud achieved Powered by Expertise and became available in the Oracle Cloud Marketplace for OCI customers, with plans to extend our services to other cloud platforms.

 

 45

 

 

 

Financing and Product Launch in February 2024

 

Following our initial public offering on the Nasdaq that closed in March 2023, on February 15, 2024, we closed our public offering of 1,971,300 ordinary shares, which included the full exercise of the underwriter’s over-allotment options at a public offering price of $7.00 per share, for aggregate gross proceeds of $13.8 million prior to deducting underwriting discounts and other offering expenses. As a result of our February 2024 offering, we have been able to accelerate our product launch plans and have already met our second quarter milestones with respect to the Beamr Cloud SaaS solution, which included completing certain features, such as codec modernization and resize transformations, and now we started working on offering additional capabilities, such as AI-specific workflows that are optimized for ML and AI in an effort to position ourselves to be at the forefront of innovation in the video processing landscape for different AI purposes. As a result, we are currently executing on our third quarter 2024 milestones in order to further develop and commercializes our SaaS solution by further investing in our sales and marketing activities, including potential customer acquisition costs, and research and development activities.

 

 46

 

 

 

Our Business Strengths

 

We believe that the following business strengths differentiate us from our competitors and are key to our success:

 

  We are a recognized video compression market leader. In January 2021 we were recognized with an Emmy® Award for the “Development of Open Perceptual Metrics for Video Encoding Optimization” and in November 2021 we won the Seagate Lyve Innovator of the Year competition. We have over 50 patents, and count among our customers leading content distributors including Netflix and Paramount.

  

  Strong value proposition. We believe our existing video compression encoding solutions are among the fastest software video encoders on the market and provide a lower total cost-of-ownership to our customers by reducing media storage, processing and delivery costs. Our SaaS solution, the Beamr Cloud, performance is up to 10x more cost efficient than our existing software-based solutions, resulting in even greater reduced costs, based on our own internal testing, media storage, processing and delivery costs.

 

  Partnering with leading technology giants to enable the adoption of our video compression solutions. We offer industry proven video optimization solutions and are collaborating in product development with industry giants such as NVIDIA, that provide incremental improvements to existing products without having to reinvent the wheel.

 

  Core technology is powered by proprietary content-adaptive quality measure. Our CABR technology, built over our proprietary BQM, achieves maximal compression of the video input while maintaining the input video resolution, format, and visual quality. The CABR powers our existing video compression encoders as well as our SaaS solution, the Beamr Cloud, in development. The BQM has excellent correlation with subjective results, confirmed in testing under ITU BT.500, an international standard for rigorous testing of image quality. The perceptual quality preservation of CABR has been repeatedly verified using large scale crowd-sourcing based testing sessions, as well as by industry leaders and tier one Hollywood studios “golden eyes”.

 

  Our management team has experience building and scaling software companies. Our visionary and experienced management team with best-in-class research and development, or R&D, capabilities and in-depth industry backgrounds and experiences has been leading us since our inception. Members of our senior leadership team have held senior product, business and technology roles at companies such as Comverse, Wix and Amdocs. Sharon Carmel, our founder and Chief Executive Officer, is a serial entrepreneur with a proven track record in the software space having co-founded Emblaze (LON: BLZ), which developed the Internet’s first vector-based graphics player, preceding Macromedia Flash, and BeInSync, which developed P2P synchronization and online backup technologies, and was acquired in 2008 by Phoenix Technologies (NASDAQ: PTEC).

 

 47

 

 

  Ongoing customer-driven development. Through our account managers, support teams, product development teams and regular outreach from senior leadership, we solicit and capture feedback from our customer base for incorporation into ongoing enhancements to our solutions. We regularly provide our customers with enhancements to our products.

 

 

Our Market Opportunity

 

According to Fortune Business Insights, the global cloud video storage market is projected to grow from $10.28 billion in 2024 to $49.75 billion in by 2032, at a compound annual growth rate, or CAGR, of 21.8% during the forecast period.

  

The fact that the video data is often required to be stored and accessed forever cannot be ignored for long periods. This brings about the problem of lifetime costs associated with the efficient storing and managing of data. While the upfront cost might appear manageable but over a period, the rise in data volumes might require organizations to result in the need to pay more in the future to keep the data in the cloud. In today’s environment, with deployment of media and entertainment, user generated content, AI video, Internet-of-Things, enterprise video, industrial solutions, autonomous vehicles, surveillance and smart cities, as well as video created by Generative AI, we believe that the usage of video and its storage on public cloud platforms is expected to increase exponentially and we believe existing solutions are not suitable for large volume storage optimization.

 

 48

 

 

 

Our Growth Strategies

 

We intend to pursue the following growth strategies:

 

  Commercialize, further develop and gain broad market acceptance for our SaaS solution. We collaborated with NVIDIA in the development of our Beamr Cloud SaaS solution. It provides a simple, easily deployable, fast, scalable, low cost and best-in-class video optimization solution resulting in reduced media storage, processing and delivery costs by 30% to 50%. Our Beamr Cloud SaaS solution is currently available through AWS and OCI, and we plan to make our next generation SaaS solution available through additional public cloud services, such as Azure and GCP, allowing us to potentially access and acquire large numbers of new customers with relatively low sales investment. According to Synergy Research Group estimates, Amazon, Microsoft and Google accounted for 65% of the total cloud spend in the first quarter of 2023.

 

  Expand business growth through collaborations and partnerships with industry-leading solution providers in new verticals. We are currently collaborating with NVIDIA and plan to expand our collaborations to develop further market-leading products. We believe that our GPU-accelerated CABR powered video optimization solutions have broad application to a wide array of verticals including UGC, internet of things, AI video, public safety, smart cities, education, enterprise, autonomous vehicles, government and media and entertainment.

  

  Continue to innovate and develop new products and features. We continue to invest in research and development to enhance our product offerings and release new products and features. We maintain close relationships with our customer base who provide us with frequent and real-time feedback, which we leverage to rapidly update and further improve our products.

 

  Selectively Pursue Acquisitions and Strategic Investments. While we have not identified any specific targets, we plan to selectively pursue acquisitions and strategic investments in businesses and technologies that strengthen our products, enhance our capabilities and/or expand our market presence in our core vertical markets. In 2016, we acquired Vanguard Video, a leading developer of software encoders.

 

 49

 

 

Our CABR System

 

At the heart of our patented optimization technology is the proprietary BQM, a novel, efficient and reliable quality evaluation algorithm which is highly correlated with the human vision system. The CABR technology, with the BQM at its core, allows encoders to make smarter, quality driven, encoding decisions. CABR is a closed-loop content-adaptive rate control mechanism enabling video encoders to lower the bitrate of their encode, while simultaneously preserving the perceptual quality of the higher bitrate encode. An integrated CABR encoding solution consists of a video encoder and the CABR rate control engine. The CABR engine comprises the CABR control module responsible for managing the optimization process and a module which evaluates video quality. The video encoder first encodes a frame using a configuration based on its regular rate control mechanism, resulting in an initial encode. Then, Beamr’s CABR rate control instructs the encoder to encode the same frame again with various values of encoding parameters, creating candidate encodes. Using the BQM, each candidate encode is compared with the initial encode, and then the best candidate is selected and placed in the output stream. The best candidate is the one that has the lowest bitrate but still has the same perceptual quality as the initial encode. Due to very efficient control algorithms, only approximately 1.5-2 iterations are required on average to find the best candidate. Combined with the real-time oriented design of BQM, and the possibility to reuse encoding decisions from the initial encode, the impact on overall performance is quite manageable. For live or low-latency encoding, there is also a mode supporting single iteration optimization, which performs a single iteration per frame only, still guaranteeing the quality preservation, occasionally at the cost of slightly reduced bitrate savings.

 

The following is a depiction of the CABR system showing how the BQM interacts with a video encoder.

 

 

 50

 

 

In testing, BQM demonstrated higher correlation with subjective results than other quality measures such as PSNR and SSIM. In user testing, under ITU BT.500, an international standard for testing image quality, the correlation of our BQM with subjective (human) results was, in our opinion, very high.

  

Beamr’s CABR technology was integrated as a new rate control mechanism into our software H.264 and HEVC encoders. With regular VBR encoding, the user of the encoder sets a target bitrate, and the resulting bitrate of the encoded video will be that target bitrate. With CABR encoding, the user also sets a target bitrate, but the resulting bitrate of the encoded video will be lower than that target. The video will be encoded to the lowest possible bitrate that is still perceptually identical to a VBR encode at that target bitrate. CABR with BQM can also be used to optimize an input video stream, by removing redundancies and creating an equivalent, lower bitrate, perceptually identical output video stream. Alternatively, a user may set the encoder to a target quality level using constant QP or CSQ encoding modes. When applying CABR over that the same quality will be obtained while reducing bitrate as much as possible.

 

As seen in the two graphs below, for VBR encoding the actual average bitrate of the encoded clip is very similar to the requested target bitrate. For CABR encoding, the actual bitrate of the encoded clips is lower than the requested target bitrate. The difference between the requested target bitrate (dotted line) and the actual encoded CABR bitrate (blue line) is the bitrate savings. As seen in the graphs, the bitrate savings increase as the target bitrate increases, since for higher target bitrates there is more redundancy present in the encoded stream, redundancy which CABR removes.

 

 

 51

 

 

 

Ultimately, Beamr’s CABR system enables the bitrate of video files to be reduced by up to 50% over the current state of the art standard compliant block based encoders, without compromising video frame quality, bitstream standard compliance or changing the artistic intent. We believe that a source video and a Beamr-optimized video viewed side-by-side will look exactly the same to the human eye. 

 

 

Beamr has integrated the CABR engine into its AVC software encoder, Beamr 4, and into its HEVC software encoder, Beamr 5. It has also been integrated into Nvidia NVENC H/W accelerated GPU encoder for AVC, HEVC and AV1 encoding. Similarly, the CABR engine can be integrated with any software or hardware video encoder, supporting any block-based video standard such as AVC (the most popular video standard supported on almost all end user devices), HEVC (the leading 4K video standard available on almost all 4K televisions), and AV1 (the emerging royalty-free standard led by Google, Apple, Microsoft, Intel and many others which is used on Netflix, Youtube and Vimeo). In addition, CABR with BQM can be used to optimize an input video stream, by removing redundancies and creating an equivalent, lower bitrate, perceptually identical output video stream. In this case no initial encode is performed, and the iterative process is applied so that the encoded or optimized frame will provide the same visual quality as the corresponding input video frame. One application of this mode is codec modernization, where the optimized encode employs a codec with higher compression efficiency compared to the codec used for the input video. This allows for automatic seamless transition to modern codecs offering better compression efficiencies, or lower bitrates / smaller files for the same quality.

 

 52

 

 

Our Product Offerings

 

Beamr Cloud: High-Efficiency, High-Quality, GPU-Accelerated and Video AI Enabler

 

We collaborated with NVIDIA, a leading developer of GPUs, to develop the world’s first GPU-accelerated encoding solution that allows fast and easy end-user deployment combined with superior video compression rates powered with our CABR rate control and BQM quality measure. As GPUs are the pixel domain of AI, our service offers the unique advantage of enriching the video with AI-driven capabilities during the same transcoding process – adding more efficiency to companies that already use AI video workflows or plan to adopt such processes.

 

Our BQM quality measure software executes directly on NVIDIA GPU cores and interacts with the NVIDIA video accelerator encoder known as NVENC. NVIDIA NVENC is a high-quality, high-performance hardware video encoder that is built into most NVIDIA GPUs. NVENC offloads video encoding to hardware, and provides extreme performance for applications such as live video encoding, cloud gaming and cloud storage. NVIDIA GPUs with NVENC are available on all major cloud platforms.

 

Our current product line of CABR software encoders used to run only on the CPU. In proof of concept tests with both Intel and NVIDIA, we have demonstrated that when our CABR is offloaded from the CPU to the GPU, the cost/performance ratio is up to 10x better than on the CPU.

 

To accommodate Beamr’s content-adaptive GPU accelerated encoding solution, NVIDIA modified the API of the NVENC. On March 27, 2023, we announced that our content adaptive technology officially supports NVIDIA GPU acceleration, which was a major milestone for us. Offloading CABR-based video encoding from the CPU to the GPU enabling low-cost, high resolution, real time CABR encoding.

 

In June 2023, we launched our first beta version of our video optimization cloud service.

  

In September 2023, we released our second beta version of our video optimization cloud service, which included a new API that empowers customers to automate large-scale video optimization in the cloud.

 

In October 2023, we announced the release of the third beta version of our video optimization cloud service and that our solution is powered by NVIDIA NVENC GPUs, which, coupled with our CABR, offers accelerated storage optimization at scale.

 

In February 2024, we launched the Beamr Cloud SaaS solution (the Beamr Cloud). We have managed to complete certain features, such as codec modernization and resize transformations, which will upgrade the user video to the latest standard, such as HEVC and eventually to AV1, while further decreasing file size and optimizing source quality. In June 2024, Beamr Cloud achieved Powered by Expertise and became available in the Oracle Cloud Marketplace for OCI customers.

 

In July 2024, Beamr Cloud was integrated with its first AI capability to allow for automatic caption and transcription generation for videos in multiple languages. During the second half of 2024, we incorporated additional customer feedback by enhancing Beamr Cloud’s core functionality, making it ready for adoption at scale, which includes giving users more control over the compression process using custom presets and adding packaging for streaming.

 

In 2025, we plan to offer additional capabilities, such as additional AI-specific workflows, in an effort to position ourselves to be at the forefront of innovation in the video processing landscape for different AI purposes. As GPU-accelerated service, we can offer to enhance videos with AI-driven capabilities during the transcoding process, enabling fast, efficient and scalable AI-driven pipelines.

 

 53

 

 

We believe the Beamr Cloud SaaS solution provides a simple, easily deployable, fast, scalable, low cost and best-in-class video optimization solution resulting in reduced media storage, processing and delivery costs. We initially plan to offer our Beamr Cloud SaaS solution through public cloud data services that utilize NVIDIA GPUs (e.g., AWS, Microsoft Azure, GCP, OCI) allowing us to potentially access and acquire large numbers of new customers with relatively low sales investment. Our Beamr Cloud SaaS solution is currently operating over and integrated with AWS with plans to extend our services to other cloud platforms (e.g., Microsoft Azure, GCP, OCI).

 

We initiated the collaboration with NVIDIA on developing the Beamr Cloud SaaS solution in January 2021. Our collaboration with NVIDIA is based on a mutual development program that is in advanced stages and that has been approved at senior levels at NVIDIA. While our collaboration has not been reduced to a written agreement, we believe that NVIDIA has a commercial incentive to complete the development and deploy the software update that enables the CABR powered NVENC because of the superior video compression rates of the NVENC when combined with our CABR solution. Since commencing the collaboration, we have successfully completed the following steps: (i) demonstrated proof of concept; (ii) jointly defined the required frame-level APIs that enable our CABR system to determine the optimal tradeoff between bitrate and quality; (iii) NVIDIA has approved the plan of record; (iv) NVIDIA completed delivery of the first version of the APIs; (v) we verified implementation of the APIs that result in significant reduction of the bitrate of video streams; (vi) in December 2022, we received a pre-final implementation from NVIDIA showing major progress, an indication that the work is close to completion; (vii) in March 2023, NVIDIA released the first version of the integrated video optimization engine; and (viii) in May 2023, NVIDIA released Video Codec SDK 12.1, which is the newest version of the integrated video optimization engine. We plan to further collaborate with NVIDIA on further development of our the Beamr Cloud SaaS solution.

 

We commercially launched our cloud based SaaS solution in February 2024 and expect that end-users of the solution will enjoy significant end-user storage and networking cost savings, by 30%-50%. In August 2024, we announced our improved pricing model for the SaaS offering, including one-time packages as well as monthly or annual subscriptions, which is attributed to the combined NVIDIA and Beamr efficiencies and accelerated video processing solutions, which allows for large scale video optimization. In addition, Beamr offers enterprise dedicated pricing plans and integrations.

 

Below is an illustrative expected cost savings calculator of the Beamr Cloud from the Company’s homepage.

 

 

 54

 

 

Following integration into the NVIDIA GPU, we believe the Beamr Cloud SaaS solution provides the following key benefits including:

 

  Attractive return on investment. In August 2024, we announced our improved pricing model for the SaaS offering, including one-time packages as well as monthly or annual subscriptions, which is attributed to the combined Nvidia and Beamr efficiencies and accelerated video processing solutions, which allows for large scale video optimization. In addition, Beamr offers enterprise dedicated pricing plans and integrations.

 

  Fast set-up. The Beamr Cloud SaaS solution is deployable in a self-service no code installation process within minutes without any specialized hardware or need to download third-party software, allowing new users to quickly derive value without any specialized training or heavy implementation or customization.

 

  Easy to use. The Beamr Cloud SaaS solution has an intuitive interface that can be easily navigated by even first-time users. Our solution removes the need for video-specific expertise and high-touch user support and troubleshooting.

 

  AI-Driven capabilities The Beamr Cloud SaaS solution enables companies with large volumes of videos who already use AI-driven enrichment or plan to do that – a high-efficiency and cost-effective way to achieve this goal.

 

  Cloud agnostic and scalable. Our Beamr Cloud SaaS solution is highly scalable and designed to be deployable across all environments employing NVIDIA GPUs, including public cloud, private cloud, on-premise and multi-cloud hybrid environments.

 

  Security. By using public cloud platforms best security practices, we address our customers security concerns.

 

  Reducing carbon footprint. Smaller video files means less disk space occupied and smaller files transferred over the network from one place to another. This in turn results in lower energy consumption, which we believe is going to be an accelerator for our service adoption.

 

Using our content adaptive bit rate solution, we estimate end users will be able to save up to 50% of their video storage costs and an average of 30% in their cost of video public cloud storage, which, based on 2020 amounts, according to Fortune Business Insights, currently stands at $9 billion.

 

In December 2023, we released a white paper to share the results of our analysis which examined how our CABR storage optimization solution can be used to assist in cutting down the sizes of video used in the context of ML. AI, Generative AI and ML for video processing are fields which are expanding at a fast pace and presents significant untapped potential. ML is an artificial intelligence field where algorithms use statistics to find patterns in data from small to massive amounts. Generative AI is artificial intelligence capable of generating text, images, or other media, using generative models. Generative AI models learn the patterns and structure of their input training data and then generate new data that has similar characteristics. According to Fortune Business Insights, the global deep learning market size, which includes AI, Generative AI and ML, is projected to grow from $17.60 billion in 2023 to $188.58 billion by 2030, at a CAGR of 40.3% during the forecast period. As part of the experiment, we collect a set of 14 user-generated content video clips, from various sources including a few different iPhone models. These source files were then optimized using our CABR storage optimization solution to obtain files that were reduced in size by 9 – 73%, with an average reduction of 40%. We found that the mean average precision is high, and that true detection results are indeed unaffected by replacing the source file with the smaller, easier-to-transfer, optimized file. When detections are stable, almost identical results will be obtained for the source and optimized clips.

 

 55

 

 

In August 2024, we announced our improved pricing model for the SaaS offering, including one-time packages as well as monthly or annual subscriptions, which is attributed to the combined Nvidia and Beamr efficiencies and accelerated video processing solutions, which allows for large scale video optimization. In addition, Beamr offers enterprise dedicated pricing plans and integrations. Based on the estimation that the global cloud video storage market is projected to grow to $13.5 billion in 2025, we anticipate that average savings are expected to be approximately 30% or $4.05 billion. This results in each 1% of savings creating $40.5 million of value. Based on our current pricing model, each 1% of savings can translate into approximately $13.36 million of potential revenues to us. The above projections are subject to a number of assumptions, including, but not limited to: (1) we may choose to change our plans to attract additional customers; (2) we have no data as to what our market penetration will be, which can be below 1% or a multiple percentage; (3) the potential revenue is calculated using standard pricing from AWS; (4) our SaaS operation is based on spreads in which we first pay AWS for computing platforms and then sell storage and bandwidth savings; and (5) our SaaS profit is dependent on a number of factors, including, but not limited to, the overall service efficiency. 

 

In October 2024, we announced a collaboration with Bridge Digital Inc., or Bridge Digital, a proven video technology integrator, to offer a specialized service for companies and organizations with large-scale video repositories, including news, sports, entertainment and user-generated content for delivery and distribution that enables companies that rely on video for their daily operations or manage vast video libraries to achieve “Forever Video”, future-proofing their content to ensure long-term compatibility through efficient, automatic, and scalable processes, all while significantly reducing costs.

 

Below is the Beamr Home page overview, playground feature and AI Generated Transcription.

 

Beamr Cloud Home Page

 

The Home page serves as a centralized dashboard that provides users with a snapshot of their current video encoding operations and efficiency statistics (the value the Beamr Cloud creates).

 

 

 56

 

 

Illustration of Playground Page

 

The ‘Playground’ feature is an automation tool that will be released in the Beamr Cloud platform designed to simplify and streamline the process of video optimization and conversion. It will provide seamless integration with cloud storage services, starting with AWS S3, and offer extensive customization options for various video processing requirements.

 

 

 57

 

 

Illustration of AI Generated Transcription

 

 

 

Video Compression Software Encoder Solutions

 

Beamr 4 AVC Encoder

 

Beamr4 is our fully standard compliant AVC (H.264) video encoder. This encoding standard is still the primary format used in video applications across the market. While the decoder and bitstream are fully defined by the standard, video coding standards do not define the encoder, and this is completely up to the implementation ingenuity. At Beamr we have spent many years perfecting our encoder, resulting in an efficient, high performance, high quality AVC encoder, which enables using less computation to achieve the same compression efficiency as competing implementations. (Compression efficiency is defined by how much you can compress the video to obtain a target quality, or vice-versa, what quality can be obtained at a specified bitrate, The higher the compression efficiency, the less bits are needed for a certain quality level). Beamr4 has an extensive API enabling deep control of the encoder configuration to maximize the benefit for each and every application or use case, and our support team is available to help users find the best setup for their specific needs.

  

Beamr 5 HEVC Encoder 

 

Beamr5 is our fully standard compliant HEVC (H.265) video encoder. This encoding standard is the primary format used today for high resolution (4K, 8K) and premium quality encoding of 10 and 12 bit and High-Dynamic-Range content. Once again, only the decoder and bitstream are defined by the standard, and encoders can differ quite significantly in how well they perform the encoding and utilize the advanced tools available in HEVC to obtain maximum compression efficiency without incurring prohibitive performance costs. An important factor in supporting live encoding is to be able to reach very good parallelization of the encoding tasks. This is not easy in video encoding which is very serial, and unevenly distributed by nature. At Beamr we have developed a unique architecture for the encoder, which enables very efficient deep parallelization making the best concurrent use of all available cores, enabling the world’s first live 8K HEVC encoder. In addition, Beamr5 is one of the few HEVC codecs that has wide support for HDR and can be used in conjunction with Dolby Vision, HDR10 and HLG — various HDR formats used around the globe. Beamr5 also has an extensive API enabling deep control of the encoder configuration to maximize the benefit for each and every application or use case, and our support team is always available to help users find the best setup for their specific needs.

 

 58

 

 

Beamr 4X AVC Content Adaptive Encoder

 

Beamr4x is achieved by adding our Content Adaptive Bit-Rate rate control, to Beamr4. Video encoders generally operate either in a bit-rate driven mode, such as VBR (Variable Bit-Rate), or in a quality driven mode. The new mode introduced in Beamr4x, enables encode that is bit-rate driven, but where any bits that are redundant for the perceptual quality of the video are swiftly removed. This is done by first compressing the video frame according to the bit-rate considerations. Then, for each frame, more aggressive compression is applied, reducing the frame size in bits to the maximal extent that is possible without compromising perceptual quality of this video frame. This is done using our novel, award winning quality measure, which can reliably report the perceptual quality of the reduced size frame, relative to the initial encode, and make sure we get to the best compression point. While this may sound like a difficult problem to solve for each frame, using our sophisticated search algorithm, we actually guess the correct compression point on the first try more often than not, and on average require less than two attempts per frame. The resulting bitstream has the same perceptual quality as the VBR encode to target bitrate would have, while offering significant bitrate savings for many use cases.

 

Beamr 5X HEVC Content Adaptive Encoder

 

Similarly, Beamr 5x combines Beamr 5 with CABR, enabling HEVC encoding with significant bitrate savings.

 

JPEGMini Photo Optimization Solutions

 

JPEGmini is a patented photo recompression technology, which significantly reduces the size of photographs without affecting their perceptual quality. JPEGmini is fully compliant with the JPEG standard, resulting in files that are fully compatible with any browser, photo software or device that support the standard JPEG format.

 

JPEGmini is capable of reducing the file size of standard JPEG photos by up to 50%, while the resulting photos are visually identical to the original photos. The JPEGmini algorithm imitates the perceptual qualities of the human visual system, ensuring that each photo is compressed to the maximum extent possible by removing redundancies, without creating any visual artifacts in the process. This enables fully automatic, maximal compression of photos with no human intervention required. JPEGmini has also been successfully tested with artificial intelligence/machine learning image sets in which a reduction of storage cost of up to 50% was obtained, without compromising classification and detection accuracy.

 

NVENC-CABR H/W accelerated encoder

 

Combining the CABR technology (ported to GPU) with the NVIDIA NVENC solution enables an offering of a cost-effective, fast, CABR encoding. As well as utilizing this in the Beamr cloud, this solution can be offered for on-prem use by customers for optimizing their video workflows. The benefits of CABR optimization in this case can be even higher than when applied to S/W encoders, due to the lower flexibility of the rate control algorithms implemented in hardware encoders.

 

Sales and Marketing

 

As of March 3, 2025, we have 7 full time and part-time sales and marketing employees and consultants, whose focus is to work together to accelerate the adoption of our existing products, to drive awareness and increase brand recognition of our products and technologies, to improve new customer acquisitions and to increase revenue from our existing customers.

 

 59

 

 

For our next-generation Beamr Cloud SaaS solution, we launched our solution on the largest cloud platform, AWS, in February 2024, in June 2024, Beamr Cloud achieved Powered by Expertise and became available in the Oracle Cloud Marketplace for OCI customers, and we plan to integrate our solution with Azure and GCP. In February 2025, Beamr Cloud also joined the AWS ISV Accelerate program, a global co-sell initiative for AWS partners, while demonstrating strong alignment with AWS’s go-to-market strategies and initiatives. Since NVIDIA GPUs are widely adopted by cloud platforms, we believe that by making the Beamr Cloud SaaS solution on cloud platforms will allow us to potentially access and acquire large numbers of new customers with relatively low sales investment through a self service, online sales process, with low touch pay as you go subscription service to our SaaS solution.

 

In addition, since the Beamr Cloud is designed to be deployable across all environments, including public cloud, private cloud, on-premise and multi-cloud hybrid environments, we intend to focus our direct sales efforts on particular vertical markets that store large amounts of video including internet of things (IoT), smart cities, surveillance, autonomous cars, AgTech, and medical imaging.

 

We primarily market and license directly our existing products to media customers through outbound sales networking and customer and partner referrals. Our direct customers include category leaders such as Netflix, Snapfish, Paramount and TAG. Our sales cycles for our existing products typically require a significant investment of time and a substantial expenditure of resources before we can realize revenue from the sale of our solutions, if any. Our typical sales cycle consists of a multi-month sales and development process involving our customers’ system designers and management and our sales personnel and software engineers. If successful, this process culminates in a customer’s decision to use our solutions in its system, which we refer to as an account win.

 

We enter into written contracts with our customers pursuant to which we license the rights to use our software and provide maintenance and technical support. Our contracts are generally for one to three-year terms, with automatic renewal terms of one year terms. Some of our contracts are on a perpetual basis. We bill most of our customers annually in advance for the fees associated with the software licenses and related support. Some of our customers are billed on a quarterly basis.

 

We focus our marketing efforts on the strength of our product and technology innovation, the value we provide and our domain expertise. We target the video engineering and information technology (IT) operations community through our marketing activities, using diverse tactics to connect with prospective customers, such as content marketing, events, social media, and public relations.

 

During 2024 we participated in eight leading trade shows and conferences, including ACM Mile High Video, GTC, NAB, SIGGRAPH, Oracle CloudWorld, IBC ,Demuxed and AWS re:Invent. During these events, Beamr executives delivered high-impact presentations to hundreds of industry professionals, showcasing our innovative technology and expanding SaaS solutions. Furthermore, we held over 100 face-to-face meetings with existing and prospective customers. These efforts focused on differentiating Beamr in the video market and highlighting the value of our high-quality, high-efficiency, GPU-accelerated SaaS offerings to key and prospective customers in emerging markets, such as Media & Entertainment, User-Generated content and Internet-of-Things.

 

We are leveraging our partnership with Nvidia, AWS and Oracle, in order to open additional opportunities with potential customers.

 

We intend to continue to invest in our sales and marketing capabilities to capitalize on our market opportunity.

 

Research and Development

 

Our research and development team is responsible for the design, development, testing and delivery of new technologies, features and integrations of our solutions, as well as the continued improvement and iteration of our existing products. It is also responsible for operating and scaling our solutions including the underlying infrastructure. Our research and development investments seek to drive core technology innovation and bring new products to market.

 

Members of our research and development team specialize in many functional areas including algorithms, machine learning, and electrical engineering as well as computer science. As we shift our focus to a SaaS based cloud service offering, we intend to make significant investments in a cloud-optimized delivery model while continuing to invest in our software offerings, both for standalone consumption and for deployment in hybrid environments.

  

Our main research and development facility is located in central Israel, which we believe is a strategic advantage for us, allowing us to leverage a talented pool of engineers and product experts.

 

As of March 3, 2025, we had 28 full-time and part-time employees and consultants dedicated to research and development. We have made substantial investments in product and technology development since our inception. Research and development expense totaled $2.9 million, $1.8 million and $2.1 million in the years ended December 31, 2024, 2023 and 2022, respectively. We expect our research and development expense to increase significantly for the foreseeable future as we enhance our existing product, develop new products for our current markets and introduce new products in new markets.

 

 60

 

 

Acquisition

 

In 2016, we acquired Vanguard Video, a provider of HEVC and H.264 codec technologies, which enabled us to integrate our CABR technology with Vanguard Videos video encoders, which today are available as Beamr 4x and Beamr 5x.

 

Competition

 

While there are several companies offering video compression solutions such as MainConcept, Ateme, Visionular, Harmonic and open source (x264/x265), we believe there is currently no direct competitor with our content-adaptive video compression solutions. There are companies which offer software solutions for video optimization such as Harmonic and Elemental, and other companies offering storage optimization (but not involving video technologies) such as EMC and Seagate. In addition, for our quality measure, some of our current competitors include SSIMWave (SSIMPlus), Apple (AVQT), Google (YouVQ) and open source (VMAF). We operate in a highly specialized area that is evolving very quickly with rapid developments. In the future, competitors could develop products or solutions that compete with our video compression solutions. For example, the public cloud platforms such as AWS, Azure, GCP and OCI could in the future develop their own video optimization hardware accelerated solutions.

 

We believe the following competitive attributes are necessary for our solutions to successfully compete in the video compression market:

 

  the performance and reliability of our solutions;
     
  cost of deployment and return on investment in terms of cost savings;
     
  sophistication, novel and innovative intellectual property and technology, and functionality of our offerings;
     
  cross-platform operability;
     
  security;
     
  ease of implementation and use of service;
     
  high quality customer support; and
     
  price.

  

We believe that we compare favorably on the basis of the factors listed above. However, many of our competitors have substantially greater financial, technical, and marketing resources; relationships with large vendor partners; larger global presence; larger customer bases; longer operating histories; greater brand recognition; and more established relationships in the industry than we do. Furthermore, new entrants not currently considered to be competitors may enter the market through acquisitions, partnerships, or strategic relationships. See “Item 3.D Risk Factors—Risks Related to Our Business and Industry—We may not be able to compete successfully against current and future competitors, some of whom have greater financial, technical, and other resources than we do. If we do not compete successfully, our business, financial condition and results of operations could be harmed.” 

 

Intellectual Property

 

Intellectual property is an important aspect of our business and we seek protection for our intellectual property rights as appropriate. To establish and protect our proprietary rights, we rely on a combination of patent, copyright, trade secret and trademark laws, know-how and continuing innovation, and contractual restrictions such as confidentiality agreements, licenses, and intellectual property assignment agreements. We strive to protect the proprietary technologies that we believe are important to our business, including seeking and maintaining patent protection intended to cover our system.

 

 61

 

 

As of March 3, 2025, our exclusively owned patent portfolio includes 53 issued patents (one of which is jointly owned), of which 33 are U.S. patents and 20 are foreign patents, and two U.S. patent applications are pending. The claims of these owned patents and patent applications are directed toward various aspects of our family of products, method of their manufacturing and research programs.

 

We pursue the registration of our domain names that we consider material to the marketing of our products, including the beamr.com.

 

We generally seek to enter into confidentiality agreements and proprietary rights agreements with our employees and consultants and to control access to, and distribution of, our proprietary information. However, we cannot guarantee that all applicable parties have executed such agreements. Such agreements can also be breached, and we may not have adequate remedies for such breach.

 

Intellectual property laws, procedures, and restrictions provide only limited protection, and any of our intellectual property rights may be challenged, invalidated, circumvented, infringed, misappropriated or otherwise violated. Furthermore, the laws of certain countries do not protect intellectual property and proprietary rights to the same extent as the laws of the United States, and we therefore may be unable to protect our proprietary technology in certain jurisdictions. Moreover, our platform and many of our products and services incorporate software components licensed to the general public under open-source software licenses. We obtain some components from software developed and released by contributors to independent open-source components of our platform. Open-source licenses grant licensees broad permissions to use, copy, modify and redistribute certain components of our platform. As a result, open-source development and licensing practices can limit the value of our proprietary software assets.

 

Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy or obtain and use our technology to develop products and services with the same functionality as our platform. Policing unauthorized use of our technology is difficult. Our competitors could also independently develop technologies like ours, and our intellectual property rights may not be broad enough for us to prevent competitors from selling products and services incorporating those technologies. For more information regarding the risks relating to intellectual property, see “Item 3.D Risk Factors—Risks Related to Information Technology, Intellectual Property and Data Security and Privacy.”

 

 62

 

 

 

Regulatory Environment

 

We are subject to a number of U.S. federal and state and foreign laws and regulations that involve matters central to our business. These laws and regulations involve privacy, data protection, intellectual property, competition, consumer protection and other subjects. Many of the laws and regulations to which we are subject are still evolving and being tested in courts and could be interpreted in ways that could harm our business. In addition, the application and interpretation of these laws and regulations are often uncertain, particularly in the new and rapidly evolving industry in which we operate. Because global laws and regulations have continued to develop and evolve rapidly, it is possible that we may not be, or may not have been, compliant with each such applicable law or regulation. 

 

 63

 

 

Employees

 

As of March 3, 2025, we had 21 employees in Israel, 12 employees who are employed by our wholly owned subsidiary in St. Petersburg, Russia, 3 employees who are employed by us who are located in Serbia and two employees who are employed by our wholly owned subsidiary in California, United States. We also have four subcontractors located in Israel and Poland who perform research and development and marketing functions. We are not bound by any collective bargaining agreements. We consider the relationship with our employees to be good. We also use outside consultants and contractors with special expertise and skills for limited engagements, including manufacturing and quality assurance.

 

Legal Proceedings

 

We are not currently party to any pending material legal proceedings. From time to time, we may become a party to litigation incident to the ordinary course of our business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

  

C. Organizational Structure

 

We have two wholly owned subsidiaries: Beamr, Inc. and Beamr Imaging RU LLC. Beamr, Inc. is our wholly owned subsidiary incorporated in 2012 in the State of Delaware. Beamr, Inc. is engaged in reselling our software and products in the U.S. and Canada. Beamr Imaging RU LLC is our wholly owned subsidiary, a limited Russian partnership formed in 2016. Beamr Imaging RU LLC is engaged in research and development for us.

 

D. Property, Plant and Equipment

 

Our principle executive offices are located in Herzliya, Israel. Our wholly owned Russian subsidiary operates from a leased office located in St Petersburg, Russia. Our employees in our wholly owned US subsidiary operate primarily from their home offices. In addition, we also lease space in Serbia for certain of our full-time research and development employees.

 

We lease all of our facilities and do not own any real property. We intend to procure additional space in the future as we continue to add employees and expand geographically. We believe our facilities are adequate and suitable for our current needs and that, should it be needed, suitable additional or alternative space will be available to accommodate our operations.

 

ITEM 4A. UNRESOLVED STAFF COMMENTS

 

Not applicable.

 

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

You should read the following discussion and analysis of our financial condition and results of operations together with the section titled “Item 3.A.—Selected Financial Data” and our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 20-F. This discussion and other parts of this Annual Report on Form 20-F contain forward-looking statements based upon current expectations that involve risks and uncertainties. This discussion and other parts of this Annual Report on Form 20-F contain forward-looking statements that involve risk and uncertainties, such as statements of our plans, objectives, expectations, and intentions. Our actual results could differ materially from those discussed in these forward looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the section titled “Item 3.D.—Risk Factors” and elsewhere in this Annual Report in Form 20-F.

 

 64

 

 

Overview

 

We are a leading innovator of video encoding, transcoding and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. With our Emmy®-winning patented technology and award-winning services, we help our customers realize the potential of video encoding and media optimization to address business-critical challenges. Our customers include tier one OTT, content distributors, video streaming platforms, and Hollywood studios who rely on our suite of products and expertise to reduce the cost and complexity associated with storing, distributing and monetizing video and images across devices.

 

At the heart of our patented optimization technology is the proprietary BQM that is highly correlated with the human visual system. BQM is integrated into our content adaptive bitrate, or CABR, system which together maximizes quality and removes visual redundancies resulting in a smaller file size. The BQM has excellent correlation with subjective results, confirmed in testing under ITU BT.500, an international standard for rigorous testing of image quality. The perceptual quality preservation of CABR has been repeatedly verified using large scale crowd-sourcing based testing sessions, as well as by industry leaders and studio “golden eyes”.

 

We currently license two core video and image compression products that help our customers use video and images to further their businesses in meaningful ways: (1) a suite of video compression software encoder solutions including the Beamr 4 H.264 encoder, Beamr 4X H.264 content adaptive encoder, Beamr 5 HEVC encoder and the Beamr 5X HEVC content adaptive encoder and (2) Beamr JPEGmini photo optimization software solutions for reducing JPEG file sizes.

 

In February 2024, we launched our Beamr Cloud Video SaaS solution, a cloud based HW-Accelerated CABR solution, which we expect will allow end-users to enjoy significant end-user storage and networking cost savings, by 30%-50%. Our Beamr Cloud SaaS solution was initially operating over and integrated with AWS. In February 2025, Beamr Cloud also joined the AWS ISV Accelerate program, a global co-sell initiative for AWS partners, while demonstrating strong alignment with AWS’s go-to-market strategies and initiatives. In June 2024, Beamr Cloud achieved Powered by Expertise and became available in the Oracle Cloud Marketplace for OCI customers, with plans to extend our services to other cloud platforms, and is powered by NVIDIA GPUs. We have managed to complete certain features, such as codec modernization and resize transformations, and we plan to offer additional capabilities, such as AI-specific workflows that are optimized for ML and AI, in an effort to position ourselves to be at the forefront of innovation in the video processing landscape for different AI purposes.

 

Until recently, our current product line was mainly geared to the high end, high quality media customers and we count among our enterprise customers Netflix, Snapfish, Paramount, VMware, Genesys, Deluxe, Citrix, Walmart, Photobox, Antix, Dalet, TAG, and other leading media companies using video and photo solutions.

 

Due to the high cost and complexity of deploying our existing software solutions and the long sales lead times, we have a made a strategic decision to focus our resources on the development and commercialization of our next-generation product, the Beamr Cloud, a SaaS solution that is designed, based on our own internal testing, to be up to 10x more cost efficient than our existing software-based solutions, resulting in reduced media storage, processing and delivery costs.

 

We collaborated with NVIDIA, a multinational technology company and a leading developer of GPUs, with an annual revenue of $130.5 billion for the fiscal year 2025, to develop the Beamr Cloud SaaS solution, the world’s first GPU accelerated encoding solution powered with our CABR, which will allow fast and easy end-user deployment combined with superior video compression rates. Our CABR software executes directly on NVIDIA GPU cores and interact swith the NVIDIA video accelerator encoder known as NVENC. NVIDIA NVENC is a high-quality, high-performance hardware video encoder that is built into most NVIDIA GPUs. NVENC offloads video encoding to hardware, and provides extreme performance for applications such as live video encoding, cloud gaming and cloud storage. NVIDIA GPUs with NVENC are available on all major cloud platforms. We plan to further collaborate with NVIDIA on further development of our the Beamr Cloud SaaS solution.

 

 65

 

 

The first version of the integrated video optimization engine was ready at the end of the first quarter of 2023. Following this, we launched the first beta version of the cloud based SaaS platform and began testing it with beta customers in June 2023. After the initial release, we launched the second and third beta versions of the cloud based SaaS platform in September 2023 and October 2023, respectively, as we build up to the commercial launch of the platform. Following that, we commercially launched the Beamr Cloud SaaS solution in February 2024 and expect that following release, end-users of the solution will enjoy significant end-user storage and networking cost savings by 30%-50%. Using the Beamr Cloud SaaS solution will potentially reduce their return on investment for storage optimization to approximately four months, compared to approximately two years with our existing software encoder solutions. Our Beamr Cloud SaaS solution was initially operating over and integrated with AWS. In February 2025, Beamr Cloud also joined the AWS ISV Accelerate program, a global co-sell initiative for AWS partners, while demonstrating strong alignment with AWS’s go-to-market strategies and initiatives. In June 2024, Beamr Cloud achieved Powered by Expertise and became available in the Oracle Cloud Marketplace for OCI customers, with plans to extend our services to other cloud platforms, and is powered by NVIDIA GPUs. We have managed to complete certain features, such as codec modernization and resize transformations, and we plan to offer additional capabilities, such as AI-specific workflows that are optimized for ML and AI, in an effort to position ourselves to be at the forefront of innovation in the video processing landscape for different AI purposes.

 

Impact of the War in Israel

 

On October 7, 2023, Hamas terrorists invaded southern Israel and launched thousands of rockets in a widespread terrorist attack on Israel. On the same day, the Israeli government declared that the country was at war and the Israeli military began to call-up reservists for active duty. On January 19, 2025, a temporary ceasefire went into effect, the result of which is uncertain. In addition, since the commencement of these events, there have been continued hostilities along Israel’s northern border with Lebanon (with the Hezbollah terror organization) and on other fronts from various extremist groups in the region, such as the Houthis in Yemen and various rebel militia groups in Syria and Iraq. Israel has carried out a number of targeted strikes on sites belonging to these terror organizations. In October 2024, Israel began limited ground operations against Hezbollah in Lebanon, and in November 2024, a ceasefire was brokered between Israel and Hezbollah . In addition, Iran recently launched direct attacks on Israel involving hundreds of drones and missiles and has threatened to continue to attack Israel and is widely believed to be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza, Hezbollah in Lebanon, the Houthi movement in Yemen and various rebel militia groups in Syria and Iraq. Some of our employees in Israel were called up for reserve service; however, our product and business development activities remain on track. The intensity and duration of the security situation in Israel is difficult to predict at this stage, as are such war’s economic implications on our business and operations and on Israel’s economy in general. If the ceasefires declared collapse or a new war commences or hostilities expand to other fronts, our operations may be adversely affected.

 

We are closely monitoring the developments of this war. See “Item 3.D Risk Factors—Risks Related to Our Operations in Israel–Political, economic and military conditions in Israel could materially and adversely affect our business.

  

Components of Our Results of Operations

 

Revenue

 

Software Licensing

 

Our revenues are mainly comprised of revenue from licensing the rights to use our software for a limited term (mainly for a period of one to three years) or on a perpetual basis for enterprises that incorporate our perpetual license in their own products delivered to end users and for our products sold to thousands of private consumers, as applicable to each contract, and from and provision of related maintenance and technical support services (i.e. Post-Contract Customer Support, or PCS).

 

Revenue from the sale of software license (either timely-based or perpetual) is recognized at a point in time in which the license is delivered to the customer. The software license is considered a distinct performance obligation, as the customer can benefit from the software on its own. Revenue from PCS services are also derived from annual maintenance providing for unspecified upgrades on a when-and-if-available basis. The right for an unspecified upgrade for the version acquired by the customer and enhancements on a when-and-if-available basis that do not specify the features, functionality and release date of future product enhancements for the customer to know what will be made available and the general timeframe in which it will be delivered. We consider the PCS performance obligation as a distinct performance obligation that is satisfied over time and recognized on a straight-line basis over the contractual period (mainly over a period of one year either for timely-based license or for perpetual license).

 

 66

 

 

As we bundle software licenses (either timely-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a relative standalone selling price basis.

 

Since we do not sell PCS on a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several hours of technical support per contract (as management believes the technology and products covered under the software license component are mature and fully functional), the standalone selling prices of the PCS are determined based on the expected cost plus a margin based on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such estimate is also corroborated with the price that the customer would have to pay to a third-party service provider for a similar support service.

 

The stand-alone selling price of the software licenses (either timely-based or perpetual) is estimated by management based on adjusted market assessment approach which represents management estimation of the price that a customer in the market will be willing to pay for such license on a stand-alone basis (i.e. without any PCS).

 

Due to the fact that these services are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction price allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses as management believes the technology and products covered under the software license component are mature and fully functional.

 

Advertising

 

Commencing 2022, revenue in small volume is also derived from the traffic operations in the Google AdSense program, a web advertising platform, that we make available on our websites. Google pays us on a cost-per-click basis. We recognize as revenue the fees paid to it by Google based on the volume of clicks through to Google AdSense advertisements.

 

Cost of Revenue

 

Cost of software licensing and related maintenance and technical support services revenues primarily consist of costs related to salaries, of our support team and additional overhead allocation costs such as rent and utilities to all departments based on relative headcount. In addition, cost of revenues includes amortization of internal-use software costs that were capitalized.

 

Gross Margins

 

Gross margins have been, and will continue to be, affected by a variety of factors, including the average sales price of our products and services, volume growth, the mix of revenues, software licenses, maintenance and technical support and professional services, onboarding of new media and telecom customers, and changes in cloud infrastructure and personnel costs.

 

Operating Expenses

 

Research and Development

 

Our research and development expenses consist primarily of costs incurred for personnel-related expenses for our technical staff, including salaries and other direct personnel-related costs excluding costs associated with creating the internally developed software related to our cloud-based SaaS. Additional expenses include consulting, amortization of acquired technology and professional fees for third-party development resources. We expect our research and development expenses to increase in absolute dollars for the foreseeable future as we continue to dedicate substantial resources to develop, improve and expand the functionality of our solutions. Subsequent costs incurred for the development of future upgrades and enhancements, which are expected to result in additional functionality, may qualify for capitalization under internal-use software and therefore may cause research and development expenses to fluctuate.

 

 67

 

 

Selling and Marketing Expenses

 

Our selling and marketing expenses consist primarily of personnel related costs for our sales and marketing functions, including salaries and other direct personnel-related costs. Additional expenses include marketing program costs, amortization of acquired customer relationships and trade names and payment processer commissions. We expect our selling and marketing expenses will increase on an absolute dollar basis for the foreseeable future as we continue to increase investments to support our growth. We also anticipate that selling and marketing expenses will increase as a percentage of revenue in the near and medium-term.

 

General and Administrative Expenses

 

Our general and administrative expenses consist primarily of personnel-related costs for our executive, finance, human resources, professional fees, information technology and legal functions, including salaries and other direct personnel-related costs. We expect general and administrative expense to increase on an absolute dollar basis for the foreseeable future as we continue to increase investments to support our growth and as a result of our becoming a public company.

 

We allocate overhead expenses related to the services agreement under which we receive recurring consulting and related services from our founder Sharon Carmel as Chief Executive Officer and an entity controlled by him, Sharon Carmel Management, Ltd. The allocation was done based on the management estimation to reflect the contribution to the related activity. 

 

Financing Income (Expenses), Net

  

Financing income (expenses), net consists of amortization of discounts and interest expense on our indebtedness, changes in the fair value of certain warrants and convertible advanced investments, interest income on bank deposits and foreign exchange gains and losses.

 

Taxes on Income

 

We are subject to taxes in jurisdictions or countries in which we conduct business. Our effective tax rate is affected by tax rates in jurisdictions and the relative amounts of income we earn in those jurisdictions, changes in the valuation of our deferred tax assets and liabilities, applicability of any valuation allowances, and changes in tax laws in jurisdictions in which we operate. Due to cumulative net operating losses, we maintain a full valuation allowance against our deferred tax assets. We consider all available evidence, both positive and negative, in assessing the extent to which a valuation allowance should be applied against our deferred tax assets. Realization of our deferred tax assets depends upon future earnings, the timing and amount of which are uncertain. Our effective tax rate is affected by tax rates in foreign jurisdictions and the relative amounts of income we earn in those jurisdictions, as well as non-deductible expenses, such as share-based compensation, and changes in our valuation allowance.

 

 68

 

 

A. Operating Results

 

The table below provides our results of operations for the years ended December 31, 2024, 2023, and 2022.

 

   Year Ended December 31, 
(U.S. dollars in thousands)  2024   2023   2022 
Revenues  $3,064   $2,909   $2,863 
Cost of revenues  $(240)  $(96)  $(98)
Gross profit  $2,824   $2,813   $2,765 
Operating expenses:               
Research and development  $(2,893)  $(1,824)  $(2,063)
Sales and marketing  $(678)  $(361)  $(905)
General and administrative  $(2,468)  $(1,506)  $(828)
Operating loss  $(3,215)  $(878)  $(1,031)
Financing income (expenses), net  $(92)  $222   $(165)
Tax on income  $(46)  $(39)  $(52)
Net loss  $(3,353)  $(695)  $(1,248)

 

Revenues, Cost of Revenues and Gross Profit

 

The following table presents our revenue, cost of revenues and gross profit for the periods indicated:

 

   Year Ended December 31, 
(U.S. dollars in thousands)  2024   2023   2022 
Revenues  $3,064   $2,909   $2,863 
Cost of revenues  $(240)  $(96)  $(98)
Gross profit  $2,824   $2,813   $2,765 

 

Revenues increased by $0.15 million or 5% to $3.06 million for the year ended December 31, 2024, from 2.9 million for the year ended December 31, 2023. The increase was primarily due to binding transactions with new customers versus other transactions that were terminated.

 

Revenues increased by $0.05 million or 2% to $2.9 million for the year ended December 31, 2023, from $2.86 million for the year ended December 31, 2022. The increase was primarily due to binding transactions with new customers versus other transactions that were terminated.

  

Operating Expenses

 

Research and Development Expenses

 

   Year Ended December 31, 
(U.S. dollars in thousands)  2024   2023   2022 
Salary and related expenses  $(1,831)  $(1,411)  $(1,722)
Professional fees  $(712)  $(229)  $(123)
Depreciation and amortization  $(8)  $(4)  $(4)
Travel and overhead expenses  $(341)  $(180)  $(214)
Total research and development expenses  $(2,893)  $(1,824)  $(2,063)

 

Research and development expenses increased by $1.06 million, or 58% to $2.8 million for the year ended December 31, 2024, from $1.8 million for the year ended December 31, 2023. The increase was primarily due to an increase of $0.4 million in salaries due to increased personnel and an increase of 0.48 million in professional fees due to additional sub-contractors and cloud costs.

 

Research and development expenses decreased by $0.2 million, or 12%, to $1.8 million for the year ended December 31, 2023, from $2 million for the year ended December 31, 2022. The decrease was primarily due to a decrease of $0.3 million in salaries due to changes in personnel and capitalization of costs consisting mainly of direct labor (including stock-based compensation expenses) associated with creating the internally developed software related to our cloud-based SaaS solution offset by an increase of $0.1 million in professional fees.

 

 69

 

 

Selling and Marketing Expenses

 

   Year Ended December 31, 
(U.S. dollars in thousands)  2024   2023   2022 
Salary and related expenses  $(278)  $(176)  $(564)
Professional fees and platform commissions  $(153)  $(93)  $(236)
Depreciation and amortization  $(21)  $(21)  $(22)
Marketing conferences and trade shows  $(121)  $(13)  $(3)
Travel and overhead expenses  $(105)  $(58)  $(80)
Total selling and marketing expenses  $(678)  $(361)  $(905)

 

Selling and marketing expenses increased by $0.31 million, or 88% to $0.67 million for the year ended December 31, 2024, from $0.36 million in 2023. The increase was primarily due to an increase in personnel and an increase in conference costs.

 

Selling and marketing expenses decreased by $0.54 million, or 60% to $0.36 million for the year ended December 31, 2023, from $0.9 million in 2022. The decrease was primarily due to a decrease in salaries and professional fees.

 

General and Administrative

 

   Year Ended December 31, 
(U.S. dollars in thousands)  2024   2023   2022 
Salary and related expenses  $(788)  $(377)  $(346)
Professional fees and consulting  $(1,454)  $(1,069)  $(504)
Overhead allocated  $222   $137   $153 
Travel, office and other expenses  $(448)  $(197)  $(131)
Total general and administrative expenses  $(2,468)  $(1,506)  $(828)

 

General and administrative expenses increased by $0.96 million, or 64% to $2.4 million for the year ended December 31, 2024, from $1.5 million in 2023. The increase was primarily due to increased personnel, an increase in professional fees related to public company requirements and increased travel expenses to attend industry and investor conferences.

 

General and administrative expenses increased by $0.7 million, or 82% to $1.5 million for the year ended December 31, 2023, from $0.83 million in 2022. The increase was primarily due to professional fees related to legal, accounting, investor relations as well as insurance coverage resulting from the completion of our initial public offering in March 2023.

 

Financing Income (Expenses), Net

 

   Year Ended December 31, 
(U.S. dollars in thousands)  2024   2023   2022 
Change in fair value of convertible advanced investment  $-   $269   $(70)
Change in fair value of derivative warrant liability  $(577)   66    - 
Amortization of discount and accrued interest on straight loan received from commercial banks  $(106)  $(157)  $(102)
Modification of terms relating to straight loan  $-   $-   $- 
Change in estimation of maturity date of liability to controlling shareholder  $-    (12)  $(40)
Amortization of discount relating to liability to controlling shareholder  $(10)  $(48)  $- 
Interest on bank deposits  $598    97    - 
Exchange rate differences and other finance expenses  $3   $7   $47 
Total financing expenses, net  $(92)  $222   $(165)

 

 70

 

 

Financing expenses, net decreased by $0.3 million, or 141% to ($0.09) million for the year ended December 31, 2024, from $(0.2) million in 2023. The decrease was primarily due to change in fair value of derivative warrant liability and a decrease in amortization of discount offset by interest income on bank deposits.

  

Financing expenses, net decreased by $0.4 million, or 230% to $(0.2) million for the year ended December 31, 2023, from $0.17 million in 2022. The decrease was primarily due to income from the change in fair value of convertible advanced investment, decrease in amortization of discount and accrued interest and interest on bank deposits, offset by the change in fair value of derivative warrant liability and change in exchange rate differences.

 

Taxes on Income

 

   Year Ended December 31, 
(U.S. dollars in thousands)  2024   2023   2022 
Taxes on income  $(46)   (39)  $(52)

 

Taxes on income increased by $0.007 million, or 17% to $0.046 million for the year ended December 31, 2024, from $0.04 million in 2023. The increase was primarily due to tax provision adjustments.

 

Taxes on income decreased by $0.01 million, or 26% to 0.04 million for the year ended December 31, 2023, from $0.05 million in 2022. The decrease was primarily due to tax provision adjustments.

 

Recent Accounting Pronouncements

 

Certain recently issued accounting pronouncements are discussed in Note 2, Significant Accounting Policies, to the consolidated financial statements included in “Item 18. Financial Statements” of this Annual Report.

 

JOBS Act

  

Under the JOBS Act, an “emerging growth company” can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an “emerging growth company” to delay the adoption of new or revised accounting standards that have different transition dates for public and private companies until those standards would otherwise apply to private companies. Although we meet the definition of an “emerging growth company” and we have elected not to use this extended transition period for complying with new or revised accounting standards.

 

B. Liquidity and Capital Resources

 

We have financed our operations through cash generated from operations, proceeds received from private offerings, proceeds from convertible advanced investments received from our current shareholders, proceeds from straight loans received from bank institutions and proceeds from our initial public offering on the Nasdaq.

 

We believe that our existing capital resources and cash flows from operations together with funds received from the initial public offering will be adequate to satisfy our expected liquidity requirements through the next twelve months. Without derogating from the foregoing estimate regarding our existing capital resources and cash flows from operations, we may decide to raise further funds in the future through additional public or private offerings. We believe that, if required, we will be able to raise additional capital or reduce discretionary spending to provide the required liquidity beyond the next twelve months.

 

Our future capital requirements will depend on many factors, including our revenue growth, the timing and extent of investments to support such growth, the expansion of sales and marketing activities, increases in general and administrative costs and many other factors as described under “Risk Factors.”

 

To the extent additional funds are necessary to meet our long-term liquidity needs as we continue to execute our business strategy, we anticipate that they will be obtained through the incurrence of additional indebtedness, additional equity financings or a combination of these potential sources of funds; however, such financing may not be available on favorable terms, or at all. If we are unable to raise additional funds when desired, our business, financial condition and results of operations could be adversely affected.

 

 71

 

 

SVB Loans

 

On February 19, 2017, we and Beamr, Inc., our wholly owned subsidiary, entered into a Loan Agreement, or the 2017 Loan Agreement, with SVB under which we had a right to borrow from SVB up to $3 million bearing interest at a floating per annum rate equal to the Wall Street Journal Prime Rate plus 3.5% (upon occurrence of an ‘default event’ as defined in the Loan Agreement, the principal amount shall bear interest at a rate per annum which is 5% above the rate that is otherwise applicable thereto) which shall be payable monthly. In June 2018, we subsequently drew down a cash amount in the aggregate principal amount of $3 million, or the 2017 Loan, payable in 36 equal installments on a monthly basis commencing the following month after drawdown. In June 2022, the loan was fully paid. The Loan is sometimes referred to herein as a “straight loan”

 

In connection with the execution of the 2017 Loan Agreement, we issued to SVB a 15-year warrant to purchase (i) 41,040 Series C Convertible Preferred Shares at an exercise price of $5.12 per share or (ii) 41,040 shares to be issued in the ‘next round’ at an exercise price equal to the lowest price per share at which we will sell and issue shares of the next round shares.

 

On April 15, 2020, we signed a deferral agreement in connection with the 2017 Loan Agreement with SVB according to which it was agreed that the original monthly repayment date for the principal due from May 2020 to October 2020 shall be extended by a period of six months commencing November 2020.

 

In addition, on April 29, 2021, or the Deferral Effective Date, we signed a second deferral agreement in connection with the 2017 Loan Agreement with SVB according to which it was agreed that the original monthly repayment date for the principal due from May 2021 to October 2021 shall be extended by a period of six months commencing November 2021. In consideration, we agreed to (i) pay to SVB a total deferral facility fee equal to $50, which fee shall be fully earned at the Deferral Effective Date, and payable in 10 monthly equal installments over the period commencing April 29, 2021 through January 29, 2022; (ii) reimburse SVB for all reasonable legal fees and expenses incurred in connection with the deferral agreement and (iii) issue to SVB a 15-year warrant to purchase 9,764 shares exercisable at an exercise price of $5.12 per share (subject to standard adjustments) into either Series C Preferred Shares or a class of securities sold and issued by us in the next equity financing round. Furthermore, if SVB exercises the warrant and the warrant value (as determined in the warrant) is lower than $50,000, then immediately following such exercise, we are required to pay the holder an amount equal to the difference between the $50,000 and the warrant value. 

 

On February 17, 2022, we entered into a second Loan and Securities Agreement, or the 2022 Loan Agreement providing a credit line against our accounts receivables. According to the 2022 Loan Agreement, commencing as of August 1, 2022 through December 31, 2022, SVB may, in its sole discretion in each instance, pursuant to our request, finance specific eligible account receivables of ours, as determined in the 2022 Loan Agreement, in a total amount equal to the face amount of the eligible account receivable multiplied by a rate of 80%, subject to reduction by SVB in its discretion, or the Advance, provided that the aggregate amount of all outstanding Advances shall not exceed the lesser of (i) an aggregate principal amount equal to $0.35 million, or the Revolving Line, or (ii) 80% of all eligible account receivables minus the sum of all outstanding principal amounts of any Advances, subject to reduction by SVB in its discretion. The outstanding principal amount of any Advance shall accrue interest at a floating rate per annum equal to the greater of (i) 8.25% and (ii) a floating per annum rate equal to the Wall Street Journal Prime Rate plus 5% (upon occurrence of a ‘default event’ as defined in the 2022 Loan Agreement, the aggregate loan principal amount shall bear interest at a rate per annum which is 5% above the rate that is otherwise applicable thereto). Interest on the principal amount of each Advance will be payable in monthly arrears (i) on each the last day of each month and (ii) on December 31, 2022, or the Revolving Line Maturity Date. The security interest granted in the 2022 Loan Agreement shall at all times continue to be a first priority perfected security. On July 26, 2022, we terminated the 2022 Loan Agreement and the security interest on all our assets was removed.

 

Upon making of the initial Advance, we agreed to issue to SVB a warrant to purchase (i) 4,784 Series C Convertible Preferred Shares, or (ii) ordinary shares in the event that we have listed its securities for trading on Nasdaq, or (iii) upon SVB’s written irrevocable election in its sole discretion, the same class and series, or other designation, of convertible preferred share or other senior equity security sold and issued by us in the next equity financing over a 15-years period commencing the issuance date of such warrant, at an exercise price of $5.12 per share, provided that if the class is the next equity financing securities, then the exercise price shall be the lowest price per share for which next equity financing securities are sold or issued by us. Upon termination of the 2022 Loan Agreement, we have no commitment to issue SVB the aforesaid warrant.

 

 72

 

 

IBI Spikes Loan

 

On July 7, 2022, we entered into a funding agreement with IBI providing for a loan, or the IBI Loan, in the amount of NIS 3.1 million (approximately $0.9 million), or the IBI Loan Agreement. The loan is repayable on a monthly basis based on a formula set forth in the IBI Loan Agreement until the earlier repayment of NIS 4,172,760 (approximately $1.2 million), or the Repayment Amount, or January 5, 2026. We may repay the IBI Loan early based on formula set forth in the IBI Loan Agreement. The IBI Loan Agreement provides for certain customary covenants and accelerates in the event of default. As of December 31, 2024, the remaining loan to IBI was NIS 0.91 million (approximately $0.25 million).

 

In consideration for the grant of the IBI Loan, we are required to pay to IBI a non-refundable one-time fee of 1.5% of the IBI Loan amount and we issued a warrant to purchase 65,562 ordinary shares at a variable exercise price. The warrant has a term of the earlier of 10 years or certain liquidation events and a variable exercise price depending on the occurrence of certain liquidation events. The warrant can be exercised on cashless exercise based on the discretion of IBI. On February 22, 2024, we received a written notice from IBI under which the exercise price of the warrant granted to IBI was determined at a fixed amount of $3.67 per ordinary share. In addition, on the same date, we issued 15,595 ordinary shares to IBI upon a partial cashless exercise of the warrant granted to IBI. On May 22, 2024, we issued 15,594 ordinary shares to IBI upon a partial cashless exercise of their remaining warrants.

 

Completion of our Initial Public Offering

 

On March 2, 2023, we closed our initial public offering of 1,950,000 ordinary shares at a public offering price of $4.00 per ordinary share, for aggregate gross proceeds of $7.8 million prior to deducting underwriting discounts and other offering expenses.

 

Our ordinary shares began trading on the Nasdaq Capital Market under the ticker symbol “BMR” on February 28, 2023.

 

Completion of our Follow-On Public Offering

 

On February 15, 2024, we closed our public offering of 1,714,200 ordinary shares at a public offering price of $7.00 per share, for aggregate gross proceeds of $12 million prior to deducting underwriting discounts and other offering expenses. On February 13, 2024, the over-allotment option for 257,100 ordinary shares was fully exercised by the underwriter for additional gross proceeds of approximately $1.8 million prior to deducting underwriting discounts and other offering expenses.

 

Cash Flows

 

The following table summarizes our cash flows for the periods presented:

 

   Year Ended December 31, 
(U.S. dollars in thousands)  2024   2023   2022 
Net cash provided by (used in) operating activities  $(1,886)  $(659)  $(645)
Net cash used in investing activities  $(330)  $(193)  $(2)
Net cash provided by (used in) financing activities  $12,583   $6,275   $312 
Change in cash, cash equivalents  $10,367   $5,423   $(335)
Cash, cash equivalents at beginning of period  $6,116   $693   $1,028 
Cash, cash equivalents at end of period  $16,483   $6,116   $693 

 

Net cash used in operating activities

 

For the year ended December 31, 2024, net cash used in operating activities was mainly due to a net loss of $3.3 million, offset by share-based compensation of $0.41 million, change in the fair value of derivative warrant liability of $0.57 million and change of $0.47 million in other working capital items as shown in the consolidated statements of cash flows of the annual financial statements

 

For the year ended December 31, 2023, net cash used in operating activities was mainly due to a net loss of $0.7 million, change in the fair value of convertible advanced instruments of $0.27 million and change in other working capital items as shown in the consolidated statements of cash flows of the annual financial statements, offset by $0.36 million of share-based compensation, change in the fair value of derivative warrant liability of $0.1 million.

 

For the year ended December 31, 2022, net cash used in operating activities was mainly due to a net loss of $1.2 million, offset by $0.2 million of share-based compensation and change in other working capital items as shown in the consolidated statements of cash flows of the annual financial statements.

 

 73

 

 

Investing Activities

 

For the year ended December 31, 2024, net cash used in investing activities was mainly due to further capitalization of internal-use software.

 

For the year ended December 31, 2023, net cash used in investing activities was mainly due to capitalization of internal-use software associated with creating the internally developed software related to our cloud-based SaaS solution.

 

For the years ended December 31, 2022, the change in net cash used in investing activities was immaterial.

 

Financing Activities

 

Net cash provided by financing activities of $12.58 million for the year ended December 31, 2024, was due to net proceeds received upon completion of public offering in the amount of $12.2 million and proceeds received from exercise of options of $0.8 million offset by $0.5 million repayments of principal relating to loans from commercial bank and controlling shareholder.

 

Net cash provided by financing activities of $6.3 million for the year ended December 31, 2023 was mainly related to proceeds received upon completion of initial public offering of $6.7 million offset by $0.5 million repayments of principal relating to loans from received from commercial bank and controlling shareholder.

 

Net cash provided by financing activities of $0.3 million for the year ended December 31, 2022 was related to $0.9 million of proceeds received from a loan granted from a commercial bank (IBI) and $0.1 million of proceeds from loan received from related party, offset by deferred offering costs of $0.1 million and repayment of principal relating to a straight loan received from a commercial bank (SVB) of $0.6 million. 

 

Contractual Obligations and Commitments

 

As of December 31, 2024, we did not have any material contractual obligation and commitments, except for lease agreements with respect to offices.

 

C. Research and Development, Patents and Licenses

 

See above, under Item 5 – “Research and Development Expenses.”

 

D. Trend Information

 

Other than as disclosed in “Item 5. Operating and Financial Review and Prospectus—Components of Our Results of Operations” and elsewhere in this Annual Report, we are not aware of any trends, uncertainties, demands, commitments or events for the period from January 1, 2024 to December 31, 2024 that are reasonably likely to have a material effect on our total revenues, income, profitability, liquidity or capital resources, or that caused the disclosed financial information to be not necessarily indicative of future operating results or financial condition. 

 

E. Critical Accounting Estimates

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Our management believes that the estimates, judgment and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.

 

See Note 2 to the audited consolidated financial statements for the year ended December 31, 2024 for additional information regarding these and our other significant accounting policies.

 

 74

 

 

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

 

A. Directors and Senior Management

 

The following table sets forth certain information relating to our directors and senior management as of March 3, 2025. Unless otherwise stated, the address for our directors and senior management is at the Company’s registered address c/o 10 HaManofim Street, Herzeliya, 4672561, Israel.

 

Name   Age   Position
Sharon Carmel   54   Chief Executive Officer, Chairman , Class I Director
Danny Sandler   39   Chief Financial Officer
Tamar Shoham   50   Chief Technology Officer
Dani Megrelishvili   49   Chief Product Officer
Haggai Barel   53   Chief Operations Officer
Michael Ozeryansky   54   V.P. of Research and Development
Tal Barnoach (1)   61   Class II Director
Lluis Pedragosa (1)   46   Class III Director
Yair Shoham (1)(2)   71   Director
Osnat Michaeli (1)(2)   56   Director

 

(1) Independent director (as defined under Nasdaq Stock Market Listing Rules).

 

(2) External director (as defined under the Companies Law)

 

Sharon Carmel, Chief Executive Officer, Chairman , Class I Director

 

Sharon Carmel, 54, serves as our Chief Executive Officer and as the Chairman of the board of directors since he founded our company in October 2009. Prior to founding Beamr, Mr. Carmel is a serial entrepreneur with a proven track record in the software space. Prior to founding Beamr, in August 2002, Mr. Carmel co-founded, BeInSync, which developed P2P synchronization and online backup technologies. Prior to that, in January 1994, Mr. Carmel co-founded Emblaze (LON: BLZ), a software company, which developed the Internet’s first vector-based graphics player. Mr. Carmel received his training in computer science and software development during his mandatory military service in the IDF.

 

Danny Sandler, Chief Financial Officer

 

Danny Sandler, 39, serves as our Chief Financial Officer since December 2021. Mr. Sandler joined us in May 2020, and prior to his current role, served as our Director of Finance. Prior to joining us, between December 2014 and May 2020, Mr. Sandler served in various roles and, most recently as Assurance Manager, in the Hi-Tech and Life Science Practice at EY, a global accounting and consulting firm. Prior to that, between November 2011 and November 2014, Mr. Sandler was a finance associate at Seeking Alpha, a crowd-sourced content service for financial markets. Mr. Sandler holds a Bachelor’s degree in Economics and Accounting from Bar-Ilan University.

 

Tamar Shoham, Chief Technology Officer

 

Tamar Shoham, 50 , serves as our Chief Technology Officer since November 2021. Mrs. Shoham is a leading imaging and video scientist, with over 20 years’ experience in algorithm development and industry-oriented research, primarily in the field of video quality and compression. Mrs. Shoham joined us in August 2009, and prior to her current role, served as our Vice President of Technology where she led our algorithm and intellectual property development. Prior to joining us, between 2006 and 2009, Mrs. Shoham was a research fellow at the NEGEV consortium, Signal and Image Processing Lab at the Technion Institute of Technology. Prior to that, between 1997 and 2005, Mrs. Shoham served as a digital signal processing algorithm developer at Comverse Ltd. Mrs. Shoham holds a Master’s degree in Electrical Engineering from the Technion Institute of Technology and a Bachelor’s degree in Electrical Engineering from Tel Aviv University.

 

 75

 

 

Dani Megrelishvili, Chief Product Officer

 

Dani Megrelishvili, 49, serves as our Chief Product Officer since December 2022. During his previous tenure with us, Mr. Megrelishvili led the JPEGmini business unit as Head of Product from November 2014 to November 2017, where he significantly contributed to the company's revenue growth and established JPEGmini as a recognized brand in the professional photography industry. From February 2012 to November 2014, he served as Head of User Experience. Prior to rejoining us, between January 2022 and November 2022, Mr. Megrelishvili served as product manager at Lexense Technologies Ltd., a legal-tech startup offering tools for handling and managing legal disputes. From June 2020 to December 2021, he held a product manager position at Wix.Com Ltd (NASDAQ: WIX), a cloud-based web development services company. Between August 2018 and June 2020, Mr. Megrelishvili provided strategic product consulting to technology companies, including ZOOZ Ltd. (acquired by PayU in 2018) and Augmented Intelligence Inc. Earlier in his career, Mr. Megrelishvili co-founded and led a startup that developed an innovative content creation platform for enterprise customers.

 

Haggai Barel, Chief Operations Officer

 

Haggai Barel, 53, has served as our Chief Operations Officer since June 2024. Mr. Barel is a seasoned entrepreneur with extensive experience of founding and leading public companies. Prior to joining Beamr, Mr. Barel previously served as the chief executive officer and founder of Deep, a company leveraging AI to create contextual visual storytelling elements and automate video production, which was acquired in 2023. Prior to that role, Mr. Barel previously founded Orca Interactive, which was a leading IPTV provider, and served as its chief executive officer from 1995 to 2012, during which time it went public on the London Stock Exchange in 2004, and was acquired by Orange (France Telecom) in 2012. From 2012 to 2015, Mr. Barel served as the Deputy CEO VO &; CEO Orca Interactive where he led the integration of Orca Interactive and Orange (France Telecom) following the merger of the two companies. Mr. Barel holds a bachelor’s degree in computer science from The Academic College and today serves on the Board Of Trustees. of Tel Aviv-Yafo, Israel. Mr. Barel is also a graduate of the Presidents Program in management from Harvard Business School and a member of YPO (Young Presidents Organization) global leadership.

 

Michael Ozeryansky, V.P. of Research and Development

 

Michael Ozeryansky, 54, serves as our Vice President of Research and Development since August 2023. Mr. Ozeryansky brings more than two decades of experience in management and software development. Prior to joining us, from February 2023 and July 2023, Mr. Ozeryansky was the V.P. of R&D at Bond Sports. Prior to that, between 2021 and 2023, Mr. Ozeryansky served as a V.P. of Engineering at Keepy AI, and between 2015 and 2021, Mr. Ozeryansky served as the Head of Engineering at Sense Education. Mr. Ozeryansky holds a Master’s degree in Management of Technological Companies from The Israeli College of Management and a Bachelor’s degree in Mathematics and Computer Sciences from Bar-Ilan University.  

 

Tal Barnoach, Class II Director

 

Tal Barnoach, 61, serves as a board member in our company since January 2014. Mr. Barnoach is a general partner at Disruptive VC, a venture capital fund since July 2014 Disruptive Opportunity Fund since 2018 and Disruptive AI since 2020. Besides his role as a general partner in Disruptive and serving as a board member of Beamr, Mr. Barnoach serves as a board member in several other technological companies like Idomoo, Anodot, Tailor Brands, Bit, Lumen, Deep, Replix, Qwilt, Minta and more. Over the last 20 years, Mr. Barnoach has founded and led companies such as S.E.A. Multimedia (which went public in 1996), Orca Interactive (acquired by France Telecom in 2008), BeInsync (acquired by Phoenix Technologies in 2008) and Dotomi (acquired by ValueClick in 2011). Mr. Barnoach holds a B.A. degree in economics from Tel Aviv University.

 

Lluis Pedragosa, Class III Director

 

Liuis Pedragosa, 46, serves as a board member in our company since August 2016, and was appointed by our shareholder, Marker LLC. Since May 2018, Mr. Pedragosa is a managing partner and the Chief Financial Officer of Team8, a cybersecurity and fintech company creation platform and a venture capital fund. Prior to that, between December 2012 and April 2018, Mr. Pedragosa was a partner and founding team member at Marker LLC, a venture capital firm with over $400 million under management. Besides his role in Team8 and serving as a board member of Beamr, Mr. Pedragosa serves as a board member in Screenz, and as a board observer in Overwolf Ltd. Mr. Pedragosa holds a Master’s degree in Business Administration from The Wharton School of the University of Pennsylvania, a Master’s degree in International Studies from the University of Pennsylvania, and a Bachelor’s of science in Business Administration from ESADE Business School.

 

 76

 

 

Yair Shoham, Director

 

Yair Shoham, 71, serves as a board member in our company since March 2023. Mr. Shoham brings more than two decades of global experience in venture capital and is a serial entrepreneur with a track record in the software and hardware spaces. Prior to joining us, between 2018 and December 2021, Mr. Shoham served as Managing Director and Israel Country Manager at Intel Capital, the venture arm of Intel Corporation. Prior to this role, between July 2012 and 2018, he served as Investment Director at Intel Capital. Prior to that, between 1999 and 2012, Mr. Shoham served as General Partner at Genesis Partners, a leading early stage Israel-based venture capital firm. During his career, Mr. Shoham has founded and led several companies such as VDOnet Corp. (acquired by Citrix Systems, Inc.), Butterfly VLSI Ltd. (acquired by Texas Instruments Incorporated), and RFWaves Ltd. (acquired by Vishay Intertechnology Inc.). Between 1995 and 2006, Mr. Shoham served as an independent board member at M-Systems Ltd., until the company was acquired by SanDisk Corporation. Mr. Shoham holds a Juris Doctor degree from Loyola University School of Law and a Bachelor’s degree in psychology from the University of Haifa.

 

Osnat Michaeli, Director

 

Osnat Michaeli, 56, serves as a board member in our company since March 2023. Ms. Michaeli brings more than two decades of global experience in finance and operations. She currently provides financial services as an external consultant to start-up companies in Israel Between May 2019 and August 2021, Ms. Michaeli served as Chief Financial Officer at Twine Solutions Ltd, a leading digital thread-dyeing technology company. Between March 2017 and May 2019, Ms. Michaeli served as Chief Financial Officer at Cardo Systems Ltd., a leading company for Bluetooth® and Dynamic Mesh Communication, and entertainment systems for motorcycle riders. Prior to that, between March 2011 and August 2015, Ms. Michaeli served as Chief Financial Officer at Kornit Digital Ltd., an international manufacturing company, which produces high-speed industrial inkjet printers, pigmented ink, and chemical products, where she held a key role in leading the company to its Initial Public Offering in 2015 (NASDAQ: KRNT). Ms. Michaeli holds a Bachelor’s degree in economics and a Master’s degree in Business Administration, both from Tel Aviv University.

 

B. Compensation  

 

The aggregate compensation we paid to our top five executive officers and directors for the year ended December 31, 2024, was approximately $1.2 million. This amount includes approximately $0.1 million paid, set aside or accrued to provide pension, severance, retirement or similar benefits or expenses and $0.2 million share based compensation expenses, but does not include business travel, professional and business association dues and expenses reimbursed to office holders, and other benefits commonly reimbursed or paid by companies in our industry. As of December 31, 2024, options to purchase 927,574 ordinary shares granted to our officers and directors were outstanding under our share option plan at a weighted average exercise price of $2.95 per share, of which 389,913 options were vested as of such date.

 

In accordance with the Companies Law, the table below reflects the compensation granted to our five most highly compensated officers during or with respect to the year ended December 31, 2024. For purposes of the table and the summary below, “compensation” includes base salary, bonuses, equity-based compensation, retirement or termination payments, benefits and perquisites such as car, phone and social benefits and any undertaking to provide such compensation.

 

Name and Principal Position   Salary(1)     Bonus(2)     Equity-Based
Compensation(3)
    Other
Compensation
    Total  
    (USD in thousands)  
Sharon Carmel, CEO(4)     188       24                   212  
Danny Sandler, CFO     164       22       34             220  
Dani Megrelishvili, CPO     180       22       146             348  
Tamar Shoham, CTO     188       22       14             224  
Michael Ozeryansky, VP R&D     173       24       11             208  

 

(1) Salary includes the officer’s gross salary plus payment by us of social benefits on behalf of the officer. Such benefits may include payments, contributions and/or allocations for savings funds (e.g., Managers’ Life Insurance Policy), pension, severance, risk insurance (e.g., life, or work disability insurance), payments for social security and tax gross-up payments, vacation, medical insurance and benefits, convalescence or recreation pay and other benefits and perquisites consistent with our policies.

 

(2) Represents annual bonuses granted to the officer based on formulas set forth in the respective resolutions of our Compensation Committee and Board of Directors with respect to 2024.
   
(3) Represents the equity-based compensation expenses recorded in our financial statements for the year ended December 31, 2024, based on the securities’ fair value on the grant date, calculated in accordance with applicable accounting guidance for equity-based compensation. For a discussion of the assumptions used in reaching this valuation, see Note 12 to our financial statements included in this Annual Report.
   
(4) On May 22, 2024, our compensation committee approved adjustments of the compensation terms of Mr. Carmel for his duties as our Chief Executive Officer, following which his salary was increased by NIS 20 thousand, subject the approval of our shareholders at a general meeting of the shareholders, which was approved on August 5, 2024.

 

 77

 

 

For so long as we qualify as a foreign private issuer, we will not be required to comply with the proxy rules applicable to U.S. domestic companies regarding disclosure of the compensation of certain executive officers on an individual basis. Pursuant to the Companies Law, we are required, after we become a public company, to disclose the annual compensation of our five most highly compensated officers or directors on an individual basis. This disclosure will not be as extensive as that required of a U.S. domestic issuer.

 

Employment Agreements with Executive Officers

 

We have entered into written employment or consulting agreements with each of our executive officers. All of these agreements contain customary provisions regarding noncompetition, confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition provisions may be limited under applicable law. In addition, we intend to enter into indemnification agreements, subject to the listing of our securities on the Nasdaq Capital Market, with each executive officer, director, and director nominee pursuant to which we will indemnify each of them up to a certain amount and to the extent that these liabilities are not covered by directors and officers insurance.

 

For a description of the terms of our options and option plans, see “Item 6.E Directors, Senior Management and Employees—Share Ownership—Share Option Plans” below.

 

Directors’ Service Contracts

 

Other than with respect to our directors that are also executive officers, we do not have written agreements with any director providing for benefits upon the termination of his employment with our company.

 

Non-Executive Board Engagement Terms

 

During the term of office as a director, each non-executive director shall be entitled to receive an annual remuneration payment of $20,000 per full year (payable in four (4) equal payments, one for each calendar quarter ending on March 31, June 30, September 30 and December 31 of each year), or a pro rata thereof. In addition, each non-executive director shall also be entitled to receive a payment of $750.00 for each face-to-face or zoom meeting of the board of directors or a committee thereof, and a payment of $500.00 for each written resolution of the board of directors or a committee thereof.

 

Since our inception we have granted options to purchase our ordinary shares to our officers, and since our initial public offering, we have granted options to purchase our ordinary shares to our directors. Such option agreements may contain acceleration provisions upon certain merger, acquisition, or change of control transactions. We describe our option plans under “Item 6.E Directors, Senior Management and Employees—Share Ownership—Share Option Plans.” If the relationship between us and an executive officer or a director is terminated, except for cause (as defined in the various Option Plan agreements), options that are vested will generally remain exercisable for three (3) months following the date of such termination if we initiate such termination or two weeks following the date of such termination, if an executive officer or a director initiates such termination.

 

 78

 

 

C. Board Practices

 

Introduction

 

Our board of directors consists of five members. We believe that Tal Barnoach, Lluis Pedragosa, Yair Shoham and Osnat Michaeli are “independent” for purposes of the Nasdaq Stock Market rules. Our amended and restated articles of association provide that the number of board of directors’ members shall be set by the general meeting of the shareholders provided that it will consist of not less than five and not more than ten. Pursuant to the Companies Law, the management of our business is vested in our board of directors. Our board of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders or to management. Our executive officers are responsible for our day-to-day management and have individual responsibilities established by our board of directors. Our Chief Executive Officer is appointed by, and serves at the discretion of, our board of directors, subject to the service agreement that we have entered into with him. All other executive officers are appointed by our Chief Executive Officer. Their terms of employment are subject to the approval of the board of directors, and are subject to the terms of any applicable employment agreements that we may enter into with them.

 

Under our amended and restated articles of association, as amended at our annual general meeting of shareholders held in August 2024, our directors (who shall be elected and serve in office in strict accordance with the provisions of the Companies Law, if so required by the Companies Law) are divided into three classes with staggered three-year terms.  Each class of directors consists, as nearly as possible, of one-third of the total number of directors constituting the entire board of directors.  At each annual general meeting of our shareholders beginning in 2025, the election or re-election of directors following the expiration of the term of office of the directors of that class of directors will be for a term of office that expires on the third annual general meeting following such election or re-election.  Each said director holds office until the third annual general meeting of our shareholders and until his or her successor is duly appointed, unless the tenure of such director expires earlier pursuant to the Companies Law and our amended and restated articles of association, or unless removed from office by a majority vote of our shareholders at a general meeting of our shareholders or upon the occurrence of certain events.

 

Our directors are divided among three classes as follows:

 

the Class I director is Mr. Sharon Carmel, who will hold office until our annual general meeting of shareholders to be held in 2025;

 

the Class II director is Mr. Tal Barnoach, who will hold office until our annual general meeting of shareholders to be held in 2026; and

 

the Class II director is Mr. Lluis Pedragosa, who will hold office until our annual general meeting of shareholders to be held in 2027.

 

In addition, if a director’s office becomes vacant, the remaining serving directors may continue to act in any manner, provided that their number is of the minimal number specified in our amended and restated articles of association. If the number of serving directors is lower than such minimum number, then our board of directors may only act in an emergency or to fill the office of director which has become vacant up to a number equal to the minimum number provided for pursuant to our amended and restated articles of association, or in order to call a general meeting of our shareholders for the purpose of electing directors to fill any of our vacancies. External directors may be elected for up to two additional three-year terms after their initial three-year term under the circumstances described below, with certain exceptions as described in “External Directors” below. External directors may be removed from office only under the limited circumstances set forth in the Companies Law.

 

Under the Companies Law, any shareholder holding at least one percent of our outstanding voting power may nominate a director. However, any such shareholder may make such a nomination only if a written notice of such shareholder’s intent to make such nomination has been given to our board of directors. Any such notice must include certain information, including the consent of the proposed director nominee to serve as our director if elected, and a declaration that the nominee signed declaring that he or she possesses the requisite skills and has the availability to carry out his or her duties. Additionally, the nominee must provide details of such skills, and demonstrate an absence of any limitation under the Companies Law that may prevent his or her election, and affirm that all of the required election-information is provided to us, pursuant to the Companies Law.

 

 79

 

 

Under the Companies Law, our board of directors must determine the minimum number of directors who are required to have accounting and financial expertise. In determining the number of directors required to have such expertise, our board of directors must consider, among other things, the type and size of the company and the scope and complexity of its operations. Our board of directors has determined that the minimum number of directors of our company who are required to have accounting and financial expertise is two.

 

The board of directors must elect one director to serve as the chairman of the board of directors to preside at the meetings of the board of directors, and may also remove that director as chairman. Pursuant to the Companies Law, neither the chief executive officer nor any of his or her relatives is permitted to serve as the chairman of the board of directors, and a company may not vest the chairman or any of his or her relatives with the chief executive officer’s authorities. In addition, a person who reports, directly or indirectly, to the chief executive officer may not serve as the chairman of the board of directors; the chairman may not be vested with authorities of a person who reports, directly or indirectly, to the chief executive officer; and the chairman may not serve in any other position in the company or a controlled company, but he or she may serve as a director or chairman of a controlled company. However, the Companies Law permits a company’s shareholders to determine, for a period not exceeding three years from each such determination, that the chairman or his or her relative may serve as chief executive officer or be vested with the chief executive officer’s authorities, and that the chief executive officer or his or her relative may serve as chairman or be vested with the chairman’s authorities. Such determination of a company’s shareholders requires either: (1) the approval of at least a majority of the shares of those shareholders present and voting on the matter (other than controlling shareholders and those having a personal interest in the determination) (shares held by abstaining shareholders shall not be considered); or (2) that the total number of shares opposing such determination does not exceed 2% of the total voting power in the company.

 

The board of directors may, subject to the provisions of the Companies Law, delegate any or all of its powers to committees of the board, and it may, from time to time, revoke such delegation or alter the composition of any such committees, subject to certain limitations. Unless otherwise expressly provided by the board of directors, the committees shall not be empowered to further delegate such powers. The composition and duties of our audit committee, financial statement examination committee and compensation committee that will be established upon the listing of our ordinary shares on the Nasdaq Capital Market, are described below.

 

The board of directors oversees how management monitors compliance with our risk management policies and procedures, and reviews the adequacy of the risk management framework in relation to the risks faced by us. The board of directors is assisted in its oversight role by an internal auditor. The internal auditor undertakes both regular and ad hoc reviews of risk management controls and procedures, the results of which will be reported to our audit committee.

  

External Directors

 

Under the Companies Law, companies incorporated under the laws of the State of Israel that are publicly traded, including Israeli companies with shares listed on the Nasdaq, are required to appoint at least two external directors who meet the qualification requirements set forth in the Companies Law. The definitions of an external director under the Companies Law and independent director under Nasdaq Stock Market rules are similar such that it would generally be expected that our two external directors will also comply with the independence requirement under Nasdaq Stock Market rules.

 

A person may not be appointed as an external director if the person is a relative of a controlling shareholder or if on the date of the person’s appointment or within the preceding two years the person or his or her relatives, partners, employers or anyone to whom that person is subordinate, whether directly or indirectly, or entities under the person’s control have or had any affiliation with any of the following, or an affiliated entity: (1) us; (2) any person or entity controlling us on the date of such appointment; (3) any relative of a controlling shareholder; or (4) any entity controlled, on the date of such appointment or within the preceding two years, by us or by a controlling shareholder. If there is no controlling shareholder or any shareholder holding 25% or more of voting rights in the company, a person may not be appointed as an external director if the person has any affiliation to the chairman of the board of directors, the chief executive officer (referred to in the Companies Law as a general manager), any shareholder holding 5% or more of the company’s shares or voting rights or the senior financial officer as of the date of the person’s appointment.

 

 80

 

 

The term “controlling shareholder” means a shareholder with the ability to direct the activities of the company, other than by virtue of being an office holder. A shareholder is presumed to have “control” of the company and thus to be a controlling shareholder of the company if the shareholder holds 50% or more of the “means of control” of the company. “Means of control” is defined as (1) the right to vote at a general meeting of a company or a corresponding body of another corporation; or (2) the right to appoint directors of the corporation or its general manager. For the purpose of approving related-party transactions, the term also includes any shareholder that holds 25% or more of the voting rights of the company if the company has no shareholder that owns more than 50% of its voting rights. For the purpose of determining the holding percentage stated above, two or more shareholders who have a personal interest in a transaction that is brought for the company’s approval are deemed as joint holders.

 

The term affiliation includes:

 

an employment relationship;

 

a business or professional relationship maintained on a regular basis;

 

control; and

 

service as an office holder, excluding service as a director in a private company prior to the first offering of its shares to the public if such director was appointed as a director of the private company in order to serve as an external director following the initial public offering.

 

The term “relative” is defined as a spouse, sibling, parent, grandparent, descendant, spouse’s descendant, sibling and parent and the spouse of each of the foregoing.

 

The term “office holder” is defined as a general manager, chief business manager, deputy general manager, vice general manager, director or manager directly subordinate to the general manager or any other person assuming the responsibilities of any of the foregoing positions, without regard to such person’s title.

 

A person may not serve as an external director if that person or that person’s relative, partner, employer, a person to whom such person is subordinate (directly or indirectly) or any entity under the person’s control has a business or professional relationship with any entity that has an affiliation with any affiliated entity, even if such relationship is intermittent (excluding insignificant relationships). Additionally, any person who has received compensation intermittently (excluding insignificant relationships) other than compensation permitted under the Companies Law may not continue to serve as an external director.

 

No person can serve as an external director if the person’s position or other affairs create, or may create, a conflict of interest with the person’s responsibilities as a director or may otherwise interfere with the person’s ability to serve as a director or if such a person is an employee of the Israeli Securities Authority or of an Israeli stock exchange. If at the time an external director is appointed all current members of the board of directors, who are not controlling shareholders or relatives of controlling shareholders, are of the same gender, then the external director to be appointed must be of the other gender. In addition, a person who is a director of a company may not be elected as an external director of another company.

 

According to regulations promulgated under the Companies law, at least one of the external directors is required to have “financial and accounting expertise,” unless another member of the audit committee, who is an independent director under the Nasdaq Stock Market rules, has “financial and accounting expertise,” and the other external director or directors are required to have “professional expertise.” An external director may not be appointed to an additional term unless: (1) such director has “accounting and financial expertise;” or (2) he or she has “professional expertise,” and on the date of appointment for another term there is another external director who has “accounting and financial expertise” and the number of “accounting and financial experts” on the board of directors is at least equal to the minimum number determined appropriate by the board of directors. 

 

 81

 

 

The regulations promulgated under the Companies Law define an external director with requisite professional qualifications as a director who satisfies one of the following requirements: (1) the director holds an academic degree in either economics, business administration, accounting, law or public administration, (2) the director either holds an academic degree in any other field or has completed another form of higher education in the company’s primary field of business or in an area which is relevant to his or her office as an external director in the company, or (3) the director has at least five years of experience serving in any one of the following, or at least five years of cumulative experience serving in two or more of the following capacities: (a) a senior business management position in a company with a substantial scope of business, (b) a senior position in the company’s primary field of business or (c) a senior position in public administration.

 

Until the lapse of a two-year period from the date that an external director of a company ceases to act in such capacity, the company in which such external director served, and its controlling shareholder or any entity under control of such controlling shareholder may not, directly or indirectly, grant such former external director, or his or her spouse or child, any benefit, including by way of (i) the appointment of such former director or his or her spouse or his child as an officer in the company or in an entity controlled by the company’s controlling shareholder, (ii) the employment of such former director, and (iii) the engagement, directly or indirectly, of such former director as a provider of professional services for compensation, directly or indirectly, including via an entity under his or her control. With respect to a relative who is not a spouse or a child, such limitations only apply for one year from the date such external director ceased to be engaged in such capacity.

 

The provisions of the Companies Law set forth special approval requirements for the election of external directors. External directors must be elected by a majority vote of the shares present and voting at a shareholders meeting, provided that either:

 

  such majority includes at least a majority of the shares held by shareholders who are non-controlling shareholders and do not have a personal interest in the election of the external director (other than a personal interest not deriving from a relationship with a controlling shareholder) that are voted at the meeting, excluding abstentions, to which we refer as a disinterested majority; or

 

  the total number of shares voted by non-controlling shareholders and by shareholders who do not have a personal interest in the election of the external director, against the election of the external director, does not exceed 2% of the aggregate voting rights in the company.

 

The initial term of an external director is three years. Thereafter, an external director may be reelected by shareholders to serve in that capacity for up to two additional three-year terms, provided that:

 

  his or her service for each such additional term is recommended by one or more shareholders holding at least 1% of the company’s voting rights and is approved at a shareholders meeting by a disinterested majority, where the total number of shares held by non-controlling, disinterested shareholders voting for such reelection exceeds 2% of the aggregate voting rights in the company. In such event, the external director so reappointed may not be a Related or Competing Shareholder, as defined below, or a relative of such shareholder, at the time of the appointment, and is not and has not had any affiliation with a Related or Competing Shareholder, at such time or during the two years preceding such person’s reappointment to serve an additional term as external director. The term “Related or Competing Shareholder” means a shareholder proposing the reappointment or a shareholder holding 5% or more of the outstanding shares or voting rights of the company, provided, that at the time of the reappointment, such shareholder, the controlling shareholder of such shareholder, or a company controlled by such shareholder, have a business relationship with the company or are competitors of the company;

 

  the external director proposed his or her own nomination, and such nomination was approved in accordance with the requirements described above;

 

  his or her service for each such additional term is recommended by the board of directors and is approved at a shareholders meeting by the same majority required for the initial election of an external director (as described above).

 

 82

 

 

The term of office for external directors for Israeli companies traded on certain foreign stock exchanges, including the Nasdaq Marketplace Rules, may be extended indefinitely in increments of additional three-year terms, in each case provided that the audit committee and the board of directors of the company confirm that, in light of the external director’s expertise and special contribution to the work of the board of directors and its committees, the reelection for such additional period(s) is beneficial to the company, and provided that the external director is reelected subject to the same shareholder vote requirements as if elected for the first time (as described above).

 

External directors may be removed from office by a special general meeting of shareholders called by the board of directors, which approves such dismissal by the same shareholder vote percentage required for their election, after receiving the board of directors arguments for such removal, or by a court, in each case, only under limited circumstances, including ceasing to meet the statutory qualifications for appointment, or violating their duty of loyalty to the company. If an external directorship becomes vacant and there are fewer than two external directors on the board of directors at the time, then the board of directors is required under the Companies Law to call a shareholders meeting as soon as practicable to appoint a replacement external director.

 

Each committee of the board of directors that is authorized to exercise the powers of the board of directors must include at least one external director, except that the audit committee and the compensation committee must include all external directors then serving on the board of directors.

 

External directors may be compensated only in accordance with regulations adopted under the Companies Law.

 

Alternate Directors

 

Our amended and restated articles of association provide, as allowed by the Companies Law, that any director may, subject to the conditions set thereto, appoint a person as an alternate to act in his place, to remove the alternate and appoint another in his place and to appoint an alternate in place of an alternate whose office is vacated for any reason whatsoever. Under the Companies Law, a person who is not qualified to be appointed as a director, a person who is already serving as a director or a person who is already serving as an alternate director for another director, may not be appointed as an alternate director. Nevertheless, a director who is already serving as a director may be appointed as an alternate director for a member of a committee of the board of directors so long as he or she is not already serving as a member of such committee, and if the alternate director is to replace an external director, he or she is required to be an external director and to have either “financial and accounting expertise” or “professional expertise,” depending on the qualifications of the external director he or she is replacing. A person who does not have the requisite “financial and accounting experience” or the “professional expertise,” depending on the qualifications of the external director he or she is replacing, may not be appointed as an alternate director for an external director. A person who is not qualified to be appointed as an independent director, pursuant to the Companies Law, may not be appointed as an alternate director of an independent director qualified as such under the Companies Law. Unless the appointing director limits the time or scope of the appointment, the appointment is effective for all purposes until the appointing director ceases to be a director or terminates the appointment.

 

Committees of the Board of Directors

 

Our board of directors has established two standing committees, the audit committee and the compensation committee.

 

Audit Committee

 

Under the Companies Law, we are required to appoint an audit committee subject to the listing of our ordinary shares on the Nasdaq Capital Market. The audit committee must be comprised of at least three directors, including all of the external directors, if applicable, (one of whom must serve as chair of the committee). The audit committee may not include the chairman of the board; a controlling shareholder of the company or a relative of a controlling shareholder; a director employed by or providing services on a regular basis to the company, to a controlling shareholder or to an entity controlled by a controlling shareholder; or a director who derives most of his or her income from a controlling shareholder.

 

 83

 

 

Our audit committee is comprised of Lluis Pedragosa, Yair Shoham and Osnat Michaeli.

  

Under the Companies Law, our audit committee is responsible for:

 

  (i) determining whether there are deficiencies in the business management practices of our company, and making recommendations to the board of directors to improve such practices;
     
  (ii) determining whether to approve certain related party transactions (including transactions in which an office holder has a personal interest and whether such transaction is extraordinary or material under Companies Law) and establishing the approval process for certain transactions with a controlling shareholder or in which a controlling shareholder has a personal interest (see “Item 6.C Directors, Senior Management and Employees—Board Practices—Approval of Related Party Transactions under Israeli Law”);
     
  (iii) determining the approval process for transactions that are “non-negligible” (i.e., transactions with a controlling shareholder that are classified by the audit committee as non-negligible, even though they are not deemed extraordinary transactions), as well as determining which types of transactions would require the approval of the audit committee, optionally based on criteria which may be determined annually in advance by the audit committee;
     
  (iv) examining our internal controls and internal auditor’s performance, including whether the internal auditor has sufficient resources and tools to dispose of its responsibilities;

 

  (v) examining the scope of our auditor’s work and compensation and submitting a recommendation with respect thereto to our board of directors or shareholders, depending on which of them is considering the appointment of our auditor;
     
  (vi) establishing procedures for the handling of employees’ complaints as to deficiencies in the management of our business and the protection to be provided to such employees; and
     
  (vii) where the board of directors approves the working plan of the internal auditor, examining such working plan before its submission to the board of directors and proposing amendments thereto.

 

Pursuant to the Companies Law, our audit committee may not conduct any discussions or approve any actions requiring its approval (see “Item 6.C Directors, Senior Management and Employees—Board Practices—Approval of Related Party Transactions under Israeli Law”), unless at the time of the approval a majority of the committee’s members are present.

 

Our board of directors intends to adopt an audit committee charter to be effective upon the listing of our ordinary shares on the Nasdaq Capital Market setting forth, among others, the responsibilities of the audit committee consistent with the rules of the SEC and Nasdaq Listing Rules (in addition to the requirements for such committee under the Companies Law), including, among others, the following:

 

  oversight of our independent registered public accounting firm and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm to the board of directors in accordance with Israeli law;

 

  recommending the engagement or termination of the person filling the office of our internal auditor, reviewing the services provided by our internal auditor and reviewing effectiveness of our system of internal control over financial reporting;

 

  recommending the terms of audit and non-audit services provided by the independent registered public accounting firm for pre-approval by our board of directors; and

 

  reviewing and monitoring, if applicable, legal matters with significant impact, finding of regulatory authorities’ findings, receive reports regarding irregularities and legal compliance, acting according to “whistleblower policy” and recommend to our board of directors if so required.

 

 84

 

 

Nasdaq Stock Market Requirements for Audit Committee

 

Under the Nasdaq Stock Market rules, we are required to maintain an audit committee consisting of at least three members, all of whom are independent and are financially literate and one of whom has accounting or related financial management expertise.

 

As noted above, the members of our audit committee include Lluis Pedragosa, Yair Shoham and Osnat Michaeli. Osnat Michaeli  serves as the chairman of our audit committee. All members of our audit committee will meet the requirements for financial literacy under the Nasdaq Stock Market rules. Our board of directors has determined that each member of our audit committee will be an audit committee financial expert as defined by the SEC rules and has the requisite financial experience as defined by the Nasdaq Stock Market rules. 

 

Under the Companies Law, our audit committee will also carry out the duties of a financial statement examination committee. As such, the audit committee will be responsible for: (i) estimations and assessments made in connection with the preparation of financial statements; (ii) internal controls related to the financial statements; (iii) completeness and propriety of the disclosure in the financial statements; (iv) the accounting policies adopted and the accounting treatments implemented in material matters of the company; and (v) value evaluations, including the assumptions and assessments on which evaluations are based and the supporting data in the financial statements.

 

Compensation Committee

 

Under the Companies Law, the board of directors of any public company must establish a compensation committee. The compensation committee must be comprised of at least three directors, including all of the external directors (if any). The compensation committee is subject to the same Companies Law restrictions as the audit committee as to: (a) who may not be a member of the committee; and (b) who may not be present during committee deliberations as described above.

 

Our compensation committee, acting pursuant to a written charter, is comprised of Tal Barnoach, Yair Shoham and Osnat Michaeli. Our compensation committee complies with the provisions of the Companies Law, the regulations promulgated thereunder on all aspects referring to its independence, authorities and practice. Our compensation committee follows home country practice as opposed to complying with the compensation committee membership and charter requirements prescribed under the Nasdaq Stock Market rules.

 

Our compensation committee will review and recommend to our board of directors: with respect to our executive officers’ and directors’: (1) annual base compensation (2) annual incentive bonus, including the specific goals and amounts; (3) equity compensation; (4) employment agreements, severance arrangements, and change in control agreements and provisions; (5) retirement grants and/or retirement bonuses; and (6) any other benefits, compensation, compensation policies or arrangements.

 

The duties of the compensation committee include the recommendation to the company’s board of directors of a policy regarding the terms of engagement of office holders, to which we refer as a compensation policy. Such policy must be adopted by the company’s board of directors, after considering the recommendations of the compensation committee. The compensation policy is then brought for approval by our shareholders, which requires a special majority (see “Item 6.C Directors, Senior Management and Employees—Board Practices—Approval of Related Party Transactions under Israeli Law”). Under the Companies Law, the board of directors may adopt the compensation policy if it is not approved by the shareholders, provided that after the shareholders oppose the approval of such policy, the compensation committee and the board of directors revisit the matter and determine that adopting the compensation policy would be in the best interests of the company. Under the Companies Law, we are required to adopt an office holder compensation policy. Our current compensation policy was approved at an extraordinary general meeting of our shareholders held in January 2023.

 

 85

 

 

The compensation policy must serve as the basis for decisions concerning the financial terms of employment or engagement of executive officers and directors, including exculpation, insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation policy must relate to certain factors, including advancement of the company’s objectives, the company’s business and its long-term strategy, and creation of appropriate incentives for executives. It must also consider, among other things, the company’s risk management, size and the nature of its operations. The compensation policy must furthermore consider the following additional factors:

 

  the education, skills, expertise and accomplishments of the relevant director or executive;
     
  the director’s or executive’s roles and responsibilities and prior compensation agreements with him or her;
     
  the relationship between the cost of the terms of service of an office holder and the average median compensation of the other employees of the company (including those employed through manpower companies), including the impact of disparities in salary upon work relationships in the company;
     
  the possibility of reducing variable compensation at the discretion of the board of directors; and the possibility of setting a limit on the exercise value of non-cash variable compensation; and
     
  as to severance compensation, the period of service of the director or executive, the terms of his or her compensation during such service period, the company’s performance during that period of service, the person’s contribution towards the company’s achievement of its goals and the maximization of its profits, and the circumstances under which the person is leaving the company.

 

The compensation policy must also include the following principles:

 

  with the exception of office holders who report directly to the chief executive officer, the link between variable compensation and long-term performance and measurable criteria;
     
  the relationship between variable and fixed compensation, and the ceiling for the value of variable compensation at the time of its grant;
     
  the conditions under which a director or executive would be required to repay compensation paid to him or her if it was later shown that the data upon which such compensation was based was inaccurate and was required to be restated in the company’s financial statements;
     
  the minimum holding or vesting period for variable, equity-based compensation; and
     
  maximum limits for severance compensation.

 

The compensation policy must also consider appropriate incentives from a long-term perspective.

 

The compensation committee will be responsible for: (1) recommending the compensation policy to a company’s board of directors for its approval (and subsequent approval by the shareholders); and (2) duties related to the compensation policy and to the compensation of a company’s office holders, including:

 

  recommending whether a compensation policy should continue in effect, if the then-current policy has a term of greater than three years (approval of either a new compensation policy or the continuation of an existing compensation policy must in any case occur every three years);
     
  recommending to the board of directors periodic updates to the compensation policy;
     
  assessing implementation of the compensation policy;
     
  determining whether the terms of compensation of certain office holders of the company need not be brought to approval of the shareholders; and
     
  determining whether to approve the terms of compensation of office holders that require the committee’s approval.

 

 86

 

 

Our compensation policy will be designed to promote our long-term goals, work plan and policy, retain, motivate and incentivize our directors and executive officers, while considering the risks that our activities involve, our size, the nature and scope of our activities and the contribution of an officer to the achievement of our goals and maximization of profits, and align the interests of our directors and executive officers with our long-term performance. To that end, a portion of an executive officer compensation package is targeted to reflect our short and long-term goals, as well as the executive officer’s individual performance. On the other hand, our compensation policy will include measures designed to reduce the executive officer’s incentives to take excessive risks that may harm us in the long-term, such as limits on the value of cash bonuses and equity-based compensation, limitations on the ratio between the variable and the total compensation of an executive officer and minimum vesting periods for equity-based compensation.

 

Our compensation policy will also address our executive officer’s individual characteristics (such as his or her respective position, education, scope of responsibilities and contribution to the attainment of our goals) as the basis for compensation variation among our executive officers and considers the internal ratios between compensation of our executive officers and directors and other employees. For example, the compensation that may be granted to an executive officer may include: base salary, annual bonuses, equity-based compensation, benefits and retirement and termination of service arrangements. All cash bonuses are limited to a maximum amount linked to the executive officer’s base salary. In addition, our compensation policy will provide for maximum permitted ratios between the total variable (cash bonuses and equity-based compensation) and non-variable (base salary) compensation components, in accordance with an officer’s respective position with the company.

 

An annual cash bonus may be awarded to executive officers upon the attainment of pre-set periodic objectives and individual targets. The annual cash bonus that may be granted to executive officers other than our chairman or Chief Executive Officer may be based entirely on a discretionary evaluation. Our Chief Executive Officer will be entitled to recommend performance objectives to such executive officers, and such performance objectives will be approved by our compensation committee (and, if required by law, by our board of directors).

 

The performance measurable objectives of our chairman and Chief Executive Officer will be determined annually by our compensation committee and board of directors. A less significant portion of the chairman’s and/or the Chief Executive Officer’s annual cash bonus may be based on a discretionary evaluation of the chairman’s or the Chief Executive Officer’s respective overall performance by the compensation committee and the board of directors based on quantitative and qualitative criteria.

 

The equity-based compensation under our compensation policy for our executive officers (including members of our board of directors) will be designed in a manner consistent with the underlying objectives in determining the base salary and the annual cash bonus, with its main objectives being to enhance the alignment between the executive officers’ interests with our long-term interests and those of our shareholders and to strengthen the retention and the motivation of executive officers in the long term. Our compensation policy will provide for executive officer compensation in the form of share options or other equity-based awards, such as restricted shares and phantom, options, in accordance with our equity incentive plan then in place. Share options granted to executive officers shall be subject to vesting periods in order to promote long-term retention of the awarded executive officers. The equity-based compensation shall be granted from time to time and be individually determined and awarded according to the performance, educational background, prior business experience, qualifications, role and the personal responsibilities of the executive officer.

 

In addition, our compensation policy will contain compensation recovery provisions which allows us under certain conditions to recover bonuses paid in excess, will enable our Chief Executive Officer to approve an immaterial change in the terms of employment of an executive officer (provided that the changes of the terms of employment are in accordance our compensation policy) and will allow us to exculpate, indemnify and insure our executive officers and directors subject to certain limitations set forth thereto.

 

 87

 

 

Our compensation policy will also provide for compensation to the members of our board of directors either: (i) in accordance with the amounts provided in the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director) of 2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel) of 2000, as such regulations may be amended from time to time; or (ii) in accordance with the amounts determined in our compensation policy.

  

Internal Auditor

 

Under the Companies Law, the board of directors of an Israeli public company must appoint an internal auditor nominated by the audit committee. As of July 31, 2023, Sapir Efrati from Deloitte & Co. Israel has been acting as our internal auditor. The role of the internal auditor is to examine, among other things, whether a company’s actions comply with the law and proper business procedure. The chairman of the Board, or whoever the Board of the Company determines from time to time is required to oversee the activities, and to assess the performance of the internal auditor as well as to review the internal auditor’s work plan. An internal auditor may not be an interested party or office holder, or a relative of any interested party or office holder, and may not be a member of the company’s independent accounting firm or its representative. The Companies Law defines an interested party as a holder of 5% or more of the outstanding shares or voting rights of a company, any person or entity that has the right to appoint at least one director or the general manager of the company or any person who serves as a director or as the general manager of a company. Our internal auditor is not our employee, but partner of a firm which specializes in internal auditing.

 

Remuneration of Directors

 

Under the Companies Law, remuneration of directors is subject to the approval of the compensation committee, thereafter by the board of directors and thereafter, unless exempted under the regulations promulgated under the Companies Law, by the general meeting of the shareholders. In case the remuneration of the directors is in accordance with regulations applicable to remuneration of the external directors then such remuneration shall be exempt from the approval of the general meeting. Where the director is also a controlling shareholder, the requirements for approval of transactions with controlling shareholders apply.

 

Fiduciary Duties of Office Holders

 

The Companies Law imposes a duty of care and a duty of loyalty on all office holders of a company.

 

The duty of care requires an office holder to act with the level of care with which a reasonable office holder in the same position would have acted under the same circumstances. The duty of care of an office holder includes a duty to use reasonable means to obtain:

 

  information on the advisability of a given action brought for his approval or performed by him by virtue of his position; and
     
  all other important information pertaining to these actions.

 

The duty of loyalty of an office holder requires an office holder to act in good faith and for the benefit of the company, and includes a duty to:

 

  refrain from any conflict of interest between the performance of his duties in the company and his performance of his other duties or personal affairs;
     
  refrain from any action that is competitive with the company’s business;
     
  refrain from exploiting any business opportunity of the company to receive a personal gain for himself or others; and
     
  disclose to the company any information or documents relating to the company’s affairs which the office holder has received due to his position as an office holder.

 

 88

 

 

Insurance

  

Under the Companies Law, a company may obtain insurance for any of its office holders against the following liabilities incurred due to acts he or she performed as an office holder, if and to the extent provided for in the company’s articles of association:

 

  breach of his or her duty of care to the company or to another person;

 

  a breach of his or her duty of loyalty to the company, provided that the office holder acted in good faith and had reasonable cause to assume that his or her act would not prejudice the company’s interests; and
     
  a financial liability imposed upon him or her in favor of another person.

 

We purchase increased insurance coverage for a company of our size.

 

Indemnification

 

The Companies Law and the Israeli Securities Law, 5728-1968, or the Securities Law, provide that a company may indemnify an office holder against the following liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant to an undertaking made in advance of an event or following an event, provided its articles of association include a provision authorizing such indemnification:

 

  a financial liability imposed on him or her in favor of another person by any judgment concerning an act performed in his or her capacity as an office holder, including a settlement or arbitrator’s award approved by a court;
     
  reasonable litigation expenses, including attorneys’ fees, expended by the office holder (a) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1) no indictment (as defined in the Companies Law) was filed against such office holder as a result of such investigation or proceeding; and (2) no financial liability as a substitute for the criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding, or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; or (b) in connection with a monetary sanction;
     
  reasonable litigation expenses, including attorneys’ fees, expended by the office holder or imposed on him or her by a court: (1) in proceedings that the company institutes, or that another person institutes on the company’s behalf, against him or her; (2) in a criminal proceeding of which he or she was acquitted; or (3) as a result of a conviction for a crime that does not require proof of criminal intent; and
     
  expenses incurred by an office holder in connection with an Administrative Procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys’ fees. An “Administrative Procedure” is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) to the Securities Law.

 

The Companies Law also permits a company to undertake in advance to indemnify an office holder, provided that if such indemnification relates to financial liability imposed on him or her, as described above, then the undertaking should be limited and shall detail the following foreseen events and amount or criterion:

 

  to events that in the opinion of the board of directors can be foreseen based on the company’s activities at the time that the undertaking to indemnify is made; and

 

 89

 

 

  in amount or criterion determined by the board of directors, at the time of the giving of such undertaking to indemnify, to be reasonable under the circumstances.

 

We intend to enter, into indemnification agreements with all of our directors and with all members of our senior management subject to the listing of our securities on the Nasdaq Capital Market. Each such indemnification agreement will provide the office holder with indemnification permitted under applicable law and up to a certain amount, and to the extent that these liabilities are not covered by directors and officers insurance.

 

Exculpation

 

Under the Companies Law, an Israeli company may not exculpate an office holder from liability for a breach of his or her duty of loyalty, but may exculpate in advance an office holder from his or her liability to the company, in whole or in part, for damages caused to the company as a result of a breach of his or her duty of care (other than in relation to distributions), but only if a provision authorizing such exculpation is included in its articles of association. Our amended and restated articles of association provide that we may exculpate, in whole or in part, any office holder from liability to us for damages caused to the company as a result of a breach of his or her duty of care, other than a breach of the duty of care in a distribution. Subject to the aforesaid limitations, under the indemnification agreements we intend to enter, we will exculpate and release our office holders from any and all liability to us related to any breach by them of their duty of care to us to the fullest extent permitted by law.

 

Limitations

 

The Companies Law provides that we may not exculpate or indemnify an office holder nor enter into an insurance contract that would provide coverage for any liability incurred as a result of any of the following: (1) a breach by the office holder of his or her duty of loyalty unless (in the case of indemnity or insurance only, but not exculpation) the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice us; (2) a breach by the office holder of his or her duty of care if the breach was carried out intentionally or recklessly (as opposed to merely negligently); (3) any act or omission committed with the intent to derive an illegal personal benefit; or (4) any fine, monetary sanction, penalty or forfeit levied against the office holder.

 

Under the Companies Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation committee and the board of directors and, with respect to certain office holders or under certain circumstances, also by the shareholders.

 

Our amended and restated articles of association permit us to exculpate (subject to the aforesaid limitation), indemnify and insure our office holders to the fullest extent permitted or to be permitted by the Companies Law.

 

The foregoing descriptions summarize the material aspects and practices of our board of directors. For additional details, we also refer you to the full text of the Companies Law, as well as of our amended and restated articles of association, which are exhibits to this Annual Report.

 

There are no service contracts between us or our Subsidiary, on the one hand, and our directors in their capacity as directors, on the other hand, providing for benefits upon termination of service.

 

Approval of Related Party Transactions under Israeli Law

 

General

 

Under the Companies Law, we may approve an action by an office holder from which the office holder would otherwise have to refrain, as described above, if:

 

  the office holder acts in good faith and the act or its approval does not cause harm to the company; and
     
  the office holder disclosed the nature of his or her interest in the transaction (including any significant fact or document) to the company at a reasonable time before the company’s approval of such matter.

 

 90

 

 

Disclosure of Personal Interests of an Office Holder

 

The Companies Law requires that an office holder disclose to the company, promptly, and, in any event, not later than the board meeting at which the transaction is first discussed, any direct or indirect personal interest that he or she may have and all related material information known to him or her relating to any existing or proposed transaction by the company. If the transaction is an extraordinary transaction, the office holder must also disclose any personal interest held by:

 

  the office holder’s relatives; or
     
  any corporation in which the office holder or his or her relatives holds 5% or more of the shares or voting rights, serves as a director or general manager or has the right to appoint at least one director or the general manager.

 

An office holder is not, however, obliged to disclose a personal interest if it derives solely from the personal interest of his or her relative in a transaction that is not considered an extraordinary transaction. Under the Companies Law, an extraordinary transaction is a transaction:

 

  not in the ordinary course of business;
     
  not on market terms; or
     
  that is likely to have a material effect on the company’s profitability, assets or liabilities.

 

The Companies Law does not specify to whom within us nor the manner in which required disclosures are to be made. We require our office holders to make such disclosures to our board of directors.

 

Under the Companies Law, once an office holder complies with the above disclosure requirement, the board of directors may approve a transaction between the company and an office holder, or a third party in which an office holder has a personal interest, unless the articles of association provide otherwise and provided that the transaction is in the company’s interest. If the transaction is an extraordinary transaction in which an office holder has a personal interest, first the audit committee and then the board of directors, in that order, must approve the transaction. Under specific circumstances, shareholder approval may also be required. Generally, a person who has a personal interest in a matter which is considered at a meeting of the board of directors or the audit committee may not be present at such a meeting unless the chairman of the audit committee or board of directors (as applicable) determines that he or she should be present in order to present the transaction that is subject to approval. A director who has a personal interest in a transaction, which is considered at a meeting of the board of directors or the audit committee, may not be present at this meeting or vote on this matter, unless a majority of members of the board of directors or the audit committee, as the case may be, has a personal interest. If a majority of the board of directors has a personal interest, then shareholder approval is generally also required.

 

Disclosure of Personal Interests of a Controlling Shareholder

 

Under the Companies Law, the disclosure requirements that apply to an office holder also apply to a controlling shareholder of a public company. Extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, including a private placement in which a controlling shareholder has a personal interest, as well as transactions for the provision of services whether directly or indirectly by a controlling shareholder or his or her relative, or a company such controlling shareholder controls, and transactions concerning the terms of engagement and compensation of a controlling shareholder or a controlling shareholder’s relative, whether as an office holder or an employee, require the approval of the audit committee or the compensation committee, as the case may be, the board of directors and a majority of the shares voted by the shareholders of the company participating and voting on the matter in a shareholders’ meeting. In addition, the shareholder approval must fulfill one of the following requirements:

 

  at least a majority of the shares held by shareholders who have no personal interest in the transaction and are voting at the meeting must be voted in favor of approving the transaction, excluding abstentions; or

 

 91

 

 

  the shares voted by shareholders who have no personal interest in the transaction who vote against the transaction represent no more than 2% of the voting rights in the company.

   

In addition, any extraordinary transaction with a controlling shareholder or in which a controlling shareholder has a personal interest with a term of more than three years requires the abovementioned approval every three years; however, such transactions not involving the receipt of services or compensation can be approved for a longer term, provided that the audit committee determines that such longer term is reasonable under the circumstances.

 

The Companies Law requires that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction with a controlling shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in the vote in question. Failure to so indicate will result in the invalidation of that shareholder’s vote.

 

The term “controlling shareholder” is defined in the Companies Law as a shareholder with the ability to direct the activities of the company, other than by virtue of being an office holder. A shareholder is presumed to be a controlling shareholder if the shareholder holds 50% or more of the voting rights in a company or has the right to appoint 50% or more of the directors of the company or its general manager. In the context of a transaction involving a shareholder of the company, a controlling shareholder also includes a shareholder who holds 25% or more of the voting rights in the company if no other shareholder holds more than 50% of the voting rights in the company. For this purpose, the holdings of all shareholders who have a personal interest in the same transaction will be aggregated.

 

Approval of the Compensation of Directors and Executive Officers

 

The compensation of, or an undertaking to indemnify, insure or exculpate, an office holder who is not a director requires the approval of the company’s compensation committee, followed by the approval of the company’s board of directors, and, if such compensation arrangement or an undertaking to indemnify, insure or exculpate is inconsistent with the company’s stated compensation policy, or if the said office holder is the chief executive officer of the company (subject to a number of specific exceptions), then such arrangement is subject to the approval of our shareholders, subject to a special majority requirement.

 

Directors. Under the Companies Law, the compensation of our directors requires the approval of our compensation committee, the subsequent approval of the board of directors and, unless exempted under the regulations promulgated under the Companies Law, the approval of the general meeting of our shareholders. If the compensation of our directors is inconsistent with our stated compensation policy, then, provided that those provisions that must be included in the compensation policy according to the Companies Law have been considered by the compensation committee and board of directors, shareholder approval by a special majority will be required.

  

Executive officers other than the chief executive officer. The Companies Law requires the approval of the compensation of a public company’s executive officers (other than the chief executive officer) in the following order: (i) the compensation committee, (ii) the company’s board of directors, and (iii) only if such compensation arrangement is inconsistent with the company’s stated compensation policy, the company’s shareholders by a special majority. However, if the shareholders of the company do not approve a compensation arrangement with an executive officer that is inconsistent with the company’s stated compensation policy, the compensation committee and board of directors may override the shareholders’ decision if each of the compensation committee and the board of directors provide detailed reasons for their decision.

 

 92

 

 

Chief executive officer. Under the Companies Law, the compensation of a public company’s chief executive officer is required to be approved by: (i) the company’s compensation committee; (ii) the company’s board of directors, and (iii) the company’s shareholders by a special majority. However, if the shareholders of the company do not approve the compensation arrangement with the chief executive officer, the compensation committee and board of directors may override the shareholders’ decision if each of the compensation committee and the board of directors provides detailed reasons for their decision. In addition, the compensation committee may exempt the engagement terms of a candidate to serve as the chief executive officer from shareholders’ approval, if the compensation committee determines that the compensation arrangement is consistent with the company’s stated compensation policy, that the chief executive officer did not have a prior business relationship with the company or a controlling shareholder of the company, and that subjecting the approval to a shareholder vote would impede the company’s ability to attain the candidate to serve as the company’s chief executive officer (and provide detailed reasons for the latter).

 

The approval of each of the compensation committee and the board of directors, with regard to the office holders and directors above, must be in accordance with the company’s stated compensation policy; however, under special circumstances, the compensation committee and the board of directors may approve compensation terms of a chief executive officer that are inconsistent with the company’s compensation policy provided that they have considered those provisions that must be included in the compensation policy according to the Companies Law and that shareholder approval was obtained by a special majority requirement.

 

Duties of Shareholders

 

Under the Companies Law, a shareholder has a duty to refrain from abusing his power in the company and to act in good faith and in an acceptable manner in exercising his rights and performing his obligations toward the company and other shareholders, including, among other things, in voting at general meetings of shareholders (and at shareholder class meetings) on the following matters:

 

  amendment of the articles of association;
     
  increase in the company’s authorized share capital;
     
  merger; and
     
  the approval of related party transactions and acts of office holders that require shareholder approval.

 

A shareholder also has a general duty to refrain from oppressing other shareholders. The remedies generally available upon a breach of contract will also apply to a breach of the above mentioned duties, and in the event of oppression of other shareholders, additional remedies are available to the injured shareholder.

 

In addition, any controlling shareholder, any shareholder that knows that its vote can determine the outcome of a shareholder vote and any shareholder that, under a company’s articles of association, has the power to appoint or prevent the appointment of an office holder, or has another power with respect to a company, is under a duty to act with fairness towards the company. The Companies Law does not describe the substance of this duty except to state that the remedies generally available upon a breach of contract will also apply in the event of a breach of the duty to act with fairness, taking the shareholder’s position in the company into account. 

 

Employment and Consulting Agreements with Executive Officers

 

We have entered into written employment or consulting agreements with each of our executive officers. These agreements provide for notice periods of varying duration for termination of the agreement by us or by the relevant executive officer, during which time the executive officer will continue to receive salary and benefits. These agreements also contain customary provisions regarding non-competition, non-solicitation, confidentiality of information and assignment of inventions. However, the enforceability of the non-competition provisions may be limited under applicable law.

 

D. Employees.

 

See “Item 4.B. Business Overview—Employees.”

 

 93

 

 

E. Share Ownership.

 

See “Item 7.A. Major Shareholders” below.

 

Share Option Plans

 

2010 Option Plan

 

In December 22, 2010, our board of directors adopted our 2010 Option Plan, or the 2010 Plan. We are no longer granting options under the 2010 Plan and currently grant options under the 2015 Plan (as defined below). There are currently 18,360 ordinary shares resulting from the exercise of certain options granted under the 2010 Plan which are held in trust in favor of the employees who exercised such options. We maintain the 2010 Plan in order to allow our employees to enjoy certain tax benefits under Israeli tax law. Of the 120,260 outstanding options as of March 3, 2025 under the 2010 Plan, all options were fully vested.

 

Administration. Our board of directors, a duly authorized committee of our board of directors, or the administrator, administer the 2010 Plan. Under the 2010 Plan, the administrator has the authority, subject to applicable law, to interpret the terms of the 2010 Plan and any option agreements or options granted thereunder, designate recipients of options, determine and amend the terms of options, including, but not limited to, the number and class of ordinary shares underlying each option, the time of grant of an option, the exercise price of an option (with the consent of the grantee in the event of an increase of the exercise price), the time and vesting schedule applicable to an option, accelerate or amend the vesting schedule applicable to an option (with the consent of the grantee in the event of an extension to the vesting schedule) and take all other actions and make all other determinations necessary or advisable for the administration of the 2010 Plan.

 

The administrator also has the authority to approve the conversion, substitution, cancellation or suspension under and in accordance with the 2010 Plan of any or all options or ordinary shares. The administrator also has the authority to amend and rescind rules and regulations relating to the 2010 Plan or terminate the 2010 Plan at any time before the date of expiration of its ten-year term.

 

Grant. All options granted pursuant to the 2010 Plan are evidenced by an option agreement. The option agreement sets forth the terms and conditions of the options, including the number of shares subject to such options, vesting schedule, the exercise price, if applicable, the tax route and other terms and conditions not inconsistent with the 2010 Plan as the administrator may determine

 

Exercise. An option under the 2010 Plan may be exercised by providing us with a written notice of exercise, specifying the number of shares with respect to which the option is being exercised and full payment of the exercise price for such shares, if applicable, in such form and method as may be determined by the administrator and permitted by applicable law. An option may not be exercised for a fraction of a share.

  

Termination of Employment. Options under the 2010 Plan shall expire in accordance with the period determined in the applicable option agreement or following the termination of the grantee’s employment or engagement with us, as set forth below. In the event of the death of a grantee while employed by or performing service for us or a subsidiary, or in the event of termination of a grantee’s employment or services for reasons of disability, the grantee, or in the case of death, such grantee’s legal successor, may exercise options that have vested prior to termination within the earlier of the twelve-month period following the date of death or termination, or the options’ expiration date.

 

In the case of termination of the grantee’s employee, other than for cause, any option that is vested prior to the date of termination may be exercised within such period of time ending on the earlier of 90 days following the termination date, or the option’s expiration date.

  

Transferability. Unless otherwise determined by the board of directors, options under the 2010 Plan may not, other than by will or laws of descent, be transferred by the grantee nor may of the rights arising under the options be subject to a mortgage, attachment or other willful encumbrance.

 

 94

 

 

Transactions. In the event of a merger, consolidation or sale of all, or substantially all, of our assets or shares, any and all outstanding, unexercised options granted under the 2010 Plan, whether vested or unvested shall be cancelled for no consideration, unless determined otherwise by our board of directors in its sole and absolute discretion to cause or effect any actions such as (i) the assumption or exchange of the options for options or shares of a successor company; (ii) the exchange of options for monetary compensation; or (iii) the determination that all unvested options and unexercised vested options shall expire on the date of such transactions.

 

2015 Share Incentive Plan

 

The 2015 Share Incentive Plan, or the 2015 Plan, was adopted by our board of directors on January 1, 2015 and its expiration was extended thereby until December 31, 2025. The 2015 Plan provides for the grant of equity-based incentive awards to our employees, directors, office holders, service providers and consultants in order to incentivize them to increase their efforts on behalf of the company and to promote the success of our business.

 

Authorized Shares. As of March 3, 2025, there are 935,419 ordinary shares reserved and available for issuance under the 2015 Plan.

 

Shares underlying an award granted under the 2015 Plan or an award granted under the 2010 Plan that has expired, or was cancelled, terminated, forfeited, or repurchased or settled in cash in lieu of issuance of shares, for any reason, without having been exercised, and if permitted by us, shares tendered to pay the exercise price or withholding tax obligations, are available for issuance under the 2015 Plan in accordance with applicable law.

 

Administration. Our board of directors, a duly authorized committee of our board of directors or the administrator administer the 2015 Plan. Under the 2015 Plan, the administrator has the authority, subject to applicable law, to interpret the terms of the 2015 Plan and any award agreements or awards granted thereunder, designate recipients of awards, determine and amend the terms of awards, including, but not limited to, the number and class of ordinary shares underlying each option award, the time of grant of an option award, the exercise price of an option award (with the consent of the grantee in the event of an increase of the exercise price), the fair market value of an ordinary share, the time and vesting schedule applicable to an award or the method of payment for an award, accelerate or amend the vesting schedule applicable to an award, prescribe the forms of agreement for use under the 2015 Plan and take all other actions and make all other determinations necessary for the administration of the 2015 Plan.

 

The administrator also has the authority to approve the conversion, substitution, cancellation or suspension under and in accordance with the 2015 Plan of any or all option awards or ordinary shares. The administrator also has the authority to modify option awards to eligible individuals who are foreign nationals or are individuals who are employed outside Israel to recognize differences in local law, tax policy or custom in order to effectuate the purposes of the 2015 Plan but without amending the 2015 Plan. The administrator also has the authority to amend and rescind rules and regulations relating to the 2015 Plan or terminate the 2015 Plan at any time before the date of expiration of its ten-year term.

 

Eligibility. The 2015 Plan provides for granting awards under various tax regimes, including, without limitation, in compliance with Section 102 of the Israeli Income Tax Ordinance (New Version), 5721-1961, or the Ordinance, and Section 3(i) of the Ordinance and for awards granted to our U.S. employees or service providers, including those who are deemed to be U.S. residents for tax purposes, in compliance with Section 422 of the Code, and Section 409A of the Code, or Incentive Stock Options.

 

Section 102 of the Ordinance allows employees, directors and officers who are not controlling shareholders and are considered Israeli residents to receive favorable tax treatment for compensation in the form of shares, options or certain other types of equity awards. Our non-employee service providers and controlling shareholders may only be granted options under section 3(i) of the Ordinance, which does not provide for similar tax benefits.

 

Grant. All awards granted pursuant to the 2015 Plan are evidenced by an award agreement, in a form approved, from time to time, by the administrator in its sole discretion. The award agreement sets forth the terms and conditions of the award, including the type of award, number of shares subject to such award, vesting schedule and conditions (including performance goals or measures) and the exercise price, if applicable, and other terms and conditions not inconsistent with the 2015 Plan as the administrator may determine. Certain awards under the 2015 Plan may constitute or provide for a deferral of compensation, subject to Section 409A of the Code, which may impose additional requirements on the terms and conditions of such awards.

 

 95

 

 

Unless otherwise determined by the administrator and stated in the award agreement, and subject to the conditions of the 2015 Plan, awards for new employees vest and become exercisable under the following schedule: 25% of the shares covered by the award, on the first anniversary of the vesting commencement date determined by the administrator (and in the absence of such determination, the date on which such award was granted), and 6.25% of the shares covered by the award at the end of each subsequent three-month period thereafter over the course of the following three years; provided that the grantee remains continuously as an employee or provides services to us throughout such vesting dates.

 

Each award granted under the 2015 Plan will expire ten years from the date of the grant thereof, unless such shorter term of expiration is otherwise designated by the administrator. In the case of an Incentive Stock Option granted to a 10% shareholder, within the meaning of Section 422(b)(6) of the Code, the exercise period shall not exceed five years from the effective date of grant of such Incentive Stock Option.

 

Awards. The 2015 Plan provides for the grant of share options (including Incentive Stock Options and Nonqualified Stock Options), restricted shares, RSUs and other share-based awards. Options granted under the 2015 Plan to our employees who are U.S. residents may qualify as Incentive Stock Options within the meaning of Section 422 of the Code, or may be non-qualified stock options. The exercise price of a stock option may not be less than 100% of the fair market value of the underlying share on the date of grant unless the administrator specifically indicates that the share option will have a lower exercise price and it complies with Section 409A of the Code, and in the case of Incentive Stock Options granted to 10% shareholders, not less than 110%.

 

Exercise. An award under the 2015 Plan may be exercised by providing us with a written notice of exercise, specifying the number of shares with respect to which the award is being exercised and full payment of the exercise price for such shares, if applicable, in such form and method as may be determined by the administrator and permitted by applicable law. An award may not be exercised for a fraction of a share. With regard to tax withholding, exercise price and purchase price obligations arising in connection with awards under the 2015 Plan, the administrator may, in its discretion, (1) accept cash, (2) provide for net withholding of shares in a cashless exercise mechanism or (3) direct a securities broker to sell shares and deliver all or a part of the proceeds to the company or the trustee, or to pledge shares to a securities broker or lender, as security for a loan, and to deliver all or part of the loan proceeds to the company or the trustee.

  

Transferability. Other than by will, the laws of descent and distribution or as otherwise provided under the 2015 Plan or determined by the administrator, neither the options nor any right in connection with such options are assignable or transferable.

 

Termination of Employment. Unless otherwise determined by the administrator and subject to the conditions of the 2015 Plan, an award may only be exercised for as long as the grantee is an employee or provides services to us. In the event of termination of a grantee’s employment or service with us or any of our affiliates, other than for cause, all vested and exercisable awards held by such grantee as of the date of termination may be exercised within three months after such date of termination, unless otherwise determined by the administrator and subject to the conditions of the 2015 Plan and in no event later than the expiration of the term of such awards. After such three-month period or expiration of the term of such awards, all such unexercised awards will terminate and the shares covered by such awards shall again be available for issuance under the 2015 Plan.

 

In the event of termination of a grantee’s employment or service with us or any of our affiliates due to such grantee’s death or permanent disability all vested and exercisable awards held by such grantee as of the date of termination may be exercised by the grantee or the grantee’s legal guardian, estate, or by a person who acquired the right to exercise the award by bequest or inheritance, as applicable, within one year after such date of termination, unless otherwise provided by the administrator and in the event of termination due to such grantee’s retirement, within three months of such termination. Any awards which are unvested as of the date of such termination or which are vested but not then exercised within the one-year period following such date, will terminate and the shares covered by such awards shall again be available for issuance under the 2015 Plan.

 

 96

 

 

Notwithstanding any of the foregoing, if a grantee’s employment or services with us or any of our affiliates is terminated for “cause” (as defined in the 2015 Plan), all outstanding awards held by such grantee (whether vested or unvested) will terminate on the date of such termination and the shares covered by such awards shall again be available for issuance under the 2015 Plan.

  

Transactions. In the event of a share split, reverse share split, share dividend, recapitalization, combination or reclassification of our shares, merger, consolidation, amalgamation, a reorganization or other similar occurrences, the administrator in its sole discretion shall make an appropriate adjustment in the number of shares related to each outstanding award and to the number of shares reserved for issuance under the 2015 Plan, to the class and kind of shares subject to the 2015 Plan, as well as the exercise price per share of each outstanding award, as applicable, the terms and conditions concerning vesting and exercisability and the term and duration of outstanding awards, or any other terms that the administrator adjusts in its discretion; provided that any fractional shares resulting from such adjustment shall be rounded to the nearest whole share unless otherwise determined by the administrator. Notwithstanding any of the foregoing, unless determined by the administrator, no adjustment shall be made by reason of the distribution of subscription rights or rights offering to outstanding shares or other issuance of shares by us.

 

In the event of a merger or consolidation of the company, or a sale of all, or substantially all, of the our shares or assets or other transaction having a similar effect on us, or liquidation or dissolution, or such other transaction or circumstances that our board of directors determines to be a relevant transaction, then without the consent of the grantee, the administrator may but is not required to (i) cause any outstanding award to be assumed or substituted by such successor corporation, (ii) regardless of whether or not the successor corporation assumes or substitutes the award (a) provide the grantee with the option to exercise the award as to all or part of the shares, and may provide for an acceleration of vesting of unvested awards, or (b) cancel the award and pay in cash, shares of the company, the acquirer or other corporation which is a party to such transaction or other property as determined by the administrator as fair in the circumstances, (iii) determine that any payments made in respect of awards shall be made or delayed to the same extent that payment of consideration to the holders of the shares in connection with the merger/sale is made or delayed, or (iv) suspend the grantee’s rights to exercise any vested portion of an award for a period of time prior to the signing or consummation of a merger/sale transaction.

 

Notwithstanding the foregoing, the administrator may upon such event amend, modify or terminate the terms of any award as it shall deem, in good faith, appropriate.

 

F. Disclosure of a registrant’s action to recover erroneously awarded compensation.

 

There was no erroneously awarded compensation that was required to be recovered pursuant to the Beamr Imaging Ltd. Executive Officer Clawback Policy during the fiscal year ended December 31, 2024. 

  

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

 

A. Major Shareholders

 

The following table sets forth information with respect to the beneficial ownership of our ordinary shares as of March 3, 2025 by:

 

  each of our directors and senior management;

 

  all of our directors and senior management as a group; and

 

  each person (or group of affiliated persons) known by us to be the beneficial owner of 5% or more of the outstanding ordinary shares.

 

The beneficial ownership of our ordinary shares is determined in accordance with the rules of the SEC and generally includes any shares over which a person exercises sole or shared voting or investment power, or the right to receive the economic benefit of ownership. For purposes of the table below, we deem ordinary shares issuable pursuant to options that are currently exercisable or exercisable within 60 days from March 3, 2025 to be outstanding and to be beneficially owned by the person holding the options for the purposes of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person. Percentage of shares beneficially owned is based on ordinary shares issued and outstanding as of March 3, 2025.

 

 97

 

 

Based upon a review of the information provided to us by our transfer agent, as of March 3, 2025, there was one holder of record of our ordinary shares, holding approximately 69% of our outstanding ordinary shares, that had a registered address in the United States. This number is not representative of the number of beneficial holders of our shares, nor is it representative of where such beneficial holders reside, since all of these shares held of record in the United States were held through Cede & Co., the nominee company of the Depository Trust Company, on behalf of hundreds of firms of brokers and banks in the United States, who in turn held such shares on behalf of several thousand clients and customers. We have also set forth below information known to us regarding any significant change in the percentage ownership of our ordinary shares by any major shareholders during the past three years. Except where otherwise indicated, we believe, based on information furnished to us by such owners, that the beneficial owners of the ordinary shares listed below have sole investment and voting power with respect to such shares.

 

All of our shareholders, including the shareholders listed below, have the same voting rights attached to their ordinary shares, and neither our principal shareholders nor our directors and executive officers have different or special voting rights with respect to their ordinary shares. A description of any material relationship that our principal shareholders have had with us or any of our predecessors or affiliates within the past three years is included under “Item 7.A Major Shareholders and Related Party Transactions—Certain Relationships and Related Party Transactions.”

  

Unless otherwise noted below, the address of each shareholder, director and executive officer is c/o Beamr Imaging Ltd., 10 HaManofim Street Herzeliya, 43305, Israel.

 

Name of beneficial owner   Number of
Shares
beneficially
owned
    Percentage
of Shares beneficially owned
 
5% or Greater Shareholder            
Disruptive Technologies III L.P.(1)     976,320       6.3 %
Directors and Executive Officers                
Sharon Carmel(2)     3,568,190       23 %
Danny Sandler(3)     57,250       *  
Tamar Shoham(4)     105,800       *  
Dani Megrelishvili(5)     149,967       1 %
Haggai Barel (6)     -       -  
Michael Ozeryansky (7)     18,750       *  
Tal Barnoach(8)     124,849       *  
Lluis Pedragosa(9)     13,728       *  
Yair Shoham(9)     13,728       *  
Osnat Michaeli(9)     13,728       *  
All directors, director nominees and executive officers as a group (10 persons)     4,065,990       26.2 %

 

* Indicates beneficial ownership of less than 1% of the total ordinary shares outstanding.

 

(1) Consists of 976,320 ordinary shares held by Disruptive Technologies III L.P. Disruptive Technology Ltd is the general partner of Disruptive Technologies L.P & Disruptive Technologies III L.P, Tal Barnoach and Adam Rothstein holds the GP and therefore they are deemed to have voting and dispositive power concerning the shares. The address of the principal office of Technologies L.P & Disruptive Technologies III L.P is PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.

 

(2) Consists of 3,568,190 ordinary shares.

 

 98

 

 

(3) Consists of 57,250 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from March 3, 2025. Does not include  42,750 ordinary shares issuable upon exercise of outstanding options that are not exercisable within 60 days of March 3, 2025.

 

(4) Consists of 105,800 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from March 3, 2025. Does not include  2,500 ordinary shares issuable upon exercise of outstanding options that are not exercisable within 60 days of March 3, 2025.

 

(5) Consists of 12,000 ordinary shares, and (ii) 137,967 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from March 3, 2025. Does not include 107,307 ordinary shares issuable upon exercise of outstanding options that are not exercisable within 60 days of March 3, 2025.

 

(6) Does not include 300,000 ordinary shares issuable upon exercise of outstanding options that are not exercisable within 60 days of March 3, 2025.

 

(7) Consists of 18,750 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from March 3, 2025. Does not include  31,250 ordinary shares issuable upon exercise of outstanding options that are not exercisable within 60 days of March 3, 2025.

 

(8) Consists of (i) 63,121 ordinary shares and (ii) options to purchase  61725 ordinary shares that are currently exercisable or will be exercisable within 60 days from March 3, 2025. Does not include 5,272 ordinary shares issuable upon exercise of outstanding options that are not exercisable within 60 days of March 3, 2025. The ordinary shares do not include shares held by Disruptive Technologies III L.P. or Disruptive Technologies L.P.

 

(9) Consists of 13,728 options to purchase ordinary shares that are currently exercisable or will be exercisable within 60 days from March 3, 2025. Does not include 5,272 ordinary shares issuable upon exercise of outstanding options that are not exercisable within 60 days of March 3, 2025.

 

To our knowledge, other than as disclosed in the table above, our other filings with the SEC and this Annual Report, there has been no significant change in the percentage ownership held by any major shareholder since January 1, 2021.

 

B. Related Party Transactions

 

The following is a description of the material terms of those transactions with related parties to which we, or our subsidiaries, are party since January 1, 2024.

 

Sharon Carmel Management

 

On November 1, 2009, we entered into a services agreement with Sharon Carmel Management Ltd., or SCM, a company owned by our Chief Executive Officer and Chairman, Sharon Carmel, according to which we receive consulting services for a current monthly gross amount of NIS 45,000 from Mr. Carmel as our full time Chief Executive Officer.

 

In addition, on February 16, 2022, we entered into an addendum to the services agreement with SCM under which it was agreed that (i) the term of the services agreement with SCM was extended until December 31, 2025 and (ii) the current liability towards SCM as was accrued for services rendered under the services agreement over a period commencing January 1, 2020 through February 16, 2022 in total amount of $359,000, or the Current Liability, will be paid in 18 equal installments (without an interest) starting on March 1, 2022, or the Commencement Date. However, in the event that we did not have available sufficient funds in any such payment date from and after the Commencement Date to repay the installments of the Current Liability and/or the on-going fee owed to SCM or in the event that we determine that according to the following 12-months period budget that we shall not have available sufficient funds to pay such installments and/or the on-going fee, then SCM agreed to postpone such payments owed to it until we will have such sufficient funds. Any unpaid on-going fee payments would be added to the Current Liability. Following the completion of our initial public offering, which closed in March 2023, the Current Liability was equal to $462,000 was paid in 18 equal installments (without an interest) that commenced in March 2023. As of December 31, 2024, the Current Liability was repaid in full.

  

On May 22, 2024, the Company's Compensation Committee approved adjustments of the compensation terms and of the Founder for his duties as Chief Executive Officer of the Company, following which his salary shall be increased by NIS 20 thousand, subject the approval of the Company’s shareholders at a general meeting of the shareholders, which was approved on August 5, 2024

 

 99

 

 

Agreements and Arrangements With, and Compensation of Executive Officers

 

Certain of our executive officers have employment agreements that contain customary provisions and representations, including confidentiality, non-competition, non-solicitation and inventions assignment undertakings by the executive officers. Under current applicable Israeli employment laws, we may not be able to enforce (either in whole or in part) covenants not to compete and therefore may be unable to prevent our competitors from benefiting from the expertise of some of our former employees. See “Item 6.B Directors, Senior Management and Employees—Compensation.”

 

Options

 

Since our inception we have granted options to purchase our ordinary shares to our officers, and since our initial public offering, we have granted options to purchase our ordinary shares to our directors. Such option agreements may contain acceleration provisions upon certain merger, acquisition, or change of control transactions. We describe our option plans under “Management—Share Option Plans.” If the relationship between us and an executive officer or a director is terminated, except for cause (as defined in the various Option Plan agreements), options that are vested will generally remain exercisable for three (3) months following the date of such termination if we initiate such termination or two weeks following the date of such termination, if an executive officer or a director initiates such termination.

  

Indemnification Agreements

 

Our amended and restated articles of association permits us to exculpate, indemnify and insure each of our directors and office holders to the fullest extent permitted by the Israeli Companies Law. Upon the closing of our initial public offering, we entered into indemnification agreements with each of our directors, director nominees and executive officers, undertaking to indemnify them to the fullest extent permitted by Israeli law, including with respect to liabilities resulting from a public offering of our shares, to the extent that these liabilities are not covered by insurance. We have also obtained directors and officers insurance for each of our executive officers and directors. For further information, see “Item 6.C Directors, Senior Management and Employees—Board Practices—Exculpation,” Item 6.C Directors, Senior Management and Employees—Board Practices—Insurance,” and “Item 6.C Directors, Senior Management and Employees—Board Practices—Indemnification.”

 

C. Interests of Experts and Counsel

 

Not applicable.

 

ITEM 8. FINANCIAL INFORMATION.

 

A. Consolidated Statements and Other Financial Information.

 

See “Item 18. Financial Statements.”

 

Legal Proceedings

 

See “Item 4.B. Business Overview—Legal Proceedings.” 

 

 100

 

 

Dividends

 

We have never declared or paid any cash dividends to our shareholders of our ordinary shares, and we do not anticipate or intend to pay cash dividends in the foreseeable future. Payment of cash dividends, if any, in the future will be at the discretion of our board of directors in compliance with applicable legal requirements and will depend on a number of factors, including future earnings, our financial condition, operating results, contractual restrictions, capital requirements, business prospects, our strategic goals and plans to expand our business, applicable law and other factors that our board of directors may deem relevant.

 

The Companies Law imposes further restrictions on our ability to declare and pay dividends

 

Payment of dividends may be subject to Israeli withholding taxes. See “Item 10.E—Additional Information—Taxation” for additional information.

 

B. Significant Changes

 

Other than as otherwise described in this Annual Report on Form 20-F and as set forth below, no significant change has occurred in our operations since the date of our consolidated financial statements included in this Annual Report on Form 20-F.

  

ITEM 9. THE OFFER AND LISTING

 

A. Offer and Listing Details

 

On February 27, 2023, our ordinary shares were approved for trading on the Nasdaq Capital Market under our ticker symbol “BMR” and began trading at the open of market on February 28, 2023.

 

 

B. Plan of Distribution

 

Not applicable.

 

C. Markets

 

Our ordinary shares are listed on the Nasdaq Capital Market.

 

D. Selling Shareholders

 

Not applicable.

 

E. Dilution

 

Not applicable.

 

F. Expenses of the Issue

 

Not applicable.

  

ITEM 10. ADDITIONAL INFORMATION

 

A. Share Capital

 

Not applicable. 

 

 101

 

 

B. Memorandum and Articles of Association

 

A copy of our Amended and Restated Articles of Association is attached as Exhibit 1.1 to this Annual Report. Other than as disclosed below, the information called for by this Item is set forth in Exhibit 2.1 to this Annual Report and is incorporated by reference into this Annual Report.

 

C. Material Contracts

 

Except as set forth below, we have not entered into any material contract within the two years prior to the date of this Annual Report on Form 20-F, other than contracts entered into in the ordinary course of business, or as otherwise described herein in “Item 4.A. History and Development of the Company”, “Item 4.B. Business Overview”, “Item 7A. Major Shareholders” or “Item 7B. Related Party Transactions” above.

 

D. Exchange Controls

 

There are currently no Israeli currency control restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the shares or interest or other payments to non-residents of Israel, except for shareholders who are subjects of countries that are, or have been, in a state of war with Israel.

 

E. Taxation.

 

The following description is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership and disposition of our ordinary shares. You should consult your own tax advisor concerning the tax consequences of your particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign, or other taxing jurisdiction.

  

Israeli Tax Considerations and Government Programs 

 

The following is a brief summary of the material Israeli tax laws applicable to us and certain Israeli Government programs that benefit us. This section also contains a discussion of material Israeli tax consequences concerning the ownership and disposition of our ordinary shares. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples of such investors include residents of Israel or traders in securities who are subject to special tax regimes not covered in this discussion. To the extent that the discussion is based on new tax legislation that has not yet been subject to judicial or administrative interpretation, we cannot assure you that the appropriate tax authorities or the courts will accept the views expressed in this discussion. The discussion below is subject to change, including due to amendments under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which change could affect the tax consequences described below.

 

General Corporate Tax Structure in Israel

 

Israeli resident (as defined below) companies, such as us, are generally subject to corporate tax at the rate of 23% since 2018. However, the effective tax rate imposed on a company that derives income from a Preferred Enterprise or a Preferred Technology Enterprise (as discussed below) may be considerably lower. Capital gains derived by an Israeli company are generally subject to tax at the prevailing corporate tax rate.

 

Law for the Encouragement of Industry (Taxes), 5729-1969

 

The Law for the Encouragement of Industry (Taxes), 5729-1969 (the “Industry Encouragement Law”), grants several tax benefits for “Industrial Companies.”

 

The Industry Encouragement Law defines an “Industrial Company” as a company resident in Israel, of which 90% or more of its income in any tax year, other than income deriving from defense loans, and is derived from an “Industrial Enterprise” owned by it. An “Industrial Enterprise” is defined as an enterprise whose principal activity in a given tax year is industrial production (and several other activities listed in the said law, and are associated with industrial production).

 

 102

 

 

The following corporate tax benefits, among others, are available to Industrial Companies:

 

amortization over an eight-year period of the cost of patents and/or rights to use a patent and know-how which were purchased in good faith and/or are used for the development or advancement of the Industrial Enterprise over an eight-year period;

 

deduction of expenses incurred in connection with the issuance and listing of shares on a stock market over a three-year period; and

 

under certain conditions, an election to file its tax returns along with related Israeli Industrial Companies.

 

There can be no assurance that we currently qualify, or will continue to qualify, as an Industrial Company or that the benefits described above will be available in the future.

 

Law for the Encouragement of Capital Investments, 5719-1959

 

Tax Benefits for Income from Preferred Enterprise

 

The Law for the Encouragement of Capital Investments, 5719-1959 (the “Investment Law”), currently provides certain tax benefits for income generated by “Preferred Companies” from their “Preferred Enterprises.” The definition of a Preferred Company includes, inter alia, a company incorporated in Israel and that is not wholly owned by a governmental entity, which:

 

owns a Preferred Enterprise, which is defined as an “Industrial Enterprise” (as defined under the Investment Law) that is classified as either a “Competitive Enterprise” (as defined under the Investment Law) or a “Competitive Enterprise in the Field of Renewable Energy” (as defined under the Investment Law);

 

is controlled and managed from Israel;

 

is not a “Family Company,” a “Home Company,” or a “Kibbutz” (collective community) as defined under the Income Tax Ordinance;

 

keeps acceptable ledgers and files reports in accordance with the provisions of the Investment Law and the Income Tax Ordinance; and

 

was not, and certain officers of which were not, convicted of certain crimes in the 10 years prior to the tax year with respect to which benefits are being claimed.

 

As of January 1, 2017, a Preferred Company is currently entitled to a reduced corporate tax rate of 16% with respect to its income derived by its Preferred Enterprise, unless the Preferred Enterprise is located in development area A, in which case the rate is currently 7.5% (our operations are currently not located in development area A).

 

Dividends paid out of income attributed to a Preferred Enterprise are generally subject to tax at the rate of 20% or such lower rate as may be provided in an applicable tax treaty. However, if such dividends are paid to an Israeli company, such dividends should be exempt from tax (although, if such dividends are subsequently distributed to non-Israeli individuals or a non-Israeli company, tax at a rate of 20% or such lower rate as may be provided in an applicable tax treaty will apply).

 

If in the future we generate taxable income, to the extent that we qualify as a “Preferred Company,” the benefits provided under the Investment Law could potentially reduce our corporate tax liabilities. Therefore, the termination or substantial reduction of the benefits available under the Investment Law could materially increase our tax liabilities.

 

Tax Benefits for Income from Preferred Technology Enterprise

 

 103

 

 

An amendment to the Investment Law was enacted as part of the Economic Efficiency Law that was published on December 29, 2016, and entered into effect as of January 1, 2017 (the “2017 Amendment”). The 2017 Amendment provides additional tax benefits to Preferred Companies for “Technology Enterprises,” as described below, and is in addition to the Preferred Enterprise regime provided under the Investment Law.

 

The 2017 Amendment provides that a technology company satisfying certain conditions will qualify as a “Preferred Technology Enterprise” and may thereby enjoy a reduced corporate tax rate of 12% on income that qualifies as “Preferred Technology Income,” as defined in the Investment Law. The tax rate is further reduced to 7.5% for a Preferred Technology Enterprise located in development area A. In addition, a Preferred Technology Enterprise may enjoy a reduced capital gains tax rate of 12% on capital gain derived from the sale of certain “Benefited Intangible Assets” (as defined in the Investment Law) to a related foreign company if the Benefited Intangible Assets were acquired from a foreign company on or after January 1, 2017 for at least NIS 200 million, pending that the sale receives is pre-approved by the IIA.

 

Dividends distributed by a Preferred Technology Enterprise that are paid out of Preferred Technology Income are subject to tax at the rate of 20%, but if they are distributed to a foreign company and at least 90% of the shares of the distributing company are held by foreign resident companies then the tax rate may be as low as 4%, subject to the fulfillment of certain conditions.

 

As we have not yet generated taxable income, there is no assurance that we qualify as a Preferred Technology Enterprise or that the benefits described above will be available to us in the future.

 

If in the future we generate taxable income, to the extent that we qualify as a “Preferred Company,” the benefits provided under the Investment Law could potentially reduce our corporate tax liabilities. Therefore, the termination or substantial reduction of the benefits available under the Investment Law could materially increase our tax liabilities.

 

The Encouragement of Research, Development and Technological Innovation in the Industry Law 5744

 

Under the Encouragement of Research, Development and Technological Innovation in the Industry Law 5744-1984 (formerly known as the Law for the Encouragement of Research and Development in Industry 5744-1984) (“Innovation Law”), and the regulations and guidelines promulgated thereunder, research and development programs which meet specified criteria and are approved by a committee of the IIA, are eligible for grants. The grants awarded are typically up to 50% of the project’s expenditures, as determined by the research committee. The grantee is required to pay royalties to the State of Israel from the sale of products developed under the program. Regulations under the Innovation Law generally provide for the payment of royalties of 3% to 6% on income generated from products and services based on technology developed using grants, until 100% of the grant, linked to the dollar and bearing interest at the LIBOR rate, is repaid. In July 2017, new regulations came into force. According to the new regulations, the royalties range between 1.3-5% depending on the company’s size and sector. The terms of the IIA participation also require that products developed with IIA grants be manufactured in Israel and that the know-how developed thereunder may not be transferred outside of Israel, unless approval is received from the IIA and additional payments are made to the IIA. However, this does not restrict the export of products that incorporate the funded know-how. The royalty repayment ceiling can reach up to three times the amount of the grant received (plus interest) if manufacturing is transferred outside of Israel, and repayment of up to six times the amount of the grant (plus interest) may be required if the technology itself is transferred outside of Israel or license to use it was granted to a foreign entity.

 

Taxation of our Shareholders

 

Capital Gains Tax

 

Israeli law generally imposes a capital gains tax (i) on the sale of any capital assets by residents of Israel, as defined for Israeli tax purposes, and (ii) on the sale of capital assets located in Israel, including shares of Israeli companies, by non-residents of Israel, unless a specific exemption is available or unless a tax treaty between Israel and the shareholder’s country of residence provides otherwise. The law distinguishes between real gain and inflationary surplus. The inflationary surplus is a portion of the total capital gain that is equivalent to the increase of the relevant asset’s purchase price which is attributable to the increase in the Israeli consumer price index or a foreign currency exchange rate between the date of purchase and the date of sale. The real gain is the excess of the total capital gain over the inflationary surplus.

 

 104

 

 

Israeli Residents

 

Generally, as of January 1, 2012 and thereafter, the tax rate applicable to real capital gains derived from the sale of shares, whether listed on a stock market or not, is 25% for Israeli individuals, unless such shareholder claims a deduction for financing expenses in connection with such shares, in which case the gain will generally be taxed at a rate of 30%. Additionally, if such shareholder is considered a “substantial shareholder” (SSH) at the time of the sale or at any time during the 12-month period preceding such sale, the tax rate will be 30%. A “substantial shareholder” is defined as one who holds, directly or indirectly, alone or “together with another” (i.e., together with a relative, or together with someone who is not a relative but with whom, according to an agreement, there is regular cooperation in material matters of the company, directly or indirectly), directly or indirectly, at least 10% of any of the “means of control” in the company. “Means of control” generally include the right to vote, receive profits, nominate a director or an executive officer, receive assets upon liquidation, or instruct someone who holds any of the aforementioned rights regarding the manner in which such rights are to be exercised. However, different tax rates will apply to dealers in securities. Israeli companies are subject to capital gains tax at the regular corporate tax rate (i.e., 23% for the tax year 2018 and thereafter) on real capital gains derived from the sale of listed shares.

 

As of January 1, 2024, Israeli resident shareholders who are individuals with taxable income that exceeds NIS 721,560 in a tax year (linked to the Israeli consumer price index each year) will be subject to an additional tax at the rate of 3% on the portion of their taxable income for such tax year that is in excess of NIS 721,560 (linked to the Israeli consumer price index each year). For this purpose, taxable income includes taxable capital gains from the sale of our shares and taxable income from dividend distributions.

 

In some instances where our shareholders are liable for Israeli tax on the sale of their ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at source.

 

Non-Israeli Residents

 

A non-Israeli resident who derives capital gains from the sale of shares in an Israeli resident company that were purchased after the company was listed for trading on a stock exchange outside of Israel will be exempt from Israeli tax so long as the shares were not held through a permanent establishment that the non-resident maintains in Israel. However, non-Israeli resident corporations will not be entitled to the foregoing exemption if (i) an Israeli resident has a controlling interest, directly or indirectly, alone, “together with another” (as defined above), or together with another Israeli resident, of more than 25% in one or more of the “means of control” (as defined above) in such non-Israeli resident corporation, or (ii) Israeli residents are the beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such non-Israeli resident corporation, whether directly or indirectly.

 

In addition, a sale of securities by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty. For example, pursuant to the provisions of the Convention between the Government of the United States of America and the Government of the State of Israel with respect to Taxes on Income, as amended (the “U.S.-Israel Tax Treaty”), capital gains arising from the sale, exchange or disposition of our ordinary shares by (i) a person who qualifies as a resident of the United States within the meaning of the U.S.-Israel Tax Treaty, (ii) who holds the shares as a capital asset, and (iii) who is entitled to claim the benefits afforded to such person by the U.S.-Israel Tax Treaty generally is generally exempt from Israeli capital gains tax. Such exemption will not apply if: (i) such person holds, directly or indirectly, shares representing 10% or more of our voting power during any part of the 12-month period preceding such sale, exchange, or disposition, subject to particular conditions; (ii) the capital gains from such sale, exchange, or disposition are attributable to a permanent establishment in Israel; or (iii) such person is an individual and was present in Israel for 183 days or more during the relevant tax year. In such case, the capital gain arising from the sale, exchange, or disposition of our ordinary shares would be subject to Israeli tax, to the extent applicable; however, under the U.S.-Israel Tax Treaty, the taxpayer may be permitted to claim a credit for such taxes against the U.S. federal income tax imposed with respect to such sale, exchange, or disposition, subject to the limitations under U.S. law applicable to foreign tax credits. The U.S.-Israel Tax Treaty does not relate to U.S. state or local taxes.

 

 105

 

 

Shareholders may be required to demonstrate that they are exempt from tax on their capital gains in order to refrain from withholding at source at the time of sale.

 

It should be noted that in the event that the real capital gain realized by an individual shareholder is not exempt from tax in Israel, the tax rates applicable to Israeli resident individual shareholders should generally apply.

 

In some instances where our shareholders may be liable for Israeli tax on the sale of their ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at source.

 

Taxation of Dividend Distributions

 

Israeli Residents

 

Israeli resident individuals are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares, other than bonus shares (share dividends). As of January 1, 2012 and thereafter, the tax rate applicable to such dividends is generally 25%. With respect to a person who is a “substantial shareholder” (as defined above) at the time the dividend is received or at any time during the preceding 12-month period, the applicable tax rate is 30%. Dividends paid from income derived from Preferred Enterprises and Preferred Technology Enterprises will generally be subject to income tax at a rate of 20%.

 

As of January 1, 2024, Israeli resident shareholders who are individuals with taxable income that exceeds NIS 721,560 in a tax year (linked to the Israeli consumer price index each year) will be subject to an additional tax at the rate of 3% on the portion of their taxable income for such tax year that is in excess of NIS 721,560 (linked to the Israeli consumer price index each year). For this purpose, taxable income includes taxable capital gains from the sale of our shares and taxable income from dividend distributions.

 

Dividends paid to an Israeli resident individual shareholder on our ordinary shares will generally be subject to withholding tax at the rates corresponding with the income tax rates detailed above unless we are provided in advance with a withholding tax certificate issued by the Israel Tax Authority stipulating a different rate.

 

Notwithstanding the above, dividends paid to an Israeli resident “substantial shareholder” (as defined above) on publicly traded shares, like our ordinary shares, which are held via a “nominee company” (as defined under the Israeli Securities Law), are generally subject to Israeli withholding tax at a rate of 25%, unless a different rate is provided under an applicable tax treaty, provided that a certificate from the Israel Tax Authority allowing for a reduced withholding tax rate is obtained in advance.

 

If the dividend is attributable partly to income derived from a Preferred Enterprise or a Preferred Technology Enterprise and partly to other sources of income, the tax rate will be a blended rate reflecting the relative portions of the various types of income. We cannot assure you that we will designate the profits that are being distributed in a way that will reduce shareholders’ tax liability.

 

Israeli resident companies are generally exempt from tax on the receipt of dividends paid on our ordinary shares.

 

Non-Israeli Residents

 

Unless a tax relief is provided by a treaty between Israel and the shareholder’s country of residence, non-Israeli residents are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25%. With respect to a person (including a corporation) who is a “substantial shareholder” (as defined above) at the time of receiving the dividend or at any time during the preceding 12-month period, absent treaty relief as mentioned above, the applicable Israeli income tax rate is 30%. Notwithstanding the above, dividends paid from income derived from Preferred Enterprises will be subject to Israeli income tax at a rate of 20%. In addition, dividends distributed by a Preferred Technology Enterprise that are paid out of Preferred Technology Income are subject to tax at the rate of 20%, but if they are distributed to a foreign company and at least 90% of the shares of the distributing company are held by foreign resident companies then the tax rate may be as low as 4%, subject to the fulfillment of certain conditions.

 

 106

 

 

In this regard, dividends paid to a non-Israeli resident shareholder on our ordinary shares will generally be subject to withholding tax at the rates corresponding with the income tax rates detailed above unless we are provided in advance with a withholding tax certificate issued by the Israel Tax Authority stipulating a different rate (e.g., in accordance with the provisions of an applicable tax treaty).

 

Notwithstanding the above, dividends paid to a non-Israeli resident “substantial shareholder” (as defined above) on publicly traded shares, like our ordinary shares, which are held via a “nominee company” (as defined under the Israeli Securities Law), are generally subject to Israeli withholding tax at a rate of 25%, unless a different rate is provided under an applicable tax treaty, provided that a certificate from the Israel Tax Authority allowing for a reduced withholding tax rate is obtained in advance.

 

In addition, it should be noted that an additional 3% tax might be applicable to individual shareholders if certain conditions are met.

 

Under the U.S.-Israel Tax Treaty, the maximum Israeli tax on dividends paid to a holder of ordinary shares who qualifies as a resident of the United States within the meaning of the U.S.-Israel Tax Treaty is 25%. Such tax rate is generally reduced to 12.5% if: (i) the shareholder is a U.S. corporation and holds at least 10% of the outstanding shares of our voting stock during the part of our tax year that precedes the date of payment of the dividends and during the whole of our prior tax year; (ii) not more than 25% of our gross income in the tax year preceding the payment of the dividends consists of interest or dividends, other than dividends or interest received from subsidiary corporations 50% or more of the outstanding shares of voting stock of which is owned by us at the time such dividends or interest are received by us; and (iii) the dividends are not sourced from income derived during a period for which we were entitled to the reduced tax rate applicable to a Preferred Enterprise under the Investment Law. If the dividends are sourced from income derived during a period for which we are entitled to the reduced tax rate applicable to a Preferred Enterprise or a Preferred Technology Enterprise under the Investment Law, to the extent that the first two conditions detailed above are met, the Israeli tax rate applicable to such dividends should be 15%.

 

If the dividend is attributable partly to income derived from a Preferred Enterprise or a Preferred Technology Enterprise and partly to other sources of income, the tax rate will be a blended rate reflecting the relative portions of the various types of income. We cannot assure you that we will designate the profits that are being distributed in a way that will reduce shareholders’ tax liability.

 

Estate and gift tax

 

Israeli law presently does not impose estate tax.

 

Israeli law also does not presently impose gift taxes upon the transfer of assets to Israeli resident individuals so long as it is demonstrated to the satisfaction of the Israel Tax Authority that the transfer was executed in good faith..

 

Certain Material U.S. Federal Income Tax Considerations

 

THE FOLLOWING SUMMARY IS INCLUDED HEREIN FOR GENERAL INFORMATION AND IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSIDERED TO BE, LEGAL OR TAX ADVICE. EACH U.S. HOLDER SHOULD CONSULT WITH HIS OR HER OWN TAX ADVISOR AS TO THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND SALE OF ORDINARY SHARES, INCLUDING THE EFFECTS OF APPLICABLE STATE, LOCAL, FOREIGN OR OTHER TAX LAWS AND POSSIBLE CHANGES IN THE TAX LAWS.

 

 107

 

 

Subject to the limitations described in the next two paragraphs, the following discussion summarizes certain material U.S. federal income tax consequences to a “U.S. Holder” arising from the purchase, ownership and sale of the ordinary shares. For this purpose, a “U.S. Holder” is a holder of ordinary shares that is: (1) an individual citizen or resident of the United States, including an alien individual who is a lawful permanent resident of the United States or meets the substantial presence residency test under U.S. federal income tax laws; (2) a corporation (or entity treated as a corporation for U.S. federal income tax purposes) created or organized under the laws of the United States or the District of Columbia or any political subdivision thereof; (3) an estate, the income of which is includable in gross income for U.S. federal income tax purposes regardless of its source; (4) a trust if a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have authority to control all substantial decisions of the trust; or (5) a trust that has a valid election in effect to be treated as a U.S. person to the extent provided in U.S. Treasury regulations.

 

This summary is for general information purposes only and does not purport to be a comprehensive description of all of the U.S. federal income tax considerations that may be relevant to a decision to purchase our ordinary shares. This summary generally considers only U.S. Holders that will own our ordinary shares as capital assets. Except to the limited extent discussed below, this summary does not consider the U.S. federal tax consequences to a person that is not a U.S. Holder, nor does it describe the rules applicable to determine a taxpayer’s status as a U.S. Holder. This summary is based on the provisions of the Code and final, temporary and proposed U.S. Treasury regulations promulgated thereunder, administrative and judicial interpretations thereof, and the United States-Israel Income Tax Treaty, all as in effect as of the date hereof and all of which are subject to change, possibly on a retroactive basis, and all of which are open to differing interpretations. We will not seek a ruling from the Internal Revenue Service, or the IRS, with regard to the U.S. federal income tax treatment of an investment in our ordinary shares by U.S. Holders and, therefore, can provide no assurances that the IRS will agree with the conclusions set forth below.

   

This discussion does not address all of the aspects of U.S. federal income taxation that may be relevant to a particular U.S. Holder based on such holder’s particular circumstances and in particular does not discuss any estate, gift, generation-skipping transfer, state, local, excise or non-U.S. tax considerations. In addition, this discussion does not address the U.S. federal income tax treatment of a U.S. Holder who is: (1) a bank, life insurance company, regulated investment company, or other financial institution or “financial services entity;” (2) a broker or dealer in securities or foreign currency; (3) a person who acquired our ordinary shares in connection with employment or other performance of services; (4) a U.S. Holder that is subject to the U.S. alternative minimum tax; (5) a U.S. Holder that holds our ordinary shares as a hedge or as part of a hedging, straddle, conversion or constructive sale transaction or other risk-reduction transaction for U.S. federal income tax purposes; (6) a tax-exempt entity; (7) real estate investment trusts or grantor trusts; (8) a U.S. Holder that expatriates out of the United States or a former long-term resident of the United States; or (9) a person having a functional currency other than the U.S. dollar. This discussion does not address the U.S. federal income tax treatment of a U.S. Holder that owns, directly or constructively, at any time, ordinary shares representing 10% or more of the shares of our company. Additionally, the U.S. federal income tax treatment of partnerships (or other pass-through entities) or persons who hold ordinary shares through a partnership or other pass-through entity are not addressed.

 

Each prospective investor is advised to consult his or her own tax adviser for the specific tax consequences to that investor of purchasing, holding or disposing of our ordinary shares, including the effects of applicable state, local, non-U.S. or other tax laws and possible changes in the tax laws.

 

Taxation of Dividends Paid on Ordinary Shares

 

We do not intend to pay dividends in the foreseeable future. In the event that we do pay dividends, and subject to the discussion under the heading “Passive Foreign Investment Companies” below and the discussion of “qualified dividend income” below, a U.S. Holder, other than certain U.S. Holders that are U.S. corporations, will be required to include in gross income as ordinary income the amount of any distribution paid on the ordinary shares (including the amount of any Israeli tax withheld on the date of the distribution), to the extent that such distribution does not exceed our current and accumulated earnings and profits, as determined for U.S. federal income tax purposes. The amount of a distribution that exceeds our earnings and profits will be treated first as a non-taxable return of capital, reducing the U.S. Holder’s tax basis for the ordinary shares to the extent thereof, and then capital gain. We do not expect to maintain calculations of our earnings and profits under U.S. federal income tax principles and, therefore, U.S. Holders should expect that the entire amount of any distribution generally will be reported as dividend income.

 

 108

 

 

In general, preferential tax rates for “qualified dividend income” and long-term capital gains are applicable for U.S. Holders that are individuals, estates or trusts. For this purpose, “qualified dividend income” means, inter alia, dividends received from a “qualified foreign corporation.” A “qualified foreign corporation” is a corporation that is entitled to the benefits of a comprehensive tax treaty with the United States that includes an exchange of information program. The IRS has stated that the United States-Israel Tax Treaty satisfies this requirement and we believe we are eligible for the benefits of that treaty.

 

In addition, our dividends will be qualified dividend income if our ordinary shares are readily tradable on the Nasdaq Capital Market or another established securities market in the United States. Dividends will not qualify for the preferential rate if we are treated, in the year the dividend is paid or in the prior year, as a passive foreign investment company, or PFIC, as described below under “Passive Foreign Investment Companies.” A U.S. Holder will not be entitled to the preferential rate: (1) if the U.S. Holder has not held our ordinary shares for at least 61 days of the 121 day period beginning on the date which is 60 days before the ex-dividend date, or (2) to the extent the U.S. Holder is under an obligation to make related payments with respect to positions in substantially similar or related property. Any days during which the U.S. Holder has diminished its risk of loss on our ordinary shares are not counted towards meeting the 61-day holding period. Finally, U.S. Holders who elect to treat the dividend income as “investment income” pursuant to Section 163(d)(4) of the Code will not be eligible for the preferential rate of taxation.

 

The amount of a distribution with respect to our ordinary shares will be measured by the amount of the fair market value of any property distributed, and for U.S. federal income tax purposes, the amount of any Israeli taxes withheld therefrom. Cash distributions paid by us in NIS will be included in the income of U.S. Holders at a U.S. dollar amount based upon the spot rate of exchange in effect on the date the dividend is includible in the income of the U.S. Holder, and U.S. Holders will have a tax basis in such NIS for U.S. federal income tax purposes equal to such U.S. dollar value. If the U.S. Holder subsequently converts the NIS into U.S. dollars or otherwise disposes of them, any subsequent gain or loss in respect of such NIS arising from exchange rate fluctuations will be U.S. source ordinary exchange gain or loss.

 

Subject to certain significant conditions and limitations, any Israeli taxes paid on or withheld from distributions from us and not refundable to a U.S. Holder may be credited against the U.S. Holder’s U.S. federal income tax liability or, alternatively, may be deducted from the U.S. Holder’s taxable income. However, as a result of recent changes to the U.S. foreign tax credit rules, a withholding tax generally may need to satisfy certain additional requirements in order to be considered a creditable tax for a U.S. Holder. We have not determined whether these requirements have been met and, accordingly, no assurance can be given that any withholding tax on dividends paid by us will be creditable. The election to deduct, rather than credit, foreign taxes, is made on a year-by-year basis and applies to all foreign taxes paid by a U.S. Holder or withheld from a U.S. Holder that year. Dividends paid with respect to our ordinary shares will be treated as foreign source income, which may be relevant in calculating the U.S. Holder’s foreign tax credit limitation. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes of income. For this purpose, dividends that we distribute generally should constitute “passive category income,” or, in the case of certain U.S. Holders, “general category income.” The rules relating to the determination of the foreign tax credit are complex, and U.S. Holders should consult their tax advisor to determine whether and to what extent such holder will be entitled to this credit.

 

Dividends paid with respect to our ordinary shares will not be eligible for the “dividends-received” deduction generally allowed to corporate U.S. Holders with respect to dividends received from U.S. corporations.

  

Taxation of the Sale, Exchange or other Disposition of Ordinary Shares

 

Except as provided under the PFIC rules described below under “Passive Foreign Investment Companies,” upon the sale, exchange or other disposition of our ordinary shares, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between such U.S. Holder’s tax basis for the ordinary shares, determined in U.S. dollars, and the U.S. dollar value of the amount realized on the disposition (or its U.S. dollar equivalent determined by reference to the spot rate of exchange on the date of disposition, if the amount realized is denominated in a foreign currency). The gain or loss realized on the sale, exchange or other disposition of ordinary shares will be long-term capital gain or loss if the U.S. Holder has a holding period of more than one year at the time of the disposition. Individuals who recognize long-term capital gains may be taxed on such gains at reduced rates of tax. The deduction of capital losses is subject to various limitations. U.S. Holders should consult their own tax advisors regarding the U.S. federal income tax consequences of receiving currency other than U.S. dollars upon the disposition of their ordinary shares.

 

 109

 

 

Passive Foreign Investment Companies

 

Special U.S. federal income tax laws apply to U.S. taxpayers who own shares of a corporation that is a PFIC. We will be treated as a PFIC for U.S. federal income tax purposes for any taxable year that either:

 

  75% or more of our gross income (including our pro rata share of gross income for any company, in which we are considered to own 25% or more of the shares by value), in a taxable year is passive; or
     
  At least 50% of our assets generally determined on the basis of a quarterly average and based upon fair market value (including our pro rata share of the assets of any company in which we are considered to own 25% or more of the shares by value) are held for the production of, or produce, passive income.

 

For this purpose, passive income generally consists of rents, dividends, interest, royalties, gains from the disposition of passive assets and gains from commodities and securities transactions. Generally, cash is treated as generating passive income and is therefore treated as a passive asset for purposes of the PFIC rules.

 

We believe that we were not a PFIC for the year ended December 31, 2024 and we will not be a PFIC for the current taxable year, although we have not determined whether we will be a PFIC in the foreseeable future. The tests for determining PFIC status are applied annually, and it is difficult to make accurate projections of future income and assets which are relevant to this determination. In addition, our PFIC status may depend in part on the market value of our ordinary shares. Accordingly, there can be no assurance that we currently are not or will not become a PFIC.

 

If we currently are or become a PFIC, each U.S. Holder who has not elected to mark the shares to market (as discussed below), would, upon receipt of certain “excess distributions” by us and upon disposition of our ordinary shares at a gain: (1) have such excess distribution or gain allocated ratably over the U.S. Holder’s holding period for the ordinary shares, as the case may be; (2) the amount allocated to the current taxable year and any period prior to the first day of the first taxable year in which we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of the other taxable years would be subject to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed deferral benefit would be imposed with respect to the resulting tax attributable to each such other taxable year. Distributions received by a U.S. Holder in a taxable year that are greater than 125% of the average annual distributions received during the shorter of the three preceding taxable years or the U.S. Holder’s holding period for the ordinary shares will be treated as excess distributions. In addition, when shares of a PFIC are acquired by reason of death from a decedent that was a U.S. Holder, the tax basis of such shares would not receive a step-up to fair market value as of the date of the decedent’s death, but instead would be equal to the decedent’s basis if lower, unless all gain were recognized by the decedent. Indirect investments in a PFIC may also be subject to these special U.S. federal income tax rules.

  

The PFIC rules described above would not apply to a U.S. Holder who makes a qualified electing fund, or QEF, election for all taxable years that such U.S. Holder has held the ordinary shares while we are a PFIC, provided that we comply with specified reporting requirements. Instead, each U.S. Holder who has made such a QEF election is required for each taxable year that we are a PFIC to include in income such U.S. Holder’s pro rata share of our ordinary earnings as ordinary income and such U.S. Holder’s pro rata share of our net capital gains as long-term capital gain, regardless of whether we make any distributions of such earnings or gain. In general, a QEF election is effective only if we make available certain required information. The QEF election is made on a shareholder-by-shareholder basis and generally may be revoked only with the consent of the IRS. We do not intend to notify U.S. Holders if we believe we will be treated as a PFIC for any tax year. In addition, we do not intend to furnish U.S. Holders annually with information needed in order to complete IRS Form 8621 and to make and maintain a valid QEF election for any year in which we or any of our subsidiaries are a PFIC. Therefore, the QEF election will not be available with respect to our ordinary shares.

 

 110

 

 

In addition, the PFIC rules described above would not apply if we were a PFIC and a U.S. Holder made a mark-to-market election. A U.S. Holder of our ordinary shares which are regularly traded on a qualifying exchange, including the Nasdaq Capital Market, can elect to mark the ordinary shares to market annually, recognizing as ordinary income or loss each year an amount equal to the difference as of the close of the taxable year between the fair market value of the ordinary shares and the U.S. Holder’s adjusted tax basis in the ordinary shares. Losses are allowed only to the extent of net mark-to-market gain previously included income by the U.S. Holder under the election for prior taxable years.

 

A U.S. Holder that owns (or is deemed to own) shares in a PFIC during any taxable year of the U.S. Holder generally is required to file an IRS Form 8621 with such U.S. Holder’s U.S. federal income tax return and provide such other information as the IRS may require. Failure to file IRS Form 8621 for each applicable taxable year may result in substantial penalties and result in the U.S. Holder’s taxable years being open to audit by the IRS until such forms are properly filed.

 

U.S. Holders who hold our ordinary shares during a period when we are a PFIC generally will be subject to the foregoing rules, even if we cease to be a PFIC. A U.S. Holder is encouraged to consult its tax advisor with respect to any available elections that may be applicable in such a situation, including a “deemed sale” election. The U.S. federal income tax rules relating to PFICs are complex. U.S. Holders are urged to consult their own tax advisors with respect to the consequences to them of an investment in a PFIC, any elections available with respect to the ordinary shares and the IRS information reporting obligations with respect to the purchase, ownership, and disposition of the ordinary shares in the event we are determined to be a PFIC.

 

Tax on Net Investment Income

 

U.S. Holders who are individuals, estates or trusts will generally be required to pay a 3.8% Medicare tax on their net investment income (including dividends on and gains from the sale or other disposition of our ordinary shares), or in the case of estates and trusts on their net investment income that is not distributed to beneficiaries of the estate or trust. In each case, the 3.8% Medicare tax applies only to the extent the U.S. Holder’s total adjusted income exceeds applicable thresholds.

  

Information Reporting and Withholding

 

A U.S. Holder may be subject to backup withholding at a rate of 24% with respect to cash dividends and proceeds from a disposition of ordinary shares. In general, backup withholding will apply only if a U.S. Holder fails to comply with specified identification procedures. Backup withholding will not apply with respect to payments made to designated exempt recipients, such as corporations and tax-exempt organizations. Backup withholding is not an additional tax and may be claimed as a credit against the U.S. federal income tax liability of a U.S. Holder, provided that the required information is timely furnished to the IRS.

 

Certain U.S. Holders with interests in “specified foreign financial assets” (including, among other assets, our ordinary shares, unless such ordinary shares are held on such U.S. Holder’s behalf through a financial institution) may be required to file an information report with the IRS if the aggregate value of all such assets exceeds $50,000 on the last day of the taxable year or $75,000 at any time during the taxable year (or such higher dollar amount as may be prescribed by applicable IRS guidance). You should consult your own tax advisor as to the possible obligation to file such information report.

 

THE DISCUSSION ABOVE IS A GENERAL SUMMARY AND IS NOT INTENDED TO CONSTITUTE A COMPLETE ANALYSIS OF ALL TAX CONSEQUENCES RELATING TO THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES. IT DOES NOT COVER ALL TAX MATTERS THAT MAY BE OF IMPORTANCE TO A PROSPECTIVE INVESTOR. EACH PROSPECTIVE INVESTOR IS URGED TO CONSULT ITS OWN TAX ADVISOR ABOUT THE TAX CONSEQUENCES TO IT RELATING TO THE PURCHASE, OWNERSHIP, AND DISPOSITION OF ORDINARY SHARES IN LIGHT OF THE INVESTOR’S OWN CIRCUMSTANCES.

 

F. Dividends and Paying Agents

 

Not applicable.

 

G. Statement by Experts

 

Not applicable.

 

H. Documents on Display

 

We are subject to certain information reporting requirements of the Exchange Act, applicable to foreign private issuers and under those requirements will file reports with the SEC. The SEC maintains an internet site at http://www.sec.gov that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. Our filings with the SEC will also be available to the public through the SEC’s website at www.sec.gov.

 

 111

 

 

As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders will be exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the Exchange Act. However, we will file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report on Form 20-F containing financial statements audited by an independent registered public accounting firm, and may submit to the SEC, on a Form 6-K, unaudited quarterly financial information.

  

I. Subsidiary Information.

 

Not applicable.

 

J. Annual Report to Security Holders.

 

Not applicable.

 

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are exposed to market risk from changes in exchange rates, interest rates and inflation. All of these market risks arise in the ordinary course of business, as we do not engage in speculative trading activities. The following analysis provides additional information regarding these risks.

 

Foreign Currency and Exchange Risk

 

Our functional currency and all of our subsidiaries all of which are primarily a direct and integral component of our operation is the U.S. dollars, as the U.S. dollars is the primary currency of the economic environment in which us and our subsidiaries have operated (which is the currency of the environment in which an entity primarily generates cash) and expects to continue to operate in the foreseeable future. Our sales are mainly denominated in U.S. dollars. A significant portion of our operating costs are in Israel and in Russia, consisting principally of salaries and related personnel expenses, and facility expenses, which are denominated in NIS and RUB. This foreign currency exposure gives rise to market risk associated with exchange rate movements of the U.S. dollar against the NIS and RUB. Furthermore, we anticipate that a significant portion of our expenses will continue to be denominated in NIS and RUB. We do not hedge against currency risk. A hypothetical 10% change in foreign currency exchange rates applicable to our business would have had an impact on our results for the year ended December 31, 2024 of $0.5 million due to NIS, and $0.01 million due to RUB. 

 

Impact of Inflation

 

While it is difficult to accurately measure the impact of inflation due to the imprecise nature of the estimates required, we do not believe inflation has had a material effect on our historical results of operations and financial condition. However, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset higher costs through price increases or other corrective measures, and our inability or failure to do so could adversely affect our business, financial condition and results of operations.

 

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

 

A. Debt Securities.

 

Not applicable.

 

B. Warrants and rights.

 

Not applicable.

 

C. Other Securities.

 

Not applicable.

 

D. American Depositary Shares

 

Not applicable.

 

 112

 

 

PART II

 

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

 

None.

 

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

 

There are no material modifications to the rights of security holders.

 

ITEM 15. CONTROLS AND PROCEDURES

 

(a) Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2023, or the Evaluation Date. Based on such evaluation, those officers have concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective. See “Item 5.E—Operating and Financial Review and Prospects—Critical Account Estimates—Internal Control Over Financial Reporting” for additional information.

 

(b) Management’s Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. Our management conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2024 based on the criteria set forth in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on that assessment, our management concluded that our internal control over financial reporting was effective as of December 31, 2024.

 

As defined in Regulation 12b-2 under the Exchange Act, a “material weakness” is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented, or detected on a timely basis.

 

As previously disclosed in our Annual Report on Form 20-F for the year ended December 31, 2022, as of December 31, 2022, our internal control over financial reporting was ineffective due to the following material weaknesses related to lack of sufficient internal accounting personnel, segregation of duties, lack of sufficient internal controls (including IT general controls, entity level controls and transaction level controls). In response to these material weaknesses, we implemented a remediation plan.

 

 113

 

 

As part of such remediation plan, in July 2023, we appointed the SOX Consultant for the provision of internal audit and Sarbanes Oxley advisory services as part of measures that we undertook to address the internal control deficiencies that have been identified. Since July 2023, we worked together with the SOX Consultant to build internal control processes and controls to ensure our internal control over financial reporting is effective. As of the year ended December 31, 2024, we did not have material weaknesses. Except for additional personnel costs, the cost of systems and the costs of our third-party service providers, we do not expect to incur any material costs related to our remediation plan.

 

Based on the results of this evaluation, management concluded that our internal control over financial reporting was effective as of December 31, 2024.

 

(c) Attestation Report of the Registered Public Accounting Firm

 

This Annual Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting due to an exemption for emerging growth companies provided in the JOBS Act.

 

(d) Changes in Internal Control over Financial Reporting

 

Except as described above, during the year ended December 31, 2024, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 16. [RESERVED]

 

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

 

Our board of directors has determined that three members of our audit committee, include Lluis Pedragosa, Yair Shoham and Osnat Michaeli. Osnat Michaeli, is an audit committee financial expert, as defined under the rules under the Exchange Act, and is independent in accordance with applicable Exchange Act rules and the Nasdaq Listing Rules.

 

ITEM 16B. CODE OF ETHICS

 

Our board of directors has adopted a Code of Ethics applicable to all of our directors and employees, including our Chief Executive Officer, Chief Financial Officer, controller or principal accounting officer, or other persons performing similar functions, which is a “code of ethics” as defined in Item 16B of Form 20-F promulgated by the SEC. The full text of the Code of Ethics is posted on our website at https://beamr.com/. Information contained on, or that can be accessed through, our website does not constitute a part of this a part of this Annual Report on Form 20-F and is not incorporated by reference herein. If we make any amendment to the Code of Ethics or grant any waivers, including any implicit waiver, from a provision of the Code of Ethics, we will disclose the nature of such amendment or waiver on our website to the extent required by the rules and regulations of the SEC. We have not granted any waivers under our Code of Business Conduct and Ethics.

 

 114

 

 

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

The following table provides information regarding fees paid by us to Fahn Kanne & Co. Grant Thornton Israel, an independent registered public accounting firm, for all services, including audit services, for the years ended December 31, 2024 and 2023:

 

   2024   2023 
(USD)        
Audit fees (1)   156    126 
Tax fees(2)   -    1 
All other fees   -    0 
Total   156    127 

 

(1) The audit fees for the years ended December 31, 2024 and 2023 includes professional services rendered in connection with the audit of our annual consolidated financial statements and the review of our consolidated interim financial statements, our statutory tax audits and assistance with review of documents filed with the SEC.

 

(2) Tax fees include professional services rendered in substance related to receive a certificate from the Israeli tax authority for an exemption or a reduction of withholding tax at the source regarding transfer of funds.

  

Pre-Approval of Auditors’ Compensation

 

Our audit committee has a pre-approval policy for the engagement of our independent registered public accounting firm to perform certain audit and non-audit services. Pursuant to this policy, which is designed to assure that such engagements do not impair the independence of our auditors, the audit committee pre-approves annually a catalog of specific audit and non-audit services in the categories of audit services, audit-related services and tax services that may be performed by our independent registered public accounting firm. If a type of service, that is to be provided by our auditors, has not received such general pre-approval, it will require specific pre-approval by our audit committee. The policy prohibits retention of the independent registered public accounting firm to perform the prohibited non-audit functions defined in applicable SEC rules.

 

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

 

Not applicable.

 

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

 

Not applicable.

 

ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT

 

Not applicable.

 

ITEM 16G. CORPORATE GOVERNANCE

 

Under the Companies Law, companies incorporated under the laws of the State of Israel, whose shares are publicly traded, including companies whose shares are listed on the Nasdaq Capital Market are considered public companies under Israeli law and are required to comply with various corporate governance requirements under Israeli law relating to such matters as external directors, the audit committee, compensation committee, compensation policy, company’s auditors, and an internal auditor. These requirements are in addition to the corporate governance requirements imposed by the Nasdaq Listing Rules, and other applicable provisions of U.S. securities laws to which we are subject as a foreign private issuer due to the listing of our ordinary shares on the Nasdaq Capital Market. However, pursuant to regulations promulgated under the Companies Law, companies with shares traded on certain U.S. stock exchanges, including the Nasdaq Capital Market, may, subject to certain conditions, “opt out” from the requirement of the Companies Law to appoint external directors and related Companies Law rules concerning the composition of the audit committee and compensation committee of the board of directors (other than the gender diversification rule under the Companies Law which requires the appointment of a director from the other gender if, at the time a director is appointed, all members of the board of directors are of the same gender). In accordance with these regulations, we have elected to “opt out” from such requirements of the Companies Law. Under these regulations, the exemptions from such Companies Law’s requirements will continue to be available to us so long as we comply with the following: (i) we do not have a “controlling shareholder” (as such term is defined under the Companies Law), (ii) our shares are traded on certain U.S. stock exchanges, including the Nasdaq Capital Market, and (iii) we comply with the director independence requirements and the requirements regarding the composition of the audit committee and the compensation committee under U.S. laws (including applicable Nasdaq rules) applicable to U.S. domestic issuers.

 

 115

 

 

In accordance with Israeli law and practice and subject to the exemption set forth in Rule 5615 of the Nasdaq Stock Market rules, we have elected to follow the provisions of the Companies Law, rather than the Nasdaq Stock Market rules, with respect to the following requirements:

 

  Quorum. While the Nasdaq Stock Market rules require that the quorum for purposes of any meeting of the holders of a listed company’s ordinary voting stock, as specified in the company’s bylaws, be no less than 33 1/3% of the company’s outstanding ordinary voting stock, under Israeli law, a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our amended and restated articles of association provide that a quorum of two or more shareholders holding at least 25% of the voting rights in person or by proxy is required for commencement of business at a general meeting. However, the quorum set forth in our amended and restated articles of association with respect to an adjourned meeting consists of any number of shareholders present in person or by proxy.

  

  Compensation of officers. Israeli law and our amended and restated articles of association do not require that the independent members of our board of directors (or a compensation committee composed solely of independent members of our board of directors) determine an executive officer’s compensation, as is generally required under the Nasdaq Stock Market rules with respect to the chief executive officer and all other executive officers. Instead, compensation of executive officers is determined and approved by our board of directors, and in certain circumstances by our shareholders, either in consistency with our office holder compensation policy or, in special circumstances in deviation therefrom, taking into account certain considerations stated in the Companies Law. See “Item 6.C Directors, Senior Management and Employees——Board Practices—Approval of Related Party Transactions under Israeli Law” for additional information.

 

  Shareholder approval. We will seek shareholder approval for all corporate actions requiring such approval under the requirements of the Companies Law, rather than seeking approval for corporation actions in accordance with Nasdaq Listing Rule 5635. In particular, under this Nasdaq Stock Market rule, shareholder approval is generally required for: (i) an acquisition of shares/assets of another company that involves the issuance of 20% or more of the acquirer’s shares or voting rights or if a director, officer or 5% shareholder has greater than a 5% interest in the target company or the consideration to be received; (ii) the issuance of shares leading to a change of control; (iii) adoption/amendment of equity compensation arrangements (although under the provisions of the Companies Law there is no requirement for shareholder approval for the adoption/amendment of the equity compensation plan); and (iv) issuances of 20% or more of the shares or voting rights (including securities convertible into, or exercisable for, equity) of a listed company via a private placement (and/or via sales by directors/officers/5% shareholders) if such equity is issued (or sold) at below the greater of the book or market value of shares. By contrast, under the Companies Law, shareholder approval is required for, among other things: (i) transactions with directors concerning the terms of their service or indemnification, exemption and insurance for their service (or for any other position that they may hold at a company), for which approvals of the compensation committee, board of directors and shareholders are all required, (ii) extraordinary transactions with controlling shareholders of publicly held companies, which require the special approval, and (iii) terms of employment or other engagement of the controlling shareholder of us or such controlling shareholder’s relative, which require special approval. In addition, under the Companies Law, a merger requires approval of the shareholders of each of the merging companies.

  

  Nomination of Directors. We will not have to comply with the requirements that we have a nominating committee composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities.

 

 116

 

 

  Director Independence. Israeli law does not require that a majority of the directors serving on our board of directors be “independent,” as defined under Nasdaq Stock Market Rule 5605(a)(2), and rather requires we have at least two external directors who meet the requirements of the Companies Law, as described below under “Management—Board Practices—External Directors.” The definition of independent director under Nasdaq Stock Market rules and external director under the Companies Law overlap to a significant degree such that we would generally expect the directors serving as external directors to satisfy the requirements to be independent under Nasdaq Stock Market rules. However, it is possible for a director to qualify as an “external director’’ under the Companies Law without qualifying as an “independent director’’ under the Nasdaq Stock Market rules, or vice-versa. Notwithstanding Israeli law, we believe that a majority of our directors will be “independent” under the Nasdaq Stock Market rules. We are required, however, to ensure that all members of our Audit Committee are “independent” under the applicable Nasdaq and SEC criteria for independence (as we cannot exempt ourselves from compliance with that SEC independence requirement, despite our status as a foreign private issuer), and we must also ensure that a majority of the members of our Audit Committee are “independent directors” as defined in the Companies Law. Furthermore, Israeli law does not require, nor do our independent directors conduct, regularly scheduled meetings at which only they are present, which the Nasdaq Stock Market rules otherwise require
     
  Approval of Related Party Transactions. All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transaction as set forth in the Companies Law, which requires the approval of the audit committee, or the compensation committee, as the case may be, the board of directors and shareholders, as may be applicable, for specified transactions, rather than approval by the audit committee or other independent body of our board of directors as required under the Nasdaq Stock Market rules. See “Item 6.C Directors, Senior Management and Employees—Board Practices—Approval of Related Party Transactions under Israeli Law” for additional information.

   

  Annual Shareholders Meeting.  As opposed to the Nasdaq Stock Market Rule 5620(a), which mandates that a listed company hold its annual shareholders meeting within one year of the company’s fiscal year-end, we are required, under the Companies Law, to hold an annual shareholders meeting each calendar year and within 15 months of the last annual shareholders meeting.
     
  Distribution of periodic reports to shareholders; proxy solicitation. As opposed to the Nasdaq Stock Market rules, which require listed issuers to make such reports available to shareholders in one of a number of specific manners, Israeli law does not require us to distribute periodic reports directly to shareholders, and the generally accepted business practice in Israel is not to distribute such reports to shareholders but to make such reports available through a public website. In addition to making such reports available on a public website, we currently make our audited consolidated financial statements available to our shareholders at our offices and will only mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC’s proxy solicitation rules.

 

Except as stated above, we intend to comply with the rules generally applicable to U.S. domestic companies listed on the Nasdaq Capital Market, subject to certain exemptions the JOBS Act provides to emerging growth companies. We may in the future decide to use other foreign private issuer exemptions with respect to some or all of the other Nasdaq Listing Rules. Following our home country governance practices, as opposed to the requirements that would otherwise apply to a company listed on the Nasdaq Capital Market, may provide less protection than is accorded to investors under the Nasdaq Listing Rules applicable to domestic issuers.

 

ITEM 16H. MINE SAFETY DISCLOSURE

 

Not applicable.

 

ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

 117

 

 

ITEM 16J. INSIDER TRADING POLICIES

 

We have adopted a statement of trading policies that governs the trading in our securities by our directors, officers and certain other covered persons, and which is reasonably designed to promote compliance with applicable insider trading laws, rules and regulations, and any listing standards applicable to the Company. A copy of the Insider Trading Policy is included as Exhibit 11.1 to this annual report. In addition, with regard to any trading in our own securities, it is our policy to comply with the federal securities laws and the applicable exchange listing requirements. 

 

ITEM 16K. CYBERSECURITY

 

We have developed and maintain a cybersecurity risk management program, consisting of cybersecurity policies, procedures, compliance and awareness programs to mitigate risk and to ensure compliance with security, availability and confidentiality trust principles. The cybersecurity process has been integrated into our overall risk management system and process, and is internally managed by our R&D department as well as our internal auditor, Deloitte & Co. Israel. Management is responsible for identifying risks that threaten achievement of the control activities stated in the management’s description of the services organizations systems. Management has implemented a process for identifying relevant risks that could affect the organization’s ability to provide secure and reliable service to its users. The risk assessment occurs annually, or as business needs change, and covers identification of risks that could act against the company’s objectives as well as specific risks related to a compromise to the security of data. See “Item 3.D Risk Factors— Risks Related to Information Technology, Intellectual Property and Data Security and Privacy—If we or our third-party service providers experience a security breach, data loss or other compromise, including if unauthorized parties obtain access to our customers’ data, our reputation may be harmed, demand for our products and services may be reduced, and we may incur significant liabilities.”

 

The level of each identified risk is determined by considering the impact of the risk itself and the likelihood of the risk materializing and high scoring risks are actioned upon. Risks are analyzed to determine whether the risk meets company risk acceptance criteria to be accepted or whether a mitigation plan will be applied. Mitigation plans include both the individual or department responsible for the plan and may include budget considerations. 

 

The oversight of cybersecurity threats is undertaken by our Vice President of Research and Development, who holds over two decades of experience in information technology and the design and architecture of information systems, and is supported by management. Our audit committee is responsible for cybersecurity oversight and monitoring risk. Management informs the audit and investment committee of such risk by committee meetings.

 

As of the date of this report, we are not aware of any material risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. 

 

 118

 

 

PART III

 

ITEM 17. FINANCIAL STATEMENTS

 

We have elected to provide financial statements and related information pursuant to Item 18.

 

ITEM 18. FINANCIAL STATEMENTS

 

The consolidated financial statements and the related notes required by this Item are included in this Annual Report on Form 20-F beginning on page F-1.

 

ITEM 19. EXHIBITS.

 

Exhibit No.   Description
1.1*   Amended and Restated Articles of Association of the Registrant
2.1*   Description of Securities Registered under Section 12
4.1   Specimen share certificate of the Registrant (filed as Exhibit 4.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on August 15, 2022, and incorporated herein by reference)
10.1   Form of Indemnification Agreement (filed as Exhibit 10.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)
10.2+   2010 Option Plan (filed as Exhibit 10.2 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)
10.3+   2015 Share Incentive Plan (filed as Exhibit 10.3 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)
10.4+   Compensation Policy (filed as Exhibit 10.4 to our Annual Report on Form 20-F as filed with the Securities and Exchange Commission on March 4, 2024, and incorporated herein by reference)
10.5   Warrant to Purchase Shares issued February 19, 2017 to Silicon Valley Bank (filed as Exhibit 10.6 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)
10.6   Form of Advance Investment Agreement dated August 6, 2019 (filed as Exhibit 10.7 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)
10.7   Warrant to Purchase Stock issued April 29, 2021 to Silicon Valley Bank (filed as Exhibit 10.10 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)
10.8   Form of Advance Investment Agreement dated August 26, 2021 (filed as Exhibit 10.11 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)
10.9^   Funding Agreement dated as of July 5, 2022 between IBI Spikes Ltd. and Beamr Imaging Ltd.  (filed as Exhibit 10.13 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on July 12, 2022, and incorporated herein by reference)

 

 119

 

 

10.10   Form of Representative’s Warrant (filed as Exhibit 4.2 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on August 15, 2022, and incorporated herein by reference)
10.11   Form of Representative’s Warrant (filed as Exhibit 4.2 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on May 30, 2023, and incorporated herein by reference)
11.1*   Insider Trading Policy
12.1*   Certification of the Chief Executive Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934
12.2*   Certification of the Chief Financial Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934
13.1*   Certification of the Chief Executive Officer pursuant to 18 U.S.C. 1350
13.2*   Certification of the Chief Executive Officer pursuant to 18 U.S.C. 1350
15.1*   Consent of Fahn Kanne & Co., the Israeli member firm of Grant Thornton International Ltd, an independent registered public accounting firm  
21.1   List of Subsidiaries of the Registrant (filed as Exhibit 21.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on February 22, 2022, and incorporated herein by reference)
97.1+   Clawback Policy (filed as Exhibit 97.1 to our Annual Report on Form 20-F as filed with the Securities and Exchange Commission on March 4, 2024, and incorporated herein by reference)
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

 

+ Indicates a management contract or any compensatory plan, contract or arrangement.

 

^ Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.

 

 120

 

 

SIGNATURES

 

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on Form 20-F filed on its behalf.

 

  BEAMR IMAGING LTD.
     
Date: March 4, 2025 By: /s/ Sharon Carmel
    Sharon Carmel
    Chief Executive Officer

 

 121

 

 

 

 

 

 

 

 

BEAMR IMAGING LTD.

 

CONSOLIDATED FINANCIAL STATEMENTS

 

AS OF DECEMBER 31, 2024

 

 

 

 

 

 

F-1

 

 

BEAMR IMAGING LTD.

 

CONSOLIDATED FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2024

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

  

Report of Independent Registered Public Accounting Firm (PCAOB ID: 1375) F-3
Consolidated Balance Sheets as of December 31, 2024 and 2023 F-4
Consolidated Statements of Operations and Comprehensive Loss for the three years ended December 31, 2024 F-5
Consolidated Statements of Changes in Shareholders’ Equity for the three years ended December 31, 2024 F-6
Consolidated Statements of Cash Flows for the three years ended December 31, 2024 F-7
Notes to Consolidated Financial Statements F-8 - F-28

 

 

 

 

 

 

 

 

F-2

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Fahn Kanne & Co.
Board of Directors and Shareholders Head Office
Beamr Imaging Ltd. 32 Hamasger Street
  Tel-Aviv 6721118, ISRAEL
  PO Box 36172, 6136101
   
  T +972 3 7106666
  F +972 3 7106660
  www.gtfk.co.il

 

Opinion on the financial statements

 

We have audited the accompanying consolidated balance sheets of Beamr Imaging Ltd. and its subsidiaries (the “Company”) as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, changes in shareholders’ equity, and cash flows for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ FAHN KANNE & CO. GRANT THORNTON ISRAEL

 

We have served as the Company’s auditor since 2021.

 

Tel Aviv, Israel

March 4, 2025

 

Certified Public Accountants

Fahn Kanne & Co. is the Israeli member firm of Grant Thornton International Ltd

 

F-3

 

 

BEAMR IMAGING LTD.

 

CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands except share and per share amounts)

 

     

As of

December 31,

 
   Note  2024   2023 
ASSETS           
Current assets:           
Cash  3  $16,483   $6,116 
Trade receivables      506    597 
Other current assets  4   195    132 
Total current assets      17,184    6,845 
              
Non-current assets:             
Property and equipment, net      43    19 
Intangible assets, net  5   489    280 
Goodwill  5   4,379    4,379 
Total non-current assets      4,911    4,678 
              
Total assets     $22,095   $11,523 
              
LIABILITIES AND SHAREHOLDERS’ EQUITY             
Current liabilities:             
Current maturities of loan, net  6  $250   $330 
Account payables      10    7 
Deferred revenue  2M   30    27 
Liability to controlling shareholder, net  13   
-
    199 
Other current liabilities  7   677    458 
Total current liabilities      967    1,021 
              
Non-current liabilities:             
Loan, net of current maturities  6  $
-
   $170 
Derivative warrants liability  8   50    72 
Total non-current liabilities      50    242 
              
Commitments and contingent liabilities  9   
 
    
 
 
              
Shareholders’ equity:  10          
Ordinary shares, par value NIS 0.05 per (the “Ordinary Shares”):             
Authorized: 222,000,000 shares at December 31, 2024 and 2023; Issued and outstanding: 15,518,794 and 13,051,343 shares at December 31, 2024 and 2023, respectively      213    179 
Additional paid-in capital      55,889    41,752 
Accumulated deficit      (35,024)   (31,671)
Total shareholders’ equity      21,078    10,260 
              
Total liabilities and shareholders’ equity     $22,095   $11,523 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

BEAMR IMAGING LTD.

 

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(U.S. dollars in thousands except share and per share amounts)

 

     

Year ended December 31,

 
   Note  2024   2023   2022 
            
Revenue  15  $3,064   $2,909   $2,863 
Cost of revenue      (240)   (96)   (98)
Gross profit      2,824    2,813    2,765 
                   
Research and development expenses      (2,893)   (1,824)   (2,063)
Sales and marketing expenses      (678)   (361)   (905)
General and administrative expenses      (2,468)   (1,506)   (828)
                   
Operating loss      (3,215)   (878)   (1,031)
                   
Financing income (expenses), net  12   (92)   222    (165)
                   
Loss before taxes on income      (3,307)   (656)   (1,196)
                   
Taxes on income  14   (46)   (39)   (52)
                   
Net loss and comprehensive loss for the year  2T  $(3,353)  $(695)  $(1,248)
                   
Basic net loss per share     $(0.22)  $(0.06)  $(0.48)
                   
Weighted average number of Ordinary Shares used in computing basic net loss per share      15,167,476    11,194,097    2,578,760 
                   
Diluted net loss per share     $(0.22)  $(0.09)  $(0.48)
                   
Weighted average number of Ordinary Shares used in computing diluted net loss per share      15,167,476    11,449,811    2,578,760 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

BEAMR IMAGING LTD.

 

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(U.S. dollars in thousands except share and per share amounts)

 

   Ordinary shares   Convertible
Ordinary 1 and 2 shares
   Convertible
Preferred shares
   Additional
paid-in
   Accumulated     
   Number   Amount   Number   Amount   Number   Amount   capital   deficit   Total 
                                     
Balance as of January 1, 2022   2,578,760   $51    1,496,880   $5    5,714,400   $78   $30,041   $(29,721)  $454 
                                              
Contribution to equity due to free interest loan from controlling shareholder (Note 13)   -    
     -
    -    
     -
    -    
     -
    112    
     -
    112 
Share-based compensation (Note 11)   -    
-
    -    
-
    -    
-
    222    
-
    222 
Net loss for the year   -    
-
    -    
-
    -    
-
    
-
    (1,248)   (1,248)
                                              
Balance as of December 31, 2022   2,578,760   $51    1,496,880   $5    5,714,400   $78   $30,375   $(30,969)  $(460)
                                              
Issuance of Ordinary Shares upon completion of an initial public offering, net of offering expenses (Note 10B)   1,950,000    27    
-
    
-
    
-
    
-
    6,355    
-
    6,382 
Voluntary conversion of all shares with preferences over Ordinary Shares into Ordinary Shares (Note 10B)   7,211,280    83    (1,496,880)   (5)   (5,714,400)   (78)   
-
    
-
    
-
 
Automatic conversion of all convertible advanced investments into Ordinary Shares (Note 10B)   1,142,856    16    
-
    
-
    
-
    
-
    4,555    
-
    4,571 
Deemed dividend resulted from trigger of down round protection feature of certain warrants granted (Note 10B)   -    
-
    -    
-
    -    
-
    7    (7)   
-
 
Share-based compensation (Note 11)   -    
-
    -    
-
    -    
-
    413    
-
    413 

Exercise of options into ordinary shares (Note 11)

   168,447    2    
-
    
-
    
-
    
-
    47    
-
    49 
Net loss for the year   -    
-
    -    
-
    -    
-
    
-
    (695)   (695)
                                              
Balance as of December 31, 2023   13,051,343   $179    
-
   $
-
    
-
   $
-
   $41,752   $(31,671)  $10,260 
                                              
Issuance of Ordinary Shares upon completion of a public offering (including exercise of over-allotment option), net of offering expenses (Note 10C)   1,971,300    27    
-
    
-
    
-
    
-
    12,259    
-
    12,286 
Issuance of Ordinary Shares upon cashless exercise of Warrants (Note 10D)   95,120    1    
-
    
-
    
-
    
-
    (1)   
-
    
-
 
Amount classified to equity upon determination of the exercise price (Note 8)   -    
-
    -    
-
    -    
-
    599    
-
    599 
Share-based compensation (Note 11)   -    
-
    -    
-
    -    
-
    491    
-
    491 

Exercise of options into ordinary shares (Note 11)

   401,031    6    
-
    
-
    
-
    
-
    789    
-
    795 
Net loss for the year   -    
-
    -    
-
    -    
-
         (3,353)   (3,353)
                                              
Balance as of December 31, 2024   15,518,794   $213    
-
   $
-
    
-
   $
-
   $55,889   $(35,024)  $21,078 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

 

BEAMR IMAGING LTD.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands except share and per share amounts)

 

   Year ended December 31 
   2024   2023   2022 
Cash flows from operating activities:            
Net loss  $(3,353)  $(695)  $(1,248)
Adjustments required to reconcile net loss to net cash used in operating activities:               
Depreciation and amortization   170    26    28 
Share-based compensation (Note 11)   418    363    222 
Amortization of discount relating to straight loan received from commercial bank   31    31    14 
Exchange rate differences on straight loan received from commercial bank   11    (12)   (12)
Change in the fair value of derivative warrant liability (Note 8)   577    (66)   
-
 
Change in the fair value of convertible advanced investments   
-
    (269)   70 
Amortization of discount relating to liability to controlling shareholder (Note 13)   10    48    40 
Change in estimation of maturity date of liability to controlling shareholder (Note 13)   
-
    12    
-
 
Exchange rate differences on straight loan received from controlling shareholder (Note 13)   (3)   (16)   
-
 
Decrease (increase) in trade receivables   91    (16)   310 
Decrease (increase) in other current assets   (63)   (68)   2 
Increase (decrease) in account payables   3    (26)   6 
Increase (decrease) in deferred revenue   3    (4)   (2)
Increase (decrease) in other current liabilities   219    33    (75)
Net cash used in operating activities   (1,886)   (659)   (645)
                
Cash flows from investing activities:               
Purchase of property and equipment   (36)   (10)   (2)
Capitalization of internal-use software (Note 5)   (294)   (183)   
-
 
Net cash used in investing activities   (330)   (193)   (2)
                
Cash flows from financing activities:               
Net proceeds received upon completion of public offering transactions (Notes 10B and 10C)   12,286    6,695    
-
 
Deferred offering costs   
-
    
-
    (98)
Repayment of principal relating to straight loan received from commercial bank   (292)   (236)   (582)
Proceeds from loan received from controlling shareholder (Note 13)   
-
    25    115 
Repayment of Facility Fee relating to straight loan received from commercial bank   
-
    
-
    (10)
Repayment of principal relating to straight loan received from controlling shareholder (Note 13)   (206)   (258)   
-
 
Proceeds from issuance of unit consist of straight loan and warrant granted to commercial bank, net   
-
    
-
    887 
Proceeds received from exercise of options into Ordinary Shares (Note 11)   795    49    
-
 
Net cash provided by financing activities   12,583    6,275    312 
                
Change in cash   10,367    5,423    (335)
Cash at beginning of year   6,116    693    1,028 
Cash at end of year  $16,483   $6,116   $693 
Non-cash investing and financing activities:               
Capitalized deferred offering costs classified into equity upon completion of initial public offering transaction (Note 10B)  $
-
   $(313)  $
-
 
Contribution to equity due to free interest loan from controlling shareholder (Note 13)  $
-
   $
-
   $112 
Automatic conversion of convertible advanced investments into shares (Note 10B)  $
-
   $4,571   $
-
 
Deemed dividend upon trigger of down round protection (Note 10B)  $
-
   $7   $
-
 
Amount classified to equity upon determination of the exercise price (Note 8)  $599   $
-
   $
-
 
Share-based compensation capitalized in internal-use software  $73   $50   $
-
 
Supplemental disclosure of cash flow information:               
Interest paid  $(85)  $(133)  $(77)
Interest received  $548   $97   $
-
 
Taxes paid  $(43)  $(38)  $(54)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-7

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 1 - GENERAL

 

A.Operations

 

Beamr Imaging Ltd. (the “Company” or “Beamr”) was incorporated in October 2009 under the laws of the State of Israel and it engages mainly in the development of technology for encoding, compressing and optimizing images and videos. In February 2024, the Company launched its next generation product, Beamr Cloud, a cloud-based Software-as-a-Service (“SaaS”) solution accelerated by NVIDIA GPUs. Beamr Cloud Video SaaS, initially operating over and integrated with AWS, aims to simplify video processing and make it accessible and affordable. In June 2024, the Company made its SaaS solution available on Oracle Cloud Infrastructure.

 

The Company’s Ordinary Shares began trading on the Nasdaq Capital Market (the “Nasdaq”) under the ticker symbol “BMR” on February 28, 2023 in connection with its initial public offering transaction (“U.S. IPO”) (see Note 10C below).

 

B.Foreign operations

 

1.Beamr Inc.

 

In 2012, the Company incorporated a wholly-owned U.S. subsidiary, Beamr Inc. (“Beamr Inc.”), for the purpose of reselling the Company’s software and products in the U.S. and Canadian markets.

 

2.Beamr Imaging RU LLC

 

In 2016, the Company incorporated a wholly-owned Russian limited partnership, Beamr Imaging RU LLC, (“Beamr Imaging RU”) for the purpose of conducting research and development services to the Company.

 

The Company and its subsidiaries, Beamr Inc. and Beamr Imaging RU, are collectively referred to as the “Group”.

 

C.Liquidity and capital resources

 

The Company has devoted substantially all of its efforts to research and development, the commercialization of its software products and raising capital for such purposes. The development and commercialization of the Company’s software and products are expected to require substantial further expenditures. To date, the Company has not yet generated sufficient revenue from operations to support its activities, and therefore it is dependent upon external sources for financing its operations. During the year ended December 31, 2024, the Company had net losses of $3,353. As of December 31, 2024, the Company had an accumulated deficit of $35,024. Management plans to finance its operations through sales of the Company’s equity securities and through revenues generated from the sales of its software products. In addition, management believes that the new SaaS solution for video optimization technology will allow the Company to potentially access new customers and new markets.

 

During the year ended December 31, 2022, the Company raised net proceeds of $887 through a funding agreement with IBI Spikes Ltd. (see also Note 6). During the year ended December 31, 2023, the Company raised net proceeds of $6,382 and $49 through completion of the U.S. IPO and exercises of options into Ordinary Shares, respectively (see also Note 10B and Note 11, respectively). During the year ended December 31, 2024, the Company raised gross proceeds of $13,800 and $795 through completion of an underwritten public offering and exercises of options into Ordinary Shares (see also Note 10C and Note 11, respectively).

 

Management has considered the significance of such conditions in relation to the Company’s ability to meet its current obligations and to achieve its business targets and determined that it has sufficient funds to fund its planned operations for at least the next 12 months.

 

D.The impact of the Russian Invasion of Ukraine

 

On February 24, 2022, Russia invaded Ukraine. The Company has an operation in Russia through its wholly-owned subsidiary, Beamr Imaging RU. The Company undertakes some of its software development and design, quality assurance and support in Russia using personnel located there. While some of the Company’s developers are located in Russia, its research and development leadership are all located in Israel. The Company has no manufacturing operations or sell any products in Russia. The Company constantly evaluates its activities in Russia and currently believes there was no significant impact on its activities. As of December 31, 2024, three employees have relocated from Russia to other locations of the Company.

 

E.The impact of Iron Sword War (Israel-Hamas war)

 

On October 7, 2023, the Hamas organization launched a series of deadly terror attacks on civilian and military targets skirting the Gaza Strip in the southern part of Israel and fired rockets on many of the communities in southern and central Israel. Following the attack, Israel’s security cabinet declared war and commenced a military campaign in Gaza against Hamas. On January 19, 2025, a temporary ceasefire went into effect, the result of which is uncertain. As of the date of these consolidated financial statements management regularly monitors developments and acts in accordance with the guidelines of the various authorities and as of the approval date of these financial statements believes there is no significant impact on its activities.

 

F-8

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

 

The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

 

A.Use of estimates in the preparation of financial statements

 

The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions include (i) revenue recognition and (ii) recoverability of the Company’s goodwill.

 

B.Functional currency

 

The functional currency of the Company and all of its subsidiaries all of which are primarily a direct and integral component of the Company’s operation is the U.S. dollar (“$” or “dollar”), as the dollar is the primary currency of the economic environment in which the Company and its subsidiaries have operated (which is the currency of the environment in which an entity primarily generates cash) and expects to continue to operate in the foreseeable future.

 

In accordance with ASC 830, “Foreign Currency Matters”, balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions included in the consolidated Statement of Operations and Comprehensive Loss, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such transactions are presented within financing income or expenses.

 

C.Principles of consolidation

 

The consolidated financial statements include the accounts of the Group. Intercompany transactions and balances have been eliminated upon consolidation.

 

D.Cash

 

Cash is short-term highly liquid investment which include short-term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals or use and that are readily convertible to cash with maturities of three months or less as of the date acquired.

 

E.Research and development expenses

 

Research and development expenses are expenses as incurred, except to the extent that such costs are associated with internal-use software that qualifies for capitalization (see also Note 2F below)

 

F.Internal-use software costs

 

The Company capitalized certain internal software development costs, consisting mainly of direct labor (including stock-based compensation expenses), associated with creating the internally developed software related to its SaaS solution.

 

In accordance with ASC 350-40, “Internal-Use Software”, the capitalization of costs to develop internal-use software begins when preliminary development efforts are successfully completed. The Company has committed project funding to develop internal-use software and it is probable that the project will be completed, and the software will be used as intended. Costs related to the design or maintenance of internal-use software are expensed as incurred. Capitalized costs are amortized over the estimated useful life of the software, which is generally three years, once the capitalized asset is ready for its intended use, using the straight-line method in which the management believes the expected benefit will be derived.

 

The Company periodically reviews internal-use software costs to determine whether the projects will be completed, placed in service, removed from service, or replaced by other internally developed or third-party software. If the asset is not expected to provide any future benefit, the asset is retired, and any unamortized cost is expensed. Capitalized internal-use software costs are recorded under intangible assets, net.

 

When events or changes in circumstances are required, the Company assesses the likelihood of recovering the cost of internal-use software. If the net book value is not expected to be fully recoverable, internal-use software would be impaired to its fair value. Measurement of any impairment loss is based on the excess of the carrying value of the asset over the fair value.

 

F-9

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

G.Goodwill and intangible assets

 

Goodwill is the amount by which the purchase price of acquired net assets in a business combination exceeded the fair values of the net identifiable assets on the date of acquisition. Goodwill is not amortized but evaluated for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Impairment of goodwill is tested at the level of the reporting unit. As required by ASC 350 “Intangibles-Goodwill and Other”, the Company chooses either to perform a qualitative assessment whether a goodwill impairment test is necessary or proceeds directly to the goodwill impairment test. Such determination is made for each reporting unit on a stand-alone basis. The qualitative assessment includes various factors such as macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, earnings multiples, gross margin and cash flows from operating activities and other relevant factors. When the Company chooses to perform a qualitative assessment and determines that it is more likely than not (more than 50 percent likelihood) that the fair value of the reporting unit is less than its carrying value, then the Company proceeds to the goodwill impairment test. If the Company determines otherwise, no further evaluation is necessary.

 

When the Company decides or is required to perform the quantitative goodwill impairment test, the Company compares the fair value of the reporting unit to its carrying value and an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value, if any.

 

The Company determined that its operations represent a single reporting unit. Prior to the completion of the U.S. IPO, the Company determined the fair value of its reporting unit by using the income approach. Upon completion of the U.S. IPO in February 2023, the fair value of the Company’s reporting unit is determined internally by the management based on observable inputs of the Company. As of the reported periods, the Company has performed the annual impairment test and has determined that impairment loss is not required to be recognized.

 

Finite lived intangible assets acquired in business combinations (i.e. trade names), are initially recorded at fair value. The cost of internal-use software is based on the criteria described in Note 2F above. Such intangible assets are amortized on a straight-line basis over their estimated useful lives. The intangible asset lives have been determined based upon the anticipated period over which the Company will derive future cash flows from the intangible assets. The Company has considered the effects of legal, regulatory, contractual, competitive, and other economic factors in determining these useful lives. Recoverability of these assets is assessed when triggering events have occurred that may give rise to an impairment loss and is determined by a comparison of the carrying amount of the asset to the future undiscounted net cash flows expected to be generated by the asset. When it is determined that the carrying value of the asset is not recoverable, the asset is written down to its estimated fair value. 

 

During all reported periods, impairment losses were not identified through the impairment test.

 

The lives used in computing straight-line amortization for financial reporting purposes are as follows:

 

Rate of depreciation  % 
     
Trade names   10 
Internal-use software   33 

 

H.Property and equipment

 

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the consolidated Statements of Operations and Comprehensive Loss.

 

The Company’s long-lived assets are reviewed for impairment, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. To date, the Company has not incurred any impairment losses.

 

The lives used in computing straight-line depreciation for financial reporting purposes are as follows:

 

Rate of depreciation  % 
     
Computers and peripheral equipment   33 
Office furniture and equipment   7-15 

 

F-10

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

I.Leases

 

The Company entered into several non-cancellable lease agreements for offices for use in its operations, which are classified as operating leases (see below), whereby the Company applies ASC Topic 842, “Leases” (“ASC 842”) under which the Company determines if an arrangement is a lease at inception.

 

Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful life of the asset, (iv) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset, or (v) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of lease term. A lease is classified as an operating lease if it does not meet any one of these criteria. Since all the Company’s lease contracts for premises do not meet any of the criteria above, the Company concluded that all its lease contracts should be classified as operating leases.

 

Right of Use (“ROU”) assets and liabilities are recognized on the commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company’s leases do not provide an implicit rate, the Company uses its Incremental Borrowing Rate (“IBR”) based on the information available on the commencement of the lease. The Company uses the long-lived assets impairment guidance in ASC 360-10, “Property, Plant, and Equipment - Overall”, to determine whether a ROU asset is impaired, and if so, the amount of the impairment loss to recognize. Certain leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option.

 

The Company also elected the short-term lease recognition exemption for all leases that qualify (leases with a term shorter than 12 months). For those leases, ROU assets or lease liabilities are not recognized and rent expense is recognized on a straight-line basis over the lease term. See also Note 9 for further information.

 

J.Employee benefit plans

 

The Company’s liability for severance pay to its Israeli employees is subject to Section 14 of the Israeli Severance Compensation Act, 1963 (“Section 14”), pursuant to which all of the Company’s employees are entitled to monthly deposits by the Company, at a rate of 8.33% of their monthly salary, made in the employee’s name with insurance companies. Under Israeli employment law, payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. The fund is made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination. The severance pay liabilities and deposits under Section 14 are not reflected in the balance sheets as severance pay risks have been irrevocably transferred to the severance funds. All deposits required through December 31, 2024 have been made.

 

K.Deferred income taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, “Income Taxes”. Accordingly, deferred income taxes are determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected to be in effect when these differences reverse. Valuation allowance in respect of deferred tax assets is provided for, if necessary, to reduce deferred tax assets is amounts more likely than not to be realized.

 

The Company accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise’s financial statements. According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The accounting policy of the Company is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such items in its consolidated financial statements during the reported periods and did not recognize any liability with respect to an unrecognized tax position in its balance sheets.

 

L.Contingencies

 

The Company and its subsidiaries may be involved in certain legal proceedings and certain business relationships that arise from time to time in the ordinary course of their business and in connection with certain agreements with third parties. Except for income tax contingencies, the Company applies the provisions of ASC Topic 450, Contingencies. Thus, the Company records accruals for contingencies to the extent that the management concludes that the occurrence is probable and that the related liabilities are estimable. Legal expenses associated with contingencies are expensed as incurred.

 

F-11

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

M.Revenue recognition

 

The Company recognizes revenue in accordance with ASC 606, “Revenue from Contracts with Customers” (“ASC 606”) under which the Company determines revenue recognition through the following five steps (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when, or as, the Company satisfies a performance obligation.

 

The Company enters into contracts that mostly include software and software related services (i.e. Post-Contract Customer Support (“PCS”)), which are generally capable as being distinct from each other and accounted for as separate performance obligations.

 

The Company derives its revenue from licensing the rights to use its software for a limited term (mainly for a period of one to three years) or on a perpetual basis for enterprises that incorporate the Company’s perpetual license in their own products delivered to end users and for the Company’s products sold to thousands private consumers, as applicable to each contract, and from, provision of related maintenance and technical support. The Company sells its products through direct sales force and indirectly through distributors and consumer platforms.

 

Revenue is recognized when control of the promised goods or services are transferred to the customers, in an amount that reflects the consideration that the company expects to receive in exchange for those goods or services. However, when the consideration for the license is based on sales of the related customer (i.e. sales-based), the company applies the provisions of ASC 606 with respect to sales-based or usage-based royalties promised in exchange for a license of intellectual property and recognizes revenue only when the underlying sales occur, as long as this approach does not result in the acceleration of revenue ahead of the Company’s performance.

 

Under ASC 606, an entity recognizes revenue when or as it satisfies a performance obligation by transferring software license (either timely-based or perpetual) or software related services to the customer, either at a point in time or over time. The Company recognizes its revenue from software sales at a point in time upon delivery of its software license. The software license is considered a distinct performance obligation, as the customer can benefit from the software on its own. The Company’s revenue from PCS are derived from annual maintenance providing for unspecified upgrades on a when-and-if-available basis. The right for an unspecified upgrade for the version acquired by the customer and enhancements on a when-and-if-available basis that do not specify the features, functionality and release date of future product enhancements for the customer to know what will be made available and the general timeframe in which it will be delivered, if any. The Company considers the PCS performance obligation as a distinct performance obligation that is satisfied over time and recognized on a straight-line basis over the contractual period (mainly over a period of one year either for timely-based license or for perpetual license).

 

As the Company bundles software licenses (either time-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a relative standalone selling price basis.

 

Since the Company does not sell PCS on a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several hours of technical support per contract (as management believes the technology and products covered under the software license component are mature and fully functional as delivered to the costumer), the standalone selling prices of the PCS are determined based on the expected cost plus a margin (“cost-plus approach”) based on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such an estimate is also corroborated with the price that the Company would have to pay to a third-party service provider for a similar support service.

 

The stand-alone selling price of software licenses (either timely-based or perpetual) is estimated by management based on an adjusted market assessment approach which represents management estimation of the price that a customer in the market will be willing to pay for such a license on a stand-alone basis (i.e. without any PCS).

 

Due to the fact that the PCS services are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction price allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses.

 

During the reported periods, costs to obtain contracts were in an insignificant amount.

 

The Company does not grant a right of return to its customers. When product delivered to the customer is subject to evaluation, the Company defers revenue until evaluation is completed subject to formal selling agreement with the customer, at which time revenue is recognized provided that all other revenue recognition criteria are met.

 

Commencing 2022, revenue is also derived from the traffic operations in the Google AdSense program, a web advertising platform, that the Company makes available on its websites. Google pays the Company on a cost-per-click basis. The Company recognizes revenue at a point of time when the fees are paid to it by Google based on the volume of clicks through Google AdSense advertisements.

 

F-12

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

M.Revenue recognition (Cont.)

 

The Company receives payments from customers based upon contractual payment schedules. Trade receivables are recorded when right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables include amounts related to contractual right to consideration for completed performance obligations not yet invoiced. As of December 31, 2024 and 2023, unbilled receivables balance amounted to $26 and $39, respectively, and are included within trade receivables balance in the Company’s Consolidated Balance Sheets.

 

As of December 31, 2024 and 2023, the Company had $30 and $27, respectively, of remaining performance obligations not yet satisfied or partly satisfied related to revenue (mostly PCS). Such amounts are presented as deferred revenue which are expected to be recognized as revenue during the next twelve months.

 

See also Note 15 for further discussion related to disaggregation of revenue.

 

N.Concentrations of credit risk and allowance for doubtful accounts

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and trade receivables as well as certain other current assets that do not amount to a significant amount. Cash which is primarily held in dollar and New Israeli Shekels (NIS), are deposited with major banks in Israel, U.S. and Russian Federation. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements. Most of the Company’s sales are mainly derived from sales to a diverse set of customers located primarily in the United States. Management periodically evaluates the collectability of the trade receivables to determine the amounts that are doubtful of collection and determine a proper allowance for doubtful accounts, as described below. Accordingly, management believes that the Company’s trade receivables do not represent a substantial concentration of credit risk.

 

The Company extends credit to customers in the normal course of business and does not require collateral or any other security to support amounts due. Management performs ongoing credit evaluations of its customers. The allowance for doubtful accounts is determined with respect to amounts the Group has determined to be doubtful of collection by considering among other things, its past experience with customers, the length of time that the balance is past due, the customer’s current ability to pay and available information about the credit risk on such customers. Provisions for the allowance for doubtful accounts are recorded under general and administrative expenses in the consolidated Statements of Operations and Comprehensive Loss. During the reported periods, the Company has not recorded allowance in respect of accounts receivable.

 

O.Fair Value Measurements

 

The Company measures and discloses fair value in accordance with the ASC 820, “Fair Value Measurements and Disclosures” which defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

 

Level 1 - unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date.

 

Level 2 - pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.

 

Level 3 - pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy. The valuation of certain financial instruments classified under fair value through profit or loss category and the fair value of reporting units for purposes of goodwill impairment analysis (in periods when such analysis is based on the income approach), fall under this category.

 

This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.

 

The fair value of cash is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.

 

F-13

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

P.Allocation of proceeds and related issuance costs

 

When multiple instruments are issued in a single transaction (package issuance), the total gross proceeds from the transaction are allocated among the individual freestanding instruments identified. The allocation occurs after identifying all the freestanding instruments and the subsequent measurement basis for those instruments.

 

Financial instruments that are required to be subsequently measured at fair value (such as derivative warrants liability) are measured at fair value and the remaining consideration is allocated to other financial instruments that are not required to be subsequently measured at fair value (i.e. straight loan), based on the relative fair value basis for such instruments.

 

Allocation of issuance costs to freestanding instruments was based on an approach that is consistent with the allocation of the proceeds, as described above. Accordingly, issuance costs allocated to the derivative warrant liability were immediately expensed. Issuance costs allocated to straight loan are recorded as a discount of the straight loan and accreted over the contractual term of straight loan up to face value of such loans using the effective interest method.

 

Q.Warrants

 

Certain warrants that were issued to (i) a commercial bank as part of entering into funding transaction and (ii) a seller through a transaction in which certain identified intangible assets have been purchased, are classified as a component of permanent equity since they are freestanding financial instruments that are legally detachable and separately exercisable, do not embody an obligation for the Company to repurchase its own shares, and permit the holders to receive a fixed number of Ordinary Shares upon exercise for a fixed exercise price and thus, are considered as indexed to the Company’s own shares. In addition, the warrants must require physical share settlement and may not provide any guarantee of value or return. As such warrants were issued together with financial instruments that are not subsequently measured at fair value the warrants were measured based on allocation of the proceeds received by the Company in accordance with the relative fair value basis. When applicable, direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.

 

In 2023, warrants granted to seller have been expired. In 2024, warrants granted to commercial bank have been fully exercised on a cashless basis.

 

Down round feature is disregarded when assessing whether an instrument is indexed to its own shares, for purposes of determining liability or equity classification. Based on its evaluation, management has determined that certain warrants with down-round protection are eligible for equity classification. Upon the occurrence of an event that triggers down round protection (i.e., when the warrants’ exercise price is adjusted downward because of the down round feature), the effect is accounted for as a deemed dividend and as a reduction of income available to common shareholders for purposes of basic earnings per share (EPS) calculation. During the year ended December 31, 2023, down-round protection was triggered upon completion of the U.S IPO under which the Company recorded a deemed dividend amounted of $7 (see also Note 10B below).

 

R.Derivative Warrants Liability

 

Certain warrants that were granted by the Company for commercial banks through funding transaction entitle the bank to exercise the warrants for a variable number of shares and/or for a variable exercise price and thus the fixed-for-fixed criteria is not met. Accordingly, the warrants are classified as a non-current liability according to the provisions of ASC 815-40, “Derivatives and Hedging - Contracts in Entity’s Own Equity” (“ASC 815-40”).

 

Until completion of the U.S. IPO, the Company’s management accounted for these warrants as a financial derivative liability measured upon initial recognition and on subsequent periods at fair value with the assistance of an independent valuation firm by using the Hybrid Method by combining the Option Pricing Method (“OPM”) and an initial public offering scenario. Upon completion of the U.S. IPO, the fair value of the aforesaid warrants derivative liability is estimated internally by the Company’s management by using the Black-Scholes Model that is based on several assumptions, of which the most significant is the expected share price volatility, which was calculated based upon historical volatility of peer companies in the same industry on weekly basis. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company’s historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable plans to pay cash dividends in the future.

 

The above assumptions are reviewed on a regular basis and changes in the estimated fair value of the outstanding warrants are recognized each reporting period as part of the “Financing (income) expenses, net” line in the consolidated Statements of Operations and Comprehensive Loss, until such warrants are exercised, expired or eligible for exercise for fixed number of shares or for fixed exercise price. When applicable, direct issuance expenses that were allocated to the above warrants were expensed, as incurred.

 

F-14

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

S.Capital contribution from a controlling shareholder

 

The fair value of the benefit received in respect of loan received from the controlling shareholder was calculated on the basis of the difference between the interest rate that the Company would have required to pay for similar loan from commercial bank and the interest rate that the Company was actually charged under the agreement with the controlling shareholders. Such benefit was accounted for as capital contribution received from the controlling shareholder as additional paid-in capital and it was recorded as discount on the loan received against at the initial measurement date. Subsequently, such discount was expensed over the economic life of the loan based on the effective interest rate method.

 

T.Basic and diluted net loss per Ordinary Share

 

The Company applies the two-class method as required by ASC 260-10, “Earnings Per Share” (“ASC 260-10”), which requires the income or loss per share for each class of shares outstanding (Ordinary Shares and all other shares with preferences over the Ordinary Shares) to be calculated assuming 100% of the Company’s earnings are distributed as dividends to each class of shares based on their contractual rights. No dividends were declared or paid during the reported periods. According to the provisions of ASC 260-10, the Company’s Convertible Preferred Shares and Convertible Ordinary 1 and 2 Shares did not have contractual obligations to share losses of the Company and therefore were not included in the computation in the period of net loss per share. Upon the listing of the Company’s Ordinary Shares on the Nasdaq in connection with the U.S. IPO in February 2023, the entire balance of the Preferred Shares and Ordinary 1 and 2 Shares was converted into Ordinary Shares.

 

Basic net loss per Ordinary Share is computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of Ordinary Shares outstanding during the period. Diluted loss per share gives effect to all potentially dilutive common shares outstanding during the year using the treasury stock method with respect to shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), options and certain warrants and using the if-converted method with respect to convertible advance investments and certain warrants accounted for as derivative liability. In computing diluted loss per share, the average share price for the period is used in determining the number of shares assumed to be purchased from the exercise of options or warrants.

 

During the years ended December 31, 2024, 2023 and 2022, the total weighted average number of Ordinary Shares related to outstanding shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), options, warrants and convertible advance investments excluded from the calculation of the diluted loss per share was 1,306,124, 3,080,012 and 9,929,970, respectively.

 

The net loss from operations and the weighted average number of Ordinary Shares used in computing basic and diluted net loss per share from operations for the years ended December 31, 2024, 2023 and 2022, are as follows:

 

   Year ended December 31, 
   2024   2023   2022 
             
Numerator:            
Net loss  $(3,353)  $(695)  $(1,248)
Deemed dividend related to trigger of down round protection feature (see Note 10B below)   
-
    (7)   
-
 
Net basic loss  $(3,353)  $(702)  $(1,248)
Change in fair value of derivative warrant liability (see Note 8 below)   
-
    (66)   
-
 
Change in fair value of convertible advanced investment (see Note 10B below)   
-
    (269)   
-
 
Net diluted loss  $(3,353)  $(1,037)  $(1,248)
                
Denominator:               
Ordinary shares used in computing basic net loss per share   15,167,476    11,194,097    2,578,760 
Incremental ordinary shares to be issued upon exercise of derivative warrant liability   
-
    24,834    
-
 
Incremental ordinary shares to be issued upon conversion of convertible advanced investments   
-
    230,880    
-
 
Ordinary shares used in computing diluted net loss per share   15,167,476    11,449,811    2,578,760 
                
Basic net loss per ordinary share  $(0.22)  $(0.06)  $(0.48)
Diluted net loss per ordinary share  $(0.22)  $(0.09)  $(0.48)

 

F-15

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

U.Share-based compensation

 

The Company measures and recognizes compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with ASC 718, “Compensation-Stock Compensation”. Share-based payments are recognized in the Statement of Operations and Comprehensive Loss as an operating expense (unless they are eligible to be capitalized as part of the cost of internal developed asset) based on fair value of the award at the grant date by using Black-Scholes option-pricing model. The inputs for the valuation analysis of the options include several assumptions of which the most significant are the fair market value of the underlying Ordinary Share, the expected share price volatility and the expected option term. Expected volatility was calculated based upon historical volatility of peer companies in the same industry on a weekly basis. The expected option term represents the period that the Company’s options are expected to be outstanding and is determined based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company’s historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable plans to pay cash dividends in the future. The Company expensed compensation costs net of estimated forfeitures over the requisite service period by applying the straight-line method.

 

Up and until the completion of the U.S. IPO, the fair value of Ordinary Shares underlying the options was determined by the Company’s management with the assistance of an independent valuation firm. Because in such periods there has been no public market for the Ordinary Shares, the Company’s management has determined fair value of the Ordinary Shares at the time of grant by considering several objective and subjective factors including data from other comparable companies, sales of Convertible Preferred Shares to unrelated third parties, operating and financial performance, the lack of liquidity of share capital and general and industry specific economic outlook, amongst other factors. From the period commencing on June 30, 2021 through March 2, 2023 (the closing date of the U.S. IPO), the valuations were performed by using Hybrid Method by combining the OPM and an initial public offering scenario.

 

Since January 1, 2019, share-based payments to non-employees are accounted in accordance with ASC 718.

 

When applicable, a modification to the terms and/or conditions of an award (i.e. a change of award’s fair value, vesting conditions or classification as an equity or a liability instrument) is accounted for as an exchange of the original award for a new award resulting in total compensation cost equal to the grant-date fair value of the original award, plus the incremental value of the modification to the award. The calculation of the incremental value is based on the excess of the fair value of the modified award following the modification over the fair value of the original award measured immediately before its terms were modified.

 

V.Accounting Pronouncements Adopted During the Current Year

 

Segment Reporting Disclosures

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which requires that all public entities, including public entities with a single reportable segment, to provide in interim and annual periods one or more measures of segment profit or loss used by the Chief Operating Decision Maker (“CODM”) to allocate resources and assess performance. Additionally, ASU 2023-07 requires disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures.

 

The Company adopted ASU 2023-07 beginning with the consolidated financial statements for the fiscal year ended December 31, 2024 and thereafter, and have applied this standard retrospectively for all prior periods presented in the consolidated financial statements. See also Note 15 for further information related to segment reporting.

 

W.Recently issued accounting pronouncements, not yet adopted

 

1.In December 2023, the FASB issued ASU 2023-09 on Improvements to Income Tax Disclosures that require greater disaggregation of income tax disclosures to the income rate tax rate reconciliation and income taxes paid. The updates are effective for annual periods beginning after December 15, 2024. The Company intends to adopt and apply the guidance in fiscal year 2025. The Company is still assessing the impact of the disclosure of this standard.

 

2.In November 2024, the FASB issued ASU 2024-03 on Disaggregation of Income Statement Expenses that enhances disclosure of certain costs and expenses to provide enhanced transparency into the expenses presented in the income statement. The updates are effective for annual periods beginning after December 15, 2026. The Company intends to adopt and apply the guidance in fiscal year 2027. The Company is still assessing the impact of the disclosure of this standard.

 

F-16

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 3 - CASH

 

  

As of

December 31,

 
   2024   2023 
         
 Denominated in U.S. dollar (*)  $16,260   $5,792 
 Denominated in New Israel Shekel   65    150 
 Denominated in other currencies   158    174 
   $16,483   $6,116 

 

(*)As of December 31, 2024, including short-term bank deposits for a period less than 3 months at an average interest rate of 5.14%.

 

NOTE 4 - OTHER CURRENT ASSETS

 

  

As of

December 31,

 
   2024   2023 
         
 Prepaid expenses  $88   $76 
 Government authorities   24    40 
 Others   83    16 
   $195   $132 

 

NOTE 5 - INTANGIBLE ASSETS, NET AND GOODWILL

 

  

As of

December 31,

 
   2024   2023 
Carrying amount:          
Trade names  $201   $201 
Internal-use software   600    233 
   $801   $434 
Accumulated amortization:          
Trade names  $174   $154 
Internal-use software   138    
-
 
   $312   $154 
           
Intangible assets, net  $489   $280 

 

During the years ended December 31, 2024, 2023 and 2022, amortization expenses were $158, $20 and $20, respectively.

 

As of December 31, 2024, the estimated future amortization expense of intangible assets is as follows:

 

2025  $220 
2026   207 
2027   62 
   $489 

 

As of the reported periods, an annual impairment analysis was performed internally by the Company’s management by comparing the fair value market of the Company, which its operation represents a single reporting unit, to the carrying amount of the net assets allocated to the reporting unit (including the entire balance of goodwill).

 

F-17

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 6 - LOAN, NET

 

On July 7, 2022 (the “Effective Date”), the Company entered into a definitive agreement with IBI Spikes Ltd. ( “IBI”), according to which the Company received an amount of NIS 3.1 million (approximately $900) (the “IBI Loan”). The Company granted IBI a right to receive consecutive monthly repayments equal to Net Cash Receipts multiplied by the Royalty Rate, as both defined in the definitive agreement, until such time as IBI receives an amount equal to NIS 4,172,760 (approximately $1.2 million) (the “Repayment Amount”) with any amount on account of the Repayment Amount which remains outstanding on the 42nd month anniversary of the later of (i) the Closing Date, and (ii) the last payment provided by IBI (the “Final Repayment Date”) to be paid to IBI at such time. Notwithstanding the above, the Company’s minimum annual payment (i.e. principal and interest) during any Annual Calculation Period will not be less than the lower of (i) $330 and (ii) outstanding Repayment Amount in recent year.

 

The Company may repay the Repayment Amount at any time prior to the Final Repayment Date. If early repayment (such amount, the “Payment Amount”) occurs prior to 12-month anniversary date of the Effective Date, then, a 50% discount will be applied on the outstanding difference between the Repayment Amount and the Payment Amount (the “Rev-Share Amount”) component of the outstanding Repayment Amount; or if early repayment occurs after 12-month anniversary date of the Closing Date but before 18-month anniversary date of the Closing Date, then, a 35% discount will be applied on the outstanding Rev-Share Amount of the outstanding Repayment Amount (the “Early Repayment Amount”).

 

In case the Company and/or its subsidiaries consummated a change of control, merger transaction, an initial public offering transaction (excluding the U.S. IPO) (an “IPO”) or sale of all or substantially all of assets (the “Exit Event”), the Company shall fully pay IBI the Repayment Amount or the Early Repayment Amount, as the case may be.

 

The Company incurred a non-refundable one-time fee of $13, reflecting 1.5% of the Payment Amount plus VAT.

 

Upon making of the Payment Amount, the Company issued warrant to IBI to purchase 65,563 of (i) the most senior class of shares outstanding or (ii) Ordinary Shares in case of an exercise following to completion of an IPO transaction (the “Warrant Share”). Each Warrant Share was exercisable until the earlier of (a) a merger transaction, (b) an IPO, or (c) a 10-years period from issuance date. The determination of the exercise price for each of the Warrant Share may be variable subject to occurrence of certain trigger events as defined in the definitive agreement. Consequently, the Warrant Share was accounted for as a derivative financial liability. See also Note 8 below.

 

For information regarding the determination of the exercise price and full exercise of the Warrant Share on a cashless basis, see also Note 8 and Note 10D2 below.

 

The following tabular presentation reflects the reconciliation of the carrying amount of the IBI Loan during the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
             
Opening balance  $500   $717   $
-
 
Net consideration allocated to IBI Loan   
-
    
-
    887 
Recognition of fair value of derivative warrant liability   
-
    
-
    (88)
Amortization of discount relating to straight loan   31    31    12 
Repayment of principal relating to straight loan   (292)   (236)   (82)
Exchange rate differences   11    (12)   (12)
Closing balance  $250   $500   $717 

 

Maturity dates of outstanding loans:

 

  

As of

December 31,

 
   2024   2023 
         
First year (current maturities)  $250   $330 
Second year   
-
    170 
Closing balance  $250   $500 

 

F-18

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 7 - OTHER CURRENT LIABILITIES

 

  

As of

December 31,

 
   2024   2023 
         
Employees and payroll accruals  $465   $279 
Accrued expenses (*)  $212   $179 
   $677   $458 

 

(*)Including interest accrued on IBI Loan amounted to $4 and $7 as of December 31, 2024 and 2023, respectively. See also Note 12 below.

 

NOTE 8 - DERIVATIVE WARRANTS LIABILITIES

 

On April 29, 2021, the Company entered into a second deferral agreement in connection with a straight loan made under a loan and security agreement that the Company previously entered into with Silicon Valley Bank (“SVB”) in February 2017, under which it was agreed, inter alia, to issue to SVB a warrants to purchase 9,764 shares (the “2021 Warrant”) at an exercise price of $5.12 per share (subject to standard adjustments), which is exercisable over a period of 15-years at SVB’s discretion. If SVB exercises the 2021 Warrant and the Warrant Value (as defined in the 2021 Warrant) is lower than an amount equal to $50 (the “Minimum Value”), then immediately following such exercise, the Company shall pay SVB an amount in cash equal to the difference between the Minimum Value and Warrant Value. The 2021 Warrant was issued on April 29, 2021.

 

Until the completion of the U.S. IPO transaction, the fair values of the above 2021 Warrant and the Warrant Share (as noted in Note 6 above) were determined by the management with the assistance of an independent valuation firm by using the Hybrid Method by combining the OPM and an IPO scenario. Because there has been no public market for the Ordinary Shares, the management has determined the fair value of the Ordinary Shares by considering several objective and subjective factors including data from other comparable companies, the lack of liquidity of share capital and general and industry specific economic outlook, amongst other factors. The fair value of the underlying Ordinary Shares was determined by management until such time as the Ordinary Shares are listed on an established stock exchange, national market system or other quotation system. Upon completion of the U.S. IPO, the fair values of the 2021 Warrant and the Warrant Share were determined internally by the management based on several assumptions by using Black-Scholes-Merton pricing model. Through the reported periods, the estimated fair value of derivative financial liability for the 2021 Warrant has not exceeded the Minimum Value and thus was determined at $50. In addition, from the issuance date of the 2021 Warrant through December 31, 2024, the 2021 Warrant was not exercised.

 

At the issuance date of the 2021 Warrant, the fair value of derivative financial liability for the Warrant Share was estimated in total amount $88 which has not changed significantly through December 31, 2022. However, as of December 31, 2023, the fair value of derivative financial liability for the Warrant Share was estimated by the management in total amount of $22 by taking into consideration (i) the likelihood for occurrence of certain trigger events as defined in the definitive agreement and (ii) the reduction in the quoted price of the Ordinary Share. Thus, during the year ended December 31, 2023, the Company recorded revaluation income amounted to $66 (see also Note 12 below).

 

On February 22, 2024, the Company received a written notice from IBI pursuant to which the exercise price of the Warrant Share granted to IBI to purchase 65,563 Ordinary Shares was determined at a fixed amount of $3.67 per Ordinary Share. Consequently, the Warrant Share was re-classified from derivative warrants liability to equity at its fair value as of that date in total amount of $599. During the year ended December 31, 2024, the Company recorded revaluation expenses of $577 due to a change in the fair value of the derivative warrants liability. In addition, through December 31, 2024, the Warrant Share was fully exercised on a cashless basis.

 

The following tabular presentation reflects the reconciliation of the fair value of derivative warrants liabilities during the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
             
Opening balance  $72   $138   $50 
Recognition of fair value of Warrant Share issued at Effective Date   
-
    
-
    88 
Amount classified to equity upon determination of the exercise price of Warrant Share (see Note 10D2 below)   (599)   
-
    
-
 
Change in fair value of derivative warrant liability (see Note 12 below)   577    (66)   
-
 
Closing balance  $50   $72   $138 

 

F-19

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 9 - COMMITMENTS

 

Lease commitments

 

A.During the reported periods, the Company entered into several short-term agreements (of 12 months or less) for the renewal of leasing of premises with unrelated party, the last of which was signed in November 2024 for a period commencing November 1, 2024 through April 30, 2025 for a monthly fee of NIS 62 thousand (approximately $17).

 

B.During the reported periods, Beamr Imaging RU entered into several short-term agreements for renewal of a leasing of premises with unrelated party, the last of which was signed in July 2024 for the period commencing July 1, 2024 through May 31, 2025 for a monthly fee of Russian Ruble 227 (approximately $2).

 

As of December 31, 2024, the future minimum commitment under binding operating lease agreements is as follows:

 

   Lease of premises 
     
2025  $80 
   $80 

 

The lease payments under the binding agreement are associated with short-term operating leases of premises with a lease term of twelve months or less. As the Company elected the short-term recognition exemption (see also Note 2I), such leases are out of scope of ASC 842 “Leases”. Consequently, these payments are recognized on a straight-line basis as an operating expense in the Consolidated Statements of Operations and Comprehensive Loss.

 

During the years ended December 31, 2024, 2023 and 2022, lease expenses were $170, $119 and $119, respectively.

 

NOTE 10 - SHAREHOLDERS’ EQUITY

 

A.Composition of shareholders’ equity:

 

  

As of

December 31, 2024

  

As of

December 31, 2023

 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
   Number of shares 
                     
Ordinary Shares of NIS 0.05 par value   222,000,000    15,518,794    222,000,000    13,051,343 

 

The Ordinary Shares confer upon the holders thereof all rights accruing to a shareholder of the Company, as provided in the Company’s Amended and Restated Articles of Association (the “Articles”), including, without limitation, the right to receive notices of, and to attend, all general meetings, the right to vote thereat with each Ordinary Share held entitling the holder thereof to one vote at all general meetings (and written actions in lieu of meetings), the right to participate and share on a per share basis in any distribution and in distribution of surplus assets and funds of the Company in the event of a liquidation event, and certain other rights as may be expressly provided for in the Articles or under the Israeli Companies Law 5759-2999. All Ordinary Shares rank pari passu amongst themselves for all intents and purposes, including, without limitation, in relation to the amounts of capital paid or credited as paid on their nominal value.

 

F-20

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 10 - SHAREHOLDERS’ EQUITY (Cont.)

 

B.Completion of underwritten U.S. public offering

 

On February 27, 2023, the Company announced the pricing of its U.S. IPO of 1,950,000 Ordinary Shares at a public offering price of $4.00 per share, for aggregate gross proceeds of $7,800, prior to deducting underwriting discounts and other offering expenses. In addition, the Company granted to the underwriters (i) warrants to purchase up to 97,500 Ordinary Shares at an exercise price of $5.00 per Ordinary Share over a period of 5-years commencing August 26, 2023 (see also Note 10D1 below) and (ii) a 45-day option to purchase up to an additional 292,500 Ordinary Shares at the public offering price, which expired in April 2023 without being exercises. The Ordinary Shares began trading on the Nasdaq Capital Market under the ticker symbol “BMR” on February 28, 2023. The IPO closed on March 2, 2023.

 

Direct and incremental costs incurred related to the U.S. IPO amounted to $1,418 (including capitalized deferred offering costs amounted to $313).

 

In connection with the U.S. IPO, the following occurred -

 

1.The holders of all shares with preferences over Ordinary Shares (i.e. Convertible Preferred Shares and Convertible Ordinary 1 and 2 Shares) voluntary effected a conversion of all such shares into 7,211,280 Ordinary Shares.

 

2.The Company’s authorized share capital increased from 22,000,000 to 222,000,000.

 

3.A reverse share split of all outstanding Ordinary Shares of the Company was effected at a ratio of 5:1 so that each 5 ordinary shares, nominal value NIS 0.01 per share, was consolidated into 1 Ordinary Share, nominal value NIS 0.05 per share, (the “Reverse Share Split”).

 

4.Automatic conversion of all outstanding Convertible Advance Investment amounts in the nominal value of $3,657 to 1,142,856 Ordinary Shares at a conversion price of $3.2 which equals 80% of the public offering price in the U.S. IPO. As a result, in 2023, the Company recorded income amounting to $269 as result of changes in the fair value of the convertible advance investment (see Note 12 below).

 

5.A down-round protection feature of certain warrants granted in previous years to commercial bank (SVB) was triggered by way of reduction of their exercise price from $5.12 to a price of $4.00, which represented the public offering price in the U.S. IPO. Such reduction was accounted for as deemed dividend estimated of $7 thousand, which was recorded as part of the additional paid-in capital versus increase of accumulated deficit. Regarding the effect of the loss per share, see also Note 2T above.

 

C.Completion of underwritten U.S. public offering

 

On February 15, 2024, the Company completed an additional underwritten U.S. public offering pursuant to which the Company received aggregate gross proceeds of $12,000, before deducting underwriting discounts and offering expenses, for issuance of 1,714,200 Ordinary Shares at a public offering price of $7.00 per share. In addition, the Company granted the underwriter (i) a 45-day option to purchase up to an additional 257,100 Ordinary Shares to cover over-allotments at the public offering price to cover over-allotments and (ii) a warrant for the purchase of up to 98,565 Ordinary Shares, at an exercise price of $8.75 per Ordinary Share over a period of 5-years commencing August 10, 2024.

 

On February 13, 2024, the over-allotment option was fully exercised by the underwriter for additional aggregate gross proceeds of approximately $1,800, before deducting underwriting discounts.

 

Direct and incremental costs incurred related to the offering amounted to $1,514.

 

The offering closed on February 15, 2024.

 

D.Cashless exercise of warrants

 

1.During the year ended December 31, 2024, the Company issued 63,931 Ordinary Shares upon partial cashless exercises of warrants granted to the underwriter in the U.S. IPO (see also Note 10B above).

 

2.During the year ended December 31, 2024, the Company issued 31,189 Ordinary Shares to IBI upon cashless exercise of Warrant Shares (see also Note 8 above).

 

F-21

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 11 - OPTIONS

 

Option plan:

 

On January 11, 2015, the Company’s Board of Directors approved and adopted the 2015 Share Incentive Plan (the “Plan”), pursuant to which the Company’s Board of Directors may award options to purchase the Company’s Ordinary Shares as well as restricted shares, RSUs and other share-based awards to designated participants. Subject to the terms and conditions of the Plan, the Company’s Board of Directors has full authority in its discretion, from time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the respective award agreements, including, but not limited to, the number of options to be granted to each optionee, the number of shares to be covered by each option, provisions concerning the time and the extent to which the options may be exercised and the nature and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election as to the type of approved 102 Option under Israeli tax law; (v) designate the type of options; (vi) take any measures, and to take actions, as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions of the Plan and to amend from time to time the terms of the Plan.

 

On May 22, 2024, the Company’s Board of Directors approved to increase the number of Ordinary Shares, reserved out of the Company’s registered share capital, to be issued under the Plan by additional 1,000,000 Ordinary Shares.

 

The Plan permits the grant of up to 3,069,280 share Ordinary Shares subject to adjustments set in the Plan. As of December 31, 2024, considering the effect of previously exercised options, there were 1,012,006 Ordinary Shares available for future issuance under the Plan.

 

The following table presents the Company’s option activity for employees and members of the Board of Directors of the Company under the Plan for the years ended December 31, 2024, 2023 and 2022:

 

   Number of
Options
  

Weighted
Average
Exercise
Price

   Weighted
average
remaining
contractual
life
   Intrinsic
value
 
       $   (years)   $ 
                 
Outstanding as of December 31, 2021   1,367,168    1.75    5.72    4,860 
Granted   286,875    1.83    -    - 
Forfeited or expired   (83,052)   1.45    -    - 
Outstanding as of December 31, 2022   1,570,991    1.78    4.97    2,435 
Exercisable as of December 31, 2022   1,048,297    1.70    3.2    1,677 

 

   Number of
Options
  

Weighted
Average
Exercise
Price

   Weighted
average
remaining
contractual
life
   Intrinsic
value
 
       $   (years)   $ 
                 
Outstanding as of December 31, 2022   1,570,991    1.78    4.97    2,435 
Granted   151,600    2.88    -    - 
Exercised   (168,447)   0.29    -    - 
Forfeited or expired   (258,777)   1.81    -    - 
Outstanding as of December 31, 2023   1,295,367    2.09    6.04    84 
Exercisable as of December 31, 2023   863,616    2.07    4.70    84 

 

 

F-22

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 11 - OPTIONS (Cont.)

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
average
remaining
contractual
life
   Intrinsic
value
 
       $   (years)   $ 
                 
Outstanding as of December 31, 2023   1,295,367    2.09    6.04    84 
Granted   462,200    4.51    -    - 
Exercised   (401,031)   1.98    -    - 
Forfeited or expired   (11,500)   2.65    -    - 
Outstanding as of December 31, 2024   1,345,036    2.95    7.17    2,677 
Exercisable as of December 31, 2024   641,851    2.15    5.12    1,786 

 

The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the deemed fair value of the Company’s Ordinary Shares on the last day of each of the applicable reported period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all options holders exercised their options on December 31 of each of the reported period. This amount is impacted by the changes in the fair market value of the Company’s Ordinary Share.

 

The outstanding and exercisable options as of December 31, 2024 were separated into range of exercise prices, as follows:

 

Exercise price  Options
outstanding
as of
December 31,
2024
   Weighted
average
remaining
contractual
term
   Options
exercisable
as of
December 31,
2024
   Weighted
average
remaining
contractual
term
 
       (years)       (years) 
                 
-   17,680    2.20    17,680    2.20 
1.14   82,580    2.04    82,580    2.04 
1.47   7,200    9.09    
-
    
-
 
1.48   50,000    8.70    15,625    8.70 
1.74   12,800    8.30    4,800    8.30 
1.83   565,974    6.53    401,950    6.04 
2.79   6,400    8.59    2,000    8.59 
2.97   69,600    9.87    
-
    
-
 
3.20   5,002    6.64    4,064    6.64 
3.59   28,800    9.74    
-
    
-
 
4.00   76,000    8.17    44,352    8.17 
4.17   28,800    1.03    28,800    1.03 
4.96   315,200    9.56    
-
    
-
 
5.02   39,000    9.49    
-
    
-
 
5.12   40,000    1.04    40,000    1.04 
    1,345,036         641,851      

 

The weighted average grant date fair value of options granted during the years ended December 31, 2024, 2023 and 2022 was $2.78, $1.66 and $0.51 per option, respectively.

 

During the years ended December 31, 2024 and 2023, 401,031 and 168,447 options were exercised for total amount of $795 and $49, respectively. During the year ended December 31, 2022, options have not been exercised.

 

F-23

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 11 - OPTIONS (Cont.)

 

The following table presents the assumptions used to estimate the fair values of the options granted in the reported periods:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Volatility (%)   52.71%-73.53%    60.48%-61.49%    61.49%
Risk-free interest rate (%)   3.6%-4.4%    3.7%-4.3%    3.64%-3.85% 
Dividend yield (%)   
-
    
-
    
-
 
Expected life (years)   6.25    6.25    6.25 
Exercise price ($)   1.47-5.02    1.48-4.00    1.83 
Share price ($)   1.72-5.24    1.48-3.73    3.30 

 

As of December 31, 2024, there was $1,633 of unrecognized compensation expenses related to unvested options, that are expected to be recognized on a straight-line basis over the requisite service period, which results in weighted average period of approximately 1.54 years.

 

The total compensation cost related to all of the Company’s equity-based awards recognized during the years ended December 31, 2024, 2023 and 2022 was comprised as follows:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Research and development  $185   $216   $144 
Sales and marketing   20    41    49 
General and administrative   213    106    29 
   $418   $363   $222 

 

NOTE 12 - FINANCING EXPENSES (INCOME), NET

 

  

Year ended December 31

 
   2024   2023   2022 
             
Change in fair value of convertible advance investment  $
-
   $(269)  $70 
Change in fair value of derivative warrant liability   577    (66)   
-
 
Amortization of discount and accrued interest relating to straight loan received from commercial banks   106    157    102 
Change in estimation of maturity date of liability to controlling shareholder   
-
    12    
-
 
Discount amortization relating to liability to controlling shareholder   10    48    40 
Interest due to bank deposits   (599)   (97)   
-
 
Exchange rate differences and other finance expenses   (2)   (7)   (47)
   $92   $(222)  $165 

 

F-24

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 13 - RELATED PARTIES TRANSACTIONS

 

The liability to controlling shareholder derives from a service agreement with the Company’s Founder under which the Company receives consulting services on recurring basis from the Founder as Chief Executive Officer indirectly through an entity controlled by the Founder (the “Service Provider”) for total current monthly gross amount of NIS 45 thousand. On March 14, 2022, the Company’s shareholders approved, among other matters, to renew the service agreement with the Founder for a period ending December 31, 2025.

 

On February 16, 2022, the Company entered into an addendum to the aforesaid service agreement with the Service Provider under which it was agreed that (i) the term of the service agreement with the Service Provider was extended to December 31, 2025 and (ii) the then current liability towards the Service Provider as was accrued for services rendered under the service agreement over a period commencing January 1, 2020 through the date hereof in total nominal amount of $357 (the “Current Liability”) will be paid in 18 equal installments (without an interest) starting on March 1, 2022 (the “Commencement Date”). However, in the event that the Company shall not have available sufficient funds in any such payment date from and after the Commencement Date to repay the installments of the Current Liability and/or the on-going fee owed to the Service Provider or in the event that the Company determines that according to the following 12-months period budget that it shall not have available sufficient funds to pay such installments and/or the on-going fee, then the Service Provider hereby agrees to postpone such payments owed to it until the Company will have such sufficient funds. Any unpaid on-going fee payments will be added to the Current Liability.

 

Since the liability towards the Founder was considered as a free interest loan which did not represent the applicable rate of risk for the Company, the addendum was accounted for as a capital contribution from a controlling shareholder. Thus, such liability was measured at fair value based on future cash payments discounted using an interest rate of 15.45% which represented the applicable rate of risk for the Company, as determined by management using the assistance of third-party appraiser. As a result, the Company recorded a discount on the balance of liability towards the Founder in total amount of $112 against additional paid-in capital (including in respect to amounts due for services period through fiscal year for 2022). Discount expenses are recorded over the economic life of the loan based on an effective interest rate method.

 

As of December 31, 2022, management has updated the repayments schedule of the obligation based on its current projection of the availability of funds. Accordingly, the obligation was expected to be repaid over the following 24-months period. However, upon completion of the U.S. IPO (see also Note 10B above), the Commencement Date was determined to be the pricing date of the U.S. IPO (February 27, 2023) under which the liability in nominal amount of NIS 1,710 thousand (approximately $462) will be paid in 18 equal monthly installments.

 

On May 22, 2024, the Company’s Compensation Committee approved adjustments of the compensation terms and of the Founder for his duties as Chief Executive Officer of the Company, following which his salary shall be increased by NIS 20 thousand, subject the approval of the Company’s shareholders at a general meeting of the shareholders, which was approved on August 5, 2024

 

F-25

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 13 - RELATED PARTIES TRANSACTIONS (Cont.)

 

The following tabular presentation reflects the reconciliation of the carrying amount of the Company’s Liability to controlling shareholder, net during the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
             
Opening balance  $199   $388   $345 
Accrued liability in respect to additional services rendered        25    115 
Recognition of capital contribution from a controlling shareholder        
 
    (112)
Repayment of liability to controlling shareholder   (206)   (258)   
-
 
Amortization of discount relating to liability to controlling shareholder   10    48    40 
Change in estimation of maturity date of liability   
-
    12    
-
 
Exchange rate differences   (3)   (16)   
-
 
Closing balance  $
-
   $199   $388 

 

The Company allocated the expenses related to the above service agreement and addendum as follows:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Research and development  $53   $36   $42 
Sales and marketing   53    36    42 
General and administrative   106    74    83 
   $212   $146   $167 


The allocation of expenses was done based on the management estimation to reflect the contribution to the related activity.

 

NOTE 14 - TAXES ON INCOME

 

A.Israeli taxation:

 

Taxable income of the Company is subject to the Israeli corporate tax at the rate of 23%.

 

As of December 31, 2024, the Company has net operating losses and capital losses carryforward for Israeli income tax purposes of approximately $30,914 and $397 respectively, which can be offset against future taxable income for an indefinite period of time.

 

The Company has final (considered final) tax assessments through the 2019 tax year.

 

B.Foreign entities:

 

1.Beamr Inc. is taxed under United States federal and state tax rules. Income tax is calculated based on a U.S. federal tax rate of 21%.

 

Beamr Inc. have not received final tax assessments for the tax years ended December 31, 2021 through 2024.

 

2.Beamr Imaging RU was taxed in 2024 and during prior periods under the Russian tax code at the rate of 0% (Clause 1.15 of Article 284 of the Tax Code of the Russian Federation, with changes provided by Federal Law No.321-FZ of 14.07.2022).

 

In 2025, Beamr Imaging RU will be taxed at a rate of 5% (Clause 1.15 of Article 284 of the Tax Code of the Russian Federation, ed. Federal Law No. 176-FZ dated 12.07.2024).

 

Beamr Imaging RU have not received final tax assessments for the tax years ended December 31, 2022 through 2024.

 

C.Taxes on income are primarily comprised from taxes incurred as result of (i) withholding tax deducted at source in accordance with U.S. - Israel tax treaty related to selling of software, (ii) implementation of the intercompany agreement between the Company and Beamr Inc. for conducting reseller services and implementation of the intercompany agreement between the Company and Beamr Imaging RU for conducting research and development services on behalf of the Company (see also Note 1B) and (iii) tax assets write off.

 

F-26

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 14 - TAXES ON INCOME (Cont.)

 

D.Loss (income) before taxes on income consists of the following:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Domestic  $3,345   $714   $1,293 
Foreign operations (Beamr Inc. and Beamr Imaging RU)   (38)   (58)   (97)
   $3,307   $656   $1,196 

 

E.Deferred income taxes reflect the net tax effects of net operating loss and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of the Company’s deferred tax assets are as follows:

 

  

As of

December 31

 
  2024   2023 
Composition of deferred tax assets:        
Net operating loss and capital losses carryforward  $7,202   $6,704 
Research and development credits   537    397 
Vacation accrual   44    44 
Net deferred tax asset before valuation allowance   7,783    7,145 
           
Valuation allowance   (7,783)   (7,145)
Net deferred tax assets  $
-
   $
-
 

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences are deductible and net operating losses are utilized. Based on consideration of these factors, the Company recorded a full valuation allowance as of December 31, 2024 and 2023.

 

F.During the years ended December 31, 2024, 2023 and 2022, the main reconciling item between the statutory tax rate of the Company (as noted in Note 14A) and the effective tax rate at the rate of 1.4%, 5.9% and 4.4%, respectively, is mainly the recognition of valuation allowance in respect of deferred taxes relating to accumulated net operating losses carried forward and other permanent and temporary differences due to the uncertainty of the realization of such deferred taxes and withholding taxes that were deducted by the Company’s customers.

 

NOTE 15 - SEGMENT GEOGRAPHICAL INFORMATION AND MAJOR CUSTOMERS

 

A.General information

 

Since inception date, the operation of the Company is conducted through one operating segment, the optimization technology for video and photo compression, which represents a single reporting unit. This activity also represents the reportable segment of the Group.

 

The Company manages its business activities on a consolidated basis and operates in one reportable segment, video technology and image science software solutions. The accounting policies of this segment are the same as those described in Note 2V above.

 

The Company’s executive management is the CODM, which uses the net loss, as reported in the Consolidated Statements of Operations and Comprehensive Loss, in evaluating the performance of the Company and determining how to allocate resources of the Company as a whole, including investing in product development.

 

F-27

 

 

BEAMR IMAGING LTD.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands except share and per share amounts)

 

NOTE 15 - SEGMENT GEOGRAPHICAL INFORMATION AND MAJOR CUSTOMERS (Cont.)

 

B.Revenue by geographic region is as follows:

 

  

Year ended December 31

 
   2024   2023   2022 
             
United States  $2,132   $2,089   $2,134 
Israel   41    66    22 
Rest of the world   891    754    707 
   $3,064   $2,909   $2,863 

 

Revenue was attributed to countries based on customer location.

 

C.Long-lived assets, net, by geographic areas:

 

  

As of

December 31,

 
   2024   2023 
         
Israel  $40   $14 
Other   3    5 
   $43   $19 

 

Such balance is comprised of property and equipment that are attributed to the geographic area in which they are located or originated, as applicable.

 

D.Major customers

 

During the years ended December 31, 2024, 2023 and 2022, the Company had one customer which accounted for 27% 26% and 26% of the Company’s total revenue, respectively. In addition, the Company had three and four customers, which accounted for in aggregate 62% and 81% of the Company’s total trade receivables as of December 31, 2024 and 2023, respectively.

 

E.Major product lines and services and timing of revenue recognition

 

In the following table, revenue is disaggregated by primary major product lines and services, and timing of revenue recognition for the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
Software license:               
Perpetual based software license - transferred at a point of time  $802   $886   $1,068 
Term-based software license - transferred at a point of time   1,995    1,844    1,630 
Total software license (*)  $2,797   $2,730   $2,698 
PCS services transferred over a period of time   128    120    123 
Web advertising at a point of time upon clicks   139    59    42 
   $3,064   $2,909   $2,863 

 

(*)Revenue recognized from sales-based software license was $46, $53 and $48 during the years ended December 31, 2024, 2023 and 2022, respectively (see also Note 2M).

 

NOTE 16 - SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

 

 

F-28

 

U.S. GAAP http://fasb.org/us-gaap/2024#DerivativeLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#DerivativeLiabilitiesNoncurrent 0001899005 false FY 0001899005 2024-01-01 2024-12-31 0001899005 dei:BusinessContactMember 2024-01-01 2024-12-31 0001899005 2024-12-31 0001899005 2023-12-31 0001899005 2023-01-01 2023-12-31 0001899005 2022-01-01 2022-12-31 0001899005 us-gaap:CommonStockMember 2021-12-31 0001899005 bmr:ConvertibleOrdinary1And2SharesMember 2021-12-31 0001899005 bmr:ConvertiblePreferredSharesMember 2021-12-31 0001899005 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001899005 us-gaap:RetainedEarningsMember 2021-12-31 0001899005 2021-12-31 0001899005 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001899005 bmr:ConvertibleOrdinary1And2SharesMember 2022-01-01 2022-12-31 0001899005 bmr:ConvertiblePreferredSharesMember 2022-01-01 2022-12-31 0001899005 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001899005 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001899005 us-gaap:CommonStockMember 2022-12-31 0001899005 bmr:ConvertibleOrdinary1And2SharesMember 2022-12-31 0001899005 bmr:ConvertiblePreferredSharesMember 2022-12-31 0001899005 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001899005 us-gaap:RetainedEarningsMember 2022-12-31 0001899005 2022-12-31 0001899005 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001899005 bmr:ConvertibleOrdinary1And2SharesMember 2023-01-01 2023-12-31 0001899005 bmr:ConvertiblePreferredSharesMember 2023-01-01 2023-12-31 0001899005 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001899005 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001899005 us-gaap:CommonStockMember 2023-12-31 0001899005 bmr:ConvertibleOrdinary1And2SharesMember 2023-12-31 0001899005 bmr:ConvertiblePreferredSharesMember 2023-12-31 0001899005 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001899005 us-gaap:RetainedEarningsMember 2023-12-31 0001899005 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001899005 bmr:ConvertibleOrdinary1And2SharesMember 2024-01-01 2024-12-31 0001899005 bmr:ConvertiblePreferredSharesMember 2024-01-01 2024-12-31 0001899005 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001899005 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001899005 us-gaap:CommonStockMember 2024-12-31 0001899005 bmr:ConvertibleOrdinary1And2SharesMember 2024-12-31 0001899005 bmr:ConvertiblePreferredSharesMember 2024-12-31 0001899005 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001899005 us-gaap:RetainedEarningsMember 2024-12-31 0001899005 2024-10-01 2024-12-31 0001899005 us-gaap:TradeNamesMember 2024-01-01 2024-12-31 0001899005 bmr:InternalUseSoftwareMember 2024-01-01 2024-12-31 0001899005 us-gaap:ComputerEquipmentMember 2024-12-31 0001899005 srt:MinimumMember us-gaap:OfficeEquipmentMember 2024-12-31 0001899005 srt:MaximumMember us-gaap:OfficeEquipmentMember 2024-12-31 0001899005 currency:USD 2024-12-31 0001899005 currency:USD 2023-12-31 0001899005 currency:ILS 2024-12-31 0001899005 currency:ILS 2023-12-31 0001899005 srt:OtherCurrencyMember 2024-12-31 0001899005 srt:OtherCurrencyMember 2023-12-31 0001899005 us-gaap:TradeNamesMember 2024-12-31 0001899005 us-gaap:TradeNamesMember 2023-12-31 0001899005 us-gaap:ComputerSoftwareIntangibleAssetMember 2024-12-31 0001899005 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-12-31 0001899005 bmr:IBISpikesLtdMember 2022-07-01 2022-07-07 0001899005 bmr:IBISpikesLtdMember 2024-01-01 2024-12-31 0001899005 bmr:IBISpikesLtdMember 2024-12-31 0001899005 bmr:TwoThousandTwentyOneWarrantMember 2021-04-29 0001899005 bmr:TwoThousandTwentyOneWarrantMember 2024-12-31 0001899005 bmr:TwoThousandTwentyOneWarrantMember 2022-12-31 0001899005 bmr:TwoThousandTwentyOneWarrantMember 2023-12-31 0001899005 us-gaap:WarrantMember 2024-02-22 2024-02-22 0001899005 us-gaap:WarrantMember 2024-02-22 0001899005 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001899005 srt:ScenarioForecastMember 2024-11-01 2025-04-30 0001899005 srt:ScenarioForecastMember 2024-07-01 2025-05-31 0001899005 us-gaap:IPOMember 2023-02-27 2023-02-27 0001899005 us-gaap:IPOMember 2023-02-27 0001899005 us-gaap:WarrantMember 2023-02-27 2023-02-27 0001899005 us-gaap:WarrantMember 2023-02-27 0001899005 us-gaap:IPOMember 2024-01-01 2024-12-31 0001899005 us-gaap:ConvertiblePreferredStockMember 2024-01-01 2024-12-31 0001899005 us-gaap:ConvertibleCommonStockMember 2024-01-01 2024-12-31 0001899005 srt:MinimumMember 2024-12-31 0001899005 srt:MaximumMember 2024-12-31 0001899005 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001899005 us-gaap:CommonStockMember 2024-12-31 0001899005 bmr:ReverseShareSplitMember 2024-01-01 2024-12-31 0001899005 bmr:ReverseShareSplitMember 2024-12-31 0001899005 srt:MinimumMember us-gaap:IPOMember 2024-12-31 0001899005 srt:MaximumMember us-gaap:IPOMember 2024-12-31 0001899005 us-gaap:IPOMember 2024-02-15 2024-02-15 0001899005 us-gaap:IPOMember 2024-02-15 0001899005 us-gaap:OverAllotmentOptionMember 2024-02-15 2024-02-15 0001899005 us-gaap:WarrantMember 2024-02-15 2024-02-15 0001899005 us-gaap:WarrantMember 2024-02-15 0001899005 us-gaap:OverAllotmentOptionMember 2024-02-13 2024-02-13 0001899005 2024-02-13 2024-02-13 0001899005 bmr:IBIMember 2024-01-01 2024-12-31 0001899005 us-gaap:CommonStockMember 2024-05-22 2024-05-22 0001899005 srt:BoardOfDirectorsChairmanMember 2021-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2021-12-31 2021-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2022-01-01 2022-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2022-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2023-01-01 2023-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2023-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2024-01-01 2024-12-31 0001899005 srt:BoardOfDirectorsChairmanMember 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice0000Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice0000Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice0000Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice0000Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice114Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice114Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice114Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice114Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice114Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice147Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice147Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice147Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice147Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice147Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice148Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice148Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice148Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice148Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice148Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice174Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice174Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice174Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice174Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice174Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice183Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice183Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice183Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice183Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice183Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice279Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice279Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice279Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice279Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice279Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice297Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice297Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice297Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice297Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice297Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice320Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice320Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice320Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice320Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice320Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice359Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice359Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice359Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice359Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice359Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice400Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice400Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice400Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice400Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice400Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice417Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice417Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice417Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice417Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice417Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice496Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice496Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice496Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice496Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice496Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice502Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice502Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice502Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice502Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice502Member 2024-01-01 2024-12-31 0001899005 bmr:ExercisePrice512Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice512Member 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember bmr:ExercisePrice512Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice512Member 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember bmr:ExercisePrice512Member 2024-01-01 2024-12-31 0001899005 bmr:ShareOptionsOutstandingMember 2024-12-31 0001899005 bmr:ShareOptionsExercisableMember 2024-12-31 0001899005 srt:MinimumMember 2024-01-01 2024-12-31 0001899005 srt:MaximumMember 2024-01-01 2024-12-31 0001899005 srt:MinimumMember 2023-01-01 2023-12-31 0001899005 srt:MaximumMember 2023-01-01 2023-12-31 0001899005 srt:MinimumMember 2022-01-01 2022-12-31 0001899005 srt:MaximumMember 2022-01-01 2022-12-31 0001899005 srt:MinimumMember 2023-12-31 0001899005 srt:MaximumMember 2023-12-31 0001899005 us-gaap:ResearchAndDevelopmentExpenseMember 2024-01-01 2024-12-31 0001899005 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-12-31 0001899005 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001899005 us-gaap:SellingAndMarketingExpenseMember 2024-01-01 2024-12-31 0001899005 us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-12-31 0001899005 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-12-31 0001899005 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-12-31 0001899005 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-12-31 0001899005 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001899005 2020-01-01 0001899005 2024-05-22 0001899005 us-gaap:IsraelTaxAuthorityMember 2024-01-01 2024-12-31 0001899005 bmr:BeamrIncMember 2024-01-01 2024-12-31 0001899005 srt:ScenarioForecastMember 2025-01-01 2025-12-31 0001899005 bmr:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001899005 bmr:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001899005 bmr:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001899005 bmr:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001899005 bmr:CustomerFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001899005 bmr:SalesbasedSoftwareLicenseMember 2024-01-01 2024-12-31 0001899005 bmr:SalesbasedSoftwareLicenseMember 2023-01-01 2023-12-31 0001899005 bmr:SalesbasedSoftwareLicenseMember 2022-01-01 2022-12-31 0001899005 country:US 2024-01-01 2024-12-31 0001899005 country:US 2023-01-01 2023-12-31 0001899005 country:US 2022-01-01 2022-12-31 0001899005 country:IL 2024-01-01 2024-12-31 0001899005 country:IL 2023-01-01 2023-12-31 0001899005 country:IL 2022-01-01 2022-12-31 0001899005 bmr:RestOfTheWorldMember 2024-01-01 2024-12-31 0001899005 bmr:RestOfTheWorldMember 2023-01-01 2023-12-31 0001899005 bmr:RestOfTheWorldMember 2022-01-01 2022-12-31 0001899005 country:IL 2024-12-31 0001899005 country:IL 2023-12-31 0001899005 bmr:OtherMember 2024-12-31 0001899005 bmr:OtherMember 2023-12-31 0001899005 bmr:PerpetualBasedSoftwareLicenseMember 2024-01-01 2024-12-31 0001899005 bmr:PerpetualBasedSoftwareLicenseMember 2023-01-01 2023-12-31 0001899005 bmr:PerpetualBasedSoftwareLicenseMember 2022-01-01 2022-12-31 0001899005 bmr:TermbasedSoftwareLicenseMember 2024-01-01 2024-12-31 0001899005 bmr:TermbasedSoftwareLicenseMember 2023-01-01 2023-12-31 0001899005 bmr:TermbasedSoftwareLicenseMember 2022-01-01 2022-12-31 0001899005 bmr:SoftwareLicenseMember 2024-01-01 2024-12-31 0001899005 bmr:SoftwareLicenseMember 2023-01-01 2023-12-31 0001899005 bmr:SoftwareLicenseMember 2022-01-01 2022-12-31 0001899005 bmr:PCSServicesTransferredOverAPeriodOfTimeMember 2024-01-01 2024-12-31 0001899005 bmr:PCSServicesTransferredOverAPeriodOfTimeMember 2023-01-01 2023-12-31 0001899005 bmr:PCSServicesTransferredOverAPeriodOfTimeMember 2022-01-01 2022-12-31 0001899005 bmr:WebAdvertisingAtAPointOfTimeUponClicksMember 2024-01-01 2024-12-31 0001899005 bmr:WebAdvertisingAtAPointOfTimeUponClicksMember 2023-01-01 2023-12-31 0001899005 bmr:WebAdvertisingAtAPointOfTimeUponClicksMember 2022-01-01 2022-12-31 xbrli:shares iso4217:USD iso4217:ILS xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:ILS iso4217:RUB bmr:Segment

Exhibit 1.1

 

PUBLIC COMPANY

 

COMPANIES LAW, 5759 – 1999

 

A COMPANY LIMITED IN SHARES

 

AMENDED AND RESTATED ARTICLES OF ASSOCIATION

 

OF

 

BEAMR IMAGING LTD

 

(C.N 51-433155-2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Index

 

Part no.   Article no.   Subject   Page
             
Part One       Preamble    
             
    1.   Name of the company   1
    2.   Objectives of the company   1
    3.   Liability of shareholders   1
    4.   The Capital   1
             
Part Two       General Provisions    
    5.   Definitions and interpretations   2
    6.   Change of articles   3
             
Part Three       Capital of the Company    
    7.   Ordinary shares   4
    8.   Redeemable securities   4
    9.   Company capital, increase of Registered capital and revocation   4
    10.   Issuance of securities   6
             
Part Four       Shareholders    
    11.   Shareholders and share certificates   7
    12.   Calls for payment   8
    13.   Forfeiture   9
             
Part Five       Transfer of shares    
    14.   Transfer of shares   11
    15.   Share transfer deed   12
    16.   Assignment of shares by law   12
    17.   Registration of share transfer   13
             
Part Six       General Meetings    
    18.   Annual General Meetings   14
    19.   Convening special meetings   14
    20.   Agenda   15
    21.   Notice of meeting   15
    22.   Quorum   16
    23.   Chairman of general meeting   17
    24.   Voting in a general meeting   17
    25.   Vote count and secret ballot   18
    26.   Vote by proxy; vote by corporation Partners   18
    27.   Voting instrument   20
    28.   Protocols   21

 

i 

 

 

Part Seven       The Board of Directors    
    30.   Members of the Board   21
    31.   Restrictions on appointment Of directors   22
    32.   An outside director   23
    33.   A corporation as director   23
    34.   An alternate director and power Of attorney   23
    35.   Vacancy of office of director   25
    36.   Authorities of the Board   26
    37.   Assumption of authorities of the board   28
    38.   Rights of a director   29
    39.   Chairman of the Board   29
    40.   Convening a meeting of the Board   29
    41.   Agenda   30
    42.   Notice of meetings of the Board   31
    43.   Quorum   31
    44.   Voting in the Board of Directors   32
    45.   Protocols in meetings of the Board   33
    46.   Defects in convening the meeting   33
    47.   Committees of the Board   34
             
Part Eight       Audit Committee    
    48.   Appointment of members of Audit committee   35
    49.   Positions and work procedures of The Audit Committee   35
             
Part Nine       Exemption, indemnification and liability insurance    
    50.   Exemption and indemnification   36
    51.   Liability insurance   37
             
Part Ten       General Manager    
    52.   General Manager   38
    53.   Removal of Authorities of the general manager   39
             
Part Eleven       Management of the company    
    54.   Registered office   39
    55.   Shareholder register and Material shareholder register   39
    56.   Auditor   40
    57.   Expiration of service of auditor   40
    58.   Wages of auditor   41

 

ii 

 

 

    59.   Authorities, obligations and Responsibility of auditor   41
    60.   Internal auditor   42
             
Part Twelve       Financial statements, accounts and signature    
    61.   Financial statements   42
    62.   Stamp and signatory rights   42
             
Part Thirteen       Dividends and bonus shares    
    63.   Dividends and bonus shares   42
             
Part Fourteen     Notices and Dissolution    
    64.   Notices   44
    65.   Dissolution   45

 

iii 

 

 

Part One: Preamble

 

1. Name of the Company:In Hebrew: ביימר אימג’ינג בע”מ
   In English: Beamr Imaging Ltd.

 

2.Objectives of the Company

 

(a)To engage in any lawful business.

 

(b)The Company may donate from time to time reasonable sums for appropriate causes, even if the donations are not within the framework of the business considerations of the Company.

 

3.Liability of the shareholders

 

(a)The liability of a shareholder for the debts of the Company is limited to the payment of the unpaid portion which he undertook to pay for the share held by him in accordance with the terms of issuance of said share.

 

4.The capital

 

The registered share capital of the Company is NIS 11,100,000 (one hundred and eleven hundred thousand) divided into 222,000,000 ordinary shares with NIS 0.05 nominal value each (hereinafter: “Ordinary Share”).

 

1

 

 

Part Two: General Provisions

 

5.Definitions and interpretations

 

Written”: In writing or any other term with the same meaning including handwritten, engraved, printed, typewritten, photocopied, or copied in any other manner that is visible, including telex, fax, telegraph, by cable or any other duplication method through electronic means.
   
Shareholder”: Under its definition in Article 11 herein.
   
The Board of
Directors
”:
The Board of Directors of the Company who was duly elected in accordance with the provisions of these articles.
   
The Company”: Beamr Imaging Ltd., or any other name which it will be called, if its name is changed.
   
Law”: Companies Law, the Companies Ordinance or any other Israeli law, which is valid, as warranted, from time to time including the provisions of any stock exchange that applies to the Company.
   
Regular
Resolution
”:
A resolution adopted by a regular majority of shareholders, voting in the general meeting by a voting instrument (on topics for which according to these articles can be adopted through a voting instrument) on their own or though proxies.
   
The Office”: The registered office of the Company at such time in Israel about which the Company notified the Companies Registrar.
   
The Articles”: The articles of association of the Company, as they will be amended from time to time by the general meeting.
   
Companies Law”: Companies Law, 5759 – 1999, as amended from time to time, and any regulations that are promulgated thereunder.
   
Securities Law”: Securities Law, 5728 – 1968, as amended from time to time, and any regulations that are promulgated thereunder.
   
Vote count”: Vote count of those voters, in accordance with the voting rights established for the shares by virtue of which the shareholders participating in the general meeting are voting. In the count of all the votes of shareholders, abstentions shall not be taken into account.

 

2

 

 

Shareholder
Register
”:
A shareholder register that must be kept in accordance with section 127 of the Companies Law.
   
Register of Material
Shareholders
”:
A register of material shareholders that must be kept in accordance with section 128 of the Companies Law.
   
Office holder”: As the term “senior office holder” is defined in Part 6 of the Securities Law.
   
Companies
Ordinance
”:
The Companies Ordinance [New Version], 5743 – 1983, as amended from time to time, and all the regulations that are promulgated thereunder.

 

(b)Interpretation

 

(1)Each term in these articles that is not defined above, shall be attributed the meaning that is afforded it by law unless the context dictates otherwise.

 

(2)References made in the singular shall include the plural and vice versa. Reference made in the masculine gender shall include the feminine (and vice versa), and words that connote persons shall include also corporations, unless the context dictates another interpretation.

 

(3)The headings of the sections in these articles are for the purpose of convenience only and shall not be used as an accessory to interpret or for the interpretation of these articles.

 

(4)The articles which may be stipulated in the Companies Law shall apply to the Company, insofar as there is no contradiction between them and the provisions of these articles.

 

(5)In the case of a contradiction between the provisions of the law which may not be stipulated in bylaws and any of the provisions of these articles – the provisions of the law shall prevail in such case, without impairing from the remainder of the provisions of the articles.

 

(6)These articles are the same as a contract between the Company and its shareholders and between the shareholders and themselves.

 

6.Change of articles

 

Subject to the provisions of relevant law, the Company may change these articles by a regular resolution adopted in the general meeting of the Company.

 

3

 

 

Part Three: Capital of the Company

 

7.Ordinary shares

 

(a)All the ordinary shares shall have equal rights among them and each regular share shall confer upon its holder the following rights:

 

(1)The right to receive invitations or notices about all general meetings of the Company, to participate in the meetings and to vote in them on any matter that is raised in the meeting, where each ordinary share confers on its holder one vote on every vote on a resolution;

 

(2)The right to participate in any distribution that the Company makes to its shareholders, and to receive dividends and/or bonus shares, if they are distributed in accordance with the provisions of these articles and the provisions of the Companies Law, proportionate to the number of the shares allocated and the rate that they are paid up by the shareholders, if they are not are not fully paid up; and

 

(3)The right to participate in the dissolution of the Company, in the distribution of the assets of the Company, that remain to be distributed, after the Company meets all of its obligations and payment of all its debts in any case, proportionate to the number of the shares allocated and the rate that such shares are paid up by the shareholders, if they are not fully paid up, and subject to the provisions of these articles and without prejudicing existing rights of all the shareholders in the Company of any kind or class.

 

(b)The Company may pay a person a commission for signing or underwriting, or agreement to sign or underwrite securities of the Company, conditional or otherwise, provided that the amount or the sum of the commission does not exceed the sum of the commission permitted by relevant law at the time of payment.

 

8.Redeemable securities

 

The Company is entitled, taking into account the provisions of relevant law, to issue redeemable shares and to redeem them. At the time of the redemption of the shares the Company will act in accordance with the provisions of the law.

 

9.Capital of the Company, increase of capital and its cancellation

 

(a)The Company may have shares, bonds, or other securities, each with different rights.

 

(b)The Company will not issue bearer shares or stock that state that their holder is a holder of bearer stock.

 

4

 

 

(c)The Company is entitled from time to time by a regular resolution adopted in a general meeting:

 

(1)To increase the registered share capital of the Company by classes of shares, as determined;

 

(2)To cancel registered share capital that has not yet been allocated, provided that there is no commitment by the Company, including a conditional commitment, to allocate the shares;

 

(3)To consolidate and redistribute its share capital into shares of a nominal value;

 

And

 

(5)To convert, from time to time, part of the allocated shares into shares with other rights.

 

(d)Unless established otherwise in a resolution approving the change of share capital, the new shares shall be subject to the provisions of these articles regarding calls for payment, forfeiture, transfer, delivery etc., applicable to the shares of the original share capital.

 

(e)Without derogating from the generality of the authority of the Board of Directors, if as a result of a consolidation or division of shares the shareholders are left with fractional shares, the Board may in its discretion, act as follows:

 

(1)Allocate to each shareholder, whom the consolidation and/or division left him with a fractional share, shares of the class of shares that exists in the capital of the Company prior to the consolidation, in such number, that together with the fractional share will create one consolidated, complete share, and said allocation shall be considered as valid immediately prior to the consolidation or distribution, as warranted;

 

(2)Determine that holders of fractional shares shall not be entitled to receive a consolidated share for the fraction of a consolidated share.

 

(3)Allocate additional shares in the same number that would prevent the creation of fractional shares for consideration, as established by the Board of Directors; and

 

(4)Cause a transfer of shares between the shareholders for a fair price in order to efficiently prevent fractional shares. The Board is authorized to appoint a trustee to conduct such share transfer among the shareholders.

 

5

 

 

10.Issuance of securities

 

(a)The Board may issue or allocate shares or other securities, that are convertible or may be exercised into shares (including bonds and warrants), until a limit of the registered share capital of the Company, under the terms, dates and for a specific sum or for a sum that is established according to an accepted formula; for this purpose convertible securities or securities which may be exercised into shares shall be deemed as if they were converted or exercised on the date of their issuance.

 

(b)The authority of the Board as set forth in article 10(a) may be delegated as enumerated in articles 10(b)(1) or 10(b)(2) herein:

 

(1)To a committee of the Board – by an issuance or allocation of securities as part of a workers compensation plan or employment agreements or wage agreements between the Company and its employees, or between the Company and the employees of an affiliated Company to which its Board agreed in advance, provided that the issuance or allocation is according to a plan that includes detailed criteria, that is delineated and approved by the Board;

 

(2)To a committee of the Board, to the general manager, to the secretary of the Company or a deputy of such position, or to another person whom the general manager recommends – in an allocation of shares following an exercise or conversion of securities of the Company.

 

(c)The Board of Directors may decide to issue a series of bonds as part of its authority to borrow on behalf of the Company, within the limits set by said authority.

 

(d)The provision of article 10(c) above does not negate the authority of the general manager or someone who is so authorized, to borrow on behalf of the Company, to issue individual bonds, promissory notes and bills of exchange, within the limits set by said authority.

 

(e)The Company shall not allocate a share the consideration of which, in full or in part, is not paid in cash, unless the consideration for the share is specified in a written document.

 

(f)If the Company decides to allocate shares with a nominal value insofar as there will be shares with a nominal value as part of the capital of the Company, for a lower amount than the nominal value, including bonus shares, it must change part of its profits into share capital (under such meaning in section 302(b) of the Companies Law), from a premium on shares, or from any other source included in its equity capital, that are listed in its last financial statements, for a sum equal to the differential between the nominal value and the amount.

 

6

 

 

Part Four: Shareholders

 

11.Shareholder and share certificates

 

(a)A shareholder of the Company is any one of the following:

 

(1)A person in whose benefit a share is registered with a member of the stock exchange and said share is included among the shares registered in the shareholder register by the relevant nominee Company; and/or

 

(2)A person who is registered as a shareholder in the shareholder register.

 

(b)Other than as stated in article 11(a) above, a person or legal entity shall not be recognized by the Company as having any right to a share, and the Company shall not be bound or recognize any benefit in equity or trust relationships or chose in action, planned or partial, but only the right of a shareholder, to a complete share, and all – unless a competent court of the law orders otherwise.

 

(c)If two or more holders are registered as joint owners of a share:

 

(1)In respect to a vote, giving proxies, and notices, the shareholder who is registered first in the shareholder register shall be considered as the sole shareholder, unless all the holders of the joint share give written notice to the Company that another person should be referred as sole shareholder.

 

(2)Each of the holders may give a valid receipt in respect to all the joint holders for each dividend, other money or property that is received from the Company for the share or in respect thereto, and the Company is entitled to pay a dividend, the other money or the property for the share to one or more shareholder of the joint holders of the share, as it chooses to do.

 

(d)Subject to the provisions of relevant law, a shareholder who is a trustee shall be registered in the shareholder register, as a shareholder, with a statement concerning his trusteeship status. Without derogating from the foregoing, the Company will recognize the trustee as a shareholder, for all intents and purposes, and will not recognize another person, including the beneficiary, as holding any right to the share.

 

(e)A shareholder registered in the shareholder register is entitled to receive from the Company one share certificate testifying to his ownership of the share.

 

A shareholder registered in the shareholder register, shall be entitled to receive one share certificate for the shares registered in his name and fully paid up, or, if the Board approves (after payment of the amount that the Board establishes from time to time), a number of share certificates, for one or more of the shares. Each share certificate shall state the number of the shares for which it is issued.

 

7

 

 

(f)Share certificates shall be issued with the stamp of the Company and with the signatures of two directors of the Company or in any other manner determined by the Board of Directors of the Company.

 

(g)A share certificate in the name of two or more persons in the name of two or more persons, shall be delivered to the person whose name appears first in the shareholder register among the names of the joint holders.

 

(h)A new share certificate may be issued in place of a share certificate that was destroyed, lost or ruined, for the payment and under the terms regarding evidence, indemnification, guarantee against damages and/or issuance of an affidavit, as determined by the Board of Directors in its sole discretion from time to time.

 

(i)The Company shall keep a register of material shareholders in addition to the shareholder register. The material shareholder register shall contain reports that the Company received pursuant to the Securities Law about the holdings of the material shareholders in Company shares.

 

12.Calls for payment

 

(a)A shareholder shall not be entitled to a dividend or participate in the allocation of bonus shares or exercise any right of a shareholder in the Company, unless he has paid up all the sums and calls for payment that he owes the Company until said time in respect to his shares in the Company.

 

(b)The Board of Directors may, from time to time, in its discretion, make calls for payment on shareholders for any sums that have not been paid up in respect to shares held by each of the shareholders, and for which pursuant to the terms of the allocation of the shares are not payable at a fixed time, and each shareholder shall pay the amount of the call made upon him, at the time and place designated by the Board of Directors. The Board of Directors may instruct that a call for payment be made in installments.

 

(c)Notice of a call for payment shall be given and shall specify the amount of payment (no less than 14 days from the date of the notice) and the place for payment provided that prior to the time of payment for the call for payment, the Board of Directors may, by written notice to the shareholders, cancel the call or extend the time for payment or payment for any part thereof.

 

(d)Joint holders of a share shall be jointly and severally liable to pay all amounts and calls for payment in respect to such share held jointly. Without derogating from the aforesaid generality, a call for payment delivered to one of the holders shall be deemed as having been delivered to all the owners.

 

8

 

 

(e)If pursuant to the terms of the issuance of a share or otherwise, an amount is made payable at a fixed time or in installments at fixed times, whether on account of the share capital or by way of premium, such amount or installment shall be payable at such time as if it were payable by virtue of a call duly made by the Board of Directors for which notice was duly given, and all the provisions of these Articles in respect to calls for payment shall be applicable to such amount or installment.

 

(f)If a call for payment or an installment is not paid on the due date or prior to such time, then the person who at such time is the holder of the share for which the call for payment was made, or for which the installment is due, shall pay interest on such sum at the maximum amount practiced at such time in Bank Leumi of Israel Ltd for unauthorized overdrafts, or at a lower rate that the Board will determine from time to time, from the date designated for its payment until the actual payment thereof, however the Board may waive the payment of interest, in whole or in part.

 

The provisions of this article do not detract or impair from the remedies and relief available to the Company by these articles or by any relevant law or agreement.

 

(g)The Board of Directors may decide to accept money from a shareholder who wishes to advance payments, in whole or in part, on account of shares which have not been fully paid up and in respect to which the time for their payment has not yet matured, and to pay interest on such sums for a period not to exceed the period between the date of payment and the date on which this sum was designated to be paid, at the rate agreed by the Board of Directors and the shareholder.

 

13.Forfeiture

 

(a)A shareholder who has not fully paid up a sum for which a call has been made by the designated date, may be furnished with a written notice by the Board of Directors demanding that he pay the unpaid sum with interest and any expenses which the Company incurs due to the default in payment on the designated date for payment.

 

(b)The notice shall specify another date for payment, which shall not be earlier than seven days after the notice, and it shall state that if the amount is not paid up by this date the share for which such notice is given may be forfeited.

 

(c)If the demands in the notice are not satisfied, the Board of Directors may, so long as the sum is not paid up, including the interest and expenses, decide to forfeit the share. The forfeiture shall also apply to any dividends announced in respect to the forfeited shares (insofar as they are eligible for dividends) which were not actually paid out prior to the forfeiture.

 

9

 

 

(d)A share that has been forfeited shall be deemed the property of the Company, and the Board of Directors may, taking into account the provisions of these articles, sell or transfer it or reallocate it in another manner, under such terms and manner as decided by the directors. A share so forfeited so long as it has not been sold, transferred or allocated again as stated, shall become a dormant share under such meaning in section 308 of the Companies Law which shall not confer any rights at all so long as it is owned by the Company.

 

(e)Insofar as nothing has been done with the forfeited share, the Board of Directors may cancel the forfeiture under the terms that it establishes.

 

(f)A shareholder whose shares have been forfeited:

 

(1)Shall cease being a shareholder in respect to the shares that were forfeited and upon the forfeiture all of his rights and obligations for the forfeited shares shall be revoked and any action and/or demand against the Company regarding the forfeited shares shall be cancelled, other than those rights and obligations which are excepted from this rule by these articles and/or which are imposed on the former shareholder by law; however

 

(2)He shall continue to be obligated to pay the Company and will pay the Company, without delay, all the calls for payment, payment installments, interest and expenses owed on account of the forfeited shares or for them at the time of the forfeiture, together with interest on those sums from the date of the forfeiture until the date of actual payment, at the maximum rate permitted at that time by law, provided that if the shares that were forfeited are sold, transferred or reissued, the shareholder’s debt will be reduced by the sum actually received by the Company (after the expenses of the sale), from their sale, transfer or reissuance, as warranted.

 

(g)The provisions in these articles regarding forfeiture shall apply to the default of payment of any sum that is to be paid on a designated date according to the terms of issuance of the share, whether on account of the share or in the form of a premium, as if it was a sum that was meant to be defrayed by virtue of a call for payment and a duly delivered notice.

 

(h)In the case of a sale after forfeiture, the Board of Directors may appoint a person to sign a transfer instrument of the share that was sold and to arrange (subject to the provisions of relevant law) so that the buyer will be registered in the shareholder register as the owner of the shares that were sold or which will be received by him in any other manner. The recipient of the share that was sold, transferred, allocated or sent shall not be responsible for how the consideration for the sale is used, if received, his right to the share shall not be harmed due to a defect or a disqualification in the forfeiture, sale, allocation or transfer process, and after he is registered in the register (subject to the provisions of relevant law) or he receives the share into his possession in any other manner, no such claim shall be raised, and the validity of the sale or the transfer shall not be appealed.

 

10

 

 

(i)An affidavit duly made by a director of the Company that a certain share of the Company has been duly forfeited on the date specified in the affidavit shall serve as conclusive proof of its content against any person who asserts a claim to the share. The affidavit with a Company receipt for the consideration, if given, for the share, in its sale or transfer, shall confer a right to the share on the transferee.

 

(j)The net proceeds of any sale following a forfeiture after the discharge of the sale expenses, shall be applied in discharging the debts and the fulfillment of the obligations of such shareholder (including the debts, obligations and agreements for which the date of discharge or maturity have not yet come due), and the balance (if any) shall be paid to him or to whoever is conferred a right to the shares following the death, bankruptcy or dissolution of the shareholder.

 

(k)The provisions of this article shall not be construed as derogating from any other relief available to the Company against the debtor shareholder.

 

Part five: Transfer of shares in the shareholder register

 

14.Transfer of shares

 

(a)Subject to the provisions of relevant law, the Board of Directors may stop the registration in the register of transfers of shares for a specific period of time, that will not exceed 30 days per year, provided that it will not do so during the 14 days prior to the determining date for ownership of a share to establish eligibility to the rights for the share (such as the determining date for eligibility to vote in a general meeting or to receive a dividend or other distribution from the Company).

 

(b)Part of a share may not be transferred, but a share which is jointly held by a number of owners, each may transfer their right to the share.

 

(c)In the case of a transfer of shares, the transferee shareholder shall have all the rights that were attached to the transferred shares and all the obligations related to them according to these articles, unless otherwise agreed in writing, between the transferor shareholder and the transferee shareholder.

 

11

 

 

15.Share transfer deed

 

(a)A transfer of shares shall not be registered in the shareholder register unless a transfer instrument is delivered to the office. A share transfer deed in the Company shall be signed by the transferor and the transferee, and the transferor will be deemed the owner of the share until the name of the transferee is registered in the shareholder register in respect to the transferred share.

 

(b)The instrument of transfer of a share shall be in the following form or as near thereto as possible, or in the usual or common form as the Board of Directors may approve:

 

Share transfer deed

 

I, ___________________ of ____________ (hereinafter: “the Transferor”) do hereby transfer to ___________________ of _______________ (hereinafter: “the Transferee”), in consideration of the amount of NIS _____________________ (in words ____________ new shekels) paid to me - _________________ shares of Beam Imaging Ltd. (Company no. _________), and they shall belong to the transferee, the administrators of his estate and representatives, subject to the terms by which I/we held the same immediately before the execution of this deed; and I/we, the transferee(s), do hereby agree to accept the shares subject to these terms.

 

In witness whereof we set our hand this ______day of ___________ month _________ year ________.

 

Signature of transferor___________ Signature of transferee__________

 

Witness to signature ____________ Witness to signature ____________

 

(c)A transfer deed shall be submitted to the office for registration, along with the share certificates that are being transferred (if there are certificates) and/or any other evidence required by the Board regarding the proprietary right of the transferor or in respect to his right to transfer the shares. Transfer deeds that are registered shall remain with the Company but any transfer deed in respect to which the Board refuses to register, shall be returned upon request, to the person who so delivered them, together with the share certificate (if delivered).

 

16.Assignment of shares by law

 

(a)The Board of Directors may, at any time and subject to the provisions of relevant law, register as a shareholder a person who is entitled to a share by law, including an heir, executor of an estate, liquidator or a trustee in a bankruptcy, after the Company is presented with a probate order, a succession order or any other sufficient evidence, as the Board deems fit, demonstrating the right to the shares. An eligible person who is so registered as a shareholder in the Company, is entitled, subject to the provisions of these articles dealing with the transfer of shares and the provisions of relevant law, to transfer these shares to another. Without derogating from the above, the Board may refuse to perform such registration or may delay it, as it is entitled to do, as if the registered owner himself transferred the share, prior to the assignment of the right.

 

12

 

 

(b)Subject to the provisions of the Companies Law and these articles:

 

(1)The executors of an estate of a shareholder who died, or in the absence of an executor of estate or administrator of an estate, persons who have a right by virtue of being heirs of the shareholder who died, shall be the only ones to be recognized by the Company as right holders to the share. A share registered in the name of two or more persons and one died, the Company shall recognize only the shareholders who are alive as the persons with rights to the share or benefits to it. Nonetheless the aforesaid shall not be construed as releasing the estate of the joint shareholder who died from all the obligations for the shares.

 

(2)A person who is entitled to a share by law but has yet to be registered in the shareholder register is not entitled: (1) to receive dividends or any other money and/or property paid for said share as if he was the registered owner of the share; and (2) by virtue of said share to benefit from all rights of a shareholder regarding notices about general meetings, to be present at them or to vote in them, or class meetings, as the case warrants, of the Company or to make use of any other right of shareholders.

 

17.Registration of transfer of shares

 

(a)Subject to the provisions of relevant law, the Company shall change the registration of ownership in the shareholder register if each of the following is present:

 

(1)The Company is delivered a transfer deed of the share with the signatures of the transferor and the transferee as stated in article 15 above, and the requirements of these articles are satisfied;

 

(2)The Company is delivered a court order to amend the register;

 

(3)It is proven to the Company that the conditions in the law to assign the right have been satisfied; or

 

(4)Another condition is satisfied which according to these articles is sufficient to that the change can be registered in the shareholder register.

 

13

 

 

(b)The transferor of the shares shall be considered the shareholder until the registration of the share transfer in the shareholder register in the name of the transferee in respect to the transferred share.

 

(c)The Company will keep all the registration in the shareholder register as stated in this article 17. The Company may destroy share transfer instruments and share certificates that were cancelled after the expiration of 7 years from the date of registration of the revision in the shareholder register, where there will be an absolute presumption that the destroyed documents as stated above were binding and valid and that the transfers, the revocations and the registrations, as warranted, were lawfully made.

 

Part Six: General Meetings

 

18.Annual general meetings

 

(a)The Company shall convene an annual meeting each year but no later than 15 months after the previous annual meeting.

 

(b)The agenda at the annual meeting shall include deliberation of the financial statements of the Company and may include appointment of directors, appointment of an auditor, or any other matter that is scheduled for the agenda as set forth in article 20 herein.

 

19.Convening special meetings

 

(a)The Board of Directors must convene a special meeting by a resolution of the Board and must convene a special meeting upon the demand of each of the following:

 

(1)Two directors or a quarter of the directors then serving;

 

(2)One or more shareholders, who hold at least five percent (5%) of the issued capital and at least one percent of the voting rights in the Company or one or more shareholders who hold at least five percent (5%) of the voting rights in the Company.

 

(b)A Board of Directors that is requested to convene a special meeting will convene such a meeting within twenty-one (21) days from the date that it received the demand to convene, and the provisions of section 63(c) of the Companies Law shall apply.

 

(c)If the Board of Directors omits to convene a special meeting as stated, the person demanding said meeting, and if shareholders – even some of them who have more than half of the voting rights, convene the meeting on his own, provided that it is not convened more than three months from the date such demand was submitted, and it shall be convened, insofar as possible, in the same manner that meetings are convened by the Board of Directors.

 

14

 

 

(d)Annual general meetings of shareholders shall be called “annual meetings” and all other meetings of the Company shall be called “special meetings”.

 

(e)A flaw in the convening of a general meeting or in the management thereof, including a flaw resulting from the non-satisfaction of a provision or term that was fixed by the Companies Law or in these articles, shall not invalidate any resolution adopted by the general meeting and shall not render defective the discussions that took place in it.

 

(f)The general meeting of the Company shall be convened in Israel, at a location to be established in the notice of the meeting.

 

20.Agenda

 

(a)The agenda in a general meeting shall be set by the Board of Directors and shall include also topics for which a special meeting was demanded to be convened pursuant to article 29 above as well as any subject that is required as set forth in article 20(b) herein.

 

(b)The general meeting shall adopt resolutions on subjects that are specified on the agenda only. Notwithstanding the above, it is understood that the general meeting, may, inter alia, adopt resolutions related to other subjects that were not included on the original agenda of the general meeting in respect to matters:

 

(1)Which the law permits to be raised even if they are not included on the original agenda of the general meeting; and –

 

(2)Which in light of the circumstances for which the general meeting is convened, the chairman of the general meeting believes is proper and correct to be discussed; or

 

(3)Which a shareholder as stated in article 19(a)(2) above, asked in writing, at least seven (7) days prior to the meeting, to raise and attached the language of the resolution, provided that the subject is appropriate to be discussed in a shareholder meeting.

 

21.Notice of a meeting

 

(a)Prior notice of at least 14 days or, if required by law, at least 35 days (as warranted by the circumstances), other than the day on which the notice is delivered and inclusive of the day for which the notice is delivered, about the convening of a general meeting, shall be given in the manner set forth in section 69 of the Companies Law and shall include the details as stated in the provisions of the aforesaid section or the provisions of any other relevant law.

 

15

 

 

(b)The notice shall be publicized in accordance with applicable securities laws governing the Company. Other than such notice, a notice or invitation to a meeting shall not be delivered to each of the shareholders of the Company, whether registered or not.

 

(c)A shareholder who is interested in voting in a general meeting will prove to the Company that he owns the share in accordance with the Companies Law.

 

Subject to the provisions of the law, shareholders who are eligible to participate and vote in the general meeting are those who are holders of shares at the time of the resolution to convene a general meeting, or by virtue thereof, provided that this date is not more than twenty one (21) days prior to the date of the general meeting, and is not less than four (4) days prior to the meeting, and in a general meeting where a vote can be made by a voting instrument, the determining date will not be more than forty (40) days prior to the date of the general meeting and no less than twenty eight (28) days prior to the meeting.

 

(d)A general meeting with a quorum present may decide to adjourn the meeting, the discussion or adoption of a resolution on a topic that is on the agenda to another time or place that it determines; at the adjourned meeting no subject shall be discussed other than a subject that was on the agenda and which was not resolved.

 

If a general meeting is adjourned for over twenty-one (21) days, notices and invitations shall be delivered for the adjourned meeting as set forth in this article 21.

 

A general meeting that was adjourned to a date that is less than twenty-one (21) days, an immediate report will be published regarding the new date, as soon as possible, but no later than seventy two (72) hours prior to the time of the adjourned general meeting.

 

22.Quorum

 

(a)Proceedings in the general meeting shall not commence until a quorum is present at the start of the proceedings.

 

(b)A quorum shall be the presence of at least two (2) shareholders who hold at least twenty five percent (25%) of the voting rights (including through a proxy or voting instrument) within one half hour from the time the meeting was designated to start.

 

16

 

 

(c)If a quorum is not present after one half hour from the time the general meeting was designated to start, the meeting shall be adjourned for one week, to the same day, same time and place or to a later date if specified in the invitation to the general meeting or to another day and/or place as will be determined by the Board of Directors in a notice to shareholders who are eligible to vote.

 

(d)If a quorum is not present at the adjourned meeting as set forth in article 22(c) above, after a half hour from the time designated for its start, the meeting shall take place with any number of participants, even if the general meeting was convened at the demand of shareholders as set forth article 19 above.

 

(e)Presence” – means the presence of the shareholder himself, through a voting instrument or proxy or a representative as set forth in article 26 herein.

 

23.Chairman of the general meeting

 

(a)The chairman of the Board of Directors shall serve as chairman of each general meeting.

 

(b)If the chairman of the Board of Directors is absent from the meeting within 15 minutes from the time designated for the meeting or if he refuses to sit as chair of the general meeting, the general meeting shall elect one of the shareholders present, to serve as chairman of the meeting.

 

(c)The chairman of the general meeting shall conduct the general meeting.

 

24.Voting in the general meeting

 

(a)Subject to the provisions of relevant law and unless established otherwise in these articles, a resolution shall be considered adopted by a regular majority of votes of shareholders present at the meeting and voting on the resolution.

 

A shareholder shall not be entitled to vote in the general meeting prior to paying all of the sums and calls for payment owed from him at such time to the Company for his shares in the Company.

 

(b)The chairman of the general meeting shall not have an additional or conclusive vote.

 

(c)A declaration by the chairman of the general meeting that a resolution was unanimously adopted or adopted by a specific majority, or that it was adjourned shall be conclusive evidence of the accuracy of the declaration and there will be no need to prove the number of votes or the votes that were given for or against the resolution.

 

17

 

 

25.Vote count or secret ballot

 

(a)Any resolution put to a vote in a general meeting shall be decided by counting votes, unless at least one shareholder present on his own or through a proxy and who holds at least five percent (5%) of the voting rights in the Company, demands, a secret ballot.

 

(b)If a demand is made for a secret ballot, the vote will take place in the same manner, time and place as the chairman of the general meeting instructs, whether immediately or after a recess or adjournment or in another manner and the results of the secret ballot shall be considered a resolution of the general meeting in which the secret ballot was demanded. Those demanding a secret ballot may cancel the demand at any time prior to the secret ballot.

 

A secret ballot regarding the selection of a chairman and adjournment of the general meeting shall take place without delay.

 

(c)A demand for a secret ballot shall not prevent the continuation of the general meeting and discussion on any issue other than the one in respect to which the secret ballot was demanded.

 

26.Vote by proxy; vote of a corporation; partners

 

(a)A shareholder may vote personally or by proxy, through an instrument appointing the proxy as set forth below, or in the case of a corporation – by a representative through an instrument of appointment as set forth below. Likewise a shareholder may vote by a voting instrument, as set forth in article 27 herein. A representative or proxy does not need to be a shareholder of the Company.

 

(b)A corporation being a shareholder of the Company may, by a resolution of its Board of Directors, directors, or any other managing body competent under the bylaws of the corporation or in accordance with a resolution of its Board of Directors, give an instrument of appointment to a representative and empower such person whom it finds suitable to be its representative at every meeting of the Company.

 

A representative of the corporation as stated above shall be entitled to exercise on behalf of the corporation that he represents those powers that the corporation itself could have used if it was a shareholder of the Company who is not a corporation.

 

(c)The instrument appointing a proxy shall be signed by the principal or his agent who is so authorized by a duly written instrument, and if the principal is a corporation – by the signature of the person authorized to issue an instrument of appointment for the corporation as set forth in article 26(b) above or by the signature of an authorized signatory of the corporation. An instrument of appointment of a representative or proxy in effect for a non-specified period, shall expire following 12 months from the date of the last signature on it.

 

18

 

 

(d)The instrument to appoint a proxy or a copy certified by an attorney or certified in another manner to the satisfaction of the Company, and confirmation of the ownership of a share as set forth in section 71 of the Companies Law, shall be deposited in the office or in another location as the Board will establish from time to time in a general manner or for a specific case, no less than forty eight (48) hours prior to the date designated for the meeting or the adjourned meeting for which the instrument of proxy is written, or on a date established by the Board in its discretion, provided that it is received in the Company prior to the time set for the general meeting or the adjourned meeting in which the person mentioned in this document intends to vote. If it is not so deposited, the instrument shall not be valid for said general meeting or an adjourned general meeting.

 

(e)Any document appointing a proxy for a particular meeting, or for a specific time frame, shall be written in the format below insofar as possible or in another format approved by the Company:

 

I ________ bearer of identity card no/company no./public company no. __________ from ___________ a shareholder in Beamr Imaging Ltd (public company ___________ hereby appoint ________ Mr./Ms. ____________ of ___________ as my proxy (and in the case of a corporation – as my representative) to vote as my proxy to vote in my name and on my behalf in a general (annual / special) meeting of the Company to be held on the date of ______ month of _______ year _________ and in any adjourned meeting.

 

In witness I set my hand on this day of __________ month ______ year ___

 

______________

Signature

 

(f)If the statement of appointment does not specify the number of shares for which it is given or it specifies a number of shares that is higher than the number of shares registered in the name of the shareholder (in the register or title certificate), the instrument of appointment shall be considered as if it was given for all of the shares registered in the name of the shareholder. If the instrument of appointment is given for a number of shares that are lower than the number of shares registered in the name of the shareholder, the shareholder shall be considered as abstaining from being present at the vote for the remainder of the shares which are registered in the name of the shareholder, and the instrument of appointment will be valid only for the number of the shares listed in it.

 

(g)A vote in accordance with an instrument of appointment shall be lawful even if the instrument has a defect that is not immediately apparent and/or if prior to said vote the principal died or became legally incompetent and/or the instrument of appointment was revoked or the power of attorney by which the instrument was signed was revoked and/or the share in respect to which the instrument was given was transferred, unless a written notice was received in the office and/or by the chairman of the general meeting prior to the meeting of the defect, the death, disqualification, revocation or transfer.

 

19

 

 

(h)Without derogating from the aforesaid, a shareholder holding more than one share shall be entitled to appoint more than one proxy or representative, subject to the following provisions:

 

(1)Each instrument of appointment will specify the class of the shares and the number of shares for which it is given.

 

(2)If the total number of shares of any class listed in the instrument of appointment is greater than the number of shares of said class registered in the name of said shareholder, the entire instrument of appointment will be null in respect to the shares of said class that was given by the shareholder.

 

(3)A shareholder or proxy or representative for the vote, nay vote by virtue of some of the shares that are in his possession or for which he is serving as a proxy or representative, and he may vote by virtue of these shares in one manner and by virtue of some shares in another manner.

 

(i)In a vote by joint holders of a share an instrument of appointment to a proxy shall be signed by the person who is authorized to vote as set forth in article 11(c)(1) above.

 

(j)A shareholder who is incompetent may vote through his lawful guardians or another person appointed by a court, and they may vote for him through proxies or instruments of appointment as stated in the provisions of these articles.

 

27.Voting instrument

 

(a)A shareholder may vote in the general meeting and in meetings of a class of shares through a voting instrument in which the shareholder will specify the manner of his vote, on resolutions on topics that the law permits voting on them through a voting instrument, and for any other subject with the Board of Directors decides that a vote in the general meeting on a specific subject may also be adopted by way of a voting instrument.

 

(b)A voting instrument in which a shareholder indicates the manner of his vote and which he completes as required, which reaches the Company by the final time established for such in the invitation to the general meeting, shall be considered as a presence in the general meeting for purposes of a quorum as set forth in article 22 above and for the purpose of counting the votes.

 

20

 

 

(c)A voting instrument that is received by the Company as set forth in article 27(b) above, for a specific matter for which a vote was not taken in the general meeting, shall be considered as abstaining on the vote in that general meeting on the resolution for an adjourned meeting pursuant to the provisions of section 74 of the Companies Law, and it will be counted in the adjourned meeting that will be held pursuant to the provisions of 74 or 79 of the Companies Law.

 

28.Protocols

 

(a)The Company shall keep protocols of the proceedings in the general meeting, and shall keep them in the office, for a period of at least seven years from the date of the general meeting.

 

(b)A protocol signed by the chairman of the general meeting, constitutes conclusive proof of the contents therein.

 

29.Meetings of a class

 

The provisions of articles 18 – 28 above shall apply, mutatis mutandis, on a meeting of shareholders of a class of shares, insofar as the Company must hold them.

 

Part Seven: The Board of Directors

 

30.Members of the Board

 

(a)The number of directors in the Company, shall be determined from time to time by a resolution of the annual general meeting, provided that the number of directors (including outside directors) shall not be less than five (5) directors and no more than ten (10) directors.

 

(b)The Directors, other than outside directors (who shall be elected and serve in office in strict accordance with the provisions of the Companies Law, if so required by the Companies Law), and until their maximum number as set forth in subsection (a) above, shall be classified, with respect to the term for which they each severally hold office, into three classes, as nearly equal in number as practicable, hereby designated as Class I, Class II and Class III.

 

(i)The term of office of the initial Class I directors shall expire at the first Annual General Meeting to be held in 2025 and when their successors are elected and qualified for a three (3) year period,

 

(ii)The term of office of the initial Class II directors shall expire at the first Annual General Meeting at least one year following the Annual General Meeting referred to in clause (ii) above and when their successors are elected and qualified for a three (3) year period, and

 

(iii)The term of office of the initial Class III directors shall expire at the first Annual General Meeting at least one year following the Annual General Meeting referred to in clause (iii) above and when their successors are elected and qualified for a three (3) year period.

 

21

 

 

Notwithstanding anything to the contrary herein, this Article 30(b) may only be amended, replaced or suspended by a resolution adopted at a General Meeting by a majority of 65% of the voting power represented at the General Meeting in person or by proxy and voting thereon.

 

(c)In addition to the outside director with accounting and financial expertise, directors with accounting and financial expertise in such number as determined by the Board of Directors of the Company from time to time.

 

(d)The office of a director shall begin from the date of his appointment or a later date if the resolution of his appointment establishes such.

 

(e)The Board of Directors is entitled at any time and from time to time to appoint any person as a director, provided that the number of directors does not exceed at any time the maximum number as specified above. A director who is so appointed, shall serve insofar as his office is not vacated in accordance with the provisions of article 35 herein.

 

(f)The Company will maintain in the office a register of directors and their alternates, if they have alternates pursuant to the provisions of article 34 herein, which will be open for inspection by any person.

 

(g)Subject to the provisions of relevant law, all the activities and resolutions of the Board, a committee of the Board or a director who is acting by virtue of his office, as well as any act that is taken according to their instructions, shall be valid, even if it is discovered afterwards that there was a defect in the appointment of a director/directors or if all or one of them were unfit from serving as directors, as if each of them was appointed lawfully and as if they all had the necessary qualifications to be a member of the Board or committee.

 

31.Restrictions on the appointment of directors

 

(a)A candidate for director must disclose to his appointer if he was convicted in a judgment of an offense as described below, and five years have not yet passed since the judgment of conviction was issued or – in respect to sub article (3) herein – the period that was established by the court according to that sub article:

 

(1)Offenses according to sections 290 to 297, 392, 415, 418 to 420 and 422 to 428, of the Penal Law, 5737 – 1977, and according to sections 52c, 52d, 53(a) and 54 of the Securities Law;

 

(2)A conviction in a foreign court for the offenses of bribery, fraud, corporate administrative offenses or insider trading; or

 

22

 

 

(3)A conviction for another offense which the court holds that due to its nature, severity or circumstances, he is not fit to serve as a director in a public company, for the period that the court determines which shall not exceed five years from the date of the judgment.

 

(b)A candidate for director in the Company will disclose if the administrative enforcement Board imposed on him any enforcement measures that prevent him from serving as a director of a public company or a private company which is a bonds company, and the period established by the administrative enforcement board in its decision has not yet passed.

 

(c)A person convicted by a judgment of an offense enumerated in article 31(a) above shall not be appointed as a director, unless the period stated in said article passed (unless a court establishes otherwise as stated in section 226(b) of the Companies Law), and a person shall not be appointed as director if the administrative enforcement board imposed on him enforcement measures prohibiting him from serving as a director in a company, for a period determined by the Board.

 

(d)A director shall not be appointed if he is a minor, legally incompetent, or declared bankrupt so long as he has not been absolved.

 

(e)A candidate for director who is one of the above in sub article (d) shall disclose this to the Company.

 

32.External director

 

(a)Two external directors shall serve in the Company, who satisfy the conditions set forth in the Companies Law, who will be appointed by the general meeting in accordance with the provisions of the Companies Law.

 

(b)At least one external director shall serve in each committee that is entitled to exercise one of the authorities of a director.

 

(c)The terms of office of external director shall be three years, and the Company may appoint him for two additional terms of three years each.

 

(d)External director shall not be removed and his term of office shall not be stopped except according to the provisions of the Companies Law.

 

33.Revoked.

 

34.Alternate director

 

(a)Subject to the provisions of the Companies Law, each director may appoint another as an alternate director and may revoke his appointment.

 

23

 

 

(b)An appointment of an alternate director and the revocation of his appointment shall be done by written notice to the Company by the appointing director or in another manner as decided by the Board of Directors. The appointment will enter into effect upon receipt of the notice by the Company or a later date as stated in the notice.

 

(c)An alternate director is the same as a director.

 

(d)The appointment of an alternate does not negate the liability of the director for whom he is serving as alternate, and it will apply taking into account the circumstances of the situation, including the appointment of the alternate director and the term of his office.

 

(e)The alternate director shall have all the authorities belonging to the director for whom is serving as the alternate. It is understood that the authorities of the alternate director shall not prejudice his authorities as director.

 

(f)An alternate director shall not be entitled to participate and vote in a meeting of the Board in which the director who appointed him participates.

 

(g)An alternate director may be appointed as a member of the Board of Directors, who is already a director, provided that the candidate for alternate director for a member of a committee, does not serve on that same committee of the Board and if he is an alternate director for an outside director, the candidate must be an outside director with accounting and financial expertise or with professional ability, in accordance with the qualifications of the director for whom he is serving as an alternate.

 

(h)The office of an alternate director or an attorney shall be vacated:

 

(1)Automatically if the office of the director, for whom he is serving as the alternate, is vacated for any reason;

 

(2)If the alternate director experiences any of the instances enumerated in article 35 herein or if for another reason established in the Companies Law he is not fit to serve as an alternate director; or

 

(3)His appointment as an alternate director is cancelled by the person who so appointed him.

 

24

 

 

35.Dismissal of a director

 

(a)The office of director shall be automatically vacated upon the occurrence of each of the following instances:

 

(1)Upon his death;

 

(2)He is found to be legally or mentally incompetent or mentally ill.

 

(3)He is declared to be bankrupt;

 

(4)If he resigns by written notice to the Company as stated in article 35(b) herein;

 

(5)If he is dismissed by a resolution of the general meeting as set forth in article 35(c) herein or is dismissed as stated in article 35(d) herein;

 

(6)On the date of the issuance of the notice of a conviction for an offense as set forth in article 35(e) herein;

 

(7)According to a decision by a court pursuant to the provisions of section 233 of the Companies Law;

 

(8)On the date of the notice about the imposition of enforcement measures by an administrative enforcement Board prohibiting him to serve as director of a public company or in the Company, as set forth in section 232a of the Companies Law; or

 

(9)A condition needed pursuant to the Companies Law no longer exists in regard to the director in order for him to serve as director or a cause for the expiration of his term as director exists.

 

(b)A director or an alternate director may resign by delivery of written notice to the Board of Directors, the chairman of the Board or the Company and his resignation shall enter into effect on the date the notice is delivered, unless another date is specified in the letter. A director or alternate director shall state the reasons for his resignation.

 

A notice received of the resignation of a director or an alternate director, shall be brought before the Board and the protocol of the first meeting convened after the resignation, shall record the fact of the resignation and the reasons given for it.

 

(c)The general meeting may at any time dismiss a director, by a regular resolution, provided that the director is given a reasonable opportunity to bring his position before the general meeting.

 

(d)If the Company becomes aware that a director or an alternate director was appointed contrary to the provisions of article 31(d) above (namely section 227(a) of the Companies Law) or contrary to the provisions of article 31(c) above (namely sections 226(a) and (a1) and 226a of the Companies Law), or that the director violated the provisions of article 31(a) above (namely section 225 of the Companies Law), article 31(e) above (namely section 227(b) of the Companies Law), or the provisions of article 35€ herein (namely section 232 of the Companies Law), the Board must decide in the meeting of the Board convened right after it becomes aware of such, to end the service of said director, if it finds, that the stated conditions are present, and from the date of the resolution the service shall expire.

 

25

 

 

(e)A director who is convicted of an offense as stated in articles 31(a) above shall notify the Company of such and his service will end on the date of the delivery of the notice, and he may not be re-appointed as director, unless the period in which the director may not serve has passed, as stated in article 31(c) above (namely section 226(a) and (a1) of the Companies Law). If the administrative enforcement Board decides to impose on a person enforcement measures which prohibit him to serve as director in any public company or the Company, he will notify the Company and his term will expire on the date of the delivery of the notice, and he may not be reappointed as director, unless the period of the prohibition has passed as set forth in article 31(c) above (namely section 226a of the Companies Law).

 

(f)A director (including an outside director) who no longer meets a requirements pursuant to the Companies Law in order to serve as a director (including an outside director) or if a reason for his service as director to expire exists, he will notify of such immediately to the Company, and his service shall expire on the date of the delivery of said notice.

 

(f)A director who violates the duty of disclosure pursuant to article 31(a) above (namely section 225 of the Companies Law), article 31(f) above (namely sections 227a and 245a of the Companies Law), article 31(e) above (namely section 227(b) of the Companies Law), or article 35(e) above (namely sections 232 and 232a of the Companies Law), shall be considered as someone who violated his fiduciary duty to the Company.

 

36.Authorities of the Board of Directors

 

(a)The Board shall delineate the policy of the Company and supervise the performance of the general manager and his activities, including the authorities listed in section 92(a) of the Companies Law.

 

(b)The authorities of the Board of Directors pursuant to article 36(a) above may not be delegated to the general manager other than as set forth in article 10(b) above.

 

(c)Without derogating from the authorities conferred on the Board of Directors pursuant to article 36(a) above and the rest of the authorities conferred on it by these articles, and without restricting or reducing in any manner these or any of the authorities, the Board of Directors shall have the following authorities:

 

26

 

 

(1)To appoint a person or persons (incorporated or otherwise), to receive and hold in trust for the Company any property belonging to the Company or in which the Company has an interest, or for any other purpose, and to do or perform any activity, act or things needed in respect to any such trust, and to act to pay the salaries of the trustee or trustees;

 

(2)To establish the authorized signatories of the Company for bills of exchange, promissory notes, receipts, endorsements, checks, dividend certificates, releases, contracts and other documents of any kind;

 

(3)To appoint, and in its discretion, to remove or suspend a general manager, manager, secretary, clerk, employee or agent, whether if they are employed on a permanent or interim basis or for special services, as the Board of Directors sees fit from time to time, and to define their authorities and obligations and to set their salaries and wages and to demand guarantees, in the cases and in the amounts that the Board deems fit;

 

(4)To establish local management for the management of any of the businesses of the Company in a specific place in Israel or abroad, and to appoint any persons to be local managers and to determine their wages or to dismiss any of these people from their service, and from time to time and at any time delegate to any person who is so appointed any powers or authorities or discretion that is conferred at such time on the Board, and to authorize the members at that time in any local committee, all or some, to fill any vacancy in it and to act notwithstanding the vacancies;

 

Any such appointment or delegation may be done under the same terms and subject to the same conditions that the Board deems proper in accordance with the Companies Law, and the Board may at any time cancel any appointment or delegation or change them. The Board may authorize the persons to whom powers, authorities or discretion were delegated and which are conferred on them at such time, to delegate them, all of some, with a secondary delegation;

 

(5)Subject to the provisions of relevant law, to appoint by power of attorney any person or persons to be the attorney or attorneys of the Company for the purposes and with the powers, authorities and discretion (which shall not exceed those given or conferred for use by the Board according to these articles or by law) for a period of time and subject to the same terms as the Board deems proper from time to time, and any such appointment may be given (if the Board sees fit to do so) to any local manager, or any Company or its members, its directors, agents or managers of any Company or firm or a person who is established by any Company or firm. Any such power of attorney may contain in it authorities for the protection or convenience of persons who come into contact or these attorneys as the Board deems fit;

 

27

 

 

(6)To open, manager, defend, compromise, or neglect any legal proceedings on behalf of or against the Company or against its officials or related in another manner to its affairs and to compromise or extend the time for payment or defrayal of any debt owed or actions or demands by the Company or against it;

 

(7)To deliver for arbitration any action or demand of the Company or against it;

 

(8)To appoint on behalf of the Company an attorney or attorneys in Israel or abroad to represent the Company before any court, legal and quasi legal bodies, government offices or bodies, municipal or otherwise in Israel or abroad and to confer on such attorney the authorities that the Board feels proper to give, including the authority to delegate his authorities, in whole or in part, to another or others;

 

(9)Subject to the provisions of the law (including section 113 of the Companies Law) and these articles, to delegate to any person, firm, Company or group of persons as stated, the powers, authorities and discretion conferred on the Board of Directors;

 

(10)The Board is entitled to exercise any authority of the Company which was not conferred by law or these articles to another organ of the Company.

 

37.Assumption of authorities of the Board

 

(a)The general meeting may assume authorities given to the Board for a specific matter, or for a specific time frame, that does not exceed the time required under the circumstances. The assumption of authorities shall be done after the Company adopts a resolution about the assumption in the general meeting.

 

(b)If the Board cannot exercise its authorities and the exercise of any of its authorities is essential for the proper management of the Company, the general meeting may exercise it in its stead, so long as the Board is prevented from doing so, provided that the general meeting establishes, that in fact the Board cannot do so and that the exercise of the authority is essential as stated.

 

(c)If the general meeting assumes authorities conferred by law on the Board, the shareholders shall have the rights, duties and liability applicable to the directors for the matter of the exercise of those authorities, mutatis mutandis, and, the provisions of chapters three, four and five of the Sixth Part of the Companies Law shall apply to them, taking into account their holdings in the Company, their participation in the meeting and the manner of their vote.

 

28

 

 

38.The rights of a director

 

Subject to relevant law and the issuance of the required approvals, a director shall not be disqualified, because of his office, from holding another office in the Company or in any other company in which the Company is a shareholder, or in which it has another benefit or from entering into a contract with the Company, whether as a vendor or buyer or in another manner.

 

39.Chairman of the Board

 

(a)The Board of Directors will choose, dismiss, with a normal majority of votes, one of the members of the Board to serve as chairman of the Board, and the provisions in articles 39(b) – (f) below will apply to him.

 

(b)The term of service of the chairman of the Board shall be until a resolution of the Board of the termination of his service and appointment of another chairman in his stead. However, it is understood, that an outgoing chairman may be re-appointed as chairman.

 

(c)If the service of a director is vacated for one of the instances listed in these articles and said director is the chairman of the Board, his appointment as chairman shall automatically expire, and another chairman shall be chosen in his stead.

 

(d)The chairman of the Board shall set the agenda as set forth in article 41 herein and will preside over the meetings of the Board.

 

(e)If the chairman of the Board of Directors is absent from a meeting 15 minutes from the designated time for the meeting or if he is unwilling to preside over the meeting, the Board of Directors shall elect one of its members to preside over the meeting and sign the protocol of the meeting. The chairman of the Board in such instance shall not have an extra or casting vote in any vote by the Board of Directors in the event of a tie vote.

 

(f)The chairman of the Board may serve as the CEO of the Company, or exercise his authorities for periods that do not exceed three years each from the date of the resolution, subject to and in accordance with the provisions of section 121(c) of the Companies Law.

 

40.Convening a meeting of the Board

 

(a)The Board of Directors will convene for meetings pursuant to the needs of the Company and at least once every three months.

 

29

 

 

(b)The Board will be convened according to one of the following methods:

 

(1)The chairman is entitled to convene a meeting at any time.

 

(2)In the following instances, the chairman of the Board will convene the Board without delay:

 

1.A notice or report by the general manager to the chairman of the Board about any irregular matter that is material for the Company that requires an act by the Board; and

 

2.Notice by the auditor of the Company to the chairman of the Board that he became aware during the audit of material deficiencies in the accounting audit of the Company.

 

(2)The chairman of the Board will convene the Board, at the demand of any of the directors at any time, including if a director becomes aware of a matter of the Company in which there may be an apparent violation of the law or may harm proper corporate governance, whereby he will act without delay to convene a meeting of the Board.

 

(c)If a meeting of the Board is not convened within seven days from the date of the notice or report by the general manager or the auditor as stated in article 40(b)(2) above or from the date of the demand as set forth in article 40(b)(2) above, each of those listed above, may convene a meeting of the Board to discuss the subject specified in the demand, notice or report, as the case warrants, within at least two business days prior to the date of the meeting.

 

(d)The Board may hold meetings through the use of any communications devices, provided that all the directors participating can hear each other simultaneously.

 

(e)The Board may adopt resolutions even without an actual meeting (such as in writing, fax or email), provided that all the directors who are entitled to participate in the meeting and vote on the matter brought for a resolution agree to do so.

 

(f)Resolutions adopted in the manner specified in subsection (e), shall be formalized in a protocol, including the resolution not to convene a meeting, and the protocol shall be signed by the chairman of the Board.

 

41.Agenda

 

The agenda of Board meetings shall be set by the chairman of the Board and shall include:

 

(a)Subjects set by the chairman of the Board;

 

30

 

 

(b)Subjects that were set as set forth in article 40 above; and

 

(c)Any subject that a director, the general manager and/or the auditor asks of the chairman of the Board, a reasonable time prior to the meeting, to include on the agenda.

 

42.Notice of a meeting of the Board of Directors

 

(a)Notice of a meeting of the Board shall be delivered to all the directors at least forty-eight (48) hours prior to the date designated for the meeting, unless all the directors gave prior written consent to convene the meeting within a shorter time frame, or in urgent cases – and with the consent of a majority of the directors – even without such notice.

 

(b)Notice pursuant to article 42(a) above shall be delivered to the address of the director in Israel that was previously delivered to the Company by the director in writing and which shall state the date of the meeting and the location, and a reasonable description of all the subjects on the agenda. It is understood that the dispatch of such notice covers the liability of the Company and the director is solely responsible to update the Company about a change of his address for the purpose of the sending of such notices. A change of address of the director shall be done by him in writing provided that it is delivered a reasonable time prior to the date designated for a meeting of the Board of Directors.

 

43.Quorum

 

(a)A quorum for discussion in meetings of the Board shall be determined, from time to time, by the general meeting and until decided otherwise it shall be at least the presence of half of the directors, who serve at the time of the meeting, on their own or through alternates. The quorum shall be established at the start of each meeting of the Board and shall constitute a quorum for the entire duration of the meeting, for all the resolutions that are on the agenda, even in the case or cases where a quorum is not present during the continuation of the meeting.

 

(b)If a half hour passes from the time designated for the start of the meeting of the Board and a quorum is not present, the meeting shall be adjourned for twenty-four (24) hours exactly (after the original time designated for the meeting) or to another time set by the chairman of the Board (but in any case no earlier than twenty-four (24) hours). The quorum at an adjourned meeting shall be the presence of at least two directors, who are serving at the time of the meeting, on their own or through an alternate. If the Board cannot act due to the absence of a quorum at the adjourned meeting, the general meeting may exercise the authorities of the Board for the purpose/s for which the meeting of the Board was convened and the provisions of article 37 above will apply.

 

31

 

 

(c)Each duly convened meeting of the Board of Directors, in which a quorum is present, shall have all the authorities, powers of attorney and discretion given to it at such time, according to the provisions of the Company, to the Board of Directors or those exercised by it in general.

 

(d)If a specific member is not appointed to the Board or if the office of a director is vacated, the remaining directors may operate for all matters, so long as their number is not less than the minimum fixed in article 30(a) above. If the number is less than the minimum, they may not exercise their authorities according to these articles, except to convene a general meeting with an agenda to appoint additional directors or to establish a lower minimum of directors or to appoint additional directors themselves. The general meeting may decide not to approve acts of the directors when their number falls below the minimum number and to exercise on its own the authorities of the Board, until the number of directors again reaches the minimum as set forth in article 30(a) above.

 

44.Voting on the Board

 

(a)Each director shall have one vote in each vote on a resolution.

 

(b)Resolutions of the Board shall be adopted by a regular majority of those present participating in the vote.

 

(c)If the votes are tied in a Board meeting, the proposed resolution shall be considered as rejected.

 

(d)Notwithstanding the aforesaid, resolutions on the subjects listed below shall not be adopted unless the subjects were on the agenda of the meeting that was duly convened, and there was no objection to the resolution by two or more of the members of the Board who participated in the meeting:

 

(1)Entering into new fields of activity and the expansion of the geographical field of activity of the Company;

 

(2)Investments in the field of activity of the Company (namely, not including investments in equipment) and the exercise of such investments;

 

(3)The transfer of any of the subjects mentioned in sections (1) and (2) to the authority of committees of the Board;

 

(4)Acquisition of Company shares, as defined in section 1 of the Companies Law, in a manner in which following the acquisition the Company will no longer be a public company, insofar as this resolution is brought for approval of the Board of the Company in accordance with the provisions of relevant law.

 

32

 

 

This majority shall apply also for resolutions on those subjects by committees of the Board and resolutions in subsidiaries of the Company, and resolutions in the committees of the Board and subsidiaries (1) shall be sent for a resolution of the Board; or (2) will be adopted only if the composition of the committee of the Board of Directors of the subsidiary is identical to the composition of the Board of Directors.

 

(e)A director (or alternate director) is entitled to vote on his own, in writing (inclusive of by fax or email) or verbally if the meeting takes place through means of communication where the directors who are participating can hear each other simultaneously.

 

45.Protocols in a meeting of the Board

 

(a)The Company will keep protocols of the proceedings in meetings of the Board and its committees and will keep them and the resolutions adopted without actual meetings of the Board, in the office for a period of seven years from the date of the meeting or adoption of the resolution, as the case warrants.

 

(b)A protocol approved and signed by the director who presided over the meeting, shall serve as prima facie proof of its contents.

 

(c)An announcement by the chairman of the Board, that a resolution was adopted unanimously or by a specific majority, or was rejected and a notation recorded in this matter in the protocol of the meeting of the Board, shall serve as prima facie proof of the authenticity of its contents, and it is not necessary to prove how many votes there were or how many were for or against the resolution.

 

46.Defects in the convening of a meeting

 

(a)A resolution adopted in a meeting of the Board that was convened without the prior conditions satisfied for its convening (hereinafter – “Defect in the Convening”) may be revoked at the demand of each of the following:

 

(1)A director who was present at the meeting, provided that he demanded that a resolution for which the defect was present not be adopted, prior to the adoption of the resolution; or

 

(2)A director who was entitled to be invited to a meeting but was not present, within a reasonable time after he was informed about the adoption of the resolution and no later than the first Board meeting that was held after he was informed of the resolution;

 

It is understood that if there was a defect in the convening of the meeting related to the notice about the location of the meeting or its time, a director who came to the meeting may not, notwithstanding said defect, demand the revocation of the resolution.

 

33

 

 

(b)The provisions of article 46(a) above shall not impair from the validity of an act done for the Company which was retroactively approved by the Board or if the party with whom the act was done did not know or could not have known about the irregularity or lack of authorization.

 

47.Committees of the Board

 

(a)Subject to the provisions of section 112 of the Companies Law which prohibits the delegation of authorities and the provisions of these articles (including article 44(d) above), the Board may establish committees of the Board and appoint members from among the Board only to them (hereinafter: “Board Committee”) and delegate all or some of its authorities to a Board committee. The Board may from time to time cancel the delegation of said authority,

 

Each committee that is so established must, when exercising its authorities, comply with all the regulations that are established by the Board of Directors.

 

(b)A Board committee will report to the Board on a regular basis about its decisions or recommendations. Decisions or recommendations of a Board committee which requires the approval of the Board, will be brought to the attention of the directors a reasonable time prior to the deliberations on the Board.

 

(c)The meetings of a Board committee and its management shall be in accordance with the provisions of procedures and management of meetings of the Board, as set forth in the provisions of these articles, mutatis mutandis, so long as they are appropriate and if they do not replace the instructions that are given by the Board according to this section.

 

(d)A committee of the Board whose job is to provide counsel or recommendations to the Board can be comprised of a person who is not a member of the Board.

 

(e)A resolution that is adopted or an act that is done by a committee of the Board, according to an authority that was delegated to it from the authorities of the Board, shall be the same as a resolution adopted or an act that was done by the Board. However, the Board may evoke any decision of a committee that it appointed, but such cancellation shall not harm the validity of a decision of a committee where the Company acted in accordance thereto with another person, who was not aware of the revocation.

 

34

 

 

Part Eight: Audit Committee

 

48.Appointment of an audit committee

 

(a)The Board of the Company shall appoint among its members an audit committee. The number of members of the audit committee shall be determined by the Board, from time to time provided that it shall not be less than three members and that all the outside directors will be members of the committee. The chairman of the Board and any director who is employed by the Company or by a controlling holder or by a corporation under the control of a controlling holder, a director who provides services, on a regular basis, to the Company, to a controlling holder in it or to a corporation under the control of a controlling holder, as well as a director whose main income is on the controlling holder, shall not be members of the audit committee. Likewise, a controlling holder or a relative thereof shall not be members of the audit committee.

 

(b)The audit committee shall choose one of its members who is an outside director to serve as chairman of the audit committee, by a resolution adopted by a regular majority of the audit committee present at such meeting.

 

(c)The term of office of the chairman of the audit committee shall be until a resolution of the audit committee about the termination of his term and the appointment of a chairman for the audit committee in his stead. However, it is understood that a chairman of the audit committee who ended his term of service may be reappointed.

 

49.Positions and work procedures of the audit committee

 

(a)Subject to relevant law, the positions of the audit committee shall be as described in section 117 of the Companies Law.

 

(b)The internal auditor of the Company shall receive notices about meetings of the audit committee and may participate in them. The internal auditor may ask the chairman of the audit committee to convene the committee to discuss a subject that he describes in his request, and the chairman of the audit committee will convene the meeting within a reasonable time from the request, if he sees a reason to do so.

 

(c)A notice of a meeting of the audit committee, in which a subject related to the audit of the financial statements is raised, shall be delivered to the internal auditor who is entitled to participate in it.

 

(d)Subject to the provisions of the Companies Law (including section 116a dealing with a quorum to deliberate and adopt resolutions in the audit committee and section 115(e) dealing with presence in meetings of the audit committee), the procedures of the meetings and activities of the audit committee and its management shall be in accordance with the provisions of the procedures and management of meetings of the Board of Directors, as described in these articles, mutatis mutandis, insofar as they are appropriate and insofar as they do not replace instructions given by the Board pursuant to this section.

 

35

 

 

Part Nine: Exemption, indemnification and liability insurance

 

50.Exemption and indemnification

 

(a)The Company is entitled to exempt in advance an office holder from his liability, in whole or in part, for damage due to a breach of the duty of care to the Company, other than a breach of the duty of care in a distribution.

 

(b)The Company may indemnify an office holder for an obligation or expense as described in paragraphs (1) – (6) herein, imposed on him following an act that he did by virtue of his being an office holder:

 

(1)A monetary duty imposed on him or expended in favor of another person by a court judgment, including a judgment issued as a settlement or a ruling of an arbitrator that is ratified by a court;

 

(2)Reasonable litigation costs, including legal fees, expended by the office holder following an investigation or proceeding that was conducted against him by the competent authority to carry out an investigation or proceeding, and which concluded without the filing of an indictment against him and without having imposed on him a monetary obligation as an alternative to a criminal proceeding, or which ended without an indictment against him but with the imposition of a monetary obligation as an alternative to a criminal proceeding for an offense that does not require proof of criminal intent or in connection to a monetary sanction;

 

The terms “conclusion of a proceeding without the filing of an indictment in a matter in which a criminal investigation was opened” and – “monetary obligation as an alternative to a criminal proceeding”, in this article shall be attributed the meaning given to them by section 260(a)(1a) of the Companies Law.

 

(3)Reasonable litigation costs, including legal fees that the officer expended or which he was charged to pay by a court, in a proceeding filed against him by the Company or on its behalf or by another person, or in a criminal indictment for which he was acquitted, or an indictment for which he was convicted of a crime that does not require proof of criminal intent.

 

(4)Other expenses expended in respect to an administrative proceeding that was conducted on his case, including reasonable litigation costs, including legal fees.

 

For this purpose “an Administrative Proceeding” - a proceeding pursuant to Parts 8(3) (Imposition of a monetary sanction by the Securities Authority), 8(4) (Imposition of administrative enforcement measures by the Administrative Enforcement Committee), or 9(1) (An Arrangement to prevent proceedings or to halt proceedings that is predicated on conditions) of the Securities Law, as amended from time to time, and a proceeding according to Section D’ of Chapter Four in Part Nine of the Companies Law and subject to any relevant law, any similar proceeding to these, by whatever name it is called.

 

36

 

 

(5)Payment to a person injured by a violation as stated in section 52(54)(a)(1)(a) of the Securities Law.

 

(6)Any other obligation or expense imposed on him or expended, following an act that he did by virtue of his being an officer in it, for which indemnification can be made according to the provisions of relevant law.

 

(c)The Company may give indemnification in one of the following ways:

 

(1)By giving an undertaking in advance to indemnify an office holder of the Company in each of the following (hereinafter: “Undertaking to Indemnify”):

 

(a)As set forth in article 50(b)(1) above, provided that the undertaking for indemnification for a monetary obligation is limited to events which according to the Board of Directors are foreseeable in light of the Company’s actual activity at the time of the giving of the undertaking for indemnification and for a sum or criteria that the Board of Directors establishes is reasonable under the circumstances, and where the undertaking for indemnification will state the events which the Board of Directors feel are foreseeable in light of the Company’s actual activity at the time of the giving of the undertaking as well as the sum or the criteria which the Board establishes are reasonable under the circumstances.

 

(b)As set forth in Articles 50(b)(2), 50(b)(3), 50(b)(4), 50(b)(5), and 50(b)(6).

 

(2)To indemnify the office holder of the Company retroactively.

 

51.Liability insurance

 

(a)The Company may enter into a contract for liability insurance for an officer of the Company for a liability that will be imposed on said officer for an act taken by virtue of his being an officer in the Company, for each of the following:

 

(1)A breach of the duty of care towards the Company or another person;

 

37

 

 

(2)Breach of a fiduciary duty against the Company provided that the officer acted in good faith and had reasonable grounds to assume that the action would not harm the welfare of the Company;

 

(3)A monetary obligation that is imposed on him in favor of another person;

 

(4)Other expenses expended by the office holder in respect to an administrative proceeding conducted in his case, including reasonable litigation expenses, including legal fees;

 

For this matter “Administrative Proceeding” – as defined in article 50(b)(4) above;

 

(5)Payment to a victim of a breach as contemplated by section 52(54)(a)(1)(a) of the Securities Law;

 

(6)Any additional obligation that may be insured by law.

 

(b)In any case where the insurance contract will have coverage for the Company itself, the office holder shall have the preemptive right instead of the Company in receiving insurance compensation.

 

Part Ten: General Manager

 

52.General Manager

 

(a)A general manager of the Company will be appointed and dismissed according to a resolution adopted by the Board of Directors of the Company, and it may appoint more than one general manager, for a fixed period of time or without any time limitation, and it may from time to time dismiss or release him or them from their office and appoint another or others in his or their stead.

 

(b)Subject to the provisions of an employment agreement between the general manager and the Company, the general manager is responsible for the ongoing management of the affairs of the Company as part of the policy set by the Board and subject to its instructions.

 

Subject to the provisions of the agreement between the general manager and the Company, the general manager will have all the authorities of management and implementation that were not conferred by law or these articles to another body of the Company, and he may be supervised by the Board, provided that if the general meeting enacts a new regulation it shall not be in his power to cancel or revoke the lawful validity of a deed done prior to such by the general meeting or in accordance with its instructions, which would have been valid if not for the new regulation that was enacted.

 

38

 

 

(d)Subject to the provisions of the law and articles 36(a) and 36(b) above, the Board of Directors may from time to time deliver and confer on the general manager at such time, some of those authorities by which it acts according to these articles, as it deems fit to manage the ordinary business of the Company and it may confer authorities for a period of time, and for certain purposes and needs for those times and under such conditions and restrictions as it deems fit as stated above.

 

(e)The general manager must notify the chairman of the Board of Directors about any irregular matter that is material to the Company; if the Company does not have a chairman of the Board or if he is prevented from serving in such capacity, the general manager will notify all the directors.

 

(f)Office holders of the Company, other than directors and the general manager (namely, a chief business manager, deputy to the general manager, legal advisor, any replacement as stated in the Company even if his title is different, and another manager subject directly to the general manager) shall be appointed and dismissed by the general manager, without derogating from the provisions of the Companies Law dealing with the approval of the terms of service and employment of an office holder.

 

53.Removal of authorities from the general manager

 

The Board of Directors may instruct the general manager how to act for a specific matter; if the general manager does not satisfy the provision and/or the general manager is prevented from exercising his authorities, the Board of Directors may exercise the required authority to implement the instruction and/or to exercise his authorities in his stead.

 

Part Eleven: Management of the Company

 

54.Registered office

 

(a)The Company will maintain an office in Israel, to which any notice to the Company can be sent. Without derogating from the provisions of any law, the Company will keep in its registered office documents as set forth in section 124 of the Companies Law.

 

(b)Delivery of a document to the Company shall be to the office as it is registered with the Companies Registrar at the time it is sent to the Company by mail.

 

(c)A person who is entitled to inspect documents, is entitled to receive a copy of them for a fee that the Board or the general manager establishes.

 

55.Register of shareholders and register of material shareholders

 

(a)The Company shall keep a register of shareholders and a register of material shareholders and will update the changes to them as soon as possible after it becomes aware of them.

 

(b)The shareholder register and the material shareholder register shall be open for inspection by any person.

 

(c)The details enumerated in section 130(a) of the Companies Law shall be recorded in the shareholder register.

 

(d)The material shareholder register shall contain reports that the Company received pursuant to the Securities Law about the holdings of the material shareholders in Company shares.

 

39

 

 

(e)The Company will keep all the records that are recorded in the shareholder register as set forth in article 55(c) above.

 

(f)The shareholder register will be prima facie proof of the contents recorded in it.

 

(g)In the case of a contradiction between the shareholder register and a share certificate, the shareholder register shall have more evidentiary value than that of the share certificate.

 

56.Auditor

 

(a)The Company will appoint an auditor who will audit the annual financial statements of the Company and give his opinion about them (hereinafter: “Audit Activity”).

 

(b)An auditor will be appointed at each annual meeting and shall serve in his capacity until the end of the following annual meeting; however, the general meeting may appoint an auditor who will serve in his position for a longer period of time, that shall not be longer than the end of the third annual meeting after the one in which he is appointed.

 

(c)The Company may appoint a number of auditors to carry out the audit activity together.

 

(d)If the office of the auditor is vacated and the Company does not have another auditor, the Board will convene a special meeting, as soon as possible, with the agenda of appointing an auditor.

 

57.Expiration of the term of the auditor

 

(a)The general meeting may terminate the service of the auditor.

 

If the agenda of the Company includes the termination of the service of the auditor or the non-renewal of his service, the audit committee will bring its position before the general meeting, after affording the auditor a reasonable opportunity to bring his position before it.

 

(b)If the Board becomes aware that there are dependent relationships pursuant to the provisions of section 160 of the Companies Law, it will notify the auditor without delay that he must act to cease such dependency immediately; if the dependency continues, the Board will convene a special meeting within a reasonable time period, with the agenda to terminate the service of the auditor.

 

(c)The general meeting that is convened as set forth in article 57(b) above, shall decide on the termination of the service of the auditor; however, the general meeting may, after the auditor brings his position before it, decide not to accept the recommendation of the Board to end his service, if it finds that the auditor has no dependency in the Company.

 

(d)The Board of Directors will give the auditor a reasonable opportunity to bring his position before the general meeting with the agenda of ending or not renewing his service, and for this purpose the auditor will be invited to participate in the general meeting.

 

40

 

 

(e)If the auditor resigns for reasons that involve an interest for shareholders in the Company, the Board will notify the Company of such.

 

(f)Without derogating from the provisions of relevant law, the Board of Directors will notify the shareholders about the reasons for the resignation of the auditor as it deems fit, and it may also give notice about its position in the matter.

 

58.Wages of the auditor

 

(a)The salary of the auditor for the audit activity and for additional services, shall be set by the Board of Directors, in accordance with the extent of the work, the duration of his employment and any additional relevant term related to his employment.

 

The Board will notify the general meeting about the wages of the auditor, and all matters related to his salary for additional services – also about the terms of contract with the auditor, including payments and undertakings of the Company towards the auditor.

 

For the purpose of this section – an accountant auditor – including a partner, employee or relative of the accountant and including a corporation under his control.

 

(b)The Company will not stipulate the payment of the fee of the auditor on terms that limit the manner of his performance of the audit activity or which make a connection between the results of the audit and his fees.

 

(c)The Company or anyone on its behalf shall not indemnify, directly or indirectly, the auditor, for an obligation imposed on him due to a breach of his professional responsibility in providing services that must be provided by an accountant auditor by law, or following the violation of another duty imposed on him by law.

 

59.Authorities, duties and responsibility of the accountant auditor

 

(a)The auditor may at any time inspect documents of the Company required by him to perform his job and receive explanations about them.

 

(b)The auditor may participate in any general meeting in which financial statements are submitted for which he conducted audit activity and any meeting of the Board which deliberates the approval of the financial statements, in meetings of the committee to inspect the financial statements and in meetings of the Board convened pursuant to article 40(b)(2)2 above; the Board of Directors will notify the auditor of the place and time of the general meeting or the Board or committee meeting for the examination of the financial statements.

 

(c)If the auditor becomes aware during his audit activity about material defects in the accounting audit of the Company, he will notify the chairman of the Board of such.

 

41

 

 

60.Internal auditor

 

(a)The Board of Directors of the Company will appoint an internal auditor; the internal auditor will be appointed in accordance with the recommendation of the audit committee.

An internal auditor shall not be an interested party in the Company, an officer in the Company, a relative of any of the above, or the auditing accountant or his representative

 

(b)The organizational supervisor over the internal auditor shall be the chairman of the Board, or whoever the Board of the Company determines from time to time.

 

(c)The internal auditor will check, inter alia, the validity of the activities of the Company in respect to compliance with the law and proper corporate governance.

 

(d)The term of service of the internal auditor shall not be terminated without his consent and he shall not be suspended, unless the Board decides on such after obtaining the position of the audit committee, and after giving the internal auditor a reasonable opportunity to state his position before the Board and before the audit committee.

 

For this purpose, the quorum for the opening of a meeting of the Board shall not be less than a majority of the directors.

 

Part Twelve: Financial statements and signature

 

61.Financial statements

 

The Company will keep accounts, and likewise will keep financial statements pursuant to the Securities Law.

 

62.Stamp and signatory right

 

(a)The Company may establish a stamp or rubber stamps for sealing documents.

 

(b)The Board will determine the person or persons (even if they are not directors) who are authorized to sign on behalf of the Company, and their signatures together with the stamp of the Company or its printed name shall bind the Company, provided that he or they acted and signed within their authority or authorities.

 

Part Thirteen: Dividends and Bonus Shares

 

63.Dividends and bonus shares

 

(a)A resolution by the Company to distribute dividends or allocate bonus shares shall be adopted by the Board of Directors of the Company. The Board of the Company shall decide on the date for payment of the dividend.

 

(b)In addition, the Board may, prior to offering a dividend, allocate from the profits of the Company, amounts, as it deems fit, as a reserve fund or funds as they establish, in the sole discretion of the Board of Directors, for unforeseeable needs or to equalize dividends with special dividends to correct, to improve or to maintain any property of the Company, and for many other types of purposes, as the Board, according to their absolute discretion, believes is beneficial for the affairs of the Company, and it may invest these allocated sums in investments that they feel are proper (other than in shares of the Company), and from time to time manage these investments or change them and use all or some of them for the benefit of the Company, and it may divide the reserve fund into special funds, as it deems fit, and use the fund or any part of it for the Company’s business, without having to keep the monies separate from the rest of the assets of the Company.

 

42

 

 

(c)A Board of Directors which announces the distribution of dividends may decide that this dividend be paid in full or in part by distribution of certain assets, in particular by the distribution of fully paid up shares, bonds or a series of bonds of any other company, or in one or more of these methods.

 

(d)In order to validate a resolution of the Board (including according to article 63(c) above), the Board may:

 

(1)Resolve any difficulty that may arise in respect to the distribution of a dividend and/or allocation of bonus shares as it deems fit;

 

(2)Issue partial certificates, including certificates for fractional shares or decide not to count fractions under a certain amount, or sell fractions and transfer their consideration to those eligible to receive them;

 

(3)To establish for the distribution of a dividend and/or allocation of bonus shares the value of any specific asset;

 

(4)To decide that payment in cash will be done for shareholders on the basis of the value that will be so established, or that parts the value of which are less than one shekel will not be taken into account in order to adjust the rights of all the parties;

 

(5)To deposit such monies or specific assets with trustees against securities, for persons eligible to receive dividends and/or bonus shares or to a fund that was converted into capital;

 

(6)If required, a proper contract will be drawn up and the Board may appoint a person to sign such contract on behalf of those eligible to receive dividends, bonus shares and/or fund converted into capital and such appointment will be valid; and/or

 

(7)To make any other arrangement (in respect to the distribution of dividends and/or allocation of bonus shares), as the Board of Directors deems fit according to its sole discretion.

 

(e)The Board of Directors may deduct and offset from any dividend, bonus or other monies that are due to be paid for shares held by a shareholder, whether or not he is the sole owner or holds the share jointly with others, all sums of money owed from him which he must defray on his own or jointly with any other person to the Company on account of calls for payment etc.

 

(f)A shareholder shall not be entitled to a dividend if he has not delivered by the date designated for such, a bank account into which the relevant sums are to be transferred. Further, a shareholder is not entitled to change the bank account number a reasonable time (to be set by the Board) prior to the date for the actual distribution of the dividend by the Company.

 

(g)The Board may invest each dividend that is not claimed within one year from the announcement of its distribution or to use it in another manner for the benefit of the Company until it is claimed. The Company is not obligated to pay interest or linkage for an unclaimed dividend.

 

(h)Shareholders entitled to a dividend, are shareholders as of the designated date for the distribution of the dividend as established in the resolution of the Board of Directors or by virtue thereof, and subject to the provisions of relevant law.

 

43

 

 

Part Fourteen: Notices and Dissolution

 

64.Notices

 

Subject to the provisions of article 21 above (to wit notice of a meeting), the arrangement set forth in article 21 above shall apply:

 

(a)The Company is entitled to deliver notice to any shareholder by personal delivery, by fax, by email or by dispatch by mail in a letter, prepaid envelope or packaging intended for the shareholder, to the address as delivered to the Company at the time of the allocation of the shares or transfer of the shares, unless said shareholder gave written notice of a change of his address (hereinafter: “Registered Address”).

 

(b)A shareholder shoes registered address is outside of Israel may, from time to time, give written notice to the Company about an address in Israel, and that address will be considered as his address for the delivery of notices – as stated above.

 

(c)All notices regarding shares, to which persons are jointly entitled, shall be delivered to the person who appears first in the shareholder register, unless they deliver other instructions, and a notice sent as stated shall serve as sufficient notice to all these shareholders.

 

(d)Any notice sent to a shareholder to his registered address, by Israel post to an address in Israel shall be considered as having been delivered three (3) business days from the day dispatch of the letter or envelope or other packaging containing the letter was delivered to the post office properly bearing the registered address of the recipient and delivered to the post office. A written certificate signed by the secretary or manager or other official of the Company that the letter, envelope or packaging containing the notice with the registered address was delivered to the post office as stated, shall serve as prima facie proof of the fact. Any notice sent by fax shall be considered as having been delivered one (1) day from the day it was sent, provided that confirmation of the dispatch of the fax is presented, and if hand delivered – at the time of delivery.

 

(e)A person who becomes eligible to a share by virtue of the law, a transfer or in any other manner, shall be copied on every notice for such share, that was duly delivered to the registered address of the shareholder (from whom the right to the share is derived) registered in the shareholder register.

 

(f)Any notice or document sent by post to a shareholder or left at his registered address, then notwithstanding the fact that said shareholder died – and it does not matter if the Company knew of the death or not – shall be seen as having been duly delivered in respect to all the shares registered, whether if they were held by the same shareholder separately or jointly with other persons, until the other person will be registered in his place as the owner or the joint owner of the shares, and such delivery will be seen, for the purposes of these articles, as sufficient delivery of the notice or the document to the personal representative, or all persons, if any, jointly interested in the same shares. Without derogating from the foregoing generality, a notice to a shareholder shall be delivered also to persons who have a right to a share due to the death or bankruptcy of a shareholder or if the shareholder is a corporation – in the event of its receivership or dissolution, after the receiver or liquidator, as warranted, is registered as the shareholder in the shareholder register.

 

44

 

 

65.Dissolution

 

(a)Without derogating from the authority of the liquidator pursuant to section 334 of the Companies Ordinance and subject to special conditions, benefits and restrictions attached to shares of the Company, shares of the Company shall have equal rights regarding the return of the capital and participation in the distribution of surplus assets of the Company whether if the Company winds up voluntarily or whether in any other manner, after defrayal of all the obligations of the Company, its assets shall be distributed, among all the shareholders, proportionate to the nominal value of their shares without taking into account any premium paid on them.

 

(b)For the purpose of article 65(a) above, a person who is entitled to shares but have not yet been allocated the shares, shall be considered as if the shares to which he is entitled were allocated to him prior to the dissolution, and that the amount paid on account of the nominal value of the shares has been paid up. In this case one who is entitled to the shares, is entitled to payment of an equal sum to the amount that he would have received in a dissolution if he would have held the shares of the Company on the eve of the adoption of the resolution of the dissolution, with a deduction of the price of the exercise that he would have had to pay if he would have exercised his right to the shares of the Company on the eve of the resolution of the dissolution.

 

(c)If the Company winds up and the property of the Company that is to be distributed among the members is not enough to return all the paid up capital, these assets will be distributed inasmuch as possible in a proportionate manner to the paid up capital, or which is considered paid up at the start of the dissolution, of the shares held by each of the members.

 

66.Forum.

 

Unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933. Any person or entity purchasing or otherwise acquiring any interest in any security of the Company shall be deemed to have notice of and consented to this provision.

 

***********************

 

 

45

 

  

Exhibit 2.1

 

DESCRIPTION OF SECURITIES

REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT

 

The descriptions of the securities contained herein summarize the material terms and provisions of the ordinary shares and warrants of Beamr Imaging Ltd. (the “Company”, “we”, “our” or “us”), registered under Section 12 of the Securities Exchange Act of 1934.

 

General

 

Our authorized share capital consists of 222,000,000 ordinary shares, par value NIS 0.05 per ordinary share.

  

All of our outstanding ordinary shares are validly issued, fully paid and non-assessable. Our ordinary shares are not redeemable and do not have any preemptive rights.

 

All ordinary shares have identical voting and other rights in all respects.

 

The Nasdaq Capital Market

 

Our ordinary shares are listed on the Nasdaq Capital Market under the symbol “BMR”.

 

Articles of Association

  

The following are summaries of material provisions of our articles of association and the Israeli Companies Law, 5759-1999, as amended, (the “Companies Law”) insofar as they relate to the material terms of our ordinary shares.

 

Purposes and Objects of the Company

 

Our purpose as set forth in our articles of association is to engage in any lawful activity.

 

Registration Number

 

Our registration number with the Israeli Registrar of Companies is 514331552.

 

The Powers of the Directors

 

Our Board of Directors shall direct our policy and shall supervise the performance of our Chief Executive Officer and his actions. Our Board of Directors may exercise all powers that are not required under the Companies Law or under our amended and restated articles of association to be exercised or taken by our shareholders.

 

Rights Attached to Shares

 

Our ordinary shares shall confer upon the holders thereof:

 

equal right to attend and to vote at all of our general meetings, whether regular or special, with each ordinary share entitling the holder thereof, which attend the meeting and participate at the voting, either in person or by a proxy or by a written ballot, to one vote;

 

equal right to participate in distribution of dividends, if any, whether payable in cash or in bonus shares, in distribution of assets or in any other distribution, on a per share pro rata basis; and

 

equal right to participate, upon our dissolution, in the distribution of our assets legally available for distribution, on a per share pro rata basis.

 

 

 

 

Election of Directors

 

Under our amended and restated articles of association, our Board of Directors must consist of at least five and not more than 10 directors (including external directors under Israeli law, if any).  Our ordinary shares do not have cumulative voting rights in the election of directors. As a result, the holders of a majority of the voting power represented at a shareholders meeting and voting on the matter have the power to elect all of our directors (other than with respect to the special approval requirements for the election of external directors, if applicable).

 

Pursuant to our amended and restated articles of association, other than the external directors (if any), for whom special election requirements apply under the Companies Law, our directors are divided into three classes, one class being elected each year at the annual general meeting of our shareholders, and serve on Board of Directors until the third annual general meeting following such election or re-election or until they are removed by a vote of 65% of the total voting power of our shareholders or upon the occurrence of certain events, in accordance with the Companies Law and our amended and restated articles of association. In addition, our amended and restated articles of association allow our board of directors to appoint directors (who are not external directors) to fill vacancies on the Board of Directors up to the maximum number of directors permitted under our amended and restated articles of association. Any director so appointed serves for a term of office equal to the remaining period of the term of office of the director whose office has been vacated (or in the case of any new director, for a term of office according to the class to which such director was assigned upon appointment).

 

Annual and Special Meetings

 

Under the Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year, at such time and place which shall be determined by our Board of Directors, that must be no later than 15 months after the date of the previous annual general meeting. All meetings other than the annual general meeting of shareholders are referred to as special general meetings. Our Board of Directors may call special meetings whenever it sees fit, upon request of two directors or one-quarter of the directors in office; and upon the request of any shareholder or shareholders holding at least five percent (5%) or a higher percent of our voting rights

 

Subject to the provisions of the Companies Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of record on a date to be decided by the board of directors, which may be between four and twenty one days prior to the date of the meeting. Resolutions regarding the following matters must be passed at a general meeting of our shareholders:

 

amendments to our amended and restated articles of association;

 

the exercise of our Board of Director’s powers by a general meeting if our Board of Directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management;

 

appointment or termination of our auditor, his conditions of employment and termination of his employment;

 

appointment of directors, including external directors;

 

approval of acts and transactions requiring general meeting approval pursuant to the provisions of the Companies Law (mainly certain related party transactions) and any other applicable law;

 

increases or reductions of our authorized share capital; and

 

a merger (as such term is defined in the Companies Law).

 

Notices

 

Our amended and restated articles of association and the Companies Law require that a notice of any annual or special shareholders meeting be provided at least 14 days prior to the meeting, and if the agenda of the meeting includes (1) the appointment or removal of directors; (2) the approval of acts and / or transactions with office holders or interested or related parties, approval of the company’s general manager or its relative to serve as the chairman of the board of directors and to exercise its powers or the approval of the chairman of the board of directors or its relative to serve as the company’s general manager; (3) an approval of a merger; or; (4) any other matter in respect of which there is a provision in the articles of association or thereunder to the effect that decisions of the general meeting may also be passed by means of a voting paper, notice must be provided at least 35 days prior to the meeting.

 

2

 

 

Quorum

 

As permitted under the Companies Law, the quorum required for our general meetings will consist of at least two shareholders present in person, by proxy, written ballot or voting by means of electronic voting system, who hold or represent between them at least 25% of the total outstanding voting rights. If within half an hour of the time set forth for the general meeting a quorum is not present, the general meeting shall stand adjourned the same day of the following week, at the same hour and in the same place, or to such other date, time and place as prescribed in the notice to the shareholders and in such adjourned meeting, if no quorum is present at the adjourned meeting within half an hour of the time arranged, any number of shareholders participating in the meeting, shall constitute a quorum.

 

If a special general meeting was summoned following the request of a shareholder, the adjourned meeting shall only take place only if there were present at least the number of shareholders required to convene a meeting as provided in section 63 of the Companies Law.  

 

Adoption of Resolutions

 

Our amended and restated articles of association provide that all resolutions of our shareholders will require a simple majority vote, unless otherwise required under the Companies Law or our amended and restated articles of association. A shareholder may vote in a general meeting in person, by proxy, by a written ballot.

 

Changing Rights Attached to Shares

 

Unless otherwise provided by the terms of the shares and subject to any applicable law, any modification of rights attached to any class of shares must be adopted by the holders of a majority of the shares of that class present a general meeting of the affected class or by a written consent of all the shareholders of the affected class.

 

The enlargement of an existing class of shares or the issuance of additional shares thereof, shall not be deemed to modify the rights attached to the previously issued shares of such class or of any other class, unless otherwise provided by the terms of the shares.

 

Limitations on the Right to Own Securities in Our Company

 

There are no limitations on the right to own our securities.  

 

Provisions Restricting Change in Control of Our Company

 

There are no specific provisions of our amended and restated articles of association that would have an effect of delaying, deferring or preventing a change in control of our company or that would operate only with respect to a merger, acquisition or corporate restructuring involving us (or our Subsidiary). However, as described below, certain provisions of the Companies Law may have such effect.

 

The Companies Law includes provisions that allow a merger transaction and requires that each company that is a party to the merger have the transaction approved by its board of directors and, unless certain requirements described under the Companies Law are met, a vote of the majority of shareholders, and, in the case of the target company, also a majority vote of each class of its shares.  For purposes of the shareholder vote of each party (unless a court rules otherwise on the application of the shareholders holding at least twenty five percent of all the voting rights in the company), the merger will not be deemed approved if shares representing a majority of the voting power present at the shareholders meeting and which are not held by the other party to the merger the person so holding or anyone acting on behalf of either of these, including relatives or corporations under their control or by any person or group of persons acting in concert who holds 25% or more of the voting power or the right to appoint 25% or more of the directors of the other party vote against the merger. If, however, the merger involves a merger with a company’s own controlling shareholder or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to the same Special Majority approval that governs all extraordinary transactions with controlling shareholders. Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that as a result of the merger the surviving company will be unable to satisfy the obligations of any of the parties to the merger, and may further give instructions to secure the rights of creditors. If the transaction would have been approved by the shareholders of a merging company but for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the petition of holders of at least 25% of the voting rights of a company. For such petition to be granted, the court must find that the merger is fair and reasonable, taking into account the value of the parties to the merger and the consideration offered to the shareholders. In addition, a merger may not be completed unless the Registrar of Companies has received all the required approvals for merger from each of the merging companies and at least (1) 50 days have passed from the time that the requisite proposals for approval of the merger were filed with the Israeli Registrar of Companies by each merging company and (2) 30 days have passed since the merger was approved by the shareholders of each merging company.

 

3

 

 

The Companies Law also provides that, subject to certain exceptions, an acquisition of shares in an Israeli public company must be made by means of a “special” tender offer if as a result of the acquisition (1) the purchaser would become a controlling shareholder if there is no controlling shareholder in the company or (2) the purchaser would become a holder of 45% or more of the voting rights in the company, unless there is already a holder of more than 45% of the voting rights in the company. These requirements do not apply if, in general, the acquisition (1) was made in a private placement that received shareholders’ approval, subject to certain conditions, (2) was from a controlling shareholder in the company which resulted in the acquirer becoming a controlling shareholder in the company, or (3) was from a holder of more than 45% of the voting rights in the company which resulted in the acquirer becoming a holder of more than 45% of the voting rights in the company. A “special” tender offer must be extended to all shareholders. In general, a “special” tender offer may be consummated only if (1) at least 5% of the voting power attached to the company’s outstanding shares will be acquired by the offeror and (2) the offer is accepted by a majority of the offerees who notified the company of their position in connection with such offer (excluding the offeror, controlling shareholders, holders of a control block, any person having a personal interest in the acceptance of the tender offer or anyone on the behalf of the abovementioned, including their relatives or corporations under their control. If a special tender offer is accepted, then the purchaser or any person or entity controlling it or any entity under common control with the purchaser or such controlling person may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer.

 

If, as a result of an acquisition of shares, the acquirer will hold more than 90% of an Israeli company’s outstanding shares or of certain class of shares, the acquisition must be made by means of a tender offer for all of the outstanding shares, or for all of the outstanding shares of such class, as applicable, or the Takeover Bid. In general, if less than 5% of the outstanding shares, or of applicable class, are not tendered in the Takeover Bid and more than half of the offerees who have no personal interest in the offer tendered their shares, all the shares that the acquirer offered to purchase will be transferred to him by operation of law, and the records of ownership of the shares shall be amended accordingly. However, a Takeover Bid will also be accepted if the shareholders who do not accept the offer hold less than 2% of the issued and outstanding share capital of the company or of the applicable class of shares. Any shareholders that was an offeree in such Takeover Bid, whether such shareholder accepted the Takeover Bid or not, may request, by petition to an Israeli court, for a period of six months following the acceptance of the Takeover Bid, (i) a ruling stating that the consideration for the shares was less than their fair value, and (ii) that the fair value should be paid as determined by the court. However, the acquirer is entitled to stipulate, under certain conditions, that tendering shareholders will forfeit such appraisal rights.

 

Lastly, Israeli tax ordinance treats some acquisitions, such as stock-for-stock exchanges between Israeli companies, less favorably than U.S. tax laws. For example, Israeli tax ordinance may, under certain circumstances, subject a shareholder who exchanges his ordinary shares for shares in another corporation to taxation prior to the sale of the shares received in such stock-for-stock swap.

 

4

 

 

Exclusive Forum

 

Our amended and restated articles of association provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended (the “Securities Act”). Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both U.S. state and federal courts have jurisdiction to entertain such claims. This choice of forum provision may limit a shareholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees and may increase the costs associated with such lawsuits, which may discourage such lawsuits against us and our directors, officers and employees. Further, the enforceability of similar forum provisions (including exclusive federal forum provisions for actions, suits, or proceedings asserting a cause of action arising under the Securities Act) in other companies’ organizational documents and similar agreements has been challenged in legal proceedings, and there is uncertainty as to whether courts would enforce the exclusive forum provision in our amended and restated articles of association. If a court were to find these provisions of our amended and restated articles of association are inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition. Any person or entity purchasing or otherwise acquiring any interest in our share capital shall be deemed to have notice of and to have consented to the choice of forum provisions of our amended and restated articles of association are described above. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. Our amended and restated articles of association also provide that unless we consent in writing to the selection of an alternative forum, the competent courts in Tel Aviv, Israel, shall be the exclusive forum for any derivative action or proceeding brought on behalf of our company, any action asserting a breach of a fiduciary duty owed by any of our directors, officers or other employees to our company or our shareholders or any action asserting a claim arising pursuant to any provision of the Companies Law or the Israeli Securities Law, 1968.

 

Changes in Our Capital

 

The general meeting may, by a simple majority vote of the shareholders attending the general meeting:

 

increase our registered share capital by the creation of new shares from the existing class or a new class, as determined by the general meeting;

 

cancel any registered share capital which have not been taken or agreed to be taken by any person;

 

consolidate and divide all or any of our share capital into shares of larger nominal value than our existing shares;

 

subdivide our existing shares or any of them, our share capital or any of it, into shares of smaller nominal value than is fixed; and

 

reduce our share capital and any fund reserved for capital redemption in any manner, and with and subject to any incident authorized, and consent required, by the Companies Law.

 

 

5

 

 

Exhibit 11.1

 

BEAMR IMAGING LTD.

 

INSIDER TRADING POLICY

AND GUIDELINES WITH RESPECT TO
CERTAIN TRANSACTIONS IN COMPANY SECURITIES

 

Date: May 22, 2024

 

This Insider Trading Policy (the “Policy”) provides guidelines to directors, officers, employees and other related individuals of Beamr Imaging Ltd, an Israeli company (the “Company”), with respect to transactions in the Company’s securities. The Company has adopted this Policy in order to ensure compliance with securities laws and to avoid even the appearance of improper conduct by anyone associated with the Company. Failure to comply with these procedures could result in a serious violation of the securities laws by you and/or the Company and can result in both civil penalties and criminal fines and imprisonment. We have all worked hard to establish the Company’s reputation for integrity and ethical conduct, and we are all responsible for preserving and enhancing this reputation. The appearance of insider trading can cause a substantial loss of confidence in the Company and its shares on the part of the public and the securities markets. This could result in an adverse impact on the Company and its shareholders. Accordingly, avoiding the appearance of engaging in share transactions on the basis of material undisclosed information can be as important as avoiding a transaction actually based on such information. The Company has appointed its Chief Financial Officer, or in his or her absence, the Company’s Chief Executive Officer (the “Compliance Officer,” as the case may be), as the Company’s Insider Trading Compliance Officer.

 

I. Applicability of Policy

 

This Policy applies to all transactions in the Company’s securities, including ordinary shares, options and any other securities the Company may issue from time to time, such as preferred shares, warrants, notes, and convertible debentures, as well as to derivative securities relating to the Company’s shares, whether or not issued by the Company, such as exchange-traded options and debt securities. It applies to all officers of the Company, all members of the Company’s Board of Directors, and all employees of, and consultants and contractors to, the Company and its subsidiaries/branches who receive or have access to Material Nonpublic Information (as defined below) regarding the Company (collectively, “Company Affiliated Persons”). Company Affiliated Persons, members of their immediate families (which include spouse and minor children), members of their households, other family members living with them or who are supported by them, are sometimes referred to in this Policy as “Insiders”. This Policy also applies to any trust or other estate in which an Insider has a substantial beneficial interest or as to which he or she serves as trustee or in a similar fiduciary capacity, and to any trust, corporation, partnership or other entity which the Insider controls, including venture capital partnerships. This Policy also applies to any person who receives Material Nonpublic Information from any Insider.

 

Any person who possesses Material Nonpublic Information regarding the Company is an Insider for so long as the information is not publicly known. Any employee can be an Insider from time to time, and would at those times be subject to this Policy.

 

The Policy imposes additional restrictions upon Insiders who have routine access to Material Nonpublic Information, referred to as “Access Insiders.” Access Insiders are: (1) members of the board of directors, (2) the executive officers (including all vice presidents), (3) the controller, and (4) the investor relations department of the Company (once established). In addition, other employees of the Company who have routine access to Material Nonpublic Information as determined by the Compliance Officer, who were notified that these additional restrictions apply to them shall also be Access Insiders until otherwise determined by the Compliance Officer.

 

 

 

 

II. General Policy

 

It is the policy of the Company to oppose the unauthorized disclosure of any nonpublic information acquired in the work-place and the misuse of Material Nonpublic Information in securities trading.

 

III. Specific Policies

 

1. Trading on Material Nonpublic Information. No Insider shall engage in any transaction involving a purchase or sale of the Company’s securities, including any offer to purchase or offer to sell, during any period commencing with the time that he or she first receives Material Nonpublic Information concerning the Company, and ending at the close of business on the first Trading Day following the date of public disclosure of that information, or at such time as such nonpublic information is no longer material. As used herein, the term “Trading Day” shall mean a day on which the NASDAQ Capital Market is open for trading.

 

2. Tipping. No Insider shall disclose (sometimes called a “Tip”) Material Nonpublic Information to any other person (including family members) where such information may be used by such person to his or her profit by trading in the securities of companies to which such information relates, nor shall such Insider or related person make recommendations or express opinions on the basis of Material Nonpublic Information as to trading in the Company’s securities.

 

3. Confidentiality of Nonpublic Information. Nonpublic information relating to the Company is the property of the Company and the unauthorized disclosure of such information is forbidden. In the event any officer, director or employee of the Company receives any inquiry from outside the Company, such as a stock analyst, for information (particularly financial results and/or projections) that may be Material Nonpublic Information, the inquiry should be referred to the Compliance Officer, and to the other appropriate Company officers, as may be provided for in the Company’s Disclosure Policy as may be in place from time to time.

 

IV. Potential Criminal and Civil Liability and/or Disciplinary Action

 

1. Liability for Insider Trading. In the United States and many other countries, the personal consequences to an Insider of illegally trading securities while in possession, or on the basis of, Material Nonpublic Information can be quite severe. In the United States there are substantial civil penalties and criminal sanctions which may be assessed for insider trading. Civil penalties are a payment of a penalty of up to three times the illicit windfall. In addition, Insiders may be subject to criminal fines of up to $5,000,000 and up to twenty years in prison for engaging in transactions in the Company’s securities at a time when they have knowledge of Material Nonpublic Information regarding the Company.

 

If you are located or engaged in dealings outside the U.S., be aware that laws regarding insider trading and similar offenses differ from country to country. Employees must abide by the laws in the country where located. However, you are required to comply with this Policy even if local law is less restrictive. If a local law conflicts with this Policy, you must consult the Compliance Officer.

 

If securities transactions ever become the subject of scrutiny, they are likely to be viewed after-the-fact with the benefit of hindsight. As a result, before engaging in any transaction an Insider should carefully consider how the transaction may be construed in the bright light of hindsight. If you have any questions or uncertainties about this Policy or a proposed transaction, please ask the Compliance Officer.

 

2

 

 

2. Liability for Tipping. Insiders may also be liable for improper transactions by any person (commonly referred to as a “Tippee”) to whom they have disclosed Material Nonpublic Information or any person to whom the Tippee discloses such Material Nonpublic Information regarding the Company or to whom they have made recommendations or expressed opinions on the basis of such information as to trading in the Company’s securities. The civil penalties and criminal sanctions for tipping by an Insider are the same as the ones for an Insider conducting insider trading, even if the disclosing person did not profit from the trading. The U.S. Securities and Exchange Commission (the “SEC”), the Financial Industry Regulatory Authority (“FINRA”) and the stock exchanges use sophisticated electronic surveillance techniques to uncover insider trading.

 

3. Possible Disciplinary Actions. The seriousness of securities law violations is reflected in the penalties and criminal sanctions such violations carry. These violations may also create negative publicity for the Company and a director’s resignation may be sought, or an officer or other employee will be subject to possible Company disciplinary action including ineligibility for future participation in the Company’s equity incentive plans or termination of employment.

 

V. Individual Responsibility

 

Every Company Affiliated Person has the individual responsibility to comply with this Policy against insider trading, regardless of whether the Company has recommended a trading window to that person or any other Insiders of the Company. The guidelines set forth in this Policy are not intended to provide a conclusive solution for all circumstances, and appropriate judgment should be exercised in connection with any trade in the Company’s securities.

 

An Insider may, from time to time, have to forego a proposed transaction in the Company’s securities even if he or she planned to make the transaction before learning of the Material Nonpublic Information and even though the Insider believes he or she may suffer an economic loss or forego anticipated profit by waiting.

 

VI. Applicability of Policy to Inside Information Regarding Other Companies

 

This Policy and the guidelines described herein also apply to Material Nonpublic Information relating to other companies, including the Company’s customers, vendors or suppliers (“Business Partners”), when that information is obtained in the course of employment with, or other services performed on behalf of, the Company. Civil penalties and criminal sanctions, and termination of employment, may result from trading on inside information regarding the Company’s Business

 

Partners. All employees should treat Material Nonpublic Information about the Company’s Business Partners with the same care required with respect to information related directly to the Company.

 

3

 

 

VII. Dissemination of Company Information

 

The prohibition of the disclosure of Material Nonpublic Information applies to all contacts made within and outside the Company. Care should be taken to prevent the disclosure of Material Nonpublic Information during all contact including phone calls and casual conversation. If in doubt about whether information falls into the category of Material Nonpublic Information, then the information should not be disclosed.

 

Prior to disclosure to any third party, any officer, director or employee of the Company who is aware of any Material Nonpublic Information concerning the Company that has not been disclosed to the public should report the intention to disclose such information promptly to the Compliance Officer and obtain approval to do so, or otherwise act in accordance with the Company’s Disclosure Policy as may be in place from time to time.

 

VIII. Definition of Material Nonpublic Information

 

Material Nonpublic Information is information which is material, and that has not been disclosed or otherwise made available to the general public by the Company.

 

It is not possible to define all categories of material information. Generally, information should be regarded as material if a reasonable investor would consider it important in making an investment decision regarding the purchase or sale of the Company’s securities or the information, if made public, would likely affect the market price of the Company’s securities. Either positive or negative information may be material. Information may be material even if it relates to future, speculative or contingent events and even if it is significant only when considered in combination with publicly available information. Nonpublic information can be material even with respect to companies that do not have publicly traded stock, such as those with outstanding bonds or bank loans.

 

While it may be difficult under this standard to determine whether particular information is material, there are various categories of information that are particularly sensitive and, as a general rule, should always be considered material. If any Insider has questions as to the materiality of information, he or she should contact the Compliance Officer for clarification. Examples of information which is deemed to be material include:

 

Financial results;

 

Projections of future earnings or losses;

 

News of a pending or proposed merger or acquisition;

 

New product or project announcements of a significant nature;

 

Expansion or curtailment of operations or the gain or loss of a substantial customer;

 

Changes in control of the Company or major changes in senior management;

 

Significant new joint ventures, alliances, or strategic partnerships or material developments in existing arrangements;

 

Impending bankruptcy or financial liquidity problems;

 

Significant product defects or modifications;

 

Significant pricing changes;

 

Events regarding the Company’s securities (e.g. stock splits, repurchases, or changes in dividend policy);

 

Changes in auditors or auditor notification that the Company may no longer rely on an audit report;

 

4

 

 

A significant purchase or sale of assets or disposition of a subsidiary or division;

 

New equity or debt offerings, significant borrowings, or other material financial transactions;

 

Significant litigation exposure due to actual or threatened litigation;

 

Significant actions by regulatory bodies;

 

Receipt, cancellation or deferral of significant purchase orders;

 

Significant actions by regulatory bodies;

 

Proposed payment of a dividend; and

 

Any of the above with respect to a subsidiary, or other affiliate of the Company.

 

Nonpublic information is information that has not been previously disclosed to the general public and is otherwise not available to the general public. It is important to note that information is not necessarily public merely because it has been discussed in the press, which will sometimes report rumors. You should presume that information is nonpublic unless you can point to its official release by the Company in at least one of the following ways:

 

1.Information contained in publicly available documents filed with securities regulatory authorities (e.g., filings with the SEC);

 

2.Issuance of press releases; or

 

3.Meetings with members of the press and the public.

 

IX. Additional Circumstances Where No Exceptions Apply

 

There are almost no exceptions to the prohibition against insider trading. For example, it does not matter that the transactions in question may have been planned before the Insider came into possession of the undisclosed material information, regardless of the economic loss that the person may believe he or she might suffer as a consequence of not trading.

 

As noted above, the definition of Insiders, to which this Policy applies, includes immediate family members of Company Affiliated Persons. Although immediate family is narrowly defined, a Company Affiliated Person should be especially careful with respect to family members or to unrelated persons living in the same household.

 

Finally, there are no limits on the size of a transaction that will trigger insider trading liability; relatively small trades have in the past occasioned investigations and lawsuits.

 

X. Trading Window

 

The period beginning ten calendar days before the end of the last month of each calendar quarter and ending one Trading Day following the date of public disclosure of the financial results for that quarter, is a particularly sensitive period of time for transactions in the Company’s shares from the perspective of compliance with applicable securities laws. This sensitivity is due to the fact that directors, officers and certain other employees will, during that period, often possess Material Nonpublic Information about the expected financial results for the quarter.

 

5

 

 

Accordingly and notwithstanding anything to the contrary herein, to ensure compliance with this Policy and applicable federal and state securities laws, it is the Company’s policy that all directors, officers and employees refrain from conducting transactions involving the purchase or sale of the Company’s securities other than during the period (the “Trading Window”) commencing at the close of business on the first Trading Day following the date of public disclosure of the financial results for a particular fiscal quarter or year and continuing until the day that is ten calendar days before the last day of the last month of the next fiscal quarter. As a courtesy to the persons subject to this Policy, the Company may provide advance notice before the Trading Window opens.

 

From time to time, the Company may also notify that directors, officers, selected employees and others are required to suspend trading because of developments known to the Company and not yet disclosed to the public. In such event, such persons are advised not to engage in any transaction involving the purchase or sale of the Company’s securities during such period and should not disclose to others the fact of such suspension of trading.

 

The purpose behind the self-imposed Trading Window period is to help establish a diligent effort to avoid any improper transaction. It should be noted, however, that even during the Trading Window, any person possessing Material Nonpublic Information concerning the Company may not attempt to “beat the market” by trading simultaneously with, or shortly after, the official release of Material Nonpublic Information. Although there is no fixed period for how long it takes the market to absorb information, out of prudence a person aware of Material Nonpublic Information should refrain from any trading activity for at least one full Trading Day following its official release, whether or not the Company has recommended a suspension of trading to that person.

 

NOTWITHSTANDING THESE TIMING GUIDELINES, IT IS ILLEGAL FOR ANY PERSON TO TRADE WHILE IN POSSESSION OF MATERIAL NONPUBLIC INFORMATION, INCLUDING SITUATIONS IN WHICH THE PERSON IS AWARE OF MAJOR DEVELOPMENTS THAT HAVE NOT YET BEEN PUBLICLY ANNOUNCED BY THE COMPANY. TRADING IN THE COMPANY’S SECURITIES DURING THE TRADING WINDOW SHOULD NOT BE CONSIDERED A “SAFE HARBOR,” AND ALL DIRECTORS, OFFICERS AND OTHER INSIDERS SHOULD USE GOOD JUDGMENT AT ALL TIMES.

 

XI. Rule 10b5-1 Plans

 

1.Summary. A trading plan meeting the requirements of Rule 10b5-1 under the Exchange Act (“Rule 10b5-1 Plan”) is a preset contract, instruction, or written plan regarding the purchase or sale of securities that, if structured properly, can provide an affirmative defense to insider trading liability even if a transaction occurs while you are aware of material, nonpublic information or during a trading restriction period. Strict compliance with the requirements of Rule 10b5-1 is required in order to be protected by the rule.

 

2.Pre-Clearance. To qualify as a Rule 10b5-1 Plan for purposes of this Policy, the plan must be approved in advance by the Compliance Officer. After submitting the proposed Rule 10b5-1 Plan to the Compliance Officer, you should generally allow at least five (5) business days for completion of the review. One of the factors that the reviewer may consider in determining whether to approve a plan is compliance with any applicable share ownership guidelines. If you plan to use a Rule 10b5-1 Plan that is not the standard form of plan provided by Oppenheimer, then you must also submit your proposed Rule 10b5-1 Plan to the Compliance Officer for review.

 

You may not enter into a Rule 10b5-1 Plan during a trading restriction period or during any time that you are aware of material, nonpublic information and Rule 10b5-1 Plan should only be adopted in good faith and not as part of a plan or scheme to evade the insider trading prohibitions of Rule 10b-5.

 

6

 

 

3.Rule 10b5-1 Plan Requirements. The following policies apply with respect to Rule 10b5-1 Plans for individuals:

 

a.You may not establish a Rule 10b5-1 Plan during a trading restriction period (see What is a trading restriction period?) or during any time that you are aware of material, nonpublic information. Rule 10b5-1 Plans must include a representation certifying that at the time of the adoption or modification: (1) they are not aware of material, nonpublic information about the Company or its securities; and (2) they are adopting the plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b-5.

 

b.Must include a minimum waiting period (also known as a “cooling-off period”), such that trading may not commence under the plan until the end of such waiting period, as follows:

 

i.for Insiders, he later of: (1) 90 days after plan adoption; or (2) two (2) business days following the public disclosure of the Company’s financial results in a Form 20-F or Current Report on Form 6-K relating to the fiscal quarter in which the plan was adopted (but not to exceed 120 days following plan adoption); and

 

ii.for individuals not covered by (i) above, at least 30 days after plan adoption.

 

The waiting period is designed to minimize the risk that a claim will be made that you were aware of material, nonpublic information concerning the Company when you entered into the Rule 10b5-1 Plan and/or that the plan was not entered into in good faith.

 

c.Must include appropriate trading instructions. You must either: (i) expressly specify the amount, price and date of the securities to be purchased or sold; (ii) provide a written formula for determining the amount, price, and date of the securities to be purchased or sold; or (iii) authorize your broker to determine the price, amount, and date of the securities to be purchased or sold on your behalf without any control or influence by you. You are not permitted to make any subsequent decisions, or exercise any subsequent influence over, how, when, or whether to effect any purchase or sale of any the Company’s securities.

 

d.You may not have more than one Rule 10b5-1 Plan in effect at any given time (i.e. “multiple overlapping plans”), subject to certain limited exceptions that comport with the requirements of Rule 10b5-1 relating to multiple or overlapping plans.

 

e.You may not adopt more than one Rule 10b5-1 Plan to execute a single trade during any consecutive 12-month period, subject to certain limited exceptions that comport with the requirements of Rule 10b5-1.

 

f.If you are an Insider, you must also confirm that all trades made pursuant to the Rule 10b5-1 Plan will be made in accordance with Rule 144 under the Securities Act of 1933, as amended.

 

g.You may not engage in any trades of the Company’s securities outside of the Rule 10b5-1 Plan while a plan is in effect.

 

7

 

 

4.Modifying, Revoking or Terminating a Rule 10b5-1 Plan. Your Rule 10b5-1 Plan may be modified by you after you establish it only upon approval as outlined below. You should not anticipate needing to make any changes to the Rule 10b5-1 Plan at the time you establish it. If you make changes to your Rule 10b5-1 Plan or revoke or early terminate your Rule 10b5-1 Plan, you may be exposed to insider trading liability if you possessed (or had access to) material, nonpublic information at the time you made those changes and subsequently engaged in transactions under the Rule 10b5-1 Plan.

 

Modifying, revoking, or early termination of a Rule 10b5-1 Plan must be approved in advance by the Compliance Officer. You may not modify, revoke or early terminate a Rule 10b5-1 Plan during a trading restriction period or during any time that you are aware of material, nonpublic information.

 

The waiting period requirement described above will apply to any modification to the amount, price or timing of a purchase or sale (including changes to related formulae) under an existing Rule 10b5-1 Plan. Trading under your Rule 10b5-1 Plan will continue pursuant to the original terms of your Rule 10b5-1 Plan until this waiting period has elapsed, at which time the modified Rule 10b5-1 Plan will become effective or the revocation or termination of the plan (as applicable).

 

Following any permitted revocation or early termination of a Rule 10b5-1 Plan, you may not establish a new Rule 10b5-1 Plan until the commencement of the next open trading window.

 

5.Additional Plan Provisions. None of the requirements or plan terms currently contemplated by this Policy are exhaustive or limiting on the Company. The Company has the right to require the inclusion of additional provisions in your plan designed to protect you and/or the Company, whether before or after the plan has been approved by the Compliance Officer, or to delete or amend existing provisions.

 

XII. Inquiries

 

All Insiders should review this Policy carefully and contact the Compliance Officer if they have a concern that a contemplated transaction in the Company’s securities might not conform with this Policy.

 

XIII. Certain Exceptions

 

For purposes of this Policy, the Company considers that the exercise of share options for cash under the Company’s share option plans or the purchase of shares under employee purchase plans in effect at the time of the adoption of this Policy and that may be adopted in the future (but not the sale of any such shares) is exempt from this Policy, since the other party to the transaction is the Company itself and the price does not vary with the market but is fixed by the terms of the option agreement or the plan. Accordingly, cashless exercises of options are subject to the Policy when they involve the sale of shares into the public marketplace.

 

Bona fide gifts of securities are not deemed to be transactions for the purposes of this Policy. Whether a gift is truly bona fide will depend on the circumstances surrounding each gift. The more unrelated the donee is to the donor, the more likely the gift would be considered “bona fide” and not a “transaction.” For example, gifts to charities, religious institutions and service organizations would likely not be “transactions.” On the other hand, gifts to dependent children followed by a sale of the “gift” securities in close proximity to the time of the gift may imply some economic benefit to the donor and, therefore, make the gift non-bona fide.

 

The restrictions in this Policy shall not apply to purchases or sales made pursuant to a Qualified Plan. For purposes of this exception, a “Qualified Plan” is a written plan for purchasing or selling the Company’s securities which meets each of the following requirements: (1) the plan is adopted by the Insider during a Trading Window; (2) the plan is adopted in good faith by the Insider when he or she is not in possession of material non-public information; (3) the plan is adhered to strictly by the Insider; (4) the plan either (a) specifies the amount of securities to be purchased or sold and the date on which the securities are to be purchased or sold, (b) includes a written formula or algorithm, or computer program, for determining the amount of securities to be purchased or sold and the price at which and the date on which the securities are to be purchased or sold, or (c) does not permit the Insider to exercise any subsequent influence over how, when, or whether to effect purchases or sales; provided, in addition, that any other person who, pursuant to the plan, does exercise such influence must not have been aware of the material nonpublic information when doing so; and (5) at the time it is adopted the plan conforms to all other requirements of Rule 10b5- 1(c)(1)(C) under the U.S. Securities Exchange Act of 1934 and any other applicable SEC rules as then in effect.

 

8

 

 

In addition to the above requirements, a Qualified Plan shall be signed and dated by the Insider, and submitted to the Compliance Officer at least two (2) Trading Days before it is filed with the broker who executes it. The Company shall have the right, at all time, to suspend purchases or sales under a Qualified Plan, for instance in the event that the Company needs to comply with requirements by underwriters for “lock-up” agreements in connection with an underwritten public offering of the Company’s securities. A Qualified Plan cannot be canceled, suspended, expanded or otherwise modified by the Insider who signed it more than once during a fiscal quarter. Any cancellation, suspension, expansion or other modification of a Qualified Plan by the Insider who established it must: (1) be in writing, signed and dated by such Insider, (2) be submitted to the Compliance Officer within two (2) Trading Days after the cancellation, suspension, expansion or other modification was reduced to writing, and (3) be made during a Trading Window, and when the Insider who established it has no Nonpublic Material Information about the Company.

 

XIV. Additional Information for Directors, Officers and Certain Employees with Routine Access to Material Nonpublic information

 

This Policy imposes additional restrictions upon Access Insiders, because of their routine access to Material Nonpublic Information.

 

1. Preclearance of Trades. The Company has determined that all Access Insiders should refrain from trading in the Company’s securities, even during the Trading Window, without first complying with the Company’s “preclearance” process. Each Access Insider should contact the Compliance Officer prior to commencing any trade in the Company’s securities. At the time of executing a trade in the Company’s securities, such individuals will be responsible for verifying that the Company has not imposed any restrictions on their ability to engage in trades. If the individual has not completed the trade within ten (10) Trading Days of notification of the intention to trade, then the individual must again notify the Compliance Officer that he or she intends to execute a trade and re-verify the nonexistence of any restrictions on such trade. For the avoidance of doubt, this paragraph shall not apply to a Qualified Plan, after it has been set up.

 

Before each transaction in the Company’s securities by a Company each officer and director should contact the Compliance Officer regarding compliance with Rule 144 under the U.S. Securities Act of 1933, as amended (“Rule 144”), which contains guidelines for the sale of privately issued shares and sales by affiliates of the Company, if such sales are not covered by an effective registration statement, to the extent applicable.

 

2. Rule 144 and Section 16 Matters for Directors and Officers. Directors and principal officers of the Company must also comply with Rule 144, or another applicable exemption from registration. The practical effect of Rule 144 is that directors and officers who sell the Company’s securities may be required to comply with a number of requirements including holding period, volume limitation, manner of sale and SEC filing requirements. The Company may provide separate memoranda and other appropriate materials to its directors and officers regarding compliance with Rule 144. In addition, if the Company is no longer considered a “foreign private issuer”, the directors and officers who trade with Company securities have to report of purchases and sales of shares through the filing of Form 4s with the U.S. Securities and Exchange Commission. The Company will advise such persons if they are subject to the requirement to file a Form 4.

 

9

 

 

XV. Specific Requirements

 

1. Speculative Trading. No Insider may engage in transactions of a speculative nature at any time. All Insiders are prohibited from short-selling the Company’s securities or engaging in transactions involving the Company’s based derivative securities. A short sale, for these purposes, means any transaction whereby one may benefit from a decline in the price of the Company’s securities. “Derivative Securities” are options, warrants, stock appreciation rights or similar rights whose value is derived from the value of an equity security, such as the Company’s common stock. This prohibition includes, but is not limited to, trading in the Company’s based put and call option contracts, transacting in straddles, hedging or monetization transaction with respect to the Company’s securities, and the like. In addition, no Insider shall engage in a transaction with respect to securities of the Company if he or she owns the security, but does not deliver it against such sale (a “short sale against the box”) within twenty days thereafter, or does not within five days after such sale deposit it in the mails or other usual channels of transportation. The above does not derogate from Insiders’ right to hold and exercise options or other derivative securities granted under the Company’s employee share option or equity incentive plans as long as such exercise is not prohibited by this Policy.

 

2. Margin Accounts and Pledges. Securities held in a margin account may be sold by the broker without the consent of the owner thereof if such owner fails to meet a margin call. Similarly, securities pledged as collateral for a loan may be sold if the owner thereof defaults on the loan. In case of an owner who is subject to this Policy, these sales may occur at a time when such person is aware of material, non-public information or otherwise not permitted to trade such securities. Therefore, this policy prohibits holding any Company securities in a margin account or pledging any Company securities as collateral for a loan.

 

3. Post-Termination Transactions. If an Insider is aware of Material Nonpublic Information at the time such Insider’s association with the Company is terminated, whether by the Insider or the Company, the Insider may not trade in Company securities until such information is no longer material or until two (2) Trading Days after such information has become public. In addition, if the Company is not in a Trading Window at the time such association with the Company is terminated, the Insider may not trade in Company securities until two (2) Trading Days after the next announcement of quarterly earnings or of the material, non-public information.

 

4. Ad hoc Restrictions. The Compliance Officer has the authority to impose restrictions on trading in the Company’s securities by appropriate individuals at any time. In such event, the Compliance Officer will notify the affected individuals, either personally, by email or by voicemail, to inform them of the restrictions.

 

5. Open Orders. Any Insider who has placed a limit order or open instruction to buy or

sell the Company’s securities shall bear responsibility for canceling such instructions immediately upon becoming in possession of Material Nonpublic Information.

 

XVI. Acknowledgement

 

Please sign the attached acknowledgement form and return it to the Compliance Officer.

 

If you have any questions with respect to this Policy, please contact the Company’s Compliance Officer, at +972-52325766 or danny@beamr.com

 

10

 

 

ACKNOWLEDGEMENT

 

I have received, read and understand the Insider Trading Policy and Guidelines with Respect to Certain Transactions in Company Securities of Beamr Imaging Ltd., a copy of which is attached hereto, and agree to comply with the provisions thereof.

 

Date:      
       
     
    Signature
     
    Name
     
    Title

 

 

 

11

 

 

Exhibit 12.1

 

CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a) or 15d-14(a)

 

I, Sharon Carmel, certify that:

 

1.I have reviewed this annual report on Form 20–F of Beamr Imaging Ltd.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4.The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting.

 

5.The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors:

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

Date: March 4, 2025 /s/ Sharon Carmel
  Sharon Carmel
  Chief Executive Officer

 

 

Exhibit 12.2

 

CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a) or 15d-14(a)

 

I, Danny Sandler, certify that:

 

1.I have reviewed this annual report on Form 20–F of Beamr Imaging Ltd.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4.The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

5.The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent function):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

Date: March 4, 2025 /s/ Danny Sandler
  Danny Sandler
  Chief Financial Officer

 

 

Exhibit 13.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350

 

In connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2024 (the “Report”) by Beamr Imaging Ltd. (the “Company”), the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 4, 2025 /s/ Sharon Carmel
  Sharon Carmel
  Chief Executive Officer

 

 

Exhibit 13.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350

 

In connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2024 (the “Report”) by Beamr Imaging Ltd. (the “Company”), the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 4, 2025 /s/ Danny Sandler
  Danny Sandler
  Chief Financial Officer

 

 

Exhibit 15.1

 

 

  Fahn Kanne & Co.
  Head Office
  32 Hamasger Street
  Tel-Aviv 6721118, ISRAEL
  PO Box 36172, 6136101
   
  T +972 3 7106666
  F +972 3 7106660
  www.gtfk.co.il

 

CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our report dated March 4, 2025, with respect to the consolidated financial statements of Beamr Imaging Ltd., included in the Annual Report on Form 20-F for the year ended December 31, 2024. We consent to the incorporation by reference of said report in the Registration Statements of Beamr Imaging Ltd. on Form S-8 (File Nos. 333-272779 and 333-280576) and Form F-3 (File No. 333-277787).

 

/s/ FAHN KANNE & CO. GRANT THORNTON ISRAEL

 

Tel-Aviv, Israel

 

March 4, 2025

 

 

 

 

Certified Public Accountants

Fahn Kanne & Co. is the Israeli member firm of Grant Thornton International Ltd.

v3.25.0.1
Cover
12 Months Ended
Dec. 31, 2024
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Financial Statement Error Correction [Flag] false
Document Shell Company Report false
Entity Interactive Data Current Yes
Document Accounting Standard U.S. GAAP
ICFR Auditor Attestation Flag false
Amendment Flag false
Document Period End Date Dec. 31, 2024
Document Fiscal Year Focus 2024
Document Fiscal Period Focus FY
Entity Information [Line Items]  
Entity Registrant Name Beamr Imaging Ltd.
Entity Central Index Key 0001899005
Entity File Number 001-41523
Entity Incorporation, State or Country Code L3
Current Fiscal Year End Date --12-31
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Shell Company false
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Entity Ex Transition Period true
Entity Contact Personnel [Line Items]  
Entity Address, Address Line One 10 HaManofim Street
Entity Address, City or Town Herzeliya
Entity Address, Country IL
Entity Address, Postal Zip Code 4672561
Entity Listings [Line Items]  
Title of 12(b) Security Ordinary shares, par value NIS 0.05 per share
Trading Symbol BMR
Security Exchange Name NASDAQ
Entity Common Stock, Shares Outstanding 15,518,794
Business Contact [Member]  
Entity Contact Personnel [Line Items]  
Contact Personnel Name Sharon Carmel
Contact Personnel Email Address sharon@beamr.com
Entity Address, Address Line One 10 HaManofim Street
Entity Address, City or Town Herzeliya
Entity Address, Country IL
Entity Address, Postal Zip Code 4672561
v3.25.0.1
Audit Information
12 Months Ended
Dec. 31, 2024
Auditor [Table]  
Auditor Name FAHN KANNE & CO. GRANT THORNTON ISRAEL
Auditor Firm ID 1375
Auditor Location Tel Aviv, Israel
Auditor Opinion [Text Block]

Opinion on the financial statements

We have audited the accompanying consolidated balance sheets of Beamr Imaging Ltd. and its subsidiaries (the “Company”) as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, changes in shareholders’ equity, and cash flows for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 16,483 $ 6,116
Trade receivables 506 597
Other current assets 195 132
Total current assets 17,184 6,845
Non-current assets:    
Property and equipment, net 43 19
Intangible assets, net 489 280
Goodwill 4,379 4,379
Total non-current assets 4,911 4,678
Total assets 22,095 11,523
Current liabilities:    
Current maturities of loan, net 250 330
Account payables 10 7
Deferred revenue 30 27
Liability to controlling shareholder, net 199
Other current liabilities 677 458
Total current liabilities 967 1,021
Non-current liabilities:    
Loan, net of current maturities 170
Derivative warrants liability 50 72
Total non-current liabilities 50 242
Commitments and contingent liabilities
Shareholders’ equity:    
Authorized: 222,000,000 shares at December 31, 2024 and 2023; Issued and outstanding: 15,518,794 and 13,051,343 shares at December 31, 2024 and 2023, respectively 213 179
Additional paid-in capital 55,889 41,752
Accumulated deficit (35,024) (31,671)
Total shareholders’ equity 21,078 10,260
Total liabilities and shareholders’ equity $ 22,095 $ 11,523
v3.25.0.1
Consolidated Balance Sheets (Parentheticals) - ₪ / shares
Dec. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Ordinary shares, par value (in New Shekels per share) ₪ 0.05 ₪ 0.05
Ordinary shares, authorized 222,000,000 222,000,000
Ordinary shares, issued 15,518,794 13,051,343
Ordinary shares, outstanding 15,518,794 13,051,343
v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenue $ 3,064 $ 2,909 $ 2,863
Cost of revenue (240) (96) (98)
Gross profit 2,824 2,813 2,765
Research and development expenses (2,893) (1,824) (2,063)
Sales and marketing expenses (678) (361) (905)
General and administrative expenses (2,468) (1,506) (828)
Operating loss (3,215) (878) (1,031)
Financing income (expenses), net (92) 222 (165)
Loss before taxes on income (3,307) (656) (1,196)
Taxes on income (46) (39) (52)
Net loss and comprehensive loss for the year $ (3,353) $ (695) $ (1,248)
Basic net loss per share (in Dollars per share) $ (0.22) $ (0.06) $ (0.48)
Weighted average number of Ordinary Shares used in computing basic net loss per share (in Shares) 15,167,476 11,194,097 2,578,760
Diluted net loss per share (in Dollars per share) $ (0.22) $ (0.09) $ (0.48)
Weighted average number of Ordinary Shares used in computing diluted net loss per share (in Shares) 15,167,476 11,449,811 2,578,760
v3.25.0.1
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Ordinary shares
Convertible Ordinary 1 and 2 shares
Convertible Preferred shares
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2021 $ 51 $ 5 $ 78 $ 30,041 $ (29,721) $ 454
Balance (in Shares) at Dec. 31, 2021 2,578,760 1,496,880 5,714,400      
Contribution to equity due to free interest loan from controlling shareholder (Note 13) 112 112
Share-based compensation (Note 11) 222 222
Net loss for the year (1,248) (1,248)
Balance at Dec. 31, 2022 $ 51 $ 5 $ 78 30,375 (30,969) (460)
Balance (in Shares) at Dec. 31, 2022 2,578,760 1,496,880 5,714,400      
Contribution to equity due to free interest loan from controlling shareholder (Note 13)          
Issuance of Ordinary Shares upon completion of an initial public offering, net of offering expenses (Note 10B) $ 27 6,355 6,382
Issuance of Ordinary Shares upon completion of an initial public offering, net of offering expenses (Note 10B) (in Shares) 1,950,000      
Voluntary conversion of all shares with preferences over Ordinary Shares into Ordinary Shares (Note 10B) $ 83 $ (5) $ (78)
Voluntary conversion of all shares with preferences over Ordinary Shares into Ordinary Shares (Note 10B) (in Shares) 7,211,280 (1,496,880) (5,714,400)      
Automatic conversion of all convertible advanced investments into Ordinary Shares (Note 10B) $ 16 4,555 4,571
Automatic conversion of all convertible advanced investments into Ordinary Shares (Note 10B) (in Shares) 1,142,856      
Deemed dividend resulted from trigger of down round protection feature of certain warrants granted (Note 10B) 7 (7)
Share-based compensation (Note 11) 413 413
Exercise of options into ordinary shares (Note 11) $ 2 47 $ 49
Exercise of options into ordinary shares (Note 11) (in Shares) 168,447     168,447
Net loss for the year (695) $ (695)
Balance at Dec. 31, 2023 $ 179 41,752 (31,671) 10,260
Balance (in Shares) at Dec. 31, 2023 13,051,343      
Contribution to equity due to free interest loan from controlling shareholder (Note 13)          
Issuance of Ordinary Shares upon completion of a public offering (including exercise of over-allotment option), net of offering expenses (Note 10C) $ 27 12,259 12,286
Issuance of Ordinary Shares upon completion of a public offering (including exercise of over-allotment option), net of offering expenses (Note 10C) (in Shares) 1,971,300      
Issuance of Ordinary Shares upon cashless exercise of Warrants (Note 10D) $ 1 (1)
Issuance of Ordinary Shares upon cashless exercise of Warrants (Note 10D) (in Shares) 95,120      
Amount classified to equity upon determination of the exercise price (Note 8) 599 599
Share-based compensation (Note 11) 491 491
Exercise of options into ordinary shares (Note 11) $ 6 789 $ 795
Exercise of options into ordinary shares (Note 11) (in Shares) 401,031     401,031
Net loss for the year   (3,353) $ (3,353)
Balance at Dec. 31, 2024 $ 213 $ 55,889 $ (35,024) $ 21,078
Balance (in Shares) at Dec. 31, 2024 15,518,794      
v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (3,353) $ (695) $ (1,248)
Adjustments required to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 170 26 28
Share-based compensation (Note 11) 418 363 222
Amortization of discount relating to straight loan received from commercial bank 31 31 14
Exchange rate differences on straight loan received from commercial bank 11 (12) (12)
Change in the fair value of derivative warrant liability (Note 8) 577 (66)
Change in the fair value of convertible advanced investments (269) 70
Amortization of discount relating to liability to controlling shareholder (Note 13) 10 48 40
Change in estimation of maturity date of liability to controlling shareholder (Note 13) 12
Exchange rate differences on straight loan received from controlling shareholder (Note 13) (3) (16)
Decrease (increase) in trade receivables 91 (16) 310
Decrease (increase) in other current assets (63) (68) 2
Increase (decrease) in account payables 3 (26) 6
Increase (decrease) in deferred revenue 3 (4) (2)
Increase (decrease) in other current liabilities 219 33 (75)
Net cash used in operating activities (1,886) (659) (645)
Cash flows from investing activities:      
Purchase of property and equipment (36) (10) (2)
Capitalization of internal-use software (Note 5) (294) (183)
Net cash used in investing activities (330) (193) (2)
Cash flows from financing activities:      
Net proceeds received upon completion of public offering transactions (Notes 10B and 10C) 12,286 6,695
Deferred offering costs (98)
Repayment of principal relating to straight loan received from commercial bank (292) (236) (582)
Proceeds from loan received from controlling shareholder (Note 13) 25 115
Repayment of Facility Fee relating to straight loan received from commercial bank (10)
Repayment of principal relating to straight loan received from controlling shareholder (Note 13) (206) (258)
Proceeds from issuance of unit consist of straight loan and warrant granted to commercial bank, net 887
Proceeds received from exercise of options into Ordinary Shares (Note 11) 795 49
Net cash provided by financing activities 12,583 6,275 312
Change in cash 10,367 5,423 (335)
Cash at beginning of year 6,116 693 1,028
Cash at end of year 16,483 6,116 693
Non-cash investing and financing activities:      
Capitalized deferred offering costs classified into equity upon completion of initial public offering transaction (Note 10B) (313)
Contribution to equity due to free interest loan from controlling shareholder (Note 13) 112
Automatic conversion of convertible advanced investments into shares (Note 10B) 4,571
Deemed dividend upon trigger of down round protection (Note 10B) 7
Amount classified to equity upon determination of the exercise price (Note 8) 599
Share-based compensation capitalized in internal-use software 73 50
Supplemental disclosure of cash flow information:      
Interest paid (85) (133) (77)
Interest received 548 97
Taxes paid $ (43) $ (38) $ (54)
v3.25.0.1
General
12 Months Ended
Dec. 31, 2024
General [Abstract]  
GENERAL

NOTE 1 - GENERAL

 

A.Operations

 

Beamr Imaging Ltd. (the “Company” or “Beamr”) was incorporated in October 2009 under the laws of the State of Israel and it engages mainly in the development of technology for encoding, compressing and optimizing images and videos. In February 2024, the Company launched its next generation product, Beamr Cloud, a cloud-based Software-as-a-Service (“SaaS”) solution accelerated by NVIDIA GPUs. Beamr Cloud Video SaaS, initially operating over and integrated with AWS, aims to simplify video processing and make it accessible and affordable. In June 2024, the Company made its SaaS solution available on Oracle Cloud Infrastructure.

 

The Company’s Ordinary Shares began trading on the Nasdaq Capital Market (the “Nasdaq”) under the ticker symbol “BMR” on February 28, 2023 in connection with its initial public offering transaction (“U.S. IPO”) (see Note 10C below).

 

B.Foreign operations

 

1.Beamr Inc.

 

In 2012, the Company incorporated a wholly-owned U.S. subsidiary, Beamr Inc. (“Beamr Inc.”), for the purpose of reselling the Company’s software and products in the U.S. and Canadian markets.

 

2.Beamr Imaging RU LLC

 

In 2016, the Company incorporated a wholly-owned Russian limited partnership, Beamr Imaging RU LLC, (“Beamr Imaging RU”) for the purpose of conducting research and development services to the Company.

 

The Company and its subsidiaries, Beamr Inc. and Beamr Imaging RU, are collectively referred to as the “Group”.

 

C.Liquidity and capital resources

 

The Company has devoted substantially all of its efforts to research and development, the commercialization of its software products and raising capital for such purposes. The development and commercialization of the Company’s software and products are expected to require substantial further expenditures. To date, the Company has not yet generated sufficient revenue from operations to support its activities, and therefore it is dependent upon external sources for financing its operations. During the year ended December 31, 2024, the Company had net losses of $3,353. As of December 31, 2024, the Company had an accumulated deficit of $35,024. Management plans to finance its operations through sales of the Company’s equity securities and through revenues generated from the sales of its software products. In addition, management believes that the new SaaS solution for video optimization technology will allow the Company to potentially access new customers and new markets.

 

During the year ended December 31, 2022, the Company raised net proceeds of $887 through a funding agreement with IBI Spikes Ltd. (see also Note 6). During the year ended December 31, 2023, the Company raised net proceeds of $6,382 and $49 through completion of the U.S. IPO and exercises of options into Ordinary Shares, respectively (see also Note 10B and Note 11, respectively). During the year ended December 31, 2024, the Company raised gross proceeds of $13,800 and $795 through completion of an underwritten public offering and exercises of options into Ordinary Shares (see also Note 10C and Note 11, respectively).

 

Management has considered the significance of such conditions in relation to the Company’s ability to meet its current obligations and to achieve its business targets and determined that it has sufficient funds to fund its planned operations for at least the next 12 months.

 

D.The impact of the Russian Invasion of Ukraine

 

On February 24, 2022, Russia invaded Ukraine. The Company has an operation in Russia through its wholly-owned subsidiary, Beamr Imaging RU. The Company undertakes some of its software development and design, quality assurance and support in Russia using personnel located there. While some of the Company’s developers are located in Russia, its research and development leadership are all located in Israel. The Company has no manufacturing operations or sell any products in Russia. The Company constantly evaluates its activities in Russia and currently believes there was no significant impact on its activities. As of December 31, 2024, three employees have relocated from Russia to other locations of the Company.

 

E.The impact of Iron Sword War (Israel-Hamas war)

 

On October 7, 2023, the Hamas organization launched a series of deadly terror attacks on civilian and military targets skirting the Gaza Strip in the southern part of Israel and fired rockets on many of the communities in southern and central Israel. Following the attack, Israel’s security cabinet declared war and commenced a military campaign in Gaza against Hamas. On January 19, 2025, a temporary ceasefire went into effect, the result of which is uncertain. As of the date of these consolidated financial statements management regularly monitors developments and acts in accordance with the guidelines of the various authorities and as of the approval date of these financial statements believes there is no significant impact on its activities.

v3.25.0.1
Significant Accounting Policies
12 Months Ended
Dec. 31, 2024
Significant Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

 

The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

 

A.Use of estimates in the preparation of financial statements

 

The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions include (i) revenue recognition and (ii) recoverability of the Company’s goodwill.

 

B.Functional currency

 

The functional currency of the Company and all of its subsidiaries all of which are primarily a direct and integral component of the Company’s operation is the U.S. dollar (“$” or “dollar”), as the dollar is the primary currency of the economic environment in which the Company and its subsidiaries have operated (which is the currency of the environment in which an entity primarily generates cash) and expects to continue to operate in the foreseeable future.

 

In accordance with ASC 830, “Foreign Currency Matters”, balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions included in the consolidated Statement of Operations and Comprehensive Loss, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such transactions are presented within financing income or expenses.

 

C.Principles of consolidation

 

The consolidated financial statements include the accounts of the Group. Intercompany transactions and balances have been eliminated upon consolidation.

 

D.Cash

 

Cash is short-term highly liquid investment which include short-term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals or use and that are readily convertible to cash with maturities of three months or less as of the date acquired.

 

E.Research and development expenses

 

Research and development expenses are expenses as incurred, except to the extent that such costs are associated with internal-use software that qualifies for capitalization (see also Note 2F below)

 

F.Internal-use software costs

 

The Company capitalized certain internal software development costs, consisting mainly of direct labor (including stock-based compensation expenses), associated with creating the internally developed software related to its SaaS solution.

 

In accordance with ASC 350-40, “Internal-Use Software”, the capitalization of costs to develop internal-use software begins when preliminary development efforts are successfully completed. The Company has committed project funding to develop internal-use software and it is probable that the project will be completed, and the software will be used as intended. Costs related to the design or maintenance of internal-use software are expensed as incurred. Capitalized costs are amortized over the estimated useful life of the software, which is generally three years, once the capitalized asset is ready for its intended use, using the straight-line method in which the management believes the expected benefit will be derived.

 

The Company periodically reviews internal-use software costs to determine whether the projects will be completed, placed in service, removed from service, or replaced by other internally developed or third-party software. If the asset is not expected to provide any future benefit, the asset is retired, and any unamortized cost is expensed. Capitalized internal-use software costs are recorded under intangible assets, net.

 

When events or changes in circumstances are required, the Company assesses the likelihood of recovering the cost of internal-use software. If the net book value is not expected to be fully recoverable, internal-use software would be impaired to its fair value. Measurement of any impairment loss is based on the excess of the carrying value of the asset over the fair value.

G.Goodwill and intangible assets

 

Goodwill is the amount by which the purchase price of acquired net assets in a business combination exceeded the fair values of the net identifiable assets on the date of acquisition. Goodwill is not amortized but evaluated for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Impairment of goodwill is tested at the level of the reporting unit. As required by ASC 350 “Intangibles-Goodwill and Other”, the Company chooses either to perform a qualitative assessment whether a goodwill impairment test is necessary or proceeds directly to the goodwill impairment test. Such determination is made for each reporting unit on a stand-alone basis. The qualitative assessment includes various factors such as macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, earnings multiples, gross margin and cash flows from operating activities and other relevant factors. When the Company chooses to perform a qualitative assessment and determines that it is more likely than not (more than 50 percent likelihood) that the fair value of the reporting unit is less than its carrying value, then the Company proceeds to the goodwill impairment test. If the Company determines otherwise, no further evaluation is necessary.

 

When the Company decides or is required to perform the quantitative goodwill impairment test, the Company compares the fair value of the reporting unit to its carrying value and an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value, if any.

 

The Company determined that its operations represent a single reporting unit. Prior to the completion of the U.S. IPO, the Company determined the fair value of its reporting unit by using the income approach. Upon completion of the U.S. IPO in February 2023, the fair value of the Company’s reporting unit is determined internally by the management based on observable inputs of the Company. As of the reported periods, the Company has performed the annual impairment test and has determined that impairment loss is not required to be recognized.

 

Finite lived intangible assets acquired in business combinations (i.e. trade names), are initially recorded at fair value. The cost of internal-use software is based on the criteria described in Note 2F above. Such intangible assets are amortized on a straight-line basis over their estimated useful lives. The intangible asset lives have been determined based upon the anticipated period over which the Company will derive future cash flows from the intangible assets. The Company has considered the effects of legal, regulatory, contractual, competitive, and other economic factors in determining these useful lives. Recoverability of these assets is assessed when triggering events have occurred that may give rise to an impairment loss and is determined by a comparison of the carrying amount of the asset to the future undiscounted net cash flows expected to be generated by the asset. When it is determined that the carrying value of the asset is not recoverable, the asset is written down to its estimated fair value. 

 

During all reported periods, impairment losses were not identified through the impairment test.

 

The lives used in computing straight-line amortization for financial reporting purposes are as follows:

 

Rate of depreciation  % 
     
Trade names   10 
Internal-use software   33 

 

H.Property and equipment

 

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the consolidated Statements of Operations and Comprehensive Loss.

 

The Company’s long-lived assets are reviewed for impairment, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. To date, the Company has not incurred any impairment losses.

 

The lives used in computing straight-line depreciation for financial reporting purposes are as follows:

 

Rate of depreciation  % 
     
Computers and peripheral equipment   33 
Office furniture and equipment   7-15 
I.Leases

 

The Company entered into several non-cancellable lease agreements for offices for use in its operations, which are classified as operating leases (see below), whereby the Company applies ASC Topic 842, “Leases” (“ASC 842”) under which the Company determines if an arrangement is a lease at inception.

 

Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful life of the asset, (iv) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset, or (v) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of lease term. A lease is classified as an operating lease if it does not meet any one of these criteria. Since all the Company’s lease contracts for premises do not meet any of the criteria above, the Company concluded that all its lease contracts should be classified as operating leases.

 

Right of Use (“ROU”) assets and liabilities are recognized on the commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company’s leases do not provide an implicit rate, the Company uses its Incremental Borrowing Rate (“IBR”) based on the information available on the commencement of the lease. The Company uses the long-lived assets impairment guidance in ASC 360-10, “Property, Plant, and Equipment - Overall”, to determine whether a ROU asset is impaired, and if so, the amount of the impairment loss to recognize. Certain leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option.

 

The Company also elected the short-term lease recognition exemption for all leases that qualify (leases with a term shorter than 12 months). For those leases, ROU assets or lease liabilities are not recognized and rent expense is recognized on a straight-line basis over the lease term. See also Note 9 for further information.

 

J.Employee benefit plans

 

The Company’s liability for severance pay to its Israeli employees is subject to Section 14 of the Israeli Severance Compensation Act, 1963 (“Section 14”), pursuant to which all of the Company’s employees are entitled to monthly deposits by the Company, at a rate of 8.33% of their monthly salary, made in the employee’s name with insurance companies. Under Israeli employment law, payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. The fund is made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination. The severance pay liabilities and deposits under Section 14 are not reflected in the balance sheets as severance pay risks have been irrevocably transferred to the severance funds. All deposits required through December 31, 2024 have been made.

 

K.Deferred income taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, “Income Taxes”. Accordingly, deferred income taxes are determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected to be in effect when these differences reverse. Valuation allowance in respect of deferred tax assets is provided for, if necessary, to reduce deferred tax assets is amounts more likely than not to be realized.

 

The Company accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise’s financial statements. According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The accounting policy of the Company is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such items in its consolidated financial statements during the reported periods and did not recognize any liability with respect to an unrecognized tax position in its balance sheets.

 

L.Contingencies

 

The Company and its subsidiaries may be involved in certain legal proceedings and certain business relationships that arise from time to time in the ordinary course of their business and in connection with certain agreements with third parties. Except for income tax contingencies, the Company applies the provisions of ASC Topic 450, Contingencies. Thus, the Company records accruals for contingencies to the extent that the management concludes that the occurrence is probable and that the related liabilities are estimable. Legal expenses associated with contingencies are expensed as incurred.

M.Revenue recognition

 

The Company recognizes revenue in accordance with ASC 606, “Revenue from Contracts with Customers” (“ASC 606”) under which the Company determines revenue recognition through the following five steps (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when, or as, the Company satisfies a performance obligation.

 

The Company enters into contracts that mostly include software and software related services (i.e. Post-Contract Customer Support (“PCS”)), which are generally capable as being distinct from each other and accounted for as separate performance obligations.

 

The Company derives its revenue from licensing the rights to use its software for a limited term (mainly for a period of one to three years) or on a perpetual basis for enterprises that incorporate the Company’s perpetual license in their own products delivered to end users and for the Company’s products sold to thousands private consumers, as applicable to each contract, and from, provision of related maintenance and technical support. The Company sells its products through direct sales force and indirectly through distributors and consumer platforms.

 

Revenue is recognized when control of the promised goods or services are transferred to the customers, in an amount that reflects the consideration that the company expects to receive in exchange for those goods or services. However, when the consideration for the license is based on sales of the related customer (i.e. sales-based), the company applies the provisions of ASC 606 with respect to sales-based or usage-based royalties promised in exchange for a license of intellectual property and recognizes revenue only when the underlying sales occur, as long as this approach does not result in the acceleration of revenue ahead of the Company’s performance.

 

Under ASC 606, an entity recognizes revenue when or as it satisfies a performance obligation by transferring software license (either timely-based or perpetual) or software related services to the customer, either at a point in time or over time. The Company recognizes its revenue from software sales at a point in time upon delivery of its software license. The software license is considered a distinct performance obligation, as the customer can benefit from the software on its own. The Company’s revenue from PCS are derived from annual maintenance providing for unspecified upgrades on a when-and-if-available basis. The right for an unspecified upgrade for the version acquired by the customer and enhancements on a when-and-if-available basis that do not specify the features, functionality and release date of future product enhancements for the customer to know what will be made available and the general timeframe in which it will be delivered, if any. The Company considers the PCS performance obligation as a distinct performance obligation that is satisfied over time and recognized on a straight-line basis over the contractual period (mainly over a period of one year either for timely-based license or for perpetual license).

 

As the Company bundles software licenses (either time-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a relative standalone selling price basis.

 

Since the Company does not sell PCS on a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several hours of technical support per contract (as management believes the technology and products covered under the software license component are mature and fully functional as delivered to the costumer), the standalone selling prices of the PCS are determined based on the expected cost plus a margin (“cost-plus approach”) based on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such an estimate is also corroborated with the price that the Company would have to pay to a third-party service provider for a similar support service.

 

The stand-alone selling price of software licenses (either timely-based or perpetual) is estimated by management based on an adjusted market assessment approach which represents management estimation of the price that a customer in the market will be willing to pay for such a license on a stand-alone basis (i.e. without any PCS).

 

Due to the fact that the PCS services are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction price allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses.

 

During the reported periods, costs to obtain contracts were in an insignificant amount.

 

The Company does not grant a right of return to its customers. When product delivered to the customer is subject to evaluation, the Company defers revenue until evaluation is completed subject to formal selling agreement with the customer, at which time revenue is recognized provided that all other revenue recognition criteria are met.

 

Commencing 2022, revenue is also derived from the traffic operations in the Google AdSense program, a web advertising platform, that the Company makes available on its websites. Google pays the Company on a cost-per-click basis. The Company recognizes revenue at a point of time when the fees are paid to it by Google based on the volume of clicks through Google AdSense advertisements.

The Company receives payments from customers based upon contractual payment schedules. Trade receivables are recorded when right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables include amounts related to contractual right to consideration for completed performance obligations not yet invoiced. As of December 31, 2024 and 2023, unbilled receivables balance amounted to $26 and $39, respectively, and are included within trade receivables balance in the Company’s Consolidated Balance Sheets.

 

As of December 31, 2024 and 2023, the Company had $30 and $27, respectively, of remaining performance obligations not yet satisfied or partly satisfied related to revenue (mostly PCS). Such amounts are presented as deferred revenue which are expected to be recognized as revenue during the next twelve months.

 

See also Note 15 for further discussion related to disaggregation of revenue.

 

N.Concentrations of credit risk and allowance for doubtful accounts

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and trade receivables as well as certain other current assets that do not amount to a significant amount. Cash which is primarily held in dollar and New Israeli Shekels (NIS), are deposited with major banks in Israel, U.S. and Russian Federation. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements. Most of the Company’s sales are mainly derived from sales to a diverse set of customers located primarily in the United States. Management periodically evaluates the collectability of the trade receivables to determine the amounts that are doubtful of collection and determine a proper allowance for doubtful accounts, as described below. Accordingly, management believes that the Company’s trade receivables do not represent a substantial concentration of credit risk.

 

The Company extends credit to customers in the normal course of business and does not require collateral or any other security to support amounts due. Management performs ongoing credit evaluations of its customers. The allowance for doubtful accounts is determined with respect to amounts the Group has determined to be doubtful of collection by considering among other things, its past experience with customers, the length of time that the balance is past due, the customer’s current ability to pay and available information about the credit risk on such customers. Provisions for the allowance for doubtful accounts are recorded under general and administrative expenses in the consolidated Statements of Operations and Comprehensive Loss. During the reported periods, the Company has not recorded allowance in respect of accounts receivable.

 

O.Fair Value Measurements

 

The Company measures and discloses fair value in accordance with the ASC 820, “Fair Value Measurements and Disclosures” which defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

 

Level 1 - unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date.

 

Level 2 - pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.

 

Level 3 - pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy. The valuation of certain financial instruments classified under fair value through profit or loss category and the fair value of reporting units for purposes of goodwill impairment analysis (in periods when such analysis is based on the income approach), fall under this category.

 

This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.

 

The fair value of cash is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.

P.Allocation of proceeds and related issuance costs

 

When multiple instruments are issued in a single transaction (package issuance), the total gross proceeds from the transaction are allocated among the individual freestanding instruments identified. The allocation occurs after identifying all the freestanding instruments and the subsequent measurement basis for those instruments.

 

Financial instruments that are required to be subsequently measured at fair value (such as derivative warrants liability) are measured at fair value and the remaining consideration is allocated to other financial instruments that are not required to be subsequently measured at fair value (i.e. straight loan), based on the relative fair value basis for such instruments.

 

Allocation of issuance costs to freestanding instruments was based on an approach that is consistent with the allocation of the proceeds, as described above. Accordingly, issuance costs allocated to the derivative warrant liability were immediately expensed. Issuance costs allocated to straight loan are recorded as a discount of the straight loan and accreted over the contractual term of straight loan up to face value of such loans using the effective interest method.

 

Q.Warrants

 

Certain warrants that were issued to (i) a commercial bank as part of entering into funding transaction and (ii) a seller through a transaction in which certain identified intangible assets have been purchased, are classified as a component of permanent equity since they are freestanding financial instruments that are legally detachable and separately exercisable, do not embody an obligation for the Company to repurchase its own shares, and permit the holders to receive a fixed number of Ordinary Shares upon exercise for a fixed exercise price and thus, are considered as indexed to the Company’s own shares. In addition, the warrants must require physical share settlement and may not provide any guarantee of value or return. As such warrants were issued together with financial instruments that are not subsequently measured at fair value the warrants were measured based on allocation of the proceeds received by the Company in accordance with the relative fair value basis. When applicable, direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.

 

In 2023, warrants granted to seller have been expired. In 2024, warrants granted to commercial bank have been fully exercised on a cashless basis.

 

Down round feature is disregarded when assessing whether an instrument is indexed to its own shares, for purposes of determining liability or equity classification. Based on its evaluation, management has determined that certain warrants with down-round protection are eligible for equity classification. Upon the occurrence of an event that triggers down round protection (i.e., when the warrants’ exercise price is adjusted downward because of the down round feature), the effect is accounted for as a deemed dividend and as a reduction of income available to common shareholders for purposes of basic earnings per share (EPS) calculation. During the year ended December 31, 2023, down-round protection was triggered upon completion of the U.S IPO under which the Company recorded a deemed dividend amounted of $7 (see also Note 10B below).

 

R.Derivative Warrants Liability

 

Certain warrants that were granted by the Company for commercial banks through funding transaction entitle the bank to exercise the warrants for a variable number of shares and/or for a variable exercise price and thus the fixed-for-fixed criteria is not met. Accordingly, the warrants are classified as a non-current liability according to the provisions of ASC 815-40, “Derivatives and Hedging - Contracts in Entity’s Own Equity” (“ASC 815-40”).

 

Until completion of the U.S. IPO, the Company’s management accounted for these warrants as a financial derivative liability measured upon initial recognition and on subsequent periods at fair value with the assistance of an independent valuation firm by using the Hybrid Method by combining the Option Pricing Method (“OPM”) and an initial public offering scenario. Upon completion of the U.S. IPO, the fair value of the aforesaid warrants derivative liability is estimated internally by the Company’s management by using the Black-Scholes Model that is based on several assumptions, of which the most significant is the expected share price volatility, which was calculated based upon historical volatility of peer companies in the same industry on weekly basis. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company’s historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable plans to pay cash dividends in the future.

 

The above assumptions are reviewed on a regular basis and changes in the estimated fair value of the outstanding warrants are recognized each reporting period as part of the “Financing (income) expenses, net” line in the consolidated Statements of Operations and Comprehensive Loss, until such warrants are exercised, expired or eligible for exercise for fixed number of shares or for fixed exercise price. When applicable, direct issuance expenses that were allocated to the above warrants were expensed, as incurred.

S.Capital contribution from a controlling shareholder

 

The fair value of the benefit received in respect of loan received from the controlling shareholder was calculated on the basis of the difference between the interest rate that the Company would have required to pay for similar loan from commercial bank and the interest rate that the Company was actually charged under the agreement with the controlling shareholders. Such benefit was accounted for as capital contribution received from the controlling shareholder as additional paid-in capital and it was recorded as discount on the loan received against at the initial measurement date. Subsequently, such discount was expensed over the economic life of the loan based on the effective interest rate method.

 

T.Basic and diluted net loss per Ordinary Share

 

The Company applies the two-class method as required by ASC 260-10, “Earnings Per Share” (“ASC 260-10”), which requires the income or loss per share for each class of shares outstanding (Ordinary Shares and all other shares with preferences over the Ordinary Shares) to be calculated assuming 100% of the Company’s earnings are distributed as dividends to each class of shares based on their contractual rights. No dividends were declared or paid during the reported periods. According to the provisions of ASC 260-10, the Company’s Convertible Preferred Shares and Convertible Ordinary 1 and 2 Shares did not have contractual obligations to share losses of the Company and therefore were not included in the computation in the period of net loss per share. Upon the listing of the Company’s Ordinary Shares on the Nasdaq in connection with the U.S. IPO in February 2023, the entire balance of the Preferred Shares and Ordinary 1 and 2 Shares was converted into Ordinary Shares.

 

Basic net loss per Ordinary Share is computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of Ordinary Shares outstanding during the period. Diluted loss per share gives effect to all potentially dilutive common shares outstanding during the year using the treasury stock method with respect to shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), options and certain warrants and using the if-converted method with respect to convertible advance investments and certain warrants accounted for as derivative liability. In computing diluted loss per share, the average share price for the period is used in determining the number of shares assumed to be purchased from the exercise of options or warrants.

 

During the years ended December 31, 2024, 2023 and 2022, the total weighted average number of Ordinary Shares related to outstanding shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), options, warrants and convertible advance investments excluded from the calculation of the diluted loss per share was 1,306,124, 3,080,012 and 9,929,970, respectively.

 

The net loss from operations and the weighted average number of Ordinary Shares used in computing basic and diluted net loss per share from operations for the years ended December 31, 2024, 2023 and 2022, are as follows:

 

   Year ended December 31, 
   2024   2023   2022 
             
Numerator:            
Net loss  $(3,353)  $(695)  $(1,248)
Deemed dividend related to trigger of down round protection feature (see Note 10B below)   
-
    (7)   
-
 
Net basic loss  $(3,353)  $(702)  $(1,248)
Change in fair value of derivative warrant liability (see Note 8 below)   
-
    (66)   
-
 
Change in fair value of convertible advanced investment (see Note 10B below)   
-
    (269)   
-
 
Net diluted loss  $(3,353)  $(1,037)  $(1,248)
                
Denominator:               
Ordinary shares used in computing basic net loss per share   15,167,476    11,194,097    2,578,760 
Incremental ordinary shares to be issued upon exercise of derivative warrant liability   
-
    24,834    
-
 
Incremental ordinary shares to be issued upon conversion of convertible advanced investments   
-
    230,880    
-
 
Ordinary shares used in computing diluted net loss per share   15,167,476    11,449,811    2,578,760 
                
Basic net loss per ordinary share  $(0.22)  $(0.06)  $(0.48)
Diluted net loss per ordinary share  $(0.22)  $(0.09)  $(0.48)
U.Share-based compensation

 

The Company measures and recognizes compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with ASC 718, “Compensation-Stock Compensation”. Share-based payments are recognized in the Statement of Operations and Comprehensive Loss as an operating expense (unless they are eligible to be capitalized as part of the cost of internal developed asset) based on fair value of the award at the grant date by using Black-Scholes option-pricing model. The inputs for the valuation analysis of the options include several assumptions of which the most significant are the fair market value of the underlying Ordinary Share, the expected share price volatility and the expected option term. Expected volatility was calculated based upon historical volatility of peer companies in the same industry on a weekly basis. The expected option term represents the period that the Company’s options are expected to be outstanding and is determined based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company’s historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable plans to pay cash dividends in the future. The Company expensed compensation costs net of estimated forfeitures over the requisite service period by applying the straight-line method.

 

Up and until the completion of the U.S. IPO, the fair value of Ordinary Shares underlying the options was determined by the Company’s management with the assistance of an independent valuation firm. Because in such periods there has been no public market for the Ordinary Shares, the Company’s management has determined fair value of the Ordinary Shares at the time of grant by considering several objective and subjective factors including data from other comparable companies, sales of Convertible Preferred Shares to unrelated third parties, operating and financial performance, the lack of liquidity of share capital and general and industry specific economic outlook, amongst other factors. From the period commencing on June 30, 2021 through March 2, 2023 (the closing date of the U.S. IPO), the valuations were performed by using Hybrid Method by combining the OPM and an initial public offering scenario.

 

Since January 1, 2019, share-based payments to non-employees are accounted in accordance with ASC 718.

 

When applicable, a modification to the terms and/or conditions of an award (i.e. a change of award’s fair value, vesting conditions or classification as an equity or a liability instrument) is accounted for as an exchange of the original award for a new award resulting in total compensation cost equal to the grant-date fair value of the original award, plus the incremental value of the modification to the award. The calculation of the incremental value is based on the excess of the fair value of the modified award following the modification over the fair value of the original award measured immediately before its terms were modified.

 

V.Accounting Pronouncements Adopted During the Current Year

 

Segment Reporting Disclosures

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which requires that all public entities, including public entities with a single reportable segment, to provide in interim and annual periods one or more measures of segment profit or loss used by the Chief Operating Decision Maker (“CODM”) to allocate resources and assess performance. Additionally, ASU 2023-07 requires disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures.

 

The Company adopted ASU 2023-07 beginning with the consolidated financial statements for the fiscal year ended December 31, 2024 and thereafter, and have applied this standard retrospectively for all prior periods presented in the consolidated financial statements. See also Note 15 for further information related to segment reporting.

 

W.Recently issued accounting pronouncements, not yet adopted

 

1.In December 2023, the FASB issued ASU 2023-09 on Improvements to Income Tax Disclosures that require greater disaggregation of income tax disclosures to the income rate tax rate reconciliation and income taxes paid. The updates are effective for annual periods beginning after December 15, 2024. The Company intends to adopt and apply the guidance in fiscal year 2025. The Company is still assessing the impact of the disclosure of this standard.

 

2.In November 2024, the FASB issued ASU 2024-03 on Disaggregation of Income Statement Expenses that enhances disclosure of certain costs and expenses to provide enhanced transparency into the expenses presented in the income statement. The updates are effective for annual periods beginning after December 15, 2026. The Company intends to adopt and apply the guidance in fiscal year 2027. The Company is still assessing the impact of the disclosure of this standard.
v3.25.0.1
Cash
12 Months Ended
Dec. 31, 2024
Cash [Abstract]  
CASH

NOTE 3 - CASH

 

  

As of

December 31,

 
   2024   2023 
         
 Denominated in U.S. dollar (*)  $16,260   $5,792 
 Denominated in New Israel Shekel   65    150 
 Denominated in other currencies   158    174 
   $16,483   $6,116 

 

(*)As of December 31, 2024, including short-term bank deposits for a period less than 3 months at an average interest rate of 5.14%.
v3.25.0.1
Other Current Assets
12 Months Ended
Dec. 31, 2024
Other Current Assets [Abstract]  
OTHER CURRENT ASSETS

NOTE 4 - OTHER CURRENT ASSETS

 

  

As of

December 31,

 
   2024   2023 
         
 Prepaid expenses  $88   $76 
 Government authorities   24    40 
 Others   83    16 
   $195   $132 
v3.25.0.1
Intangible Assets, Net and Goodwill
12 Months Ended
Dec. 31, 2024
Intangible Assets, Net and Goodwill [Abstract]  
INTANGIBLE ASSETS, NET AND GOODWILL

NOTE 5 - INTANGIBLE ASSETS, NET AND GOODWILL

 

  

As of

December 31,

 
   2024   2023 
Carrying amount:          
Trade names  $201   $201 
Internal-use software   600    233 
   $801   $434 
Accumulated amortization:          
Trade names  $174   $154 
Internal-use software   138    
-
 
   $312   $154 
           
Intangible assets, net  $489   $280 

 

During the years ended December 31, 2024, 2023 and 2022, amortization expenses were $158, $20 and $20, respectively.

 

As of December 31, 2024, the estimated future amortization expense of intangible assets is as follows:

 

2025  $220 
2026   207 
2027   62 
   $489 

 

As of the reported periods, an annual impairment analysis was performed internally by the Company’s management by comparing the fair value market of the Company, which its operation represents a single reporting unit, to the carrying amount of the net assets allocated to the reporting unit (including the entire balance of goodwill).

v3.25.0.1
Loans, Net
12 Months Ended
Dec. 31, 2024
Loans, Net [Abstract]  
LOANS, NET

NOTE 6 - LOAN, NET

 

On July 7, 2022 (the “Effective Date”), the Company entered into a definitive agreement with IBI Spikes Ltd. ( “IBI”), according to which the Company received an amount of NIS 3.1 million (approximately $900) (the “IBI Loan”). The Company granted IBI a right to receive consecutive monthly repayments equal to Net Cash Receipts multiplied by the Royalty Rate, as both defined in the definitive agreement, until such time as IBI receives an amount equal to NIS 4,172,760 (approximately $1.2 million) (the “Repayment Amount”) with any amount on account of the Repayment Amount which remains outstanding on the 42nd month anniversary of the later of (i) the Closing Date, and (ii) the last payment provided by IBI (the “Final Repayment Date”) to be paid to IBI at such time. Notwithstanding the above, the Company’s minimum annual payment (i.e. principal and interest) during any Annual Calculation Period will not be less than the lower of (i) $330 and (ii) outstanding Repayment Amount in recent year.

 

The Company may repay the Repayment Amount at any time prior to the Final Repayment Date. If early repayment (such amount, the “Payment Amount”) occurs prior to 12-month anniversary date of the Effective Date, then, a 50% discount will be applied on the outstanding difference between the Repayment Amount and the Payment Amount (the “Rev-Share Amount”) component of the outstanding Repayment Amount; or if early repayment occurs after 12-month anniversary date of the Closing Date but before 18-month anniversary date of the Closing Date, then, a 35% discount will be applied on the outstanding Rev-Share Amount of the outstanding Repayment Amount (the “Early Repayment Amount”).

 

In case the Company and/or its subsidiaries consummated a change of control, merger transaction, an initial public offering transaction (excluding the U.S. IPO) (an “IPO”) or sale of all or substantially all of assets (the “Exit Event”), the Company shall fully pay IBI the Repayment Amount or the Early Repayment Amount, as the case may be.

 

The Company incurred a non-refundable one-time fee of $13, reflecting 1.5% of the Payment Amount plus VAT.

 

Upon making of the Payment Amount, the Company issued warrant to IBI to purchase 65,563 of (i) the most senior class of shares outstanding or (ii) Ordinary Shares in case of an exercise following to completion of an IPO transaction (the “Warrant Share”). Each Warrant Share was exercisable until the earlier of (a) a merger transaction, (b) an IPO, or (c) a 10-years period from issuance date. The determination of the exercise price for each of the Warrant Share may be variable subject to occurrence of certain trigger events as defined in the definitive agreement. Consequently, the Warrant Share was accounted for as a derivative financial liability. See also Note 8 below.

 

For information regarding the determination of the exercise price and full exercise of the Warrant Share on a cashless basis, see also Note 8 and Note 10D2 below.

 

The following tabular presentation reflects the reconciliation of the carrying amount of the IBI Loan during the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
             
Opening balance  $500   $717   $
-
 
Net consideration allocated to IBI Loan   
-
    
-
    887 
Recognition of fair value of derivative warrant liability   
-
    
-
    (88)
Amortization of discount relating to straight loan   31    31    12 
Repayment of principal relating to straight loan   (292)   (236)   (82)
Exchange rate differences   11    (12)   (12)
Closing balance  $250   $500   $717 

 

Maturity dates of outstanding loans:

 

  

As of

December 31,

 
   2024   2023 
         
First year (current maturities)  $250   $330 
Second year   
-
    170 
Closing balance  $250   $500 
v3.25.0.1
Other Current Liabilities
12 Months Ended
Dec. 31, 2024
Other Current Liabilities [Abstract]  
OTHER CURRENT LIABILITIES

NOTE 7 - OTHER CURRENT LIABILITIES

 

  

As of

December 31,

 
   2024   2023 
         
Employees and payroll accruals  $465   $279 
Accrued expenses (*)  $212   $179 
   $677   $458 

 

(*)Including interest accrued on IBI Loan amounted to $4 and $7 as of December 31, 2024 and 2023, respectively. See also Note 12 below.
v3.25.0.1
Derivative Warrants Liabilities
12 Months Ended
Dec. 31, 2024
Derivative Warrants Liabilities [Abstract]  
DERIVATIVE WARRANTS LIABILITIES

NOTE 8 - DERIVATIVE WARRANTS LIABILITIES

 

On April 29, 2021, the Company entered into a second deferral agreement in connection with a straight loan made under a loan and security agreement that the Company previously entered into with Silicon Valley Bank (“SVB”) in February 2017, under which it was agreed, inter alia, to issue to SVB a warrants to purchase 9,764 shares (the “2021 Warrant”) at an exercise price of $5.12 per share (subject to standard adjustments), which is exercisable over a period of 15-years at SVB’s discretion. If SVB exercises the 2021 Warrant and the Warrant Value (as defined in the 2021 Warrant) is lower than an amount equal to $50 (the “Minimum Value”), then immediately following such exercise, the Company shall pay SVB an amount in cash equal to the difference between the Minimum Value and Warrant Value. The 2021 Warrant was issued on April 29, 2021.

 

Until the completion of the U.S. IPO transaction, the fair values of the above 2021 Warrant and the Warrant Share (as noted in Note 6 above) were determined by the management with the assistance of an independent valuation firm by using the Hybrid Method by combining the OPM and an IPO scenario. Because there has been no public market for the Ordinary Shares, the management has determined the fair value of the Ordinary Shares by considering several objective and subjective factors including data from other comparable companies, the lack of liquidity of share capital and general and industry specific economic outlook, amongst other factors. The fair value of the underlying Ordinary Shares was determined by management until such time as the Ordinary Shares are listed on an established stock exchange, national market system or other quotation system. Upon completion of the U.S. IPO, the fair values of the 2021 Warrant and the Warrant Share were determined internally by the management based on several assumptions by using Black-Scholes-Merton pricing model. Through the reported periods, the estimated fair value of derivative financial liability for the 2021 Warrant has not exceeded the Minimum Value and thus was determined at $50. In addition, from the issuance date of the 2021 Warrant through December 31, 2024, the 2021 Warrant was not exercised.

 

At the issuance date of the 2021 Warrant, the fair value of derivative financial liability for the Warrant Share was estimated in total amount $88 which has not changed significantly through December 31, 2022. However, as of December 31, 2023, the fair value of derivative financial liability for the Warrant Share was estimated by the management in total amount of $22 by taking into consideration (i) the likelihood for occurrence of certain trigger events as defined in the definitive agreement and (ii) the reduction in the quoted price of the Ordinary Share. Thus, during the year ended December 31, 2023, the Company recorded revaluation income amounted to $66 (see also Note 12 below).

 

On February 22, 2024, the Company received a written notice from IBI pursuant to which the exercise price of the Warrant Share granted to IBI to purchase 65,563 Ordinary Shares was determined at a fixed amount of $3.67 per Ordinary Share. Consequently, the Warrant Share was re-classified from derivative warrants liability to equity at its fair value as of that date in total amount of $599. During the year ended December 31, 2024, the Company recorded revaluation expenses of $577 due to a change in the fair value of the derivative warrants liability. In addition, through December 31, 2024, the Warrant Share was fully exercised on a cashless basis.

 

The following tabular presentation reflects the reconciliation of the fair value of derivative warrants liabilities during the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
             
Opening balance  $72   $138   $50 
Recognition of fair value of Warrant Share issued at Effective Date   
-
    
-
    88 
Amount classified to equity upon determination of the exercise price of Warrant Share (see Note 10D2 below)   (599)   
-
    
-
 
Change in fair value of derivative warrant liability (see Note 12 below)   577    (66)   
-
 
Closing balance  $50   $72   $138 
v3.25.0.1
Commitments
12 Months Ended
Dec. 31, 2024
Commitments [Abstract]  
COMMITMENTS

NOTE 9 - COMMITMENTS

 

Lease commitments

 

A.During the reported periods, the Company entered into several short-term agreements (of 12 months or less) for the renewal of leasing of premises with unrelated party, the last of which was signed in November 2024 for a period commencing November 1, 2024 through April 30, 2025 for a monthly fee of NIS 62 thousand (approximately $17).

 

B.During the reported periods, Beamr Imaging RU entered into several short-term agreements for renewal of a leasing of premises with unrelated party, the last of which was signed in July 2024 for the period commencing July 1, 2024 through May 31, 2025 for a monthly fee of Russian Ruble 227 (approximately $2).

 

As of December 31, 2024, the future minimum commitment under binding operating lease agreements is as follows:

 

   Lease of premises 
     
2025  $80 
   $80 

 

The lease payments under the binding agreement are associated with short-term operating leases of premises with a lease term of twelve months or less. As the Company elected the short-term recognition exemption (see also Note 2I), such leases are out of scope of ASC 842 “Leases”. Consequently, these payments are recognized on a straight-line basis as an operating expense in the Consolidated Statements of Operations and Comprehensive Loss.

 

During the years ended December 31, 2024, 2023 and 2022, lease expenses were $170, $119 and $119, respectively.

v3.25.0.1
Shareholders’ Equity
12 Months Ended
Dec. 31, 2024
Shareholders’ Equity [Abstract]  
SHAREHOLDERS’ EQUITY

NOTE 10 - SHAREHOLDERS’ EQUITY

 

A.Composition of shareholders’ equity:

 

  

As of

December 31, 2024

  

As of

December 31, 2023

 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
   Number of shares 
                     
Ordinary Shares of NIS 0.05 par value   222,000,000    15,518,794    222,000,000    13,051,343 

 

The Ordinary Shares confer upon the holders thereof all rights accruing to a shareholder of the Company, as provided in the Company’s Amended and Restated Articles of Association (the “Articles”), including, without limitation, the right to receive notices of, and to attend, all general meetings, the right to vote thereat with each Ordinary Share held entitling the holder thereof to one vote at all general meetings (and written actions in lieu of meetings), the right to participate and share on a per share basis in any distribution and in distribution of surplus assets and funds of the Company in the event of a liquidation event, and certain other rights as may be expressly provided for in the Articles or under the Israeli Companies Law 5759-2999. All Ordinary Shares rank pari passu amongst themselves for all intents and purposes, including, without limitation, in relation to the amounts of capital paid or credited as paid on their nominal value.

B.Completion of underwritten U.S. public offering

 

On February 27, 2023, the Company announced the pricing of its U.S. IPO of 1,950,000 Ordinary Shares at a public offering price of $4.00 per share, for aggregate gross proceeds of $7,800, prior to deducting underwriting discounts and other offering expenses. In addition, the Company granted to the underwriters (i) warrants to purchase up to 97,500 Ordinary Shares at an exercise price of $5.00 per Ordinary Share over a period of 5-years commencing August 26, 2023 (see also Note 10D1 below) and (ii) a 45-day option to purchase up to an additional 292,500 Ordinary Shares at the public offering price, which expired in April 2023 without being exercises. The Ordinary Shares began trading on the Nasdaq Capital Market under the ticker symbol “BMR” on February 28, 2023. The IPO closed on March 2, 2023.

 

Direct and incremental costs incurred related to the U.S. IPO amounted to $1,418 (including capitalized deferred offering costs amounted to $313).

 

In connection with the U.S. IPO, the following occurred -

 

1.The holders of all shares with preferences over Ordinary Shares (i.e. Convertible Preferred Shares and Convertible Ordinary 1 and 2 Shares) voluntary effected a conversion of all such shares into 7,211,280 Ordinary Shares.

 

2.The Company’s authorized share capital increased from 22,000,000 to 222,000,000.

 

3.A reverse share split of all outstanding Ordinary Shares of the Company was effected at a ratio of 5:1 so that each 5 ordinary shares, nominal value NIS 0.01 per share, was consolidated into 1 Ordinary Share, nominal value NIS 0.05 per share, (the “Reverse Share Split”).

 

4.Automatic conversion of all outstanding Convertible Advance Investment amounts in the nominal value of $3,657 to 1,142,856 Ordinary Shares at a conversion price of $3.2 which equals 80% of the public offering price in the U.S. IPO. As a result, in 2023, the Company recorded income amounting to $269 as result of changes in the fair value of the convertible advance investment (see Note 12 below).

 

5.A down-round protection feature of certain warrants granted in previous years to commercial bank (SVB) was triggered by way of reduction of their exercise price from $5.12 to a price of $4.00, which represented the public offering price in the U.S. IPO. Such reduction was accounted for as deemed dividend estimated of $7 thousand, which was recorded as part of the additional paid-in capital versus increase of accumulated deficit. Regarding the effect of the loss per share, see also Note 2T above.

 

C.Completion of underwritten U.S. public offering

 

On February 15, 2024, the Company completed an additional underwritten U.S. public offering pursuant to which the Company received aggregate gross proceeds of $12,000, before deducting underwriting discounts and offering expenses, for issuance of 1,714,200 Ordinary Shares at a public offering price of $7.00 per share. In addition, the Company granted the underwriter (i) a 45-day option to purchase up to an additional 257,100 Ordinary Shares to cover over-allotments at the public offering price to cover over-allotments and (ii) a warrant for the purchase of up to 98,565 Ordinary Shares, at an exercise price of $8.75 per Ordinary Share over a period of 5-years commencing August 10, 2024.

 

On February 13, 2024, the over-allotment option was fully exercised by the underwriter for additional aggregate gross proceeds of approximately $1,800, before deducting underwriting discounts.

 

Direct and incremental costs incurred related to the offering amounted to $1,514.

 

The offering closed on February 15, 2024.

 

D.Cashless exercise of warrants

 

1.During the year ended December 31, 2024, the Company issued 63,931 Ordinary Shares upon partial cashless exercises of warrants granted to the underwriter in the U.S. IPO (see also Note 10B above).

 

2.During the year ended December 31, 2024, the Company issued 31,189 Ordinary Shares to IBI upon cashless exercise of Warrant Shares (see also Note 8 above).
v3.25.0.1
Options
12 Months Ended
Dec. 31, 2024
Options [Abstract]  
OPTIONS

NOTE 11 - OPTIONS

 

Option plan:

 

On January 11, 2015, the Company’s Board of Directors approved and adopted the 2015 Share Incentive Plan (the “Plan”), pursuant to which the Company’s Board of Directors may award options to purchase the Company’s Ordinary Shares as well as restricted shares, RSUs and other share-based awards to designated participants. Subject to the terms and conditions of the Plan, the Company’s Board of Directors has full authority in its discretion, from time to time and at any time, to determine (i) the designate participants; (ii) the terms and provisions of the respective award agreements, including, but not limited to, the number of options to be granted to each optionee, the number of shares to be covered by each option, provisions concerning the time and the extent to which the options may be exercised and the nature and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel or suspend awards, as necessary; (iii) determine the fair market value of the shares covered by each award; (iv) make an election as to the type of approved 102 Option under Israeli tax law; (v) designate the type of options; (vi) take any measures, and to take actions, as deemed necessary or advisable for the administration and implementation of the Plan; (vii) interpret the provisions of the Plan and to amend from time to time the terms of the Plan.

 

On May 22, 2024, the Company’s Board of Directors approved to increase the number of Ordinary Shares, reserved out of the Company’s registered share capital, to be issued under the Plan by additional 1,000,000 Ordinary Shares.

 

The Plan permits the grant of up to 3,069,280 share Ordinary Shares subject to adjustments set in the Plan. As of December 31, 2024, considering the effect of previously exercised options, there were 1,012,006 Ordinary Shares available for future issuance under the Plan.

 

The following table presents the Company’s option activity for employees and members of the Board of Directors of the Company under the Plan for the years ended December 31, 2024, 2023 and 2022:

 

   Number of
Options
  

Weighted
Average
Exercise
Price

   Weighted
average
remaining
contractual
life
   Intrinsic
value
 
       $   (years)   $ 
                 
Outstanding as of December 31, 2021   1,367,168    1.75    5.72    4,860 
Granted   286,875    1.83    -    - 
Forfeited or expired   (83,052)   1.45    -    - 
Outstanding as of December 31, 2022   1,570,991    1.78    4.97    2,435 
Exercisable as of December 31, 2022   1,048,297    1.70    3.2    1,677 

 

   Number of
Options
  

Weighted
Average
Exercise
Price

   Weighted
average
remaining
contractual
life
   Intrinsic
value
 
       $   (years)   $ 
                 
Outstanding as of December 31, 2022   1,570,991    1.78    4.97    2,435 
Granted   151,600    2.88    -    - 
Exercised   (168,447)   0.29    -    - 
Forfeited or expired   (258,777)   1.81    -    - 
Outstanding as of December 31, 2023   1,295,367    2.09    6.04    84 
Exercisable as of December 31, 2023   863,616    2.07    4.70    84 
   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
average
remaining
contractual
life
   Intrinsic
value
 
       $   (years)   $ 
                 
Outstanding as of December 31, 2023   1,295,367    2.09    6.04    84 
Granted   462,200    4.51    -    - 
Exercised   (401,031)   1.98    -    - 
Forfeited or expired   (11,500)   2.65    -    - 
Outstanding as of December 31, 2024   1,345,036    2.95    7.17    2,677 
Exercisable as of December 31, 2024   641,851    2.15    5.12    1,786 

 

The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the deemed fair value of the Company’s Ordinary Shares on the last day of each of the applicable reported period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all options holders exercised their options on December 31 of each of the reported period. This amount is impacted by the changes in the fair market value of the Company’s Ordinary Share.

 

The outstanding and exercisable options as of December 31, 2024 were separated into range of exercise prices, as follows:

 

Exercise price  Options
outstanding
as of
December 31,
2024
   Weighted
average
remaining
contractual
term
   Options
exercisable
as of
December 31,
2024
   Weighted
average
remaining
contractual
term
 
       (years)       (years) 
                 
-   17,680    2.20    17,680    2.20 
1.14   82,580    2.04    82,580    2.04 
1.47   7,200    9.09    
-
    
-
 
1.48   50,000    8.70    15,625    8.70 
1.74   12,800    8.30    4,800    8.30 
1.83   565,974    6.53    401,950    6.04 
2.79   6,400    8.59    2,000    8.59 
2.97   69,600    9.87    
-
    
-
 
3.20   5,002    6.64    4,064    6.64 
3.59   28,800    9.74    
-
    
-
 
4.00   76,000    8.17    44,352    8.17 
4.17   28,800    1.03    28,800    1.03 
4.96   315,200    9.56    
-
    
-
 
5.02   39,000    9.49    
-
    
-
 
5.12   40,000    1.04    40,000    1.04 
    1,345,036         641,851      

 

The weighted average grant date fair value of options granted during the years ended December 31, 2024, 2023 and 2022 was $2.78, $1.66 and $0.51 per option, respectively.

 

During the years ended December 31, 2024 and 2023, 401,031 and 168,447 options were exercised for total amount of $795 and $49, respectively. During the year ended December 31, 2022, options have not been exercised.

The following table presents the assumptions used to estimate the fair values of the options granted in the reported periods:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Volatility (%)   52.71%-73.53%    60.48%-61.49%    61.49%
Risk-free interest rate (%)   3.6%-4.4%    3.7%-4.3%    3.64%-3.85% 
Dividend yield (%)   
-
    
-
    
-
 
Expected life (years)   6.25    6.25    6.25 
Exercise price ($)   1.47-5.02    1.48-4.00    1.83 
Share price ($)   1.72-5.24    1.48-3.73    3.30 

 

As of December 31, 2024, there was $1,633 of unrecognized compensation expenses related to unvested options, that are expected to be recognized on a straight-line basis over the requisite service period, which results in weighted average period of approximately 1.54 years.

 

The total compensation cost related to all of the Company’s equity-based awards recognized during the years ended December 31, 2024, 2023 and 2022 was comprised as follows:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Research and development  $185   $216   $144 
Sales and marketing   20    41    49 
General and administrative   213    106    29 
   $418   $363   $222 
v3.25.0.1
Financing Expenses (Income), Net
12 Months Ended
Dec. 31, 2024
Financing Expenses (Income), Net [Abstract]  
FINANCING EXPENSES (INCOME), NET

NOTE 12 - FINANCING EXPENSES (INCOME), NET

 

  

Year ended December 31

 
   2024   2023   2022 
             
Change in fair value of convertible advance investment  $
-
   $(269)  $70 
Change in fair value of derivative warrant liability   577    (66)   
-
 
Amortization of discount and accrued interest relating to straight loan received from commercial banks   106    157    102 
Change in estimation of maturity date of liability to controlling shareholder   
-
    12    
-
 
Discount amortization relating to liability to controlling shareholder   10    48    40 
Interest due to bank deposits   (599)   (97)   
-
 
Exchange rate differences and other finance expenses   (2)   (7)   (47)
   $92   $(222)  $165 
v3.25.0.1
Related Parties Transactions
12 Months Ended
Dec. 31, 2024
Related Parties Transactions [Abstract]  
RELATED PARTIES TRANSACTIONS

NOTE 13 - RELATED PARTIES TRANSACTIONS

 

The liability to controlling shareholder derives from a service agreement with the Company’s Founder under which the Company receives consulting services on recurring basis from the Founder as Chief Executive Officer indirectly through an entity controlled by the Founder (the “Service Provider”) for total current monthly gross amount of NIS 45 thousand. On March 14, 2022, the Company’s shareholders approved, among other matters, to renew the service agreement with the Founder for a period ending December 31, 2025.

 

On February 16, 2022, the Company entered into an addendum to the aforesaid service agreement with the Service Provider under which it was agreed that (i) the term of the service agreement with the Service Provider was extended to December 31, 2025 and (ii) the then current liability towards the Service Provider as was accrued for services rendered under the service agreement over a period commencing January 1, 2020 through the date hereof in total nominal amount of $357 (the “Current Liability”) will be paid in 18 equal installments (without an interest) starting on March 1, 2022 (the “Commencement Date”). However, in the event that the Company shall not have available sufficient funds in any such payment date from and after the Commencement Date to repay the installments of the Current Liability and/or the on-going fee owed to the Service Provider or in the event that the Company determines that according to the following 12-months period budget that it shall not have available sufficient funds to pay such installments and/or the on-going fee, then the Service Provider hereby agrees to postpone such payments owed to it until the Company will have such sufficient funds. Any unpaid on-going fee payments will be added to the Current Liability.

 

Since the liability towards the Founder was considered as a free interest loan which did not represent the applicable rate of risk for the Company, the addendum was accounted for as a capital contribution from a controlling shareholder. Thus, such liability was measured at fair value based on future cash payments discounted using an interest rate of 15.45% which represented the applicable rate of risk for the Company, as determined by management using the assistance of third-party appraiser. As a result, the Company recorded a discount on the balance of liability towards the Founder in total amount of $112 against additional paid-in capital (including in respect to amounts due for services period through fiscal year for 2022). Discount expenses are recorded over the economic life of the loan based on an effective interest rate method.

 

As of December 31, 2022, management has updated the repayments schedule of the obligation based on its current projection of the availability of funds. Accordingly, the obligation was expected to be repaid over the following 24-months period. However, upon completion of the U.S. IPO (see also Note 10B above), the Commencement Date was determined to be the pricing date of the U.S. IPO (February 27, 2023) under which the liability in nominal amount of NIS 1,710 thousand (approximately $462) will be paid in 18 equal monthly installments.

 

On May 22, 2024, the Company’s Compensation Committee approved adjustments of the compensation terms and of the Founder for his duties as Chief Executive Officer of the Company, following which his salary shall be increased by NIS 20 thousand, subject the approval of the Company’s shareholders at a general meeting of the shareholders, which was approved on August 5, 2024

The following tabular presentation reflects the reconciliation of the carrying amount of the Company’s Liability to controlling shareholder, net during the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
             
Opening balance  $199   $388   $345 
Accrued liability in respect to additional services rendered        25    115 
Recognition of capital contribution from a controlling shareholder        
 
    (112)
Repayment of liability to controlling shareholder   (206)   (258)   
-
 
Amortization of discount relating to liability to controlling shareholder   10    48    40 
Change in estimation of maturity date of liability   
-
    12    
-
 
Exchange rate differences   (3)   (16)   
-
 
Closing balance  $
-
   $199   $388 

 

The Company allocated the expenses related to the above service agreement and addendum as follows:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Research and development  $53   $36   $42 
Sales and marketing   53    36    42 
General and administrative   106    74    83 
   $212   $146   $167 


The allocation of expenses was done based on the management estimation to reflect the contribution to the related activity.

v3.25.0.1
Taxes on Income
12 Months Ended
Dec. 31, 2024
Taxes on Income [Abstract]  
TAXES ON INCOME

NOTE 14 - TAXES ON INCOME

 

A.Israeli taxation:

 

Taxable income of the Company is subject to the Israeli corporate tax at the rate of 23%.

 

As of December 31, 2024, the Company has net operating losses and capital losses carryforward for Israeli income tax purposes of approximately $30,914 and $397 respectively, which can be offset against future taxable income for an indefinite period of time.

 

The Company has final (considered final) tax assessments through the 2019 tax year.

 

B.Foreign entities:

 

1.Beamr Inc. is taxed under United States federal and state tax rules. Income tax is calculated based on a U.S. federal tax rate of 21%.

 

Beamr Inc. have not received final tax assessments for the tax years ended December 31, 2021 through 2024.

 

2.Beamr Imaging RU was taxed in 2024 and during prior periods under the Russian tax code at the rate of 0% (Clause 1.15 of Article 284 of the Tax Code of the Russian Federation, with changes provided by Federal Law No.321-FZ of 14.07.2022).

 

In 2025, Beamr Imaging RU will be taxed at a rate of 5% (Clause 1.15 of Article 284 of the Tax Code of the Russian Federation, ed. Federal Law No. 176-FZ dated 12.07.2024).

 

Beamr Imaging RU have not received final tax assessments for the tax years ended December 31, 2022 through 2024.

 

C.Taxes on income are primarily comprised from taxes incurred as result of (i) withholding tax deducted at source in accordance with U.S. - Israel tax treaty related to selling of software, (ii) implementation of the intercompany agreement between the Company and Beamr Inc. for conducting reseller services and implementation of the intercompany agreement between the Company and Beamr Imaging RU for conducting research and development services on behalf of the Company (see also Note 1B) and (iii) tax assets write off.
D.Loss (income) before taxes on income consists of the following:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Domestic  $3,345   $714   $1,293 
Foreign operations (Beamr Inc. and Beamr Imaging RU)   (38)   (58)   (97)
   $3,307   $656   $1,196 

 

E.Deferred income taxes reflect the net tax effects of net operating loss and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of the Company’s deferred tax assets are as follows:

 

  

As of

December 31

 
  2024   2023 
Composition of deferred tax assets:        
Net operating loss and capital losses carryforward  $7,202   $6,704 
Research and development credits   537    397 
Vacation accrual   44    44 
Net deferred tax asset before valuation allowance   7,783    7,145 
           
Valuation allowance   (7,783)   (7,145)
Net deferred tax assets  $
-
   $
-
 

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences are deductible and net operating losses are utilized. Based on consideration of these factors, the Company recorded a full valuation allowance as of December 31, 2024 and 2023.

 

F.During the years ended December 31, 2024, 2023 and 2022, the main reconciling item between the statutory tax rate of the Company (as noted in Note 14A) and the effective tax rate at the rate of 1.4%, 5.9% and 4.4%, respectively, is mainly the recognition of valuation allowance in respect of deferred taxes relating to accumulated net operating losses carried forward and other permanent and temporary differences due to the uncertainty of the realization of such deferred taxes and withholding taxes that were deducted by the Company’s customers.
v3.25.0.1
Segment Geographical Information And Major Customers
12 Months Ended
Dec. 31, 2024
Segment Geographical Information And Major Customers [Abstract]  
SEGMENT GEOGRAPHICAL INFORMATION AND MAJOR CUSTOMERS

NOTE 15 - SEGMENT GEOGRAPHICAL INFORMATION AND MAJOR CUSTOMERS

 

A.General information

 

Since inception date, the operation of the Company is conducted through one operating segment, the optimization technology for video and photo compression, which represents a single reporting unit. This activity also represents the reportable segment of the Group.

 

The Company manages its business activities on a consolidated basis and operates in one reportable segment, video technology and image science software solutions. The accounting policies of this segment are the same as those described in Note 2V above.

 

The Company’s executive management is the CODM, which uses the net loss, as reported in the Consolidated Statements of Operations and Comprehensive Loss, in evaluating the performance of the Company and determining how to allocate resources of the Company as a whole, including investing in product development.

B.Revenue by geographic region is as follows:

 

  

Year ended December 31

 
   2024   2023   2022 
             
United States  $2,132   $2,089   $2,134 
Israel   41    66    22 
Rest of the world   891    754    707 
   $3,064   $2,909   $2,863 

 

Revenue was attributed to countries based on customer location.

 

C.Long-lived assets, net, by geographic areas:

 

  

As of

December 31,

 
   2024   2023 
         
Israel  $40   $14 
Other   3    5 
   $43   $19 

 

Such balance is comprised of property and equipment that are attributed to the geographic area in which they are located or originated, as applicable.

 

D.Major customers

 

During the years ended December 31, 2024, 2023 and 2022, the Company had one customer which accounted for 27% 26% and 26% of the Company’s total revenue, respectively. In addition, the Company had three and four customers, which accounted for in aggregate 62% and 81% of the Company’s total trade receivables as of December 31, 2024 and 2023, respectively.

 

E.Major product lines and services and timing of revenue recognition

 

In the following table, revenue is disaggregated by primary major product lines and services, and timing of revenue recognition for the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
Software license:               
Perpetual based software license - transferred at a point of time  $802   $886   $1,068 
Term-based software license - transferred at a point of time   1,995    1,844    1,630 
Total software license (*)  $2,797   $2,730   $2,698 
PCS services transferred over a period of time   128    120    123 
Web advertising at a point of time upon clicks   139    59    42 
   $3,064   $2,909   $2,863 

 

(*)Revenue recognized from sales-based software license was $46, $53 and $48 during the years ended December 31, 2024, 2023 and 2022, respectively (see also Note 2M).
v3.25.0.1
Subsequent Events
12 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 16 - SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure      
Net Income (Loss) $ (3,353) $ (695) $ (1,248)
v3.25.0.1
Insider Trading Policies and Procedures
3 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.0.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]

We have developed and maintain a cybersecurity risk management program, consisting of cybersecurity policies, procedures, compliance and awareness programs to mitigate risk and to ensure compliance with security, availability and confidentiality trust principles. The cybersecurity process has been integrated into our overall risk management system and process, and is internally managed by our R&D department as well as our internal auditor, Deloitte & Co. Israel. Management is responsible for identifying risks that threaten achievement of the control activities stated in the management’s description of the services organizations systems. Management has implemented a process for identifying relevant risks that could affect the organization’s ability to provide secure and reliable service to its users. The risk assessment occurs annually, or as business needs change, and covers identification of risks that could act against the company’s objectives as well as specific risks related to a compromise to the security of data. See “Item 3.D Risk Factors— Risks Related to Information Technology, Intellectual Property and Data Security and Privacy—If we or our third-party service providers experience a security breach, data loss or other compromise, including if unauthorized parties obtain access to our customers’ data, our reputation may be harmed, demand for our products and services may be reduced, and we may incur significant liabilities.”

The level of each identified risk is determined by considering the impact of the risk itself and the likelihood of the risk materializing and high scoring risks are actioned upon. Risks are analyzed to determine whether the risk meets company risk acceptance criteria to be accepted or whether a mitigation plan will be applied. Mitigation plans include both the individual or department responsible for the plan and may include budget considerations. 

The oversight of cybersecurity threats is undertaken by our Vice President of Research and Development, who holds over two decades of experience in information technology and the design and architecture of information systems, and is supported by management. Our audit committee is responsible for cybersecurity oversight and monitoring risk. Management informs the audit and investment committee of such risk by committee meetings.

As of the date of this report, we are not aware of any material risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. 

Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] The cybersecurity process has been integrated into our overall risk management system and process, and is internally managed by our R&D department as well as our internal auditor, Deloitte & Co. Israel.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]

As of the date of this report, we are not aware of any material risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. 

Cybersecurity Risk Board of Directors Oversight [Text Block] The oversight of cybersecurity threats is undertaken by our Vice President of Research and Development, who holds over two decades of experience in information technology and the design and architecture of information systems, and is supported by management.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our audit committee is responsible for cybersecurity oversight and monitoring risk. Management informs the audit and investment committee of such risk by committee meetings.
v3.25.0.1
Accounting Policies, by Policy (Policies)
12 Months Ended
Dec. 31, 2024
Significant Accounting Policies [Abstract]  
Use of estimates in the preparation of financial statements Use of estimates in the preparation of financial statements

The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions include (i) revenue recognition and (ii) recoverability of the Company’s goodwill.

Functional currency Functional currency

The functional currency of the Company and all of its subsidiaries all of which are primarily a direct and integral component of the Company’s operation is the U.S. dollar (“$” or “dollar”), as the dollar is the primary currency of the economic environment in which the Company and its subsidiaries have operated (which is the currency of the environment in which an entity primarily generates cash) and expects to continue to operate in the foreseeable future.

In accordance with ASC 830, “Foreign Currency Matters”, balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions included in the consolidated Statement of Operations and Comprehensive Loss, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such transactions are presented within financing income or expenses.

Principles of consolidation
C.Principles of consolidation

The consolidated financial statements include the accounts of the Group. Intercompany transactions and balances have been eliminated upon consolidation.

Cash
D.Cash

Cash is short-term highly liquid investment which include short-term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals or use and that are readily convertible to cash with maturities of three months or less as of the date acquired.

Research and development expenses
E.Research and development expenses

Research and development expenses are expenses as incurred, except to the extent that such costs are associated with internal-use software that qualifies for capitalization (see also Note 2F below)

Internal-use software costs Internal-use software costs

The Company capitalized certain internal software development costs, consisting mainly of direct labor (including stock-based compensation expenses), associated with creating the internally developed software related to its SaaS solution.

In accordance with ASC 350-40, “Internal-Use Software”, the capitalization of costs to develop internal-use software begins when preliminary development efforts are successfully completed. The Company has committed project funding to develop internal-use software and it is probable that the project will be completed, and the software will be used as intended. Costs related to the design or maintenance of internal-use software are expensed as incurred. Capitalized costs are amortized over the estimated useful life of the software, which is generally three years, once the capitalized asset is ready for its intended use, using the straight-line method in which the management believes the expected benefit will be derived.

The Company periodically reviews internal-use software costs to determine whether the projects will be completed, placed in service, removed from service, or replaced by other internally developed or third-party software. If the asset is not expected to provide any future benefit, the asset is retired, and any unamortized cost is expensed. Capitalized internal-use software costs are recorded under intangible assets, net.

When events or changes in circumstances are required, the Company assesses the likelihood of recovering the cost of internal-use software. If the net book value is not expected to be fully recoverable, internal-use software would be impaired to its fair value. Measurement of any impairment loss is based on the excess of the carrying value of the asset over the fair value.

Goodwill and intangible assets Goodwill and intangible assets

Goodwill is the amount by which the purchase price of acquired net assets in a business combination exceeded the fair values of the net identifiable assets on the date of acquisition. Goodwill is not amortized but evaluated for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Impairment of goodwill is tested at the level of the reporting unit. As required by ASC 350 “Intangibles-Goodwill and Other”, the Company chooses either to perform a qualitative assessment whether a goodwill impairment test is necessary or proceeds directly to the goodwill impairment test. Such determination is made for each reporting unit on a stand-alone basis. The qualitative assessment includes various factors such as macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, earnings multiples, gross margin and cash flows from operating activities and other relevant factors. When the Company chooses to perform a qualitative assessment and determines that it is more likely than not (more than 50 percent likelihood) that the fair value of the reporting unit is less than its carrying value, then the Company proceeds to the goodwill impairment test. If the Company determines otherwise, no further evaluation is necessary.

When the Company decides or is required to perform the quantitative goodwill impairment test, the Company compares the fair value of the reporting unit to its carrying value and an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value, if any.

The Company determined that its operations represent a single reporting unit. Prior to the completion of the U.S. IPO, the Company determined the fair value of its reporting unit by using the income approach. Upon completion of the U.S. IPO in February 2023, the fair value of the Company’s reporting unit is determined internally by the management based on observable inputs of the Company. As of the reported periods, the Company has performed the annual impairment test and has determined that impairment loss is not required to be recognized.

Finite lived intangible assets acquired in business combinations (i.e. trade names), are initially recorded at fair value. The cost of internal-use software is based on the criteria described in Note 2F above. Such intangible assets are amortized on a straight-line basis over their estimated useful lives. The intangible asset lives have been determined based upon the anticipated period over which the Company will derive future cash flows from the intangible assets. The Company has considered the effects of legal, regulatory, contractual, competitive, and other economic factors in determining these useful lives. Recoverability of these assets is assessed when triggering events have occurred that may give rise to an impairment loss and is determined by a comparison of the carrying amount of the asset to the future undiscounted net cash flows expected to be generated by the asset. When it is determined that the carrying value of the asset is not recoverable, the asset is written down to its estimated fair value. 

During all reported periods, impairment losses were not identified through the impairment test.

The lives used in computing straight-line amortization for financial reporting purposes are as follows:

Rate of depreciation  % 
     
Trade names   10 
Internal-use software   33 
Property and equipment Property and equipment

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the consolidated Statements of Operations and Comprehensive Loss.

The Company’s long-lived assets are reviewed for impairment, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. To date, the Company has not incurred any impairment losses.

The lives used in computing straight-line depreciation for financial reporting purposes are as follows:

Rate of depreciation  % 
     
Computers and peripheral equipment   33 
Office furniture and equipment   7-15 
Leases Leases

The Company entered into several non-cancellable lease agreements for offices for use in its operations, which are classified as operating leases (see below), whereby the Company applies ASC Topic 842, “Leases” (“ASC 842”) under which the Company determines if an arrangement is a lease at inception.

Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful life of the asset, (iv) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset, or (v) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of lease term. A lease is classified as an operating lease if it does not meet any one of these criteria. Since all the Company’s lease contracts for premises do not meet any of the criteria above, the Company concluded that all its lease contracts should be classified as operating leases.

Right of Use (“ROU”) assets and liabilities are recognized on the commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company’s leases do not provide an implicit rate, the Company uses its Incremental Borrowing Rate (“IBR”) based on the information available on the commencement of the lease. The Company uses the long-lived assets impairment guidance in ASC 360-10, “Property, Plant, and Equipment - Overall”, to determine whether a ROU asset is impaired, and if so, the amount of the impairment loss to recognize. Certain leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option.

The Company also elected the short-term lease recognition exemption for all leases that qualify (leases with a term shorter than 12 months). For those leases, ROU assets or lease liabilities are not recognized and rent expense is recognized on a straight-line basis over the lease term. See also Note 9 for further information.

Employee benefit plans Employee benefit plans

The Company’s liability for severance pay to its Israeli employees is subject to Section 14 of the Israeli Severance Compensation Act, 1963 (“Section 14”), pursuant to which all of the Company’s employees are entitled to monthly deposits by the Company, at a rate of 8.33% of their monthly salary, made in the employee’s name with insurance companies. Under Israeli employment law, payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. The fund is made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination. The severance pay liabilities and deposits under Section 14 are not reflected in the balance sheets as severance pay risks have been irrevocably transferred to the severance funds. All deposits required through December 31, 2024 have been made.

Deferred income taxes Deferred income taxes

The Company accounts for income taxes in accordance with ASC Topic 740, “Income Taxes”. Accordingly, deferred income taxes are determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases of assets and liabilities under the applicable tax law. Deferred tax balances are computed using the enacted tax rates expected to be in effect when these differences reverse. Valuation allowance in respect of deferred tax assets is provided for, if necessary, to reduce deferred tax assets is amounts more likely than not to be realized.

The Company accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise’s financial statements. According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The accounting policy of the Company is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such items in its consolidated financial statements during the reported periods and did not recognize any liability with respect to an unrecognized tax position in its balance sheets.

Contingencies
L.Contingencies

The Company and its subsidiaries may be involved in certain legal proceedings and certain business relationships that arise from time to time in the ordinary course of their business and in connection with certain agreements with third parties. Except for income tax contingencies, the Company applies the provisions of ASC Topic 450, Contingencies. Thus, the Company records accruals for contingencies to the extent that the management concludes that the occurrence is probable and that the related liabilities are estimable. Legal expenses associated with contingencies are expensed as incurred.

Revenue recognition Revenue recognition

The Company recognizes revenue in accordance with ASC 606, “Revenue from Contracts with Customers” (“ASC 606”) under which the Company determines revenue recognition through the following five steps (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when, or as, the Company satisfies a performance obligation.

The Company enters into contracts that mostly include software and software related services (i.e. Post-Contract Customer Support (“PCS”)), which are generally capable as being distinct from each other and accounted for as separate performance obligations.

The Company derives its revenue from licensing the rights to use its software for a limited term (mainly for a period of one to three years) or on a perpetual basis for enterprises that incorporate the Company’s perpetual license in their own products delivered to end users and for the Company’s products sold to thousands private consumers, as applicable to each contract, and from, provision of related maintenance and technical support. The Company sells its products through direct sales force and indirectly through distributors and consumer platforms.

Revenue is recognized when control of the promised goods or services are transferred to the customers, in an amount that reflects the consideration that the company expects to receive in exchange for those goods or services. However, when the consideration for the license is based on sales of the related customer (i.e. sales-based), the company applies the provisions of ASC 606 with respect to sales-based or usage-based royalties promised in exchange for a license of intellectual property and recognizes revenue only when the underlying sales occur, as long as this approach does not result in the acceleration of revenue ahead of the Company’s performance.

Under ASC 606, an entity recognizes revenue when or as it satisfies a performance obligation by transferring software license (either timely-based or perpetual) or software related services to the customer, either at a point in time or over time. The Company recognizes its revenue from software sales at a point in time upon delivery of its software license. The software license is considered a distinct performance obligation, as the customer can benefit from the software on its own. The Company’s revenue from PCS are derived from annual maintenance providing for unspecified upgrades on a when-and-if-available basis. The right for an unspecified upgrade for the version acquired by the customer and enhancements on a when-and-if-available basis that do not specify the features, functionality and release date of future product enhancements for the customer to know what will be made available and the general timeframe in which it will be delivered, if any. The Company considers the PCS performance obligation as a distinct performance obligation that is satisfied over time and recognized on a straight-line basis over the contractual period (mainly over a period of one year either for timely-based license or for perpetual license).

As the Company bundles software licenses (either time-based or perpetual) together with PCS, the transaction price is allocated to the separate performance obligations on a relative standalone selling price basis.

Since the Company does not sell PCS on a stand-alone basis and due to the fact that these services are usually involved with limited customer support, mainly based on several hours of technical support per contract (as management believes the technology and products covered under the software license component are mature and fully functional as delivered to the costumer), the standalone selling prices of the PCS are determined based on the expected cost plus a margin (“cost-plus approach”) based on estimation of direct fulfillment cost (an hourly service) and a reasonable margin. Such an estimate is also corroborated with the price that the Company would have to pay to a third-party service provider for a similar support service.

The stand-alone selling price of software licenses (either timely-based or perpetual) is estimated by management based on an adjusted market assessment approach which represents management estimation of the price that a customer in the market will be willing to pay for such a license on a stand-alone basis (i.e. without any PCS).

Due to the fact that the PCS services are usually involved with limited customer support, mainly based on several hours of technical support per contract, the transaction price allocated to the PCS is considered insignificant. Consequently, most of the transaction price is allocated to the software licenses.

During the reported periods, costs to obtain contracts were in an insignificant amount.

The Company does not grant a right of return to its customers. When product delivered to the customer is subject to evaluation, the Company defers revenue until evaluation is completed subject to formal selling agreement with the customer, at which time revenue is recognized provided that all other revenue recognition criteria are met.

Commencing 2022, revenue is also derived from the traffic operations in the Google AdSense program, a web advertising platform, that the Company makes available on its websites. Google pays the Company on a cost-per-click basis. The Company recognizes revenue at a point of time when the fees are paid to it by Google based on the volume of clicks through Google AdSense advertisements.

The Company receives payments from customers based upon contractual payment schedules. Trade receivables are recorded when right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables include amounts related to contractual right to consideration for completed performance obligations not yet invoiced. As of December 31, 2024 and 2023, unbilled receivables balance amounted to $26 and $39, respectively, and are included within trade receivables balance in the Company’s Consolidated Balance Sheets.

As of December 31, 2024 and 2023, the Company had $30 and $27, respectively, of remaining performance obligations not yet satisfied or partly satisfied related to revenue (mostly PCS). Such amounts are presented as deferred revenue which are expected to be recognized as revenue during the next twelve months.

See also Note 15 for further discussion related to disaggregation of revenue.

Concentrations of credit risk and allowance for doubtful accounts Concentrations of credit risk and allowance for doubtful accounts

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and trade receivables as well as certain other current assets that do not amount to a significant amount. Cash which is primarily held in dollar and New Israeli Shekels (NIS), are deposited with major banks in Israel, U.S. and Russian Federation. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Company does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements. Most of the Company’s sales are mainly derived from sales to a diverse set of customers located primarily in the United States. Management periodically evaluates the collectability of the trade receivables to determine the amounts that are doubtful of collection and determine a proper allowance for doubtful accounts, as described below. Accordingly, management believes that the Company’s trade receivables do not represent a substantial concentration of credit risk.

The Company extends credit to customers in the normal course of business and does not require collateral or any other security to support amounts due. Management performs ongoing credit evaluations of its customers. The allowance for doubtful accounts is determined with respect to amounts the Group has determined to be doubtful of collection by considering among other things, its past experience with customers, the length of time that the balance is past due, the customer’s current ability to pay and available information about the credit risk on such customers. Provisions for the allowance for doubtful accounts are recorded under general and administrative expenses in the consolidated Statements of Operations and Comprehensive Loss. During the reported periods, the Company has not recorded allowance in respect of accounts receivable.

Fair Value Measurements Fair Value Measurements

The Company measures and discloses fair value in accordance with the ASC 820, “Fair Value Measurements and Disclosures” which defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level 1 - unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date.

Level 2 - pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.

Level 3 - pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy. The valuation of certain financial instruments classified under fair value through profit or loss category and the fair value of reporting units for purposes of goodwill impairment analysis (in periods when such analysis is based on the income approach), fall under this category.

This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.

The fair value of cash is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.

Allocation of proceeds and related issuance costs
P.Allocation of proceeds and related issuance costs

When multiple instruments are issued in a single transaction (package issuance), the total gross proceeds from the transaction are allocated among the individual freestanding instruments identified. The allocation occurs after identifying all the freestanding instruments and the subsequent measurement basis for those instruments.

Financial instruments that are required to be subsequently measured at fair value (such as derivative warrants liability) are measured at fair value and the remaining consideration is allocated to other financial instruments that are not required to be subsequently measured at fair value (i.e. straight loan), based on the relative fair value basis for such instruments.

Allocation of issuance costs to freestanding instruments was based on an approach that is consistent with the allocation of the proceeds, as described above. Accordingly, issuance costs allocated to the derivative warrant liability were immediately expensed. Issuance costs allocated to straight loan are recorded as a discount of the straight loan and accreted over the contractual term of straight loan up to face value of such loans using the effective interest method.

Warrants Warrants

Certain warrants that were issued to (i) a commercial bank as part of entering into funding transaction and (ii) a seller through a transaction in which certain identified intangible assets have been purchased, are classified as a component of permanent equity since they are freestanding financial instruments that are legally detachable and separately exercisable, do not embody an obligation for the Company to repurchase its own shares, and permit the holders to receive a fixed number of Ordinary Shares upon exercise for a fixed exercise price and thus, are considered as indexed to the Company’s own shares. In addition, the warrants must require physical share settlement and may not provide any guarantee of value or return. As such warrants were issued together with financial instruments that are not subsequently measured at fair value the warrants were measured based on allocation of the proceeds received by the Company in accordance with the relative fair value basis. When applicable, direct issuance expenses that were allocated to such warrants were deducted from additional paid-in capital.

In 2023, warrants granted to seller have been expired. In 2024, warrants granted to commercial bank have been fully exercised on a cashless basis.

Down round feature is disregarded when assessing whether an instrument is indexed to its own shares, for purposes of determining liability or equity classification. Based on its evaluation, management has determined that certain warrants with down-round protection are eligible for equity classification. Upon the occurrence of an event that triggers down round protection (i.e., when the warrants’ exercise price is adjusted downward because of the down round feature), the effect is accounted for as a deemed dividend and as a reduction of income available to common shareholders for purposes of basic earnings per share (EPS) calculation. During the year ended December 31, 2023, down-round protection was triggered upon completion of the U.S IPO under which the Company recorded a deemed dividend amounted of $7 (see also Note 10B below).

Derivative Warrants Liability Derivative Warrants Liability

Certain warrants that were granted by the Company for commercial banks through funding transaction entitle the bank to exercise the warrants for a variable number of shares and/or for a variable exercise price and thus the fixed-for-fixed criteria is not met. Accordingly, the warrants are classified as a non-current liability according to the provisions of ASC 815-40, “Derivatives and Hedging - Contracts in Entity’s Own Equity” (“ASC 815-40”).

Until completion of the U.S. IPO, the Company’s management accounted for these warrants as a financial derivative liability measured upon initial recognition and on subsequent periods at fair value with the assistance of an independent valuation firm by using the Hybrid Method by combining the Option Pricing Method (“OPM”) and an initial public offering scenario. Upon completion of the U.S. IPO, the fair value of the aforesaid warrants derivative liability is estimated internally by the Company’s management by using the Black-Scholes Model that is based on several assumptions, of which the most significant is the expected share price volatility, which was calculated based upon historical volatility of peer companies in the same industry on weekly basis. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company’s historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable plans to pay cash dividends in the future.

The above assumptions are reviewed on a regular basis and changes in the estimated fair value of the outstanding warrants are recognized each reporting period as part of the “Financing (income) expenses, net” line in the consolidated Statements of Operations and Comprehensive Loss, until such warrants are exercised, expired or eligible for exercise for fixed number of shares or for fixed exercise price. When applicable, direct issuance expenses that were allocated to the above warrants were expensed, as incurred.

Capital contribution from a controlling shareholder
S.Capital contribution from a controlling shareholder

The fair value of the benefit received in respect of loan received from the controlling shareholder was calculated on the basis of the difference between the interest rate that the Company would have required to pay for similar loan from commercial bank and the interest rate that the Company was actually charged under the agreement with the controlling shareholders. Such benefit was accounted for as capital contribution received from the controlling shareholder as additional paid-in capital and it was recorded as discount on the loan received against at the initial measurement date. Subsequently, such discount was expensed over the economic life of the loan based on the effective interest rate method.

Basic and diluted net loss per Ordinary Share Basic and diluted net loss per Ordinary Share

The Company applies the two-class method as required by ASC 260-10, “Earnings Per Share” (“ASC 260-10”), which requires the income or loss per share for each class of shares outstanding (Ordinary Shares and all other shares with preferences over the Ordinary Shares) to be calculated assuming 100% of the Company’s earnings are distributed as dividends to each class of shares based on their contractual rights. No dividends were declared or paid during the reported periods. According to the provisions of ASC 260-10, the Company’s Convertible Preferred Shares and Convertible Ordinary 1 and 2 Shares did not have contractual obligations to share losses of the Company and therefore were not included in the computation in the period of net loss per share. Upon the listing of the Company’s Ordinary Shares on the Nasdaq in connection with the U.S. IPO in February 2023, the entire balance of the Preferred Shares and Ordinary 1 and 2 Shares was converted into Ordinary Shares.

Basic net loss per Ordinary Share is computed by dividing the net loss for the period applicable to ordinary shareholders, by the weighted average number of Ordinary Shares outstanding during the period. Diluted loss per share gives effect to all potentially dilutive common shares outstanding during the year using the treasury stock method with respect to shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), options and certain warrants and using the if-converted method with respect to convertible advance investments and certain warrants accounted for as derivative liability. In computing diluted loss per share, the average share price for the period is used in determining the number of shares assumed to be purchased from the exercise of options or warrants.

During the years ended December 31, 2024, 2023 and 2022, the total weighted average number of Ordinary Shares related to outstanding shares with preferences over Ordinary Shares (Convertible Ordinary 1 and 2 shares and Convertible Preferred Shares), options, warrants and convertible advance investments excluded from the calculation of the diluted loss per share was 1,306,124, 3,080,012 and 9,929,970, respectively.

The net loss from operations and the weighted average number of Ordinary Shares used in computing basic and diluted net loss per share from operations for the years ended December 31, 2024, 2023 and 2022, are as follows:

   Year ended December 31, 
   2024   2023   2022 
             
Numerator:            
Net loss  $(3,353)  $(695)  $(1,248)
Deemed dividend related to trigger of down round protection feature (see Note 10B below)   
-
    (7)   
-
 
Net basic loss  $(3,353)  $(702)  $(1,248)
Change in fair value of derivative warrant liability (see Note 8 below)   
-
    (66)   
-
 
Change in fair value of convertible advanced investment (see Note 10B below)   
-
    (269)   
-
 
Net diluted loss  $(3,353)  $(1,037)  $(1,248)
                
Denominator:               
Ordinary shares used in computing basic net loss per share   15,167,476    11,194,097    2,578,760 
Incremental ordinary shares to be issued upon exercise of derivative warrant liability   
-
    24,834    
-
 
Incremental ordinary shares to be issued upon conversion of convertible advanced investments   
-
    230,880    
-
 
Ordinary shares used in computing diluted net loss per share   15,167,476    11,449,811    2,578,760 
                
Basic net loss per ordinary share  $(0.22)  $(0.06)  $(0.48)
Diluted net loss per ordinary share  $(0.22)  $(0.09)  $(0.48)
Share-based compensation Share-based compensation

The Company measures and recognizes compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with ASC 718, “Compensation-Stock Compensation”. Share-based payments are recognized in the Statement of Operations and Comprehensive Loss as an operating expense (unless they are eligible to be capitalized as part of the cost of internal developed asset) based on fair value of the award at the grant date by using Black-Scholes option-pricing model. The inputs for the valuation analysis of the options include several assumptions of which the most significant are the fair market value of the underlying Ordinary Share, the expected share price volatility and the expected option term. Expected volatility was calculated based upon historical volatility of peer companies in the same industry on a weekly basis. The expected option term represents the period that the Company’s options are expected to be outstanding and is determined based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The expected dividend yield assumption is based on the Company’s historical experience and expectation of no future dividend payouts. The Company has historically not paid cash dividends and has no foreseeable plans to pay cash dividends in the future. The Company expensed compensation costs net of estimated forfeitures over the requisite service period by applying the straight-line method.

Up and until the completion of the U.S. IPO, the fair value of Ordinary Shares underlying the options was determined by the Company’s management with the assistance of an independent valuation firm. Because in such periods there has been no public market for the Ordinary Shares, the Company’s management has determined fair value of the Ordinary Shares at the time of grant by considering several objective and subjective factors including data from other comparable companies, sales of Convertible Preferred Shares to unrelated third parties, operating and financial performance, the lack of liquidity of share capital and general and industry specific economic outlook, amongst other factors. From the period commencing on June 30, 2021 through March 2, 2023 (the closing date of the U.S. IPO), the valuations were performed by using Hybrid Method by combining the OPM and an initial public offering scenario.

Since January 1, 2019, share-based payments to non-employees are accounted in accordance with ASC 718.

When applicable, a modification to the terms and/or conditions of an award (i.e. a change of award’s fair value, vesting conditions or classification as an equity or a liability instrument) is accounted for as an exchange of the original award for a new award resulting in total compensation cost equal to the grant-date fair value of the original award, plus the incremental value of the modification to the award. The calculation of the incremental value is based on the excess of the fair value of the modified award following the modification over the fair value of the original award measured immediately before its terms were modified.

Accounting Pronouncements Adopted During the Current Year Accounting Pronouncements Adopted During the Current Year

Segment Reporting Disclosures

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which requires that all public entities, including public entities with a single reportable segment, to provide in interim and annual periods one or more measures of segment profit or loss used by the Chief Operating Decision Maker (“CODM”) to allocate resources and assess performance. Additionally, ASU 2023-07 requires disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures.

The Company adopted ASU 2023-07 beginning with the consolidated financial statements for the fiscal year ended December 31, 2024 and thereafter, and have applied this standard retrospectively for all prior periods presented in the consolidated financial statements. See also Note 15 for further information related to segment reporting.

Recently issued accounting pronouncements, not yet adopted
W.Recently issued accounting pronouncements, not yet adopted
1.In December 2023, the FASB issued ASU 2023-09 on Improvements to Income Tax Disclosures that require greater disaggregation of income tax disclosures to the income rate tax rate reconciliation and income taxes paid. The updates are effective for annual periods beginning after December 15, 2024. The Company intends to adopt and apply the guidance in fiscal year 2025. The Company is still assessing the impact of the disclosure of this standard.
2.In November 2024, the FASB issued ASU 2024-03 on Disaggregation of Income Statement Expenses that enhances disclosure of certain costs and expenses to provide enhanced transparency into the expenses presented in the income statement. The updates are effective for annual periods beginning after December 15, 2026. The Company intends to adopt and apply the guidance in fiscal year 2027. The Company is still assessing the impact of the disclosure of this standard.
v3.25.0.1
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Significant Accounting Policies [Abstract]  
Schedule of Computing Straight-Line Amortization

The lives used in computing straight-line amortization for financial reporting purposes are as follows:

 

Rate of depreciation  % 
     
Trade names   10 
Internal-use software   33 
Schedule of Computing Straight-line Depreciation

The lives used in computing straight-line depreciation for financial reporting purposes are as follows:

 

Rate of depreciation  % 
     
Computers and peripheral equipment   33 
Office furniture and equipment   7-15 
Schedule of Computing Basic and Diluted Net Loss Per Share

The net loss from operations and the weighted average number of Ordinary Shares used in computing basic and diluted net loss per share from operations for the years ended December 31, 2024, 2023 and 2022, are as follows:

 

   Year ended December 31, 
   2024   2023   2022 
             
Numerator:            
Net loss  $(3,353)  $(695)  $(1,248)
Deemed dividend related to trigger of down round protection feature (see Note 10B below)   
-
    (7)   
-
 
Net basic loss  $(3,353)  $(702)  $(1,248)
Change in fair value of derivative warrant liability (see Note 8 below)   
-
    (66)   
-
 
Change in fair value of convertible advanced investment (see Note 10B below)   
-
    (269)   
-
 
Net diluted loss  $(3,353)  $(1,037)  $(1,248)
                
Denominator:               
Ordinary shares used in computing basic net loss per share   15,167,476    11,194,097    2,578,760 
Incremental ordinary shares to be issued upon exercise of derivative warrant liability   
-
    24,834    
-
 
Incremental ordinary shares to be issued upon conversion of convertible advanced investments   
-
    230,880    
-
 
Ordinary shares used in computing diluted net loss per share   15,167,476    11,449,811    2,578,760 
                
Basic net loss per ordinary share  $(0.22)  $(0.06)  $(0.48)
Diluted net loss per ordinary share  $(0.22)  $(0.09)  $(0.48)
v3.25.0.1
Cash (Tables)
12 Months Ended
Dec. 31, 2024
Cash [Abstract]  
Schedule of Cash
  

As of

December 31,

 
   2024   2023 
         
 Denominated in U.S. dollar (*)  $16,260   $5,792 
 Denominated in New Israel Shekel   65    150 
 Denominated in other currencies   158    174 
   $16,483   $6,116 

 

(*)As of December 31, 2024, including short-term bank deposits for a period less than 3 months at an average interest rate of 5.14%.
v3.25.0.1
Other Current Assets (Tables)
12 Months Ended
Dec. 31, 2024
Other Current Assets [Abstract]  
Schedule of Other Current Assets
  

As of

December 31,

 
   2024   2023 
         
 Prepaid expenses  $88   $76 
 Government authorities   24    40 
 Others   83    16 
   $195   $132 
v3.25.0.1
Intangible Assets, Net and Goodwill (Tables)
12 Months Ended
Dec. 31, 2024
Intangible Assets, Net and Goodwill [Abstract]  
Schedule of Intangible Assets, Net and Goodwil
  

As of

December 31,

 
   2024   2023 
Carrying amount:          
Trade names  $201   $201 
Internal-use software   600    233 
   $801   $434 
Accumulated amortization:          
Trade names  $174   $154 
Internal-use software   138    
-
 
   $312   $154 
           
Intangible assets, net  $489   $280 
Schedule of the Estimated Future Amortization Expense of Intangible Assets

As of December 31, 2024, the estimated future amortization expense of intangible assets is as follows:

 

2025  $220 
2026   207 
2027   62 
   $489 
v3.25.0.1
Loans, Net (Tables)
12 Months Ended
Dec. 31, 2024
Loans, Net [Abstract]  
Schedule of the Reconciliation of the Carrying Amount

The following tabular presentation reflects the reconciliation of the carrying amount of the IBI Loan during the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
             
Opening balance  $500   $717   $
-
 
Net consideration allocated to IBI Loan   
-
    
-
    887 
Recognition of fair value of derivative warrant liability   
-
    
-
    (88)
Amortization of discount relating to straight loan   31    31    12 
Repayment of principal relating to straight loan   (292)   (236)   (82)
Exchange rate differences   11    (12)   (12)
Closing balance  $250   $500   $717 
Schedule of Maturity Dates of Outstanding Loans

Maturity dates of outstanding loans:

 

  

As of

December 31,

 
   2024   2023 
         
First year (current maturities)  $250   $330 
Second year   
-
    170 
Closing balance  $250   $500 
v3.25.0.1
Other Current Liabilities (Tables)
12 Months Ended
Dec. 31, 2024
Other Current Liabilities [Abstract]  
Schedule of Other Current Liabilities
  

As of

December 31,

 
   2024   2023 
         
Employees and payroll accruals  $465   $279 
Accrued expenses (*)  $212   $179 
   $677   $458 

 

(*)Including interest accrued on IBI Loan amounted to $4 and $7 as of December 31, 2024 and 2023, respectively. See also Note 12 below.
v3.25.0.1
Derivative Warrants Liabilities (Tables)
12 Months Ended
Dec. 31, 2024
Derivative Warrants Liabilities [Abstract]  
Schedule of Reconciliation of the Fair Value of Derivative Warrants Liabilities

The following tabular presentation reflects the reconciliation of the fair value of derivative warrants liabilities during the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
             
Opening balance  $72   $138   $50 
Recognition of fair value of Warrant Share issued at Effective Date   
-
    
-
    88 
Amount classified to equity upon determination of the exercise price of Warrant Share (see Note 10D2 below)   (599)   
-
    
-
 
Change in fair value of derivative warrant liability (see Note 12 below)   577    (66)   
-
 
Closing balance  $50   $72   $138 
v3.25.0.1
Commitments (Tables)
12 Months Ended
Dec. 31, 2024
Commitments [Abstract]  
Schedule of Future Minimum Commitment Under Binding Lease Agreeements

As of December 31, 2024, the future minimum commitment under binding operating lease agreements is as follows:

 

   Lease of premises 
     
2025  $80 
   $80 
v3.25.0.1
Shareholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2024
Shareholders’ Equity [Abstract]  
Schedule of Composition of Shareholders' Equity Composition of shareholders’ equity:
  

As of

December 31, 2024

  

As of

December 31, 2023

 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
   Number of shares 
                     
Ordinary Shares of NIS 0.05 par value   222,000,000    15,518,794    222,000,000    13,051,343 
v3.25.0.1
Options (Tables)
12 Months Ended
Dec. 31, 2024
Options [Abstract]  
Schedule of Company’s Share Option Activity for Employees and Members of the Board of Directors

The following table presents the Company’s option activity for employees and members of the Board of Directors of the Company under the Plan for the years ended December 31, 2024, 2023 and 2022:

 

   Number of
Options
  

Weighted
Average
Exercise
Price

   Weighted
average
remaining
contractual
life
   Intrinsic
value
 
       $   (years)   $ 
                 
Outstanding as of December 31, 2021   1,367,168    1.75    5.72    4,860 
Granted   286,875    1.83    -    - 
Forfeited or expired   (83,052)   1.45    -    - 
Outstanding as of December 31, 2022   1,570,991    1.78    4.97    2,435 
Exercisable as of December 31, 2022   1,048,297    1.70    3.2    1,677 

 

   Number of
Options
  

Weighted
Average
Exercise
Price

   Weighted
average
remaining
contractual
life
   Intrinsic
value
 
       $   (years)   $ 
                 
Outstanding as of December 31, 2022   1,570,991    1.78    4.97    2,435 
Granted   151,600    2.88    -    - 
Exercised   (168,447)   0.29    -    - 
Forfeited or expired   (258,777)   1.81    -    - 
Outstanding as of December 31, 2023   1,295,367    2.09    6.04    84 
Exercisable as of December 31, 2023   863,616    2.07    4.70    84 
   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
average
remaining
contractual
life
   Intrinsic
value
 
       $   (years)   $ 
                 
Outstanding as of December 31, 2023   1,295,367    2.09    6.04    84 
Granted   462,200    4.51    -    - 
Exercised   (401,031)   1.98    -    - 
Forfeited or expired   (11,500)   2.65    -    - 
Outstanding as of December 31, 2024   1,345,036    2.95    7.17    2,677 
Exercisable as of December 31, 2024   641,851    2.15    5.12    1,786 
Schedule of Outstanding and Exercisable Share Options Separated Ranges of Exercise Prices

The outstanding and exercisable options as of December 31, 2024 were separated into range of exercise prices, as follows:

 

Exercise price  Options
outstanding
as of
December 31,
2024
   Weighted
average
remaining
contractual
term
   Options
exercisable
as of
December 31,
2024
   Weighted
average
remaining
contractual
term
 
       (years)       (years) 
                 
-   17,680    2.20    17,680    2.20 
1.14   82,580    2.04    82,580    2.04 
1.47   7,200    9.09    
-
    
-
 
1.48   50,000    8.70    15,625    8.70 
1.74   12,800    8.30    4,800    8.30 
1.83   565,974    6.53    401,950    6.04 
2.79   6,400    8.59    2,000    8.59 
2.97   69,600    9.87    
-
    
-
 
3.20   5,002    6.64    4,064    6.64 
3.59   28,800    9.74    
-
    
-
 
4.00   76,000    8.17    44,352    8.17 
4.17   28,800    1.03    28,800    1.03 
4.96   315,200    9.56    
-
    
-
 
5.02   39,000    9.49    
-
    
-
 
5.12   40,000    1.04    40,000    1.04 
    1,345,036         641,851      
Schedule of Assumptions Used to Estimate the Fair Values of the Options Granted

The following table presents the assumptions used to estimate the fair values of the options granted in the reported periods:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Volatility (%)   52.71%-73.53%    60.48%-61.49%    61.49%
Risk-free interest rate (%)   3.6%-4.4%    3.7%-4.3%    3.64%-3.85% 
Dividend yield (%)   
-
    
-
    
-
 
Expected life (years)   6.25    6.25    6.25 
Exercise price ($)   1.47-5.02    1.48-4.00    1.83 
Share price ($)   1.72-5.24    1.48-3.73    3.30 
Schedule of Company’s Equity-Based Awards Recognized

The total compensation cost related to all of the Company’s equity-based awards recognized during the years ended December 31, 2024, 2023 and 2022 was comprised as follows:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Research and development  $185   $216   $144 
Sales and marketing   20    41    49 
General and administrative   213    106    29 
   $418   $363   $222 
v3.25.0.1
Financing Expenses (Income), Net (Tables)
12 Months Ended
Dec. 31, 2024
Financing Expenses (Income), Net [Abstract]  
Schedule of Financing Expenses (Income), Net
  

Year ended December 31

 
   2024   2023   2022 
             
Change in fair value of convertible advance investment  $
-
   $(269)  $70 
Change in fair value of derivative warrant liability   577    (66)   
-
 
Amortization of discount and accrued interest relating to straight loan received from commercial banks   106    157    102 
Change in estimation of maturity date of liability to controlling shareholder   
-
    12    
-
 
Discount amortization relating to liability to controlling shareholder   10    48    40 
Interest due to bank deposits   (599)   (97)   
-
 
Exchange rate differences and other finance expenses   (2)   (7)   (47)
   $92   $(222)  $165 
v3.25.0.1
Related Parties Transactions (Tables)
12 Months Ended
Dec. 31, 2024
Related Parties Transactions [Abstract]  
Schedule of Expenses Related to Service Agreement and the Office Services Agreement

The following tabular presentation reflects the reconciliation of the carrying amount of the Company’s Liability to controlling shareholder, net during the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
             
Opening balance  $199   $388   $345 
Accrued liability in respect to additional services rendered        25    115 
Recognition of capital contribution from a controlling shareholder        
 
    (112)
Repayment of liability to controlling shareholder   (206)   (258)   
-
 
Amortization of discount relating to liability to controlling shareholder   10    48    40 
Change in estimation of maturity date of liability   
-
    12    
-
 
Exchange rate differences   (3)   (16)   
-
 
Closing balance  $
-
   $199   $388 
Schedule of Expenses Related to Service Agreement and the Office Services Agreement

The Company allocated the expenses related to the above service agreement and addendum as follows:

 

  

Year ended December 31

 
   2024   2023   2022 
             
Research and development  $53   $36   $42 
Sales and marketing   53    36    42 
General and administrative   106    74    83 
   $212   $146   $167 
v3.25.0.1
Taxes on Income (Tables)
12 Months Ended
Dec. 31, 2024
Taxes on Income [Abstract]  
Schedule of loss (Income) Before Taxes on Income Loss (income) before taxes on income consists of the following:
  

Year ended December 31

 
   2024   2023   2022 
             
Domestic  $3,345   $714   $1,293 
Foreign operations (Beamr Inc. and Beamr Imaging RU)   (38)   (58)   (97)
   $3,307   $656   $1,196 
Schedule of Deferred Income Taxes Reflect the Net Tax Effects of Net Operating Loss The significant components of the Company’s deferred tax assets are as follows:
  

As of

December 31

 
  2024   2023 
Composition of deferred tax assets:        
Net operating loss and capital losses carryforward  $7,202   $6,704 
Research and development credits   537    397 
Vacation accrual   44    44 
Net deferred tax asset before valuation allowance   7,783    7,145 
           
Valuation allowance   (7,783)   (7,145)
Net deferred tax assets  $
-
   $
-
 
v3.25.0.1
Segment Geographical Information And Major Customers (Tables)
12 Months Ended
Dec. 31, 2024
Segment Geographical Information And Major Customers [Abstract]  
Schedule of Revenues by Geographic Region
  

Year ended December 31

 
   2024   2023   2022 
             
United States  $2,132   $2,089   $2,134 
Israel   41    66    22 
Rest of the world   891    754    707 
   $3,064   $2,909   $2,863 
Schedule of Long-Lived Assets Net by Geographic Areas
  

As of

December 31,

 
   2024   2023 
         
Israel  $40   $14 
Other   3    5 
   $43   $19 
Schedule of Revenue Disaggregated by Primary Major Product Lines and Services

In the following table, revenue is disaggregated by primary major product lines and services, and timing of revenue recognition for the years ended December 31, 2024, 2023 and 2022:

 

  

Year ended December 31,

 
   2024   2023   2022 
Software license:               
Perpetual based software license - transferred at a point of time  $802   $886   $1,068 
Term-based software license - transferred at a point of time   1,995    1,844    1,630 
Total software license (*)  $2,797   $2,730   $2,698 
PCS services transferred over a period of time   128    120    123 
Web advertising at a point of time upon clicks   139    59    42 
   $3,064   $2,909   $2,863 

 

(*)Revenue recognized from sales-based software license was $46, $53 and $48 during the years ended December 31, 2024, 2023 and 2022, respectively (see also Note 2M).
v3.25.0.1
General (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
General [Abstract]      
Net loss $ (3,353) $ (695) $ (1,248)
Accumulative deficit (35,024) (31,671)  
Net amounts raised   6,382 887
Proceeds received from exercise of options into Ordinary Shares 795 $ 49
Gross proceeds of completion of an underwritten public offering $ 13,800    
v3.25.0.1
Significant Accounting Policies (Details) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Significant Accounting Policies [Abstract]      
Employee compensation percentage 8.33%    
Unbilled receivables $ 26 $ 39  
Revenue 30 $ 27  
Dividend amounted $ 7    
Percentage of dividend 100.00%    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) 1,306,124 3,080,012 9,929,970
v3.25.0.1
Significant Accounting Policies - Schedule of Computing Straight-Line Amortization (Details)
12 Months Ended
Dec. 31, 2024
Trade Names [Member]  
Schedule of Computing Straight-Line Amortization (Details)  
Property, plant and equipment, depreciation percentage 10.00%
Internal-Use Software [Member]  
Schedule of Computing Straight-Line Amortization (Details)  
Property, plant and equipment, depreciation percentage 33.00%
v3.25.0.1
Significant Accounting Policies - Schedule of Computing Straight-line Depreciation (Details)
Dec. 31, 2024
Computers and peripheral equipment [Member]  
Schedule of Computing Straight-line Depreciation (Line Items)  
Property, plant and equipment, depreciation percentage 33.00%
Minimum [Member] | Office furniture and equipment [Member]  
Schedule of Computing Straight-line Depreciation (Line Items)  
Property, plant and equipment, depreciation percentage 7.00%
Maximum [Member] | Office furniture and equipment [Member]  
Schedule of Computing Straight-line Depreciation (Line Items)  
Property, plant and equipment, depreciation percentage 15.00%
v3.25.0.1
Significant Accounting Policies - Schedule of Computing Basic and Diluted Net Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Numerator:      
Net loss $ (3,353) $ (695) $ (1,248)
Deemed dividend related to trigger of down round protection feature (see Note 10B below) (7)
Net basic loss (3,353) (702) (1,248)
Change in fair value of derivative warrant liability (see Note 8 below) (66)
Change in fair value of convertible advanced investment (see Note 10B below) (269)
Net diluted loss $ (3,353) $ (1,037) $ (1,248)
Denominator:      
Ordinary shares used in computing basic net loss per share (in Shares) 15,167,476 11,194,097 2,578,760
Incremental ordinary shares to be issued upon exercise of derivative warrant liability $ 24,834
Incremental ordinary shares to be issued upon conversion of convertible advanced investments $ 230,880
Ordinary shares used in computing diluted net loss per share (in Shares) 15,167,476 11,449,811 2,578,760
Basic net loss per ordinary share (in Dollars per share) $ (0.22) $ (0.06) $ (0.48)
Diluted net loss per ordinary share (in Dollars per share) $ (0.22) $ (0.09) $ (0.48)
v3.25.0.1
Cash (Details)
Dec. 31, 2024
Cash [Abstract]  
Short term bank deposit average interest rate 5.14%
v3.25.0.1
Cash - Schedule of Cash (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Schedule of Cash and Cash Equivalents [Line Items]    
Cash $ 16,483 $ 6,116
Denominated in U.S. dollar [Member]    
Schedule of Cash and Cash Equivalents [Line Items]    
Cash [1] 16,260 5,792
Denominated in New Israel Shekel [Member]    
Schedule of Cash and Cash Equivalents [Line Items]    
Cash 65 150
Denominated in other currencies [Member]    
Schedule of Cash and Cash Equivalents [Line Items]    
Cash $ 158 $ 174
[1] As of December 31, 2024, including short-term bank deposits for a period less than 3 months at an average interest rate of 5.14%.
v3.25.0.1
Other Current Assets - Schedule of Other Current Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Other Current Assets [Abstract]    
Prepaid expenses $ 88 $ 76
Government authorities 24 40
Others 83 16
Total other current assets $ 195 $ 132
v3.25.0.1
Intangible Assets, Net and Goodwill (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Intangible Assets, Net and Goodwill [Abstract]      
Total amortization expenses $ 158 $ 20 $ 20
v3.25.0.1
Intangible Assets, Net and Goodwill - Schedule of Intangible Assets, Net and Goodwil (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Schedule of Intangible Assets, Net and Goodwil [Line Items]    
Carrying amount $ 801 $ 434
Accumulated amortization 312 154
Intangible assets, net 489 280
Trade names [Member]    
Schedule of Intangible Assets, Net and Goodwil [Line Items]    
Carrying amount 201 201
Accumulated amortization 174 154
Internal-Use Software [Member]    
Schedule of Intangible Assets, Net and Goodwil [Line Items]    
Carrying amount 600 233
Accumulated amortization $ 138
v3.25.0.1
Intangible Assets, Net and Goodwill - Schedule of the Estimated Future Amortization Expense of Intangible Assets (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]  
2025 $ 220
2026 207
2027 62
Intangible assets, net $ 489
v3.25.0.1
Loans, Net (Details) - IBI Spikes Ltd [Member]
₪ in Thousands, $ in Thousands
12 Months Ended
Jul. 07, 2022
USD ($)
Jul. 07, 2022
ILS (₪)
Dec. 31, 2024
USD ($)
shares
Loan, Net [Line Items]      
Agreement amount received $ 900 ₪ 3,100  
Royalty amount received $ 1,200 ₪ 4,172,760  
Percentage of outstanding repayment and payment amount     50.00%
Percentage of discount outstanding     35.00%
Non-refundable one-time fee | $     $ 13
Percentage of payment amount plus VAT     1.50%
Issuance of warrants | shares     65,563
v3.25.0.1
Loans, Net - Schedule of the Reconciliation of the Carrying Amount (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Loans, Net [Abstract]      
Opening balance $ 500 $ 717
Net consideration allocated to IBI Loan 887
Recognition of fair value of derivative warrant liability (88)
Amortization of discount relating to straight loan 31 31 12
Repayment of principal relating to straight loan (292) (236) (82)
Exchange rate differences 11 (12) (12)
Closing balance $ 250 $ 500 $ 717
v3.25.0.1
Loans, Net - Schedule of Maturity Dates of Outstanding Loans (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Maturity Dates of Outstanding Loans [Abstract]        
First year (current maturities) $ 250 $ 330    
Second year 170    
Closing balance $ 250 $ 500 $ 717
v3.25.0.1
Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Other Current Liabilities [Abstract]    
Accrued interest $ 4 $ 7
v3.25.0.1
Other Current Liabilities - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Jan. 01, 2020
Schedule of Other Current Liabilities [Abstract]      
Employees and payroll accruals $ 465 $ 279  
Accrued expenses [1] 212 179  
Total other current liabilities $ 677 $ 458 $ 357
[1] Including interest accrued on IBI Loan amounted to $4 and $7 as of December 31, 2024 and 2023, respectively. See also Note 12 below.
v3.25.0.1
Derivative Warrants Liabilities (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Feb. 22, 2024
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2024
₪ / shares
Feb. 15, 2024
$ / shares
Dec. 31, 2023
₪ / shares
Feb. 27, 2023
$ / shares
Apr. 29, 2021
USD ($)
$ / shares
shares
Derivative Warrants Liabilities [Line Items]                  
Derivative financial liability   Derivative warrants liability Derivative warrants liability            
Revaluation income amount     $ 66            
Ordinary share, per share (in Dollars per share) | ₪ / shares         ₪ 0.05   ₪ 0.05    
Derivative warrants liability   $ 577 (66)          
2021 Warrant [Member]                  
Derivative Warrants Liabilities [Line Items]                  
Warrants to purchase shares (in Shares) | shares                 9,764
Exercise price per share (in Dollars per share) | $ / shares                 $ 5.12
Warrant value                 $ 50
Derivative financial liability   50 $ 22 $ 88          
Warrant [Member]                  
Derivative Warrants Liabilities [Line Items]                  
Exercise price per share (in Dollars per share) | $ / shares           $ 8.75   $ 5  
Revaluation income amount   $ 577              
Warrant share granted (in Shares) | shares 65,563                
Ordinary share, per share (in Dollars per share) | $ / shares $ 3.67                
Derivative warrants liability $ 599                
v3.25.0.1
Derivative Warrants Liabilities - Schedule of Reconciliation of the Fair Value of Derivative Warrants Liabilities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Reconciliation of the Fair Value of Derivative Warrants Liabilities [Abstract]      
Opening balance $ 72 $ 138 $ 50
Recognition of fair value of Warrant Share issued at Effective Date 88
Amount classified to equity upon determination of the exercise price of Warrant Share (see Note 10D2 below) (599)
Change in fair value of derivative warrant liability (see Note 12 below) 577 (66)
Closing balance $ 50 $ 72 $ 138
v3.25.0.1
Commitments (Details)
₽ in Thousands, $ in Thousands
6 Months Ended 11 Months Ended 12 Months Ended
Apr. 30, 2025
USD ($)
Apr. 30, 2025
ILS (₪)
May 31, 2025
USD ($)
May 31, 2025
RUB (₽)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Commitments [Line Items]              
Lease expenses         $ 170 $ 119 $ 119
Forecast [Member]              
Commitments [Line Items]              
Rental fee $ 17 ₪ 62          
Monthly fee     $ 2 ₽ 227      
v3.25.0.1
Commitments - Schedule of Future Minimum Commitment Under Binding Lease Agreeements (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Schedule of Future Minimum Commitment Under Binding Lease Agreeements [Abstract]  
2023 $ 80
Total $ 80
v3.25.0.1
Shareholders’ Equity (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
May 22, 2024
shares
Feb. 15, 2024
USD ($)
$ / shares
shares
Feb. 13, 2024
USD ($)
Feb. 27, 2023
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2024
₪ / shares
Shareholders’ Equity [Line Items]                
Aggregate gross proceeds (in Dollars) | $         $ 12,286 $ 6,695  
Shares issuable         7,211,280      
Reverse share split         5:1      
Convertible advance investment amounts (in Dollars) | $           $ 4,571    
Changes in the fair value (in Dollars) | $         $ 269      
Exercise price per share (in Dollars per share) | $ / shares             $ 1.83  
Dividends (in Dollars) | $         $ 7      
Direct and incremental costs (in Dollars) | $     $ 1,514          
Warrant [Member]                
Shareholders’ Equity [Line Items]                
Ordinary shares       97,500        
Exercise price per share (in Dollars per share) | $ / shares   $ 8.75   $ 5        
Additional ordinary shares       292,500        
Public offering shares   98,565            
Term   5 years            
Class of Warrant or Right, Date from which Warrants or Rights Exercisable   Aug. 10, 2024            
Minimum [Member]                
Shareholders’ Equity [Line Items]                
Authorized share capital         22,000,000      
Exercise price per share (in Dollars per share) | $ / shares         $ 1.47 $ 1.48    
Maximum [Member]                
Shareholders’ Equity [Line Items]                
Authorized share capital         222,000,000      
Exercise price per share (in Dollars per share) | $ / shares         $ 5.02 $ 4    
Convertible Preferred Shares [Member]                
Shareholders’ Equity [Line Items]                
Shares issuable         1      
Convertible Ordinary Shares [Member]                
Shareholders’ Equity [Line Items]                
Shares issuable         2      
Convertible advance investment amounts (in Dollars) | $         $ 3,657      
Convertible advance investment shares         1,142,856      
Conversion price per share (in Dollars per share) | $ / shares         $ 3.2      
Conversion percentage         80.00%      
Common Stock [Member]                
Shareholders’ Equity [Line Items]                
Ordinary shares 1,000,000              
Public offering price per share | ₪ / shares               ₪ 0.01
Ordinary shares, reverse share split         5      
IPO [Member]                
Shareholders’ Equity [Line Items]                
Ordinary shares       1,950,000 63,931      
Public offering price per share | $ / shares       $ 4        
Aggregate gross proceeds (in Dollars) | $   $ 12,000   $ 7,800        
Initial public offering (in Dollars) | $         $ 1,418      
Capitalized deferred offering costs amount (in Dollars) | $         $ 313      
Public offering shares   1,714,200            
Offering price per share (in Dollars per share) | $ / shares   $ 7            
IPO [Member] | Minimum [Member]                
Shareholders’ Equity [Line Items]                
Exercise price per share (in Dollars per share) | $ / shares         $ 5.12      
IPO [Member] | Maximum [Member]                
Shareholders’ Equity [Line Items]                
Exercise price per share (in Dollars per share) | $ / shares         $ 4      
Reverse Share Split [Member]                
Shareholders’ Equity [Line Items]                
Public offering price per share | ₪ / shares               ₪ 0.05
Ordinary shares, reverse share split         1      
Over-Allotment Option [Member]                
Shareholders’ Equity [Line Items]                
Aggregate gross proceeds (in Dollars) | $     $ 1,800          
Public offering shares   257,100            
IBI [Member]                
Shareholders’ Equity [Line Items]                
Ordinary shares         31,189      
v3.25.0.1
Shareholders’ Equity - Schedule of Composition of Shareholders' Equity (Details) - shares
Dec. 31, 2024
Dec. 31, 2023
Schedule of Composition of Shareholders' Equity [Abstract]    
Authorized shares 222,000,000 222,000,000
Issued and outstanding shares 15,518,794 13,051,343
v3.25.0.1
Shareholders’ Equity - Schedule of Composition of Shareholders' Equity (Parentheticals) (Details) - ₪ / shares
Dec. 31, 2024
Dec. 31, 2023
Schedule of Composition of Shareholders' Equity [Abstract]    
Ordinary Shares, par value ₪ 0.05 ₪ 0.05
v3.25.0.1
Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
May 22, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Options [Line Items]        
Grant of ordinary shares under option plan   3,069,280    
Number of ordinary shares available for future issuance   1,012,006    
Weighted average grant date fair value of options granted (in Dollars per share)   $ 2.78 $ 1.66 $ 0.51
Exercised share options   401,031 168,447  
Options exercised (in Dollars)   $ 795 $ 49
Unrecognized compensation expenses related to unvested options (in Dollars)   $ 1,633    
Weighted average period   1 year 6 months 14 days    
Ordinary Shares [Member]        
Options [Line Items]        
Additional ordinary shares 1,000,000      
v3.25.0.1
Options - Schedule of Company’s Share Option Activity for Employees and Members of the Board of Directors (Details) - Board of Directors [Member] - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Company’s Share Option Activity for Employees and Members of the Board of Directors [Line Items]        
Number of Share Options, Outstanding balance 1,367,168 1,345,036 1,295,367 1,570,991
Weighted Average Exercise Price, Outstanding balance $ 1.75 $ 2.95 $ 2.09 $ 1.78
Weighted average remaining contractual life, Outstanding balance 5 years 8 months 19 days 7 years 2 months 1 day 6 years 14 days 4 years 11 months 19 days
Intrinsic value, Outstanding balance $ 4,860 $ 2,677 $ 84 $ 2,435
Number of Share Options, Exercisable   641,851 863,616 1,048,297
Weighted Average Exercise Price, Exercisable   $ 2.15 $ 2.07 $ 1.7
Weighted average remaining contractual life, Exercisable   5 years 1 month 13 days 4 years 8 months 12 days 3 years 2 months 12 days
Intrinsic value, Exercisable   $ 1,786 $ 84 $ 1,677
Number of Share Options, Granted   462,200 151,600 286,875
Weighted Average Exercise Price, Granted   $ 4.51 $ 2.88 $ 1.83
Number of Share Options, Exercised   (401,031) (168,447)  
Weighted Average Exercise Price, Exercised   $ 1.98 $ 0.29  
Number of Share Options, Forfeited or expired   (11,500) (258,777) (83,052)
Weighted Average Exercise Price, Forfeited or expired   $ 2.65 $ 1.81 $ 1.45
v3.25.0.1
Options - Schedule of Outstanding and Exercisable Share Options Separated Ranges of Exercise Prices (Details)
12 Months Ended
Dec. 31, 2024
$ / shares
shares
Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 1,345,036
Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 641,851
0.00 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 17,680
Weighted average remaining contractual term 2 years 2 months 12 days
0.00 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 17,680
Weighted average remaining contractual term 2 years 2 months 12 days
1.14 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 1.14
1.14 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 82,580
Weighted average remaining contractual term 2 years 14 days
1.14 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 82,580
Weighted average remaining contractual term 2 years 14 days
1.47 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 1.47
1.47 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 7,200
Weighted average remaining contractual term 9 years 1 month 2 days
1.47 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable
Weighted average remaining contractual term
1.48 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 1.48
1.48 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 50,000
Weighted average remaining contractual term 8 years 8 months 12 days
1.48 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 15,625
Weighted average remaining contractual term 8 years 8 months 12 days
1.74 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 1.74
1.74 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 12,800
Weighted average remaining contractual term 8 years 3 months 18 days
1.74 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 4,800
Weighted average remaining contractual term 8 years 3 months 18 days
1.83 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 1.83
1.83 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 565,974
Weighted average remaining contractual term 6 years 6 months 10 days
1.83 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 401,950
Weighted average remaining contractual term 6 years 14 days
2.79 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 2.79
2.79 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 6,400
Weighted average remaining contractual term 8 years 7 months 2 days
2.79 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 2,000
Weighted average remaining contractual term 8 years 7 months 2 days
2.97 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 2.97
2.97 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 69,600
Weighted average remaining contractual term 9 years 10 months 13 days
2.97 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable
Weighted average remaining contractual term
3.20 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 3.2
3.20 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 5,002
Weighted average remaining contractual term 6 years 7 months 20 days
3.20 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 4,064
Weighted average remaining contractual term 6 years 7 months 20 days
3.59 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 3.59
3.59 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 28,800
Weighted average remaining contractual term 9 years 8 months 26 days
3.59 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable
Weighted average remaining contractual term
4.00 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 4
4.00 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 76,000
Weighted average remaining contractual term 8 years 2 months 1 day
4.00 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 44,352
Weighted average remaining contractual term 8 years 2 months 1 day
4.17 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 4.17
4.17 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 28,800
Weighted average remaining contractual term 1 year 10 days
4.17 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 28,800
Weighted average remaining contractual term 1 year 10 days
4.96 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 4.96
4.96 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 315,200
Weighted average remaining contractual term 9 years 6 months 21 days
4.96 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable
Weighted average remaining contractual term
5.02 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 5.02
5.02 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 39,000
Weighted average remaining contractual term 9 years 5 months 26 days
5.02 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable
Weighted average remaining contractual term
5.12 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price (in Dollars per share) | $ / shares $ 5.12
5.12 [Member] | Share options outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options outstanding 40,000
Weighted average remaining contractual term 1 year 14 days
5.12 [Member] | Share options exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options exercisable 40,000
Weighted average remaining contractual term 1 year 14 days
v3.25.0.1
Options - Schedule of Assumptions Used to Estimate the Fair Values of the Options Granted (Details) - $ / shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Assumptions Used to Estimate the Fair Values of the Options Granted [Line Items]      
Volatility (%)     61.49%
Dividend yield (%)
Expected life (years) 6 years 3 months 6 years 3 months 6 years 3 months
Exercise price ($) (in Dollars per share)     $ 1.83
Share price ($) (in Dollars per share)     $ 3.3
Minimum [Member]      
Schedule of Assumptions Used to Estimate the Fair Values of the Options Granted [Line Items]      
Volatility (%) 52.71% 60.48%  
Risk-free interest rate (%) 3.60% 3.70% 3.64%
Exercise price ($) (in Dollars per share) $ 1.47 $ 1.48  
Share price ($) (in Dollars per share) $ 1.72 $ 1.48  
Maximum [Member]      
Schedule of Assumptions Used to Estimate the Fair Values of the Options Granted [Line Items]      
Volatility (%) 73.53% 61.49%  
Risk-free interest rate (%) 4.40% 4.30% 3.85%
Exercise price ($) (in Dollars per share) $ 5.02 $ 4  
Share price ($) (in Dollars per share) $ 5.24 $ 3.73  
v3.25.0.1
Options - Schedule of Company’s Equity-Based Awards Recognized (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Company’s Equity-Based Awards Recognized [Line Items]      
Share-based compensation $ 418 $ 363 $ 222
Research and development [Member]      
Schedule of Company’s Equity-Based Awards Recognized [Line Items]      
Share-based compensation 185 216 144
Sales and marketing [Member]      
Schedule of Company’s Equity-Based Awards Recognized [Line Items]      
Share-based compensation 20 41 49
General and administrative [Member]      
Schedule of Company’s Equity-Based Awards Recognized [Line Items]      
Share-based compensation $ 213 $ 106 $ 29
v3.25.0.1
Financing Expenses (Income), Net - Schedule of Financing Expenses (Income), Net (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Financing Expenses (Income), Net [Abstract]      
Change in fair value of convertible advance investment $ (269) $ 70
Change in fair value of derivative warrant liability 577 (66)
Amortization of discount and accrued interest relating to straight loan received from commercial banks 106 157 102
Change in estimation of maturity date of liability to controlling shareholder 12
Discount amortization relating to liability to controlling shareholder 10 48 40
Interest due to bank deposits (599) (97)
Exchange rate differences and other finance expenses (2) (7) (47)
Total Financing income (expenses), net $ 92 $ (222) $ 165
v3.25.0.1
Related Parties Transactions (Details)
₪ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2024
ILS (₪)
May 22, 2024
ILS (₪)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
ILS (₪)
Jan. 01, 2020
USD ($)
Related Parties Transactions [Abstract]              
Total current monthly gross amount | ₪   ₪ 45          
Current liability | $ $ 677     $ 458     $ 357
Interest rate 15.45% 15.45%          
Additional paid-in capital | $ $ 112            
Total nominal amount current liability         $ 462 ₪ 1,710  
Liability in nominal amount paid | ₪     ₪ 20        
v3.25.0.1
Related Parties Transactions - Schedule of the Reconciliation of the Carrying Amount of the Company (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of the Reconciliation of the Carrying Amount of the Company [Abstract]      
Opening balance $ 199 $ 388 $ 345
Accrued liability in respect to additional services rendered   25 115
Recognition of capital contribution from a controlling shareholder   (112)
Repayment of liability to controlling shareholder (206) (258)
Amortization of discount relating to liability to related party 10 48 40
Change in estimation of maturity date of liability 12
Exchange rate differences (3) (16)
Closing balance $ 199 $ 388
v3.25.0.1
Related Parties Transactions - Schedule of Expenses Related to Service Agreement and the Office Services Agreement (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Expenses Related to Service Agreement and the Office Services Agreement [Line Items]      
Costs and expenses $ 212 $ 146 $ 167
Research and development [Member]      
Schedule of Expenses Related to Service Agreement and the Office Services Agreement [Line Items]      
Costs and expenses 53 36 42
Sales and marketing [Member]      
Schedule of Expenses Related to Service Agreement and the Office Services Agreement [Line Items]      
Costs and expenses 53 36 42
General and administrative [Member]      
Schedule of Expenses Related to Service Agreement and the Office Services Agreement [Line Items]      
Costs and expenses $ 106 $ 74 $ 83
v3.25.0.1
Taxes on Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Taxes on Income [Line Items]        
Federal tax rate   0.00%    
Operating Loss Carryforwards (in Dollars)   $ 30,914    
Deferred Tax Assets, Capital Loss Carryforwards (in Dollars)   $ 397    
E ffective tax rate   1.40% 5.90% 4.40%
Beamr Inc [Member]        
Taxes on Income [Line Items]        
Federal tax rate   21.00%    
Israel Tax Authority [Member]        
Taxes on Income [Line Items]        
Federal tax rate   23.00%    
Forecast [Member]        
Taxes on Income [Line Items]        
Federal tax rate 5.00%      
v3.25.0.1
Taxes on Income - Schedule of loss (Income) Before Taxes on Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of loss (Income) Before Taxes on Income [Abstract]      
Domestic $ 3,345 $ 714 $ 1,293
Foreign operations (Beamr Inc. and Beamr Imaging RU) (38) (58) (97)
Loss (income) before taxes on income $ 3,307 $ 656 $ 1,196
v3.25.0.1
Taxes on Income - Schedule of Deferred Income Taxes Reflect the Net Tax Effects of Net Operating Loss (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Composition of deferred tax assets:    
Net operating loss and capital losses carryforward $ 7,202 $ 6,704
Research and development credits 537 397
Vacation accrual 44 44
Net deferred tax asset before valuation allowance 7,783 7,145
Valuation allowance (7,783) (7,145)
Net deferred tax assets
v3.25.0.1
Segment Geographical Information And Major Customers (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
Segment
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Concentration Risk [Line Items]      
Number of operating segments (in Segment) | Segment 1    
Revenue from Contract with Customer, Including Assessed Tax (in Dollars) $ 3,064 $ 2,909 $ 2,863
Sales-based Software License [Member]      
Concentration Risk [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax (in Dollars) $ 46 $ 53 $ 48
Customer Concentration Risk [Member] | One Customer [Member] | Revenue Benchmark [Member]      
Concentration Risk [Line Items]      
Risk percentage 27.00% 26.00% 26.00%
Customer Concentration Risk [Member] | Customer Three [Member] | Accounts Receivable [Member]      
Concentration Risk [Line Items]      
Risk percentage 62.00%    
Customer Concentration Risk [Member] | Customer Four [Member] | Accounts Receivable [Member]      
Concentration Risk [Line Items]      
Risk percentage   81.00%  
v3.25.0.1
Segment Geographical Information And Major Customers - Schedule of Revenues by Geographic Region (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Concentration Risk [Line Items]      
Revenue by geographic region $ 3,064 $ 2,909 $ 2,863
United States [Member]      
Concentration Risk [Line Items]      
Revenue by geographic region 2,132 2,089 2,134
Israel [Member]      
Concentration Risk [Line Items]      
Revenue by geographic region 41 66 22
Rest of the world [Member]      
Concentration Risk [Line Items]      
Revenue by geographic region $ 891 $ 754 $ 707
v3.25.0.1
Segment Geographical Information And Major Customers - Schedule of Long-Lived Assets Net by Geographic Areas (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets, net, by geographic areas $ 43 $ 19
Israel [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets, net, by geographic areas 40 14
Other [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets, net, by geographic areas $ 3 $ 5
v3.25.0.1
Segment Geographical Information And Major Customers - Schedule of Revenue Disaggregated by Primary Major Product Lines and Services (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Software license:      
Revenue $ 3,064 $ 2,909 $ 2,863
Perpetual based software license [Member]      
Software license:      
Revenue 802 886 1,068
Term-based software license [Member]      
Software license:      
Revenue 1,995 1,844 1,630
Total software license [Member]      
Software license:      
Revenue [1] 2,797 2,730 2,698
PCS services transferred over a period of time [Member]      
Software license:      
Revenue 128 120 123
Web advertising at a point of time upon clicks [Member]      
Software license:      
Revenue $ 139 $ 59 $ 42
[1] Revenue recognized from sales-based software license was $46, $53 and $48 during the years ended December 31, 2024, 2023 and 2022, respectively (see also Note 2M).

Beamr Imaging (NASDAQ:BMR)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025 Beamr Imaging 차트를 더 보려면 여기를 클릭.
Beamr Imaging (NASDAQ:BMR)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025 Beamr Imaging 차트를 더 보려면 여기를 클릭.